ESC Heart Failure Congress 2013 Final Programme - European ...

THE ANNUAL MEETING OF THE HEART FAILURE ASSOCIATION OF THE ESC 

The Heart Failure Specialist of Tomorrow 

From Diagnosis to Intervention 

F I N A L P R O G R A M M E

congress Floor plan 

Speaker 

Service Centre 

GUIMARAES 

GUARDA 

HANDS-ON 

TUTORIALS 

LISBOA 

LEVEL 1 

HFA 

LOUNGE 

To Restaurant 

COIMBRA 

To Exhibition, 

Posters and 

Registration 

FARO 

EVORA 

To Exhibition, 

Posters and 

Registration 

MAIN 

ENTRANCE 

REGISTRATION 

LEVEL 0 

EXHIBITION 

To Lecture Rooms, 

Speaker Service Centre 

and HFA Lounge 

POSTERS

18:00 - 19:15 - Special Session Room Lisboa 

Research 

Opening ceRemOny 

Chairpersons: 

S.D. Anker (Berlin, DE); 

B.M. Pieske (Graz, AT); 

P.E. Vardas (Heraklion, GR) 

Welcome to Heart Failure 2013 by the Scientific chairperson. 

B.M. Pieske (Graz , AT) 

Welcome to Heart Failure 2013 by the Local Hosts. 

D.A. Brito (Lisbon, PT); J. Silva-Cardoso (Porto, PT) 

Welcome to Heart Failure 2013 by the president of the HFA. 

S.D. Anker (Berlin, DE) 

Welcome to Heart Failure 2013 by the president of the eSc. 


Heart Failure Association Lifetime Achievement Awards 2013. 

Introduction: S.D Anker (Berlin, DE), B.M. Pieske (Graz, AT) 

Basic and Translational Research Award 

Keynote Lecture 

clinical Research Award 


Award ceremony. 

P.E. Vardas (Heraklion, GR), S.D Anker (Berlin, DE), B.M. Pieske (Graz, AT), 

D.A. Brito (Lisbon, PT), J. Silva-Cardoso (Porto, PT) 

closing remarks. 

S.D. Anker (Berlin, DE), B.M. Pieske (Graz, AT) 

Joins us for a cocktail reception in the exhibition area 

New Therapies 

Interventions 

Knowledge

Why do Heart Failure professionals 

join the HFA? 

www.escardio.org/HFA 

The Heart Failure Association 

(HFA) of the ESC provides you 

with a Full rAngE oF 

productS And SErvicES 

• Online education with 

CME Credits 

• Access to European Journal 

of Heart Failure online 

• Fellowship of the HFA 

and much more... 

SEE tHE 

diFFErEncE, 

Join uS todAy!

TABLe OF cOnTenTS 

Welcome Address ..................................................................................................................................................................................................4 

Organising Committee ....................................................................................................................................................................................5 

The Heart Failure Association of the ESC ....................................................................................................................................6 

HFA Membership Programme ................................................................................................................................................................7 

Congress Resources ............................................................................................................................................................................................8 

Scientific Programme .........................................................................................................................................................................................9 

Programme at a glance ................................................................................................................................................................................12 

Congress Timetable ...........................................................................................................................................................................................16 

Saturday .........................................................................................................................................................................................................................17 

Opening Ceremony ................................................................................................................................................................................24 

Sunday 

Morning ................................................................................................................................................................................................................25 

Afternoon ............................................................................................................................................................................................................34 

Monday 

Morning ................................................................................................................................................................................................................47 

Afternoon ............................................................................................................................................................................................................58 

Tuesday 

Morning ................................................................................................................................................................................................................67 

Featured Posters ...................................................................................................................................................................................................75 

Moderated Poster Session 1 ....................................................................................................................................................................83 

Moderated Poster Session 2 ...................................................................................................................................................................119 

Moderated Poster Session 3 ..................................................................................................................................................................155 

HFA Winter Meeting Posters ..................................................................................................................................................................191 

List of sessions ........................................................................................................................................................................................................199 

Chairpersons & Judges ...............................................................................................................................................................................202 

Speakers .......................................................................................................................................................................................................................204 

Authors..........................................................................................................................................................................................................................207 

3

WeLcOme ADDReSS 

Dear Friends and colleagues, dear members of the HFA Heart Failure community! 

The Heart Failure Association of the European Society of Cardiology is pleased to welcome you to the Heart 

Failure Congress 2013 in Lisbon. 

The Heart Failure Congress is a unique forum where cardiologists, interventional heart failure specialists, 

cardiac surgeons, internists, general physicians interested in cardiology, basic scientists, epidemiologists, 

cardiac nurses, industry affiliates and others have the opportunity to meet and exchange ideas and 

information. 

Heart Failure 2013 is an international event open to anyone interested in any aspect of heart failure from 

epidemiology, through basic and translational research to prevention, diagnosis, and management. Major 

clinical aspects are reinforced in the HFA Focus - case based sessions. 

With the help of our hosting and supporting national societies, the Portuguese Society of Cardiology, the 

Brazilian Society of Cardiology, and the Spanish Society of Cardiology, we were able to set up a programme 

that addresses clinical needs and interests from outpatient management to interventional and surgical heart 

failure therapies. In fact, clinical case sessions, hands-on sessions, as well as special sessions on interventions, 

devices and procedures in heart failure reflect the broad opportunities we can offer nowadays to our 

patients. 

The programme also includes updates on the latest clinical trials, reviews of the best published papers and 

a summary of the most important heart failure presentations at the recent major international cardiology 

conferences. Specific series of sessions will comprehensively discuss current hot topics, such as diastolic 

heart failure, the role of the heart failure specialist of tomorrow, and the value of novel imaging 

modalities and biomarkers for diagnosis, phenotyping, and therapy monitoring. A central role 

within the programme is dedicated to interventional cardiology, electrophysiology and cardiac surgery 

in the field of heart failure. Additionally, several European Associations and National Cardiological and 

Heart Failure Societies from all over the world will offer their contribution to different perspectives of heart 

failure management, making this Congress truly the international Heart Failure Congress. The programme 

is substantiated by a higher-than-ever number of top-quality satellite symposia, underlining the growing 

importance of Heart Failure management strategies worldwide. 

A record number of more than 1 500 abstracts has been submitted. Top ranking abstracts were selected 

for oral presentation in addition to being displayed in poster form. A new feature of this Congress is that all 

poster will be moderated; in addition, selected posters will be presented in Featured Poster Sessions. Top 

ranking posters from the HFA Basic Science Winter Research Meeting 2013, and posters on ongoing clinical 

trials in the Clinical Trials Forum will be permanently displayed in designated areas. All these sessions form 

perfect platforms to meet and discuss with peers and colleagues. 

Lively, international Lisbon is the ideal venue for a Congress with our profile and scope. The city’s wealth 

of historical, cultural and social attractions is undoubtedly the perfect addition to complete your Congress 

experience! 

Thank you for being with us in Lisbon. Enjoy your time, learn something new, meet colleagues and friends. 

Lisbon 2013 will be a Congress to remember! 

S.D. Anker FeSc (Berlin, DE) 

president HFA of the eSc (2012 - 2014) 

B. pieske FeSc (Graz, AT) 

Scientific chairperson 

4 

J. Silva-cardoso, FeSc (Porto, PT) 

Local Host & president-elect 

portuguese Society of cardiology 

D.A. Brito FeSc (Lisbon, PT) 

Local Host

Heart Failure 2013 Scientific Programme Committee 

B. Pieske FESC (Graz, AT) 

Scientific chairperson 

S.D. Anker FESC (Berlin, DE) 

president, HFA of the eSc (2012 - 2014) 

Local committee 

H. Madeira (Lisbon, PT) 

F. Ceia (Lisbon, PT) 

M. Candida Fonseca (Lisbon, PT) 

Board of the Heart Failure Association (HFA) of the ESC (2012 - 2014) 

Stefan Anker FESC (DE) president 

Gerasimos Filippatos FESC (GR) president elect 

Piotr Ponikowski FESC (PL) immediate past-president 

Burkert Pieske FESC (AT) chairperson of the clinical Section 

Zoltan Papp FESC (HU) chairperson of the Basic Science Section 

Petar Seferovic FESC (RS) coordinator for national HF Societies & Working groups 

Aldo Maggioni FESC (IT) Secretary 

Frank Ruschitzka FESC (CH) Treasurer 

Clinical section 

Marisa Crespo-Leiro FESC (ES) 

Arno Hoes FESC (NL) 

Ekaterini Lambrinou (CY) 

Adelino Leite-Moreira (PT) 

Basic Sciences Section 

Stephane Heymans (NL) 

Ludwig Neyses (UK) 

Christoph Maack (DE) 

Alexandre Mebazaa FESC (FR) 

Ex-officio 

Dirk van Veldhuisen FESC (NL) 

ORgAniSing cOmmiTTee 

D.A. Brito FESC (Lisbon, PT) Fernando Bacal FESC 

Local Host Brazilian Society of cardiology 

J. Silva-Cardoso FESC (Porto, PT) José R. Gonzalez-Juanatey FESC 

Local Host & president-elect president-elect 

portuguese Society of cardiology Spanish Society of cardiology 

S. Martins (Lisbon, PT) 

B.E. Moura (Porto, PT) 

Viatcheslav Mareev (RU) 

Theresa McDonagh FESC (UK) 

Massimo Piepoli FESC (IT) 

Jillian Riley NFESC (UK) 

Sui Generi 

Kenneth Dickstein FESC (NO) 

John McMurray FESC (UK) 

Andrew Coats FESC (UK) 

5

EURJHF_13_1_Cover.qxd 12/7/10 9:22 PM Page 1 

HeART FAiLuRe ASSOciATiOn 

OF THe eSc (HFA) 

EducAtion 

KnoWlEdgE 

AdvocAcy 

nEtWorKing 

mission: ‘To improve quality of life and longevity, through better prevention, diagnosis and 

treatment of heart failure, including the establishment of networks for its management, 

education and research’ 

• 7 100 members 

• 9 committees or Study groups working 

on education, organising workshops or 

writing scientific papers 

• Network of 45 national Heart Failure 

Societies/Working groups: 

HFA Summit organised annually 

13 1 

January 2011 European Journal of Heart Failure 

Pages 1–114 

2 

Volume 13 Number 1 January 2011 

ISSN 1388-9842 (Print) ISSN 1879-0844 (Online) 

Position Statement on cardiovascular 

side effects of cancer therapy 

Epidemiology of HFPEF 

Study design papers: 

ATMOSPHERE and ASTRONAUT 

Urinary 8-OHdG: a biomarker in chronic HF 

Cardiorenal anaemia syndrome 

Human neuregulin-1 therapy 

Editor-in-Chief: 

Dirk J. van Veldhuisen 

Deputy Editors: 

Adriaan A. Voors 

Wiek H. van Gilst 

MEMBER OF THE ESC JOURNAL FAMILY 

European Journal of 

HeartFailure 

1 www.eurjhf.oxfordjournals.org 

Journal of the Heart Failure Association of the ESC 

• european Journal 

of Heart Failure: 

Impact Factor 4.896 (2011) 

• Online Heart Failure education: 

CME-EBAC accredited State of the Art 

modules based on HF Curriculum and 

latest Guidelines 

Demo available on ESC-HFA stand B50 

2 013 

CONGRESS ORGANISED BY THE HEART FAILURE ASSOCIATION OF THE ESC 

The Heart Failure Specialist of Tomorrow 

From Diagnosis to Intervention 

25-28 MAY LISBON 

PORTUGAL 


d5404_Visuel_HF2013_Update2.indd 1 13/12/12 12:20:38 

• Heart Failure congress: 

4 000 participants/year 

1 500 abstracts submitted 

• Advanced Heart Failure curriculum: 

Find out what you need to know – 

written and assessed by the Heart Failure 

Association 

6 

• eSc clinical practice guidelines: 

Participation in developing ESC Guidelines 

for the diagnosis and treatment of acute and 

chronic heart failure 2012 and more. 

• Registry: 

Collaboration with ESC 

Eurobservational research programme 

on Heart Failure registry and 

Peripartum Cardiomyopathy registry 

• Fellowships: 

e 168 000 distributed per year: Training 

Research Fellowship and Nurse Fellowship 

Get more information on ESC-HFA stand B50 

d5455_Pub_HFM_FP_HF2012_v3.indd 1 14/03/13 16:11 

• patient Website: 

www.heartfailurematters.org 

70 000 visitors/month 

• Heart Failure Awareness Day: 

In May every year 

Volunteers participate in 35 countries 

• Advocacy: 

HFA is your voice in the political arena – a 

white paper on heart failure is in preparation 

And much more: www.escardio.org/HFA

HFA memBeRSHip pROgRAmme 

providing services and products for you 

The Heart Failure Association has membership packages that will help you meet your goals: 

• Educational programmes that will help advance your career 

• Access to latest developments in the field of heart failure 

• And challenging ways to get involved in your association. 

Special Membership offer to congress attendees 

visit the ESc-HFA stand b50 to know more 

basic 

Members 

Why you should join? 

The Heart Failure Association provides the means to help you meet your goals: 

online 

Members 

Full 

Members 

Reception of the quarterly HFA newsletter ✔ ✔ ✔ 

Automatic ESC membership ✔ ✔ ✔ 

Access to online EJHF ✔ ✔ 

Access to HFA CME online education programme ✔ ✔ 

Access slides from HFA congresses/events ✔ ✔ 

Discounts on the print version of EJHF ✔ ✔ 

Opportunity to review abstracts for HFA congress ✔ ✔ 

Opportunity to contribute to HFA newsletters ✔ ✔ 

Opportunity to contribute to HFA educational materials ✔ ✔ 

Eligible for HFA Committees and Study Groups membership ✔ ✔ 

Voting rights at HFA general assembly ✔ ✔ 

Access HFA Members Lounge at HF Congress ✔ 

Discount on registration for HFA ETP courses ✔ 

Opportunity to review HFA fellowships and other HFA grants ✔ 

Opportunity to propose HFA ETP courses (respecting HFA rules) ✔ 

Opportunity to apply to become “Fellow of the HFA” (FHFA) ✔ 

Opportunity to become HFA Board member ✔ 

• continuing education: Gain CME credits while learning with our online education programme 

based on the latest heart failure guidelines and the heart failure curriculum 

• eSc knowledge resources: resources centre for visualising presentations and abstracts from 

the Heart Failure Congresses and other events. Plus have online access for the European Journal 

of Heart Failure 

• Leadership opportunities: Grow personally and professionally when you serve on one of HFA 

Committees or Study Groups 

7

cOngReSS ReSOuRceS 

Abstract CD-ROM 

All accepted abstracts have been 

published on the Abstract CD-Rom. This 

can be obtained at the Vifor Pharma Ltd. stand 

A80 in the Exhibition. Hand in the voucher in your 

Congress bag to collect your copy. 

The Abstract CD- 

Rom is supported by 

Vifor Pharma Ltd. in 

the form of an unrestricted educational grant. 

CME Accreditation 

The Heart Failure 2013 Congress is 

accredited by the European Board for 

Accreditation in Cardiology (EBAC) for 

18 hours of External CME credits. 

Each participant should claim only those hours 

of credit that have actually been spent in the 

educational activity. EBAC works in cooperation 

with the European Accreditation Council for 

Continuing Medical Education (EACCME) which is 

an institution of the European Union of Medical 

Specialists (UEMS). EBAC credits are recognised 

by the American Medical Association towards the 

Physician’s Recognition Award (PRA). Detailed 

instructions for converting these credits to AMA 

PRA Category 1 Credits are available on the AMA 

website. 

eBAc certificates will be available at the 

Registration desks from monday 27 may at 12:00. 

nEW! 

Congress News 

Pick up your free daily newspaper of the 

Heart Failure Congress 2013, share the 

exclusive scientific highlights of the day and read 

full scientific articles and useful information. 

Mobile App 

Heart Failure 2013 Congress 

at your fingertips! 

• View the entire scientific 

programme 

• Search for sessions, 

presentations, abstracts 

• Find exhibitors and 

sponsors 

• Navigate the floor plans 

• Create your personal itinerary 

• Make your own “to do” list and take notes 

• Share with colleagues 

• Receive the latest news 

Search for 

“HF2013” in App Store/Google play 

The Mobile app is 

supported by RESMED, 

in the form of an unrestricted educational grant 

e-Library 

All slide presentations, abstracts and posters are available for electronic consultation 

on-site in the e-library located next to the Poster Area. 

Industry Programme 

Consult this new document to find: 

• List of Industry Partners, exhibition floorplan, Hands-on sessions and Satellite Symposia 

Programmes 

• Venue floorplan and general information 

• A Notepad! 

programme changes / Date of print 

The organisers cannot be held liable for any changes in the programme due to external or unforeseen 

circumstances. Date of print is April 2013. 

8

ScienTiFic pROgRAmme 

Heart Failure congress 2013 is a unique and unlimited opportunity to network! 

The Heart Failure Congress brings together all the disciplines and professionals involved in cardiology, 

including doctors, basic scientists, epidemiologists, nurses, interventionalists, technicians and key 

opinion leaders. 

Main theme 

This year’s spotlight is “The heart failure specialist of tomorrow – from diagnosis to intervention” 

Heart failure diagnosis and therapy is at the core of a number of (sub)disciplines including imaging, 

invasive cardiology, electrophysiology, and cardiac surgery. In addition, heart failure specialists have 

to deal with co-morbidities such as renal and pulmonary disease, diabetes, anaemia and depression, 

to name a few. 

What are the requirements for the Heart Failure specialist of tomorrow? Which skills do we need to 

acquire? 

Explore and discuss the essentials of imaging modalities, electrophysiology, valvular and coronary 

interventions, device therapies that may form the basis for a future interventional heart failure 

specialist. 

We will review and discuss current Guidelines from different disciplines that address heart failure and 

will provide a comprehensive update on new heart failure entities, emerging diagnostic techniques, 

and therapeutic options. 

Awards: Come and support the presenters! 

young investigator Award (yiA) Sessions 

Basic Science and Clinical 

A competition designed for abstract submitters / presenters 35 years old or under. Finalists will 

present their research in oral YIA sessions moderated by two chairpersons and a panel of experts to 

judge the presentations and determine a First Prize Winner (€ 1000) and two Runners-Up (€ 250). 

Basic Science: Sunday 26 may, 16:30 - 18:00 in Room guimaraes 

clinical: Sunday 26 may, 08:30 - 10:00 in Room guarda 

nursing investigator Award (niA) Session 

Selected finalists will present their findings in an oral session moderated by two chairpersons and a 

panel of expert judges who will determine a First Prize Winner (€ 1000) and two Runners-Up (€ 250). 

Sunday 26 may, 16:30 - 18:00 in Room guarda 

9


The abstract-based programme: 

Rapid fire sessions 

Flash presentations on research highlights, followed by discussions animated by two experts 

chairing the session! 

These abstracts will be available for further consultation and discussion in the form of a Poster 

displayed immediately after the session outside the lecture room. 

monday 27 may 2013, 08:30 - 10:00 in Room guarda and 16:30 - 18:00 in Room guimaraes 

Tuesday 28 may 2013, 08:30 - 10:00 in Room guimaraes 

Featured poster sessions 

Special interest posters will be displayed in the form of a poster in the dedicated Poster Area. 

Presenters will briefly discuss key points of their research with two moderators in front of an 

appreciative audience during official coffee breaks. 

moderated poster sessions - NEW 

These sessions cover the majority of posters presented at the congress, combining a visual display 

of research highlights with maximum time for peer to peer interaction. Each poster will be 

displayed for two half-days (an afternoon then a morning) in one of three categories. 

This year all posters will be moderated by 2 experts in the respective field, ensuring high quality 

interaction feedback. 

• clinical Research 

• Basic Science 

• clinical cases 

You will have the opportunity to interact with the poster presenters during the coffee breaks of 

these two half days. 

Visiting experts will also visit the poster presenters at least once, so come and listen! 

Moderated Poster sessions are a very popular platform where our community truly comes together 

to network and exchange knowledge. 

moderated poster Session 1: From Saturday 25 May 14:00 until Sunday 26 May 12:30. 

moderated poster Session 2: From Sunday 26 May 14:00 until Monday 27 May 12:30. 

moderated poster Session 3: From Monday 27 May 14:00 until Tuesday 28 May 12:30. 

NEW in the Poster Area 

• Heart Failure Winter Meeting Abstracts 

• Clinical Forum: Late Breaking trials, Clinical trials, Late Breaking Research for Clinical & Basic 

Science… 

will be on display for the entire duration of the Congress! 

Come and meet with the presenters! 

10

don’t miss! 


Late Breaking Trial Sessions 

Presenters will share the very latest results of their research in front of an eager audience. The 

presentations will be concluded by a review from an expert. These are amongst the most popular 

sessions at the Congress. An opportunity not to be missed! 

Sunday 26 may 2013, 11:00 - 12:30 in Room Lisboa 

monday 27 may 2013, 11:00 - 12:30 in Room Lisboa 

Highlight sessions: 

The 2013 Scientific Programme in a nutshell! 

• clinical Highlights of the Heart Failure 2013 congress: 

Tuesday 28 may 2013, 11:00 - 12:30 in Room evora 

• Basic & Translational Science Highlights of the Heart Failure 2013 congress: 

Tuesday 28 may 2013, 11:00 - 12:30 in Room guimaraes 

What’s new in industry? 

Industry representatives will present highlights of their current programme in heart failure research 

as well as any products in the pipeline. Each presentation will be followed by a panel discussion. 

We encourage questions from the audience. 

monday 27 may 2013, 11:00 - 12:30 in Room guarda 

FOCUS 

HFA Focus – case based interactive sessions 

Discussions around practical cases by experts who will call upon the audience to react to the 

management of the case. Sessions will be concluded by recommendations based on the new 

2012 ESC Guidelines on the diagnosis and treatment of heart failure in Room coimbra 

The Heart Failure 2013 Scientific programme Committee wishes to express its warmest thanks for 

their contribution to the programme to: 

• American Society of Clinical Oncology (ASCO) • ASEAN Federation of Cardiology • Asian HF 

Network • Brazilian Society of Cardiology • China • ESC Working Group on Myocardial Function 

• Heart Failure Society of America (HFSA) • Japan • Portuguese Society of Cardiology • Spanish 

Society of Cardiology • 

11

pROgRAmme AT A gLAnce 

mODeRATeD pOSTeR SeSSiOnS 

New this year ! Sessions will be two half days long. 

pages 

moderated poster Session 1: From Saturday 25 May 14:00-18:00 and Sunday 26 May 08:00-12:30. 83 to 117 

moderated poster Session 2: From Sunday 26 May 14:00-18:00 and Monday 27 May 08:00-12:30. 119 to 154 

moderated poster Session 3: From Monday 27 May 14:00-18:00 and Tuesday 28 May 08:00-12:30. 155 to 189 

SATuRDAy 25 mAy 2013 - AFTeRnOOn 

Heart Failure Winter Meeting 2013 Posters - Saturday 25 May 14:00 - Tuesday 28 May 12:30 - Poster Area 

new this year! Heart Failure Winter meeting 2013 abstracts will be on display for the entire duration of the congress. 

12:30 - 14:00 

• 2012 & 2013 Best of the european Journal of .......................Evora 

Heart Failure 

• gender, pregnancy and heart failure .................................... Coimbra 

• How to improve heart failure care and .........................................Faro 

investigation in portugal 

14:15 - 15:45 

• Ventricular arrhythmias and sudden death ............................Evora 

in heart failure: modern therapy 

• From pharmacological management to ................................Guarda 

destination therapy 

• imaging in heart failure 1: update 2013 .......................................Faro 

• novel diagnostic approaches for HFpeF .............................. Coimbra 

15:45 - 16:30 

• Featured poster Session 1 ..........................................................Poster Area 

16:15 - 17:45 - Satellite Symposia 

• Bridging the gap between expectations ........................... Coimbra 

and reality in eHealth heart failure care: 

new scientific approaches and first-hand 

experiences with real-life implementation 

Sponsored by ALERE 

• emerging therapies in acute heart failure: .................................Faro 

improving patient outcomes 

Sponsored by the heart.org / Medscape Education 

• ccm (cardiac contractility modulation): ...............................Guarda 

when medication is not enough 

Sponsored by Impulse Dynamics 

18:00 - 19:15 

• Opening ceremony ................................................................................... Lisboa 

SunDAy 26 mAy 2013 - mORning 



08:30 - 10:00 

• more on new devices for heart failure ....................................... Lisboa 

• Biomarkers: state-of-art and the future ........................................Evora 

• Diagnosis of heart failure and co-morbidities .................. Coimbra 

• From circulatory support to transplantation ...............................Faro 

• young investigator Award: clinical .............................................Guarda 

• epigenetics of heart failure........................................................Guimaraes 

10:00 - 11:00 


12 

11:00 - 12:30 

• Late breaking trials 1 ................................................................................ Lisboa 

• Atrial fibrillation in heart failure: news in 2013 ......................Evora 

• How to manage arrhythmias in heart failure ................... Coimbra 

• pulmonary hypertension in heart failure .......................................Faro 

• novel biomarkers in heart failure: targets for ....................Guarda 

therapy? 

• The matrix modulates cardiac cell fate in ......................Guimaraes 

heart failure


SunDAy 26 mAy 2013 - AFTeRnOOn 




• can early referral of severe mitral regurgitation .....................Faro 

save lives? From diagnosis to intervention 

Sponsored by Abbott Vascular 


• cardiac resynchronization therapy response: ...................... Lisboa 

from patient selection to therapy optimization 

Sponsored by Medtronic 

• evidence-based medicine in an area of ................................ Coimbra 

tension between clinical trial and real-world 

evidence: a survey of recent data on mRAs 

Sponsored by Pfizer 

• prognostic value of sympathetic innervation ......................Guarda 

imaging in patient with heart failure (HF) 

Sponsored by GE healthcare 

• Keeping the beat going ...............................................................Guimaraes 

Sponsored by Thoratec Corporation 

14:15 - 15:45 

• Valvular interventions in the heart failure patient .............. Lisboa 

• new therapies in acute heart failure ............................................Evora 

• The heart failure patient with coronary............................... Coimbra 

Artery Disease 

• cardiac rehabilitation and exercise training ................................Faro 

in heart failure. 

• Telemonitoring in heart failure: what is needed ..............Guarda 

to make this ready for routine use? 

• novel concepts for myocardial regeneration ..............Guimaraes 

15:45 - 16:30 


16:30 - 18:00 

• What is controversial in the 2012 eSc ........................................ Lisboa 

Heart Failure guidelines? 

• Anticoagulation and antithrombotic therapy .........................Evora 

in heart failure 

• pharmacological treatment and referral to ........................ Coimbra 

cardiology 

• How to treat HFpeF in 2013: practical .............................................Faro 

considerations 

• nursing investigator Award ..............................................................Guarda 

• young investigator Award: Basic Science .......................Guimaraes 


• Biomarkers-guided therapy in Heart Failure: .............................Faro 

Role of galectin-3 

Organised by Charité University Berlin and 

Sponsored by an educational grant from BG Medicine 

& BioMérieux 


• SHiFTing evidence in heart failure management ............... Lisboa 

Sponsored by Servier 

• understanding the complex pathways in .......................... Coimbra 

the progression of heart failure: changing the mindset 

of how we manage acute and chronic heart failure 

Sponsored by Novartis Pharma 

mOnDAy 27 mAy 2013 - mORning 



08:30 - 10:00 

• Device therapy in heart failure: news and .............................. Lisboa 

innovations 

• The heart and cancer ................................................................................Evora 

• Renal denervation: from heart failure.................................... Coimbra 

prevention to heart failure therapy? 

• management of co-morbidities in heart failure ........................Faro 

• Rapid Fire Session 1.................................................................................Guarda 

• gene therapy for heart failure: ready for .......................Guimaraes 

the clinic? 

10:00 - 11:00 


11:00 - 12:30 

• Late breaking trials 2 ................................................................................ Lisboa 

• imaging in heart failure 2: update 2013 .....................................Evora 

• cardiac inotropes and beyond: update 2013 .................. Coimbra 

• management of acute heart failure: 2013 update .................Faro 

and perspectives 

• What’s new in industry? ......................................................................Guarda 

• Oxidative stress in heart failure: mechanisms .............Guimaraes 

and treatment 

13


mOnDAy 27 mAy 2013 - AFTeRnOOn 




• Reducing hospital readmissions for ..................................................Faro 

heart failure - can galectin-3 help? 

Organised by Charité University Berlin and 

Sponsored by an educational grant from BG Medicine 

& BioMérieux 


• prevention of heart failure hospitalizations .............................Evora 

with management of pulmonary artery pressures: 

insights from the cHAmpiOn Trial 

Sponsored by CardioMEMS 

14:15 - 15:45 

• HFpeF: update 2013 ................................................................................ Lisboa 

• new chronic heart failure medications at .................................Evora 

the horizon 

• How to manage valvular disease in heart failure ......... Coimbra 

14:15 - 15:45 

• update on myocarditis and pericarditis .........................................Faro 

• Failing hearts and failing brains ...................................................Guarda 

• Amplifier and economizer in cardiac ................................Guimaraes 

beta-adrenergic signaling 

15:45 - 16:30 

• Featured poster Session 5 .........................................................Poster Area 

16:30 - 18:00 

• meet the trialist: acute heart failure in 2013 .......................... Lisboa 

• controversies in the management of heart ...................... Coimbra 

failure 

• Heart failure in cardiomyopathies ......................................................Faro 

• What you should know about exercise training ..............Guarda 

• Rapid Fire Session 2 ........................................................................Guimaraes 

TueSDAy 28 mAy 2013 - mORning 



08:30 - 10:00 

• u-shape relationship in heart failure? ...........................................Evora 

• What a busy clinician needs to know about ..................... Coimbra 

hypertension 

• HFA/eSc cardiologists of Tomorrow session: ............................Faro 

the heart failure specialist of tomorrow 

• update on optimised pharmacological ...................................Guarda 

management in heart failure with reduced 

ejection fraction 

• Rapid Fire Session 3.........................................................................Guimaraes 

10:00-11:00 


11:00 - 12:30 

• Highlights ...........................................................................................................Evora 

• Workshop on treatment development for .......................... Coimbra 

muscle wasting and cachexia in chronic heart failure 

• non-pharmacological management of HFReF .........................Faro 

• Should i take my medicine? ..............................................................Guarda 

• Highlights: basic and translational science ...................Guimaraes 

HAnDS-On TuTORiALS 

• Hands-on tutorials sponsored by RESMED Hands-on tutorials Room 1 

Screening for Sleep Disorder Beathing in Heart Failure, practical and clinical aspects (Room 1.08) 

Sunday 26 May from 10:00 to 11:00 and from 12:30 to 13:30 

Monday 27 May from 10:00 to 11:00 and from 12:30 to 13:30 

• Hands-on tutorials sponsored by Abbott Vascular Hands-on tutorials Room 2 

Deep dive in understanding the percutaneous mitral Valve Repair procedure for treating mitral Regurgitation 

Sunday 26 May from 08:30 to 09:30 

Monday 27 May from 08:30 to 09:30 

Hands-on percutaneous mitral Valve Repair: Device & Screening 

Sunday 26 May from 10:00 to 10:45 and from 11:00 to 11:45 

from 15:00 to 15:45 and from 16:00 to 16:45 

Monday 27 May from 10:00 to 10:45 and from 11:00 to 11:45 



• Hands-on tutorials sponsored by Impulse Dynamics Hands-on tutorials Room 3 

cardiac contractility modulation 

Multiple sessions per day 

• Hands-on tutorials sponsored by BioVentrix Hands-on tutorials Room 4 

The latest advance in structural heart therapies: less invasive ventricular enhancement 


14

cOngReSS TimeTABLe 

21:00 

20:00 

19:00 

18:00 

17:00 

16:00 

15:00 

14:00 

13:00 

12:00 

11:00 

10:00 

09:00 

08:00 

07:00 

21:30 

20:30 

19:30 

18:30 

17:30 

16:30 

15:30 

14:30 

13:30 

12:30 

11:30 

10:30 

09:30 

08:30 

07:30 

Industry Registration Public Registration 

Friday 

24 May 

Registration 


Exhibition 

Saturday 

25 May 

Posters 

Reception 

in Exhibition 

Opening 

Ceremony 

Satellite 

Symposia 

Scientific 

Sessions 

Scientific 

Sessions 

FP* 

Registration 


Sunday 

26 May 

Exhibition 

Satellite 

Symposia 

Scientific 

Sessions 

Posters 

Coffee Scientific Satellite Scientific Coffee 

Break Sessions Symposia Sessions Break 

FP* FP* 

Registration 

Scientific 

Sessions 

16 


Monday 

27 May 

Exhibition 

Posters 

Scientific 

Sessions 

Coffee 

Break 

FP* 

Scientific 

Sessions 

Satellite 

Symposia 

Scientific 

Sessions 

Scientific Coffee 

Sessions Break 

FP* 

Registration 


Tuesday 

28 May 

Scientific 

Sessions 

Posters 

Coffee 

Break 

Scientific 

Sessions 

FP* 

07:30 08:30 09:30 10:30 11:30 12:30 13:30 14:30 15:30 16:30 17:30 18:30 19:30 20:30 21:30 

07:00 08:00 09:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00 

*Featured posters, more information p.11


at your 

fingertips! 

The Mobile app is supported by ResMed, 

in the form of an unrestricted educational grant 

• View the entire scientific programme 

• Search for sessions, presentations, abstracts 

• Find exhibitors and sponsors 

• Navigate the floor plans 

• Create your personal itinerary 

• Make your own “to do” list and take notes 

• Share with colleagues 

• Receive the latest news 

Search for “HF2013” in App Store/Google play 

17 

SATURDAY 

SESSIONS

satUrDaY 

sessions 

saturDaY 25 MaY 2013 - afternoon sessions 

12:30 - 14:00 - Special Session Room Evora 

2012 & 2013 Best of the European Journal of Heart Failure 

Chairpersons: F. Ruschitzka (Zurich, CH); P. Van Der Meer (Groningen, DE) 

12:30 Basic mechanisms and pathophysiology. 1 

K.C. Wollert (Hannover, de) 

12:48 Biomarkers and diagnosis. 2 

s. Heymans (Maastricht, NL) 

13:06 Imaging. 3 

F.J. Pinto (Lisbon, PT) 

13:24 Interventional and device therapies. 4 

J.-N. Trochu (Nantes, FR) 

13:42 Pharmacological management. 5 

To be announced 

12:30 - 14:00 - Symposium Room Coimbra 

Gender, pregnancy and heart failure 

Chairpersons: V. Regitz-Zagrosek (Berlin, DE); P. Seferovic (Belgrade, RS) 

12:30 Heart failure in women vs men: epidemiological differences and similarities. 6 

A. Ahmed (Birmingham, Us) 

12:48 Pregnancy-associated heart failure: causes and therapy. 7 

A.M. shah (London, GB) 

13:06 Management of cardiovascular disease during pregnancy. 8 

P.G. Pieper (Groningen, NL) 

13:24 Peripartum cardiomyopathy: definition and diagnosis. 9 

K. sliwa-Hahnle (Cape Town, ZA) 

13:42 Peripartum cardiomyopathy: management. 10 

d. Hilfiker-Kleiner (Hannover, de) 

18


12:30 - 14:00 - Symposium Room Faro 

How to improve heart failure care and investigation in Portugal 

Local track 

Chairpersons: H. Madeira (Lisbon, PT); L.M. Goncalves (Coimbra, PT) 

12:30 Portuguese registries on chronic heart failure and on acute heart failure. 11 

C. Fonseca (Oeiras, PT) 

12:45 Creating a heart failure clinic network. 12 

B.e. Moura (Porto, PT) 

13:00 Myocarditis, hypertrophic cardiomyopathy and Tako-Tsubo cardiomyopathy 

registries. 13 

d. Brito (Lisbon, PT) 

13:15 Familial dilated cardiomyopathy registry (FATIMA). 14 

e. Martins (Porto, PT) 

13:30 Developing a network on heart failure clinical investigation. 15 

J. silva-Cardoso (Porto, PT) 

13:45 Panel. 16 

N. Cardim (Lisbon, PT); J. Ferreira santos (setubal, PT); R. Baptista (Coimbra, PT); 

N.J. Lousada (Lisbon, PT); M. Peres (santarem, PT); M.s. Robalo Martins (Lisbon, PT) 

14:15 - 15:45 - Symposium Room Evora 

Ventricular arrhythmias and sudden death in heart failure: modern therapy 

Joint session with China 

Chairpersons: S.D. Anker (Berlin, DE); Dayi Hu (Beijing, CN) 

14:15 Currents, waves and spirals: pathophysiology and risk stratification of 

ventricular arrhythmias. 17 

F.R. Heinzel (Graz, AT) 

14:33 Pharmacological management of ventricular arrhythmias. 18 

J. Kautzner (Prague, CZ) 

14:51 Ablation of VTs: when, which patients, epicardial? The trial data. 19 

K.-H. Kuck (Hamburg, de) 

15:09 Ablation of VTs: The Chinese experience. 20 

Rong Bai (Beijing, CN) 

15:27 Pacing and ICD: options for all patients? 21 

Cheuk-Man Yu (Hong Kong, HK) 

19 

satUrDaY 

sessions

satUrDaY 

sessions 



Novel diagnostic approaches for HFPEF 

Chairpersons: J.R. Gonzalez Juanatey (Santiago De Compostela, ES); 

W.J. Paulus (Amsterdam, NL) 

14:15 Biomarkers: BNP and beyond. 22 

I.s. Anand (Minneapolis, Us) 

14:33 New echocardiographic imaging modalities. 23 

e. Kraigher-Krainer (Graz, AT) 

14:51 Hemodynamics and the diastolic stress test. 24 

B. Borlaug (Rochester, Us) 

15:09 MRI and PET. 25 


15:27 A practical approach to diagnose true heart failure with preserved EF. 26 



Imaging in heart failure 1: update 2013 

Joint session with the Portuguese Society of Cardiology and the 

Brazilian Society of Cardiology 

Chairpersons: F. Bacal (Sao Paulo, BR); F.J. Pinto (Lisbon, PT) 

14:15 Echocardiography: new modalities. 27 

e. Rohde (Porto Alegre, BR) 

14:33 Assessing valvular anatomy and function. 28 

P. Nihoyannopoulos (London, GB) 

14:51 Cardiac CT. 29 

N. Bettencourt de sousa (Villa Nova de Gaia, PT) 

15:09 Cardiac MRI: the future gold standard? 30 

A.M.G. Almeida (Lisbon, PT) 

15:27 PET scanning. 31 

P.G. Camici (Milan, IT) 

20


14:15 - 15:45 - Symposium Room Guarda 

From pharmacological management to destination therapy 

Chairpersons: J. Nanas (Athens, GR); W.T. Abraham (Columbus, US) 

14:15 Inotropic support: intermittent, continous, long-term? 32 

M. Metra (Brescia, IT) 

14:33 Short-term circulatory support: IABP and beyond. 33 

K. Werdan (Halle, de) 

14:51 Percutaneously implantable assist devices. 34 

G. Hasenfuss (Göttingen, de) 

15:09 Long-term support: from bridging to destination therapy. 35 

J.R. Pepper (London, GB) 

15:27 When to wean, when to transplant? 36 

M.A. Gomez sanchez (Madrid, es) 

21 

satUrDaY 

sessions

satUrDaY 

sessions 


16:15 - 17:45 - Satellite Symposium Room Coimbra 

Bridging the gap between expectations and reality in eHealth heart failure 

care: new scientific approaches and first-hand experiences with real-life 

implementation 

Sponsored by ALERE 

Chairpersons: J.G.F. Cleland (Kingston Upon Hull, GB); F.X. Kleber (Potsdam, DE) 

16:15 Introduction. 37 

J.G.F. Cleland (Kingston Upon Hull, GB) 

16:20 Innovative eHealth solutions to strengthen self-care in heart failure: key 

success factors and main obstacles as identified by applied research. 38 


16:40 Point-of-care testing and patient self-monitoring of biomarkers: novel 

approaches to personalize next generation eHealth programs in heart failure. 39 

A. Maisel (solana Beach, Us) 

17:00 Taking the human being rather than the patient back aboard: application of 

person-centred care concepts for opening up new dimensions in heart failure 

eHealth. 40 

I. ekman (Gothenburg, se) 

17:20 Transfer research findings to pratical use: practical implementation of heart 

failure eHealth programmes in daily regular care. 41 

s. sonntag (Berlin, de) 

17:40 Summary. 42 

F.X. Kleber (Potsdam, de) 

16:15 - 17:45 - Satellite Symposium Room Faro 

Emerging therapies in acute heart failure: improving patient outcomes 

Sponsored by the heart.org / Medscape Education 

Chairpersons: M. Komajda (Paris, FR); M.R. Cowie (London, GB) 

16:15 Welcome and introduction. 

M. Komajda (Paris, FR) 

43 

16:20 The burden of and challenges in treating AHF in 2013. 


44 

16:30 Diagnosis and assessment of AHF today. 

M.R. Cowie (London, GB) 

45 

16:45 Pathophysiologic targets for AHF therapy. 

G. Cotter (durham, Us) 

46 

17:00 Improving outcomes and looking to the future: Two case studies in AHF - 

Pump failure case. 

C. Mueller (Basel, CH) 

47 

17:15 Improving outcomes and looking to the future: Two case studies in AHF - 

Vascular resistance & afterload mismatch. 

A.A. Voors (Groningen, NL) 

48 

17:30 Panel discussion on cases and question period. 


22 

49


16:15 - 17:45 - Satellite Symposium Room Guarda 

CCM (Cardiac contractility modulation): when medication is not enough 

Sponsored by Impulse Dynamics 

Chairpersons: S.D. Anker (Berlin, DE); A. Auricchio (Lugano, CH) 

16:15 Cardiac Contractility Modulation (CCM): how does it work? 50 


16:37 The evidence base for CCM: a meta-analysis of the randomized trials using 

individual patient data. 51 

A.J.s. Coats (Coventry, GB) 

17:00 The eligible patients. Facilitating the indication pathway for CCM. 52 

K.H. Kuck (Hamburg, de) 

17:22 Patients benefiting from CCM – 2 interesting cases. 53 

M. Taborsky (Olomul, CZ) 

23 

satUrDaY 

sessions

satUrDaY 

sessions 



Research 

OPENING CEREMONy 

Chairpersons: 

S.D. Anker (Berlin, DE); 

B.M. Pieske (Graz, AT); 


Welcome to Heart Failure 2013 by the Scientific Chairperson. 

B.M. Pieske (Graz , AT) 

Welcome to Heart Failure 2013 by the Local Hosts. 

d.A. Brito (Lisbon, PT); J. silva-Cardoso (Porto, PT) 

Welcome to Heart Failure 2013 by the President of the HFA. 

s.d. Anker (Berlin, de) 

Welcome to Heart Failure 2013 by the President of the ESC. 

P.e. Vardas (Heraklion, GR) 

Heart Failure Association Lifetime Achievement Awards 2013. 

Introduction: s.d Anker (Berlin, de), B.M. Pieske (Graz, AT) 

Basic and Translational Research Award 


Clinical Research Award 


Award Ceremony. 

P.e. Vardas (Heraklion, GR), s.d Anker (Berlin, de), B.M. Pieske (Graz, AT), 

d.A. Brito (Lisbon, PT), J. silva-Cardoso (Porto, PT) 

Closing remarks. 

s.d. Anker (Berlin, de), B.M. Pieske (Graz, AT) 

Joins us for a cocktail reception in the exhibition area 

New Therapies 

24 

Interventions 

Knowledge

ESC eLEARNING PLATFORM 


eLearning 

Association 

programme 

State of the Art Modules - CME Accredited - 3D Animations - Based on heart failure 

Curriculum and latest Guidelines - Content written by experts - Case studies 

Available modules 

• Diagnosis of heart failure 

• Symptoms and health-related quality of life in chronic heart failure 

• How to use diuretics in heart failure 

• How to use ACE inhibitors & ARBs in heart failure 

• How to use beta-blockers in heart failure patients 

• Co-morbidities in HF 1: secondary prevention 

• Co-morbidities in HF 2: anaemia & iron deficiency 

Available this summer 

• Overview of the 2012 heart failure Guidelines 

• Best papers 2012 on heart failure 

• A basic understanding of heart rate and heart rhythm in heart failure 

• When to consider a left ventricular 

assist device and transplantation 

And much more to come! 

Exclusive Access for 

HFA Online and Full Members 

Find out more 


learn.escardio.org 

25 

SUNDAY 

SESSIONS

sunday 

sEssIOns 

SuNDAy 26 MAy 2013 - HANDS-oN TUToRIALS 

Sponsored by ResMed Europe Hands-on Room 1 

10:00 - 11:00 Screening for sleep disordered breathing in heart failure – 

Practical & clinical aspects 

Chairperson: T.E. Herrscher Bjorkeng (oslo, No) 



Chairperson: T.E. Herrscher Bjorkeng (oslo, No) 

“Participants will learn about the principles of diagnosing and treating sleep-disordered breathing 

types. They will hear about screening methods, from clinical screening to specific devices. 

Through clinical cases, they will get to know how to use ApneaLink screening devices and how 

to interpret test results.“ 

Sponsored by Abbott Vascular Hands-on Room 2 

08:30 - 09:30 Deep dive in understanding the percutaneous mitral valve 

repair procedure for treating mitral regurgitation 

Chairperson: D. Van Hees (Diegem, BE) 

10:00 - 10:45 Hands-on percutaneous mitral valve repair: device & screening 



Chairperson: P. Romitelli (Diegem, BE) 





Understand Percutaneous Mitral Valve Repair (PMVR) therapy : 

From screening to procedure and from technical to clinical aspects 

Interact with Percutaneous Mitral Valve Repair device 

Obtain answer to questions you might have related to the therapy 

26

SuNDAy 26 MAy 2013 - HANDS-oN TUToRIALS 

Sponsored by Impulse Dynamics Hands-on Room 3 


Cardiac Contractility Modulation (CCM) 

1 - About CCm 

2 - easiness of Implant, case reports 

3 - How-to: Working with the CCm-device 

4 - Interactive sessions 

Sponsored by BioVentrix Hands-on Room 4 

08:30 - 09:15 Understanding the Significance of SVR in the Era of STICH and PCI 

Chairperson: Dr. Lon Annest 

09:15 - 10:00 Surgical & TransCatheter Volume Reduction/Reshaping Technique 










27 

SUNDAY 

SESSIONS

sunday 

sessions 

sunDAY 26 MAY 2013 - morning sessions 

08:30 - 10:00 - Main Session Room Lisboa 

More on new devices for heart failure 

Chairpersons: P.E. Vardas (Heraklion, GR); F. Ruschitzka (Zurich, CH) 

08:30 update on CRT and ICD therapy for heart failure in 2013. 60 

P.e. Vardas (Heraklion, GR) 

08:42 Improving on CRT using cardiac contractility modulation? A 10-year 

retrospective and look to the future 61 


08:54 Pressure monitoring devices: will they help reduce hospitalisations? 62 


09:06 Algysil injection to enhance cardiac contractility physics. 63 


09:18 Springs, splints, nets and more contractility enhancers: what will survive to 2020? 64 

W.T. Abraham (Columbus, Us) 

09:30 Devices for HFpEF?! 65 

J.-N. Trochu (Nantes, FR) 

09:42 Panel Discussion. 


Biomarkers: state-of-art and the future 

Chairpersons: C. Mueller (Basel, CH); A. Maisel (Solana Beach, US) 

08:30 Biomarker-guided therapy: evidence and ongoing trials. 67 

R.A. de Boer (Groningen, NL) 

08:48 GDF-15 and other inflammatory markers. 68 

K.C. Wollert (Hannover, de) 

09:06 Novel Biomarkers in HFPEF: diagnosis and prognosis. 69 

d.J. van Veldhuisen (Groningen, NL) 

09:24 update on natriuretic peptides: use and limits. 70 

I.s. Anand (Minneapolis, Us) 

09:42 Biomarkers as surrogates in heart failure trials. 71 

J.J.V. McMurray (Glasgow, GB) 

28


08:30 - 10:00 - HFA Focus session Room Coimbra 

Diagnosis of heart failure and co-morbidities 

Local Track 

Chairpersons: J. Kautzner (Prague, CZ); J. Silva-Cardoso (Porto, PT); J.A. Brito (Lisbon, PT) 

Clinical case 1: diagnosis of heart failure. 72 

C. Fonseca (Oeiras, PT) 

Clinical case 2: heart failure co-morbidities. 73 

R. Tato (Lisbon, PT) 

Panel. 74 

s.M.R. Amorim (Porto, PT); N.J. Lousada (Lisbon, PT); V. Proenca (Oeiras, PT) 


From circulatory support to transplantation 

Joint session with the Spanish Society of Cardiology 

Chairpersons: J.R. Pepper (London, GB); N. Manito Lorite (Barcelona, ES) 

08:30 Indications and contraindications for transplantation. 75 

e. Roig (Barcelona, es) 

08:48 VADs as bridge to transplant: how to select the patient and the device? 76 

M. Jessup (Philadelphia, Us) 

09:06 Management of pre-transplant pulmonary hypertension. 77 

M.G. Crespo-Leiro (La Coruna, es) 

09:24 Immunosupression and immunological monitoring after transplant. 78 

L. Potena (Bologna, IT) 

09:42 Current standards for a VAD and transplant programme. 79 

J. Vanhaecke (Leuven, Be) 

29 

sUnDAY 

sessions

sunday 

sessions 


08:30 - 10:00 - young Investigators Awards Abstracts Room Guarda 

Young Investigator Award: Clinical 

Chairpersons: A.J.S. Coats (Coventry, GB); P. Seferovic (Belgrade, RS) 

Judges: M. Packer (Dallas, US); B. Pitt (Ann Arbor, US); 

V. Regitz-Zagrosek (Berlin, DE); M. Senni (Bergamo, IT) 

08:30 Phenotyping and outcome on contemporary management of patients with 

peripartum cardiomyopathy: a German prospective study 80 

A. Haghikia, e. Podewski, e. Libhaber, P. Roentgen, d. Tsikas, J. Bauersachs, 

K. sliwa, d. Hilfiker-Kleiner (Hannover, de; Cape Town, ZA) 

08:45 High-throughput genotyping and phenotyping reveals new genetic 

determinants of clinical phenotype in hypertrophic cardiomyopathy 81 

L. Rocha Lopes, A. Zekavati, P. syrris, C. Giambartolomei, C.O. Mahony, 

C. dalageorgou, M. Hubank, W. Mc Kenna, V. Plagnol, P. elliott (London, GB) 

09:00 In patients with diabetes, obesity is associated with an increased risk of 

developing heart failure but, paradoxically, a lower mortality (>150,000 

patient-years follow-up) 82 

P. Costanzo, P. Pellicori, d. Hepburn, e. Kilpatrick, K. Goode, P. Perrone-Filardi, 

J.G.F. Cleland, s. Atkin (Hull, GB; Naples, IT) 

09:15 The effects of inspiratory muscle training in patients with heart failure with 

preserved ejection fraction 83 

P. Palau sampio, e. dominguez Mafe, B. Mascarell Gregori, e. Nunez Botero, 

J.M. Ramon Ferrandis, P. Vergara Lozano, J. sanchis Fores, F.J. Chorro Gasco, 

J. Nunez Villota (Valencia and Castellón, es) 

09:30 Cheyne Stokes respiration in patients with heart failure detected by a novel 

non-contact monitor of nocturnal respiration 84 

H.O. savage, R. Khushaba, P. Bateman, s. Farrugia, K. schindhelm, A.K. simonds, 

M.R. Cowie (London, GB; sydney, AU) 

09:45 Percutaneous balloon mitral valvuloplasty during pregnancy: a twenty-year 

experience 85 

M. Hassine, F. Ben Amor, A. elloumi, Z. dridi, F. Betbout, H. Gamra (Monastir, TN) 

30


08:30 - 10:00 - Symposium Room Guimaraes 

Epigenetics of heart failure 

Chairpersons: L.J. De Windt (Maastricht, NL); J. Molkentin (Cincinnati, US) 

08:30 Genome-wide epigenomics in heart failure. 86 

R. Foo (singapore, sG) 

08:45 Histone modifications in heart failure. 87 

M. Hohl (Homburg, de) 

09:00 Role of histone methyltransferases in cell differentiation: 

lessons from skeletal muscles. 88 

s. Aid-si-Ali (Paris, FR) 

09:15 Promoter methylation in cardiac fibrosis. 89 

P.A. da Costa Martins (Maastricht, NL) 

09:30 Epigenetics as therapeutic targets. 90 

L.H. Lehmann (Heidelberg, de) 


Late breaking trials 1 

Chairpersons: S.D. Anker (Berlin, DE); J.J.V. McMurray (Glasgow, GB) 

Latest updates 

This session will feature the latest breakthrough in clinical heart failure research. 

Consult session details in the Congress News, on your Mobile Application or on the Website! 

Trial Presentations of 10 minutes followed by a discussant review and questions from the 

audience and chairpersons for 5 minutes. 


Atrial fibrillation in heart failure: news in 2013 

Arrhythmias 

Chairpersons: V. Mareev (Moscow, RU); G.Y.H. Lip (Birmingham, GB) 

11:00 Epidemiology and risk prediction for incident atrial fibrillation in heart failure. 105 

A.J. Camm (London, GB) 

11:18 Pharmacological management of atrial fibrillation in heart failure. 106 

G.Y.P. Lip (Birmingham, GB) 

11:36 Cardioversion of atrial fibrillation in heart failure: when and how? 107 

A.s. Manolis (Glyfada-Athens, GR) 

11:54 Ablation for the management of atrial fibrillation in the heart failure patient. 108 


12:12 How to anticoagulate? 109 

s. Homma (New York, Us) 

31 

sUnDAY 

sessions

sunday 

sessions 



How to manage arrhythmias in heart failure 

Focus session & joint session with Spanish Society of Cardiology 

Chairpersons: F. Ruschitzka (Zurich, CH); J.L. Lopez-Sendon (Madrid, ES) 

HFREF and atrial fibrillation: rhythm control, rate control, ablation? 110 

W. Haverkamp (Berlin, de) 

Ventricular arrhythmia management in the ICD patient: which drugs, when to 

ablate? 111 

G. Hindricks (Leipzig, de) 

The heart failure patient with Bradyarrhythmia: tolerate, pace or synchronise? 112 

L. Mont (Barcelona, es) 

Discussion. 113 

F.J. Pinto (Lisbon, PT); G. Fenelon (sao Paulo, BR); A.P. Maggioni (Florence, IT) 


Pulmonary hypertension in heart failure 

Chairpersons: D. Brito (Lisbon, PT); Y. Cavusoglu (Eskisehir, TR) 

11:00 Pathophysiology of pulmonary hypertension in heart failure. 114 

I.M. Lang (Vienna, AT) 

11:18 Epidemiology and diagnosis of pulmonary hypertension. 115 

C.s.P. Lam (singapore, sG) 

11:36 Current management strategies. 116 

s. Rosenkranz (Koln, de) 

11:54 Novel therapies: the concept of PDE5 inhibition. 117 

M. Guazzi (san donato Milanese, IT) 

12:12 Current trials on PDE5 inhibition: RELAX, PITCH and SilHF. 118 

K. dickstein (stavanger, NO) 

32 

FoCUS



Novel biomarkers in heart failure: targets for therapy? 

Chairpersons: A. Mebazaa (Paris, FR); S. Von Haehling (Berlin, DE) 

11:00 High sensitivity troponins. 119 

A. Mebazaa (Paris, FR) 

11:10 Inflammatory mediators and ST2. 120 

d. Tousoulis (Athens, GR) 

11:20 Cardiorenal markers for heart failure (NGAL, cystatin, NAG). 121 

d.J. van Veldhuisen (Groningen, NL) 

11:30 Adenomedullin. 122 

W.F. Peacock (Houston, Us) 

11:40 Galectin-3. 123 


11:50 Multi-marker strategies. 124 


12:00 Panel discussion. 


The matrix modulates cardiac cell fate in heart failure 

Chairpersons: D. Hilfiker-Kleiner (Hannover, DE); A. Leite-Moreira (Porto, PT) 

11:00 Osteonectin and osteoglycin modulate cardiac inflammation and fibrosis in 

heart failure. 126 


11:18 Syndecans are essential in myocyte hypertrophy and interstitial fibrosis. 127 

G. Christensen (Oslo, NO) 

11:36 MicroRNA regulation of matrix proteins. 128 

T. Thum (Hannover, de) 

11:54 Thrombospondins regulating myocyte survival and function in heart failure. 129 

J. Molkentin (Cincinnati, Us) 

12:12 Omics-guided discovery of novel matrix proteins involved in heart failure. 130 

M. Mayr (London, GB) 

33 

sUnDAY 

sessions

sunday 

sessions 

sunDAY 26 MAY 2013 - afternoon sessions 

12:45 - 14:00 - Satellite Symposium Room Lisboa 

Cardiac resynchronization therapy response: from patient selection to therapy 

optimization 

Sponsored by Medtronic 

Chairpersons: A. Auricchio (Lugano, CH); K. Dickstein (Stavanger, No) 


A. Auricchio (Lugano, CH) 

12:50 Block heart failure: cardiac resynchronisation therapy (CRT) or dual-chamber 

pacing (DDD) in atrioventricular block patients? 132 


13:10 Which patients benefit from cardiac resynchronisation therapy: learnings from 

REVERSE. 133 

C. Linde (stockholm, se) 

13:30 Algorithms to automatically adapt to the individual patient's needs. 134 

W. Mullens (Genk, Be) 

13:50 Conclusion. 135 



Evidence-based medicine in an area of tension between clinical trial and realworld 

evidence: a survey of recent data on MRAs 

Sponsored by Pfizer 

Chairpersons: J.J.V. McMurray (Glasgow, GB); F. Zannad (Vandoeuvre-Les-Nancy, FR) 



12:50 Risk scoring in patients with heart failure in daily practice - based on an 

analysis of EMPHASIS-HF. 137 


13:05 Implications of age for the management of CHF. 138 

B. Pitt (Ann Arbor, Us) 

13:20 Real-world data vs. clinical trials evidence in CHF – precautions for interpretation. 139 

F. Zannad (Vandoeuvre-Les-Nancy, FR) 


34



Can early referral of severe mitral regurgitation save lives? From diagnosis to 

intervention 

Sponsored by Abbott Vascular 

Chairpersons: P. Ponikowski (Wroclaw, PL); S.D. Anker (Berlin, DE) 



12:50 Does MR kill? 142 

A.P. Maggioni (Florence, IT) 

13:05 Treating severe MR in 2013. 143 

R. Rosenhek (Vienna, AT) 

13:20 The place of interventional therapies. 144 


13:35 Closing remarks. 145 

P. Ponikowski (Wroclaw, PL) 

12:45 - 14:00 - Satellite Symposium Room Guarda 

Prognostic value of sympathetic innervation imaging in patient with heart failure (HF) 

Sponsored by GE Healthcare 

Chairpersons: E. De Teresa Galvan (Malaga, ES); P. Marzullo (Pisa, IT) 

12:45 A clinical HF cardiologist’s perspective on risk assessment. 146 

F. Fedele (Rome, IT) 

13:10 Significance of preserved cardiac sympathetic function in HF patients: Is this 

the future for identifying the low-risk patient? 147 

A.J.H.A. scholte (Leiden, NL) 

13:35 Imaging techniques to support diagnosis and treatment decision in 

cardiac patients. 148 

P. Marzullo (Pisa, IT) 

35 

sUnDaY 

sessions

sunday 

sessions 


12:45 - 14:00 - Satellite Symposium Room Guimaraes 

Keeping the beat going 

Sponsored by Thoratec Corporation 

Chairpersons: D. Zimpfer (Vienna, AT); U. Jorde (New York, US) 


d. Zimpfer (Vienna, AT) 

12:50 Long term VAD therapy? – What have we learned? 150 

U. Jorde (New York, Us) 

13:10 Debate: should a stable VAD patient be transplanted? 151 

F. Gustafsson (Copenhagen, dK); J. Bauersachs (Hannover, de) 

13:25 Debate: is old ever too old? 152 

d. Milicic (Zagreb, HR); d. Zimpfer (Vienna, AT) 

13:40 Evolution of VADs – Where are we going? 153 

M. Kirsch (Paris, FR) 

13:55 Closing remarks. 154 

U. Jorde (New York, Us) 

36


14:15 - 15:45 - Symposium Room Lisboa 

Valvular interventions in the heart failure patient 

Chairpersons: P. Ponikowski (Wroclaw, PL); W. Schillinger (Göttingen, DE) 

14:15 Catheter-based valvular interventions 2013: state-of-the-art. 155 

s. Blankenberg (Mainz, de) 

14:30 TAVI in patients with reduced ejection fraction: benefits and risks. 156 


14:45 Edge-to-edge mitral repair in secondary mitral regurgitation: key in heart failure? 157 

W. schillinger (Gottingen, de) 

15:00 Valvular surgery in heart failure: when and for whom? 158 

O. Alfieri (Brescia, IT) 



New therapies in acute heart failure 

Chairpersons: G.S. Filippatos (Athens, GR); A.A. Voors (Groningen, NL) 

14:15 Renin inhibitors. 160 

M. Gheorghiade (Chicago, Us) 

14:30 Relaxin. 161 


14:45 Omecamtiv. 162 


15:00 ularitide. 163 


15:15 Clevidipine. 164 



37 

sUnDaY 

sessions

sunday 

sessions 



The heart failure patient with Coronary Artery Disease 

Chairpersons: G. Hasenfuss (Göttingen, DE); F. Ruschitzka (Zurich, CH) 

Multi-vessel disease and negative viability testing. 166 

d. Milicic (Zagreb, HR) 

Chronic Total Occlusion with depressed ejection fraction. 167 


The NyHA III patient with ischemic mitral regurgitation. 168 

K.H. Kuck (Hamburg, de) 


A. Leite-Moreira (Porto, PT); s. Rosenkranz (Köln, de); L. Kober (Gentofte, dK) 


Cardiac rehabilitation and exercise training in heart failure. 

Joint session with the Portuguese Society of Cardiology 

Chairpersons: A. Cohen-Solal (Paris, FR); 

J.R. Gonzalez Juanatey (Santiago De Compostela, ES) 

14:15 When. 170 

F. Vilas-Boas (salvador, BR) 

14:33 How. 171 

R. Bover Freire (Madrid, es) 

14:51 Assessment: cardiopulmonary exercise test. 172 

M. Mendes (Carnaxide, PT) 

15:09 Results from randomized trials. 173 

M.F. Piepoli (Piacenza, IT) 

15:27 Overcoming the barriers for the application of exercise training recommendations. 174 


38 

FoCUS



Telemonitoring in heart failure: what is needed to make this ready for routine use? 

Chairpersons: J.G.F. Cleland (Kingston Upon Hull, GB); I. Ekman (Gothenburg, SE) 

14:15 The case for remote patient monitoring. 175 

A.W. Hoes (Utrecht, NL) 

14:30 Telemonitoring: the view of the professional. 176 

J. Boyne (Maastricht, NL) 

14:45 Telemonitoring: impact on quality of life? 177 

J. Riley (London, GB) 

15:00 Activity monitoring. 178 

F. Koehler (Berlin, de) 

15:30 How will it work in the future? 180 


15:15 Biomarker Telemonitoring: the next step? 179 

F.M. Fruhwald (Graz, AT) 


Novel concepts for myocardial regeneration 

A joint session with the ESC working group on myocardial function 

Chairpersons: J. Bauersachs (Hannover, DE); D.L. Brutsaert (Kontich, BE) 

14:15 MicroRNA-induced adult cardiomyocyte regeneration. 181 

M. Giacca (Trieste, IT) 

14:33 Notch signaling and novel non-coding RNAs in cardiac regeneration. 182 

T. Pedrazzini (Lausanne, CH) 

14:51 Circadian rhythms in cardiac regeneration. 183 

L.W. Van Laake (Utrecht, NL) 

15:09 Cardiac tissue engineering. 184 

W.-H. Zimmermann (Göttingen, de) 

15:27 Stem cell therapy in heart failure: a critical reappraisal. 185 

J. Bauersachs (Hannover, de) 

39 

sUnDaY 

sessions

sunday 

sessions 



What is controversial in the 2012 ESC Heart Failure Guidelines? 

Chairpersons: J.J.V. McMurray (Glasgow, GB); M. Boehm (Homburg/Saar, DE) 

16:30 Definition and diagnosis. 186 


16:40 Pharmacological management. 187 


16:50 Non-pharmacological management. 188 

s. Adamopoulos (Athens, GR) 

17:00 Devices. 189 

C. Linde (stockholm, se) 

17:10 Acute heart failure. 190 

G.s. Filippatos (Athens, GR) 

17:20 The gaps in evidence. 191 




Anticoagulation and antithrombotic therapy in heart failure 

Heart failure management 

Chairpersons: S. Homma (New York, US); K. Dickstein (Stavanger, No) 

16:30 Anticoagulation for atrial fibrillation in heart failure: which drug, when, how long? 193 

G.Y.H. Lip (Birmingham, GB) 

16:42 Anticoagulation in Afib and Heart Failure in China. 194 

dayi Hu (Beijing, CN) 

16:54 Anticoagulation for heart failure in sinus rhythm: trial results and 

recommendations. 195 


17:06 New antithrombotic agents. 196 


17:18 Anticoagulation and antiplatelet therapy management in special situations. 197 



40



Pharmacological treatment and referral to cardiology 

Local track Heart Failure in Primary Care - Clinical case sessions 

Chairpersons: A.W. Hoes (Utrecht, NL); B.E. Moura (Porto, PT); 

D. Brito (Lisbon, PT); M.T. Peneda (Almada, PT) 

Clinical case 1: pharmacological treatment of heart failure. 199 

R. Ascencao (Lisbon, PT) 

Clinical case 2: referral of heart failure patients to cardiology. 200 

M.A. Gaspar (Lisbon, PT) 

Panel. 201 

M.B. Campelo (Matosinhos, PT); M.R. Cowie (London, GB); 

C.M. Tavares Aguiar (Lisbon, PT); P. seferovic (Belgrade, Rs) 


How to treat HFPEF in 2013: practical considerations 

Joint Session with the ASIAN-HF network and ASEAN Federation of Cardiology 

Chairpersons: C.S.P. Lam (Singapore, SG); B.M. Pieske (Graz, AT); 

H. Krum (Melbourne, AU) 

16:30 The general approach: are there ethnic differences? 202 

R. doughty (Auckland, NZ) 

16:48 Pharmacotherapy: is there any role for ACE-inhibitors, ARBs and Beta-Blockers? 203 


17:06 Is there a role for device therapy? 204 

Cheuk-Man Yu (Hong Kong, HK) 

17:24 Management of major comorbidities. 205 

F.K. Triposkiadis (Larissa, GR) 

17:42 yes, we can! The case for individualised therapy. 206 


41 

sUnDaY 

sessions

sunday 

sessions 


16:30 - 18:00 - Patient Care Investigators Awards Abstracts Room Guarda 

Nursing Investigator Award 

Chairpersons: D. Fitzsimons (Belfast, GB); E. Lambrinou (Nicosia, CY) 

Judges: I. Ekman (Gothenburg, SE); M.G. Crespo-Leiro (La Coruna, ES); 

M. Lainscak (Golnik, SI); C. Angermann (Würzburg, DE) 

16:30 Factors influencing caregiver burden in partners of patients with heart failure, 

a long term follow up 207 

M. Liljeroos, s. Agren, K. Arestedt, T. Jaarsma, A. stromberg (Linkoping and Kalmar, se) 

16:45 Evaluation of a home-based intravenous diuretic pathway for heart failure 

patients 208 

C. Watson, C. senior, d. Hockey, J. Austin, L. Blue, H.F. Mcintyre (Hastings, Leeds, 

Wales and London, GB) 

17:00 Despite free health-care service, poor socioeconomic status is a strong and 

independent risk factor for adverse outcome in heart failure patients, a Danish 

nationwide cohort study 209 

s.B. Christensen, C. Andersson, M.G. Charlot, F. Gustafsson, M. Madsen, 

G.H. Gislason (Copenhagen, dK) 

17:15 Prognosis in heart failure; patients own perceptions 210 

M.H.L. Van der Wal, A. stromberg, T. Jaarsma (Linkoping, se) 

17:30 Home visit improves knowledge, self-care and adhesion in heart failure: 

randomized clinical trial HELEN-I 211 

C. Mussi, K.B. Ruschel, e.N. souza, A.N.M. Lopes, M. Trojahn, C.P. Camargo, 

e.R. Rabelo (Porto Alegre, BR) 

17:45 Memorial symptom assessment scale-heart failure and application in Chinese 

people with heart failure 212 

J.Y. Guo, Z. Li, R.L. Lv, X.F. Kang (Beijing, CN) 

42


16:30 - 18:00 - young Investigators Awards Abstracts Room Guimaraes 

Young Investigator Award: Basic Science 

Chairpersons: C. Maack (Hamburg, DE); S. Heymans (Maastricht, NL) 

Judges: R. Fischmeister (Chatenay-Malabry, FR); Z. Papp (Debrecen, HU); 

L.S. Maier (Göttingen, DE); L.J. De Windt (Maastricht, NL) 

16:30 Rheb1 plays an essential role in post-natal heart growth in mice 213 

Y.s. Cao, Z.Z. Yang, X.L. Li (Nanjing, CN) 

16:45 Cardiac sympathetic neurons establish and maintain cardiomyocyte size 

heterogeneity throughout the myocardium 214 

N. Pianca, T. Zaglia, L. Nalotto, M. Franzoso, P. Brum, M. sandri, M. Mongillo 

(Padova, IT; sao Paulo, BR) 

17:00 Experimental and clinical aortic stenosis; myocardial activation of the four 

pro-hypertrophic NFAT transcription factors is attenuated by relief of pressure 

overload 215 

I.G. Lunde, B. skrbic, T. Tonnessen, H. Kvaloy, U.H. enger, I. sjaastad, 

G. Christensen, C.R. Carlson (Oslo, NO) 

17:15 Nitric oxide regulates cardiac intracellular Na levels by modulating Na/K 

ATPase via PKC and phospholemman-dependent mechanism. 216 

d. Pavlovic, A. Hall, e. Kennington, K. Aughton, W. Fuller, s. despa, d. Bers, 

M. shattock (London and dundee, GB; davis, Us) 

17:30 Targeting macrophage subsets attenuates cardiac remodeling and 

dysfunction following experimental myocarditis in rat. 217 

s. Rinkevich-shop, T. Ben-Mordechai, d. Kain, M.s. Feinberg, N. Landa-Rouben, 

J. Leor (Tel Hashomer, IL) 

17:45 FRET measurements of local cAMP signalling in the sarcolemmal T-tubular 

compartment of cardiomyocytes 218 

R.K. Perera, V.O. Nikolaev (Götttingen, de) 

43 

sUnDaY 

sessions

sunday 

sessions 


18:15 - 19:45 - Satellite Symposium Room Lisboa 

SHIFTing evidence in heart failure management 

Sponsored by SERVIER 

Chairpersons: K. Swedberg (Gothenburg, SE); S.D. Anker (Berlin, DE) 


K. swedberg (Gothenburg, se) 

18:20 Persistent challenges in the management of heart failure. 220 


18:40 Ivabradine in heart failure patients: adding quality to quantity. 221 


19:00 Saving lives and expenditure with ivabradine. 222 


19:20 Ivabradine: from guidelines to clinical practice. 223 

B.M. Pieske (Graz, AT) 

19:40 Conclusion. 224 



Understanding the complex pathways in the progression of heart failure: 

changing the mindset of how we manage acute and chronic heart failure 

Sponsored by Novartis Pharma 

Chairpersons: G.S. Filippatos (Athens, GR); A.A. Voors (Groningen, NL) 

18:15 Welcome and introduction. 225 


18:20 Embarking on a downward journey – What are the mechanisms responsible 

for acute decompensation in patients with heart failure? 226 

G. Cotter (durham, Us) 

18:40 Where does the downward journey take us? The pathophysiological 

consequences of acute heart failure on end organs. 227 

P. Liu (Toronto, CA) 

19:00 Symptom control or long-term benefits in acute heart failure – Can we take 

the same road to reach different destinations? 228 


19:20 Preparing for the long journey ahead: exploring new paths in the 

management of chronic heart failure. 229 

M. Packer (dallas, Us) 

19:40 Summary and close. 230 


44



Biomarkers-guided therapy in Heart Failure - Role of galectin-3 

Organised by Charité university Berlin and sponsored by an educational grant from 

BG Medicine & BioMérieux 

Chairpersons: F.J. Pinto (Lisbon, PT); A. Maisel (Solana Beach, US) 


F.J. Pinto (Lisbon, PT) 

18:20 Galectin-3 as a modifiable risk factor in systolic and diastolic heart failure. 232 

R.A. de Boer (Groningen, NL) 

18:35 Biomarker-guided aldosterone antagonist therapy: an emerging role 

for galectin-3. 233 


18:50 Improving risk stratification in acute heart failure: galectin-3 in the emergency 

room. 234 


19:05 General discussion. 

45 

sUnDaY 

sessions

Eupace_11-1_Cover.qxd 12/12/08 08:45 PM Page 1 

11 

1 

January 2009 

Europace Pages 1–132 

oxford 

European Journal of Heart Failure 

at the heart of The ESC Journal Family 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

Volume 11 Number 1 January 2009 ISSN 1099-5129 

Journal EP Endurance sport practice as a risk factor for 

EP 

atrial fibrillation 

Review of postural orthostatic tachycardia 

syndrome 

Remote monitoring of implanted devices 

may improve early detection of AF 

Visualization of isthmus anatomy by MRI to 

guide difficult flutter ablation 

Sleep apnoea and arrhythmias 

Education in EP: unusual irregular tachycardia 

Editor-in-Chief: John Camm 

Co-Editor: Luc Jordaens 


www.europace.oxfordjournals.org 

18 months FREE access to our journal when you become 

a Full or Online HFA member during Heart Failure 2013 

Visit the ESC booth NOW! 

Eheart_32_1_cover.qxd 12/3/10 6:20 PM Page 1 

ISSN 0195-668X (Print) 

ISSN 1522-9645 (Online) 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

Peri-procedural myocardial injury during PCI 

Optimal timing of coronary intervention 

in non-STEMI 

Primary angioplasty in very old patients 

Rosuvastatin for primary prevention 

CD14CD16 monocytes and 

cardiovascular outcome 

Editor-in-Chief: Thomas F. Lüscher 

Deputy Editors: Josep Brugada 

Bernard J. Gersh 

Ulf Landmesser 

EURJHF_13_1_Cover.qxd Frank 12/7/10 Ruschitzka9:22 

PM Page 1 

William Wijns 

Senior Consulting Editors: John A. Camm 

Diederick E. Grobbee 

Tiny Jaarsma 

Gerald Maurer 

Michael Piper 

Patrick W. Serruys 

Dirk van Veldhuisen 

Visualization of pulmonary vein anatomy (an accessory pulmonary vein) by 

rotational angiography during adenosine-induced asystole. See article on 

pages 35 to 41 

www.eurheartj.org 

Europace 

European Pacing, Arrhythmias 

and Cardiac Electrophysiology 

of the European Heart Rhythm Association, 

a Registered Branch of the ESC and the ESC Working 

Group on Cardiac Cellular Electrophysiology 



European 

Heart Journal 

Journal of the European Society of Cardiology 

Mediterranean jellyfish sting-induced Tako–Tsubo cardiomyopathy. 

See figure legend on page 18. 

www.eurointervention.org Volume 8 - Number 2 - June 2012 - ISSN: 1774-024X 

EuroIntervention 

Offi cial Journal of EuroPCR and the European Association 

of Percutaneous Cardiovascular Interventions (EAPCI) 

Longitudinal stent deformation: 

QCA analysis 

Longitudinal stent deformation: 

MAUDE insights 

OCT guidance for bifurcations 

IVUS and VH assessment of stent edges 

SYNERGY/PROMUS stent vascular compatibility 

Polylactic acid-based resorbable stent study 

Risk stratification and aortic stenosis 

ESC for Nurses 

ESC for General Practice 

Physicians 

PAGE EDITOR-IN-CHIEF 

Patrick W. Serruys 

205 

27-31 August 2011 

CO-EDITORS 

Pim de Feyter 

Carlo Di Mario 

Jean Marco 

Marie-Claude Morice 

Manel Sabaté 

Horst Sievert 

William Wijns 

DEPUTY EDITORS 

Nico Bruining 

Pieter Kappetein 

Let’s meet in Paris on Saturday 27 

Pascal Vranckx 

August to combine our efforts! 

SUPPLEMENTS EDITORS 

Jean Fajadet 

Alec Vahanian 

Learning objective: To know when and how to use antithrombotic/ 

antiarrhythmic drugs and ablationfor atrial fibrillation 

Learning objective: To know when and how to use natriuretichormones in case of dyspnea 

Learning objective: To know therapeutic targets after acute coronary 

syndrome and the management of antiplatelet drugs 

Learning objectives: To inform the patient with PM or ICD -Understand 

and educate the patient with a defibrillator life vest 

Learning objective: Discover fun ways to educate the patient with heart failure 

Nurses, attend this one-day programme for €50*! 

Register now online at www.escardio.org 

13 1 

January 2011 European Journal of Heart Failure 

Pages 1–114 

2 

Position Statement on cardiovascular 

side effects of cancer therapy 

Epidemiology of HFPEF 

Study design papers: 

ATMOSPHERE and ASTRONAUT 

Urinary 8-OHdG: a biomarker in chronic HF 

Cardiorenal anaemia syndrome 

Human neuregulin-1 therapy 

Editor-in-Chief: 

Dirk J. van Veldhuisen 

Deputy Editors: 

Adriaan A. Voors 

Wiek H. van Gilst 

1 

FREE online Access in 2014 

for all Heart Failure 2013 Congress Delegates * 

* Standard, Student and Nurse fees 

www.escardio.org/journals 

Contact us using publications@escardio.org for any questions about the ESC Journals 

3 

10 

3 

September 2011 European Journal of Cardiovascular Nursing 

Pages 137–194 

ELSEVIER 




47 

Cvrese_89_1_cover.qxd 12/9/10 8:28 PM Page 1 


HeartFailure 

Journal of the Heart Failure Association of the ESC 

www.eurjhf.oxfordjournals.org 

Impact Factor 2011 

4.896 

Volume 10 Number 3 September 2011 ISSN 1474-5151 


Cardiovascular 

Nursing 

Journal of the Council on Cardiovascular 

Nursing and Allied Professions 

Frailty 

Heart failure 

Motivational interviewing 

Self-efficacy 

Patient education 

Patients and Partners 

Exercise 

Editor- in- Chief: Tiny Jaarsma 

Co-Editors: Anna Strömberg 

David R. Thompson 

www.elsevier.com/locate/ejcnurse 

89 1 

1 January 2011 

Cardiovascular Research Pages 1–253 

ISSN 0008-6363 (Print) 

ISSN 1755-3245 (Online) 

Mast cells in myocardial remodelling 

Protecting mitochondria with angiotensin II 

G-CSF in cardiac stem cell therapy 

Prevention of reentrant arrhythmias 

Cardiac sodium pump as signal transducer 

Editor-in-Chief: H. Michael Piper 

Co-Editor: David Garcia-Dorado 

2 

Ejecho_New_cover_1_Sample.qxd 14/7/11 5:01 PM Page 1 

Volume 89 Number 1 1 January 2011 


Research 

www.cardiovascres.org 


Journal of the European Society of Cardiology 

00 

0 

Month 2011 

European Heart Journal Cardiovascular Imaging Pages XXX–XXX 

2 

2012 


European Heart Journal 


Imaging 

Cardiovascular imaging including 

echocardiography 

Magnetic resonance 

Computed tomography 

Nuclear and invasive imaging 

Editor-in-Chief: Gerald Maurer 

Deputy Editors: Thomas Binder 

Heinz Sochor 

Senior Associate Editors: Juhani Knuuti 

Luc Piérard 

Sven Plein 


Formerly European Journal of Echocardiography 

See pp. XXX. 

www.ehjcimaging.oxfordjournals.org 

monday 

SESSIonS

MONDAy 27 MAy 2013 - HANDS-oN TUToRIALS 

Sponsored by ResMed Europe Hands-on Room 1 



Chairperson: T. Bitter (Bad oeynhausen, DE) 



Chairperson: T. Bitter (Bad oeynhausen, DE) 

“Participants will learn about the principles of diagnosing and treating sleep-disordered breathing 

types. They will hear about screening methods, from clinical screening to specific devices. 

Through clinical cases, they will get to know how to use ApneaLink screening devices and how 

to interpret test results.“ 

Sponsored by Abbott Vascular Hands-on Room 2 

08:30 - 09:30 Deep dive in understanding the percutaneous mitral valve 

repair procedure for treating mitral regurgitation 











Chairperson: P. Romitelli (Diegem, BE)) 



Understand Percutaneous Mitral Valve Repair (PMVR) therapy : 

From screening to procedure and from technical to clinical aspects 

Interact with Percutaneous Mitral Valve Repair device 

Obtain answer to questions you might have related to the therapy 

49 

monday 

SESSIonS

monday 

SESSIonS 

MONDAy 27 MAy 2013 - HANDS-oN TUToRIALS 

Sponsored by Impulse Dynamics Hands-on Room 3 


Cardiac Contractility Modulation (CCM) 

1 - About CCm 

2 - easiness of Implant, case reports 

3 - How-to: Working with the CCm-device 

4 - Interactive sessions 

Sponsored by BioVentrix Hands-on Room 4 













50

monDAY 27 mAY 2013 - morning sessions 


Device therapy in heart failure: news and innovations 

Chairpersons: B.M. Pieske (Graz, AT); K. Dickstein (Stavanger, No) 

08:30 Cardiac resynchronisation therapy: are indications changing? 236 

F. Ruschitzka (Zurich, CH) 

08:42 Subcutaneous ICD devices: first clinical experiences. 237 

M. Borggrefe (Mannheim, de) 

08:55 Vagus nerve stimulation: ready for prime time? 238 


09:08 Baroreceptor stimulation: current status. 239 


09:21 Interatrial shunting in HFPEF. 240 

F. Gustafsson (Copenhagen, dK) 

09:34 Technological developments at the horizon. 241 

J.R. Teerlink (san Francisco, Us) 



The heart and cancer 

Joint session with Heart Failure Society of America (HFSA) 

& American Society of Clinical Oncology (ASCO) 

Chairpersons: T.L. Force (Philadelphia, US); S.D. Anker (Berlin, DE); T.M. Suter (Bern, CH) 

08:30 Cancer and heart disease: how big is the problem? 243 

T.L. Force (Philadelphia, Us) 

08:45 Treating cancer but harming the heart: experience from completed and 

ongoing trials. 244 

M. ewer (Houston, Us) 

09:00 Mechanistic insights into anthracycline cardiotoxicity and pharmacological 

cardioprotection. 245 

M. sterba (Prague, CZ) 

09:15 Treating cardiotoxicity: from clinical experience in oncology to guidelines. 246 

T. suter (Bern, CH) 

09:30 Setting the standards for cardiology related end-points in cancer trials. 247 


09:45 Cardiac drugs and devices for cancer patients: myth or reality? 248 

M. Lainscak (Golnik, sI) 

51 

monday 

sessions

monday 

sessions 



Renal denervation: from heart failure prevention to heart failure therapy? 

Chairpersons: L.M. Ruilope (Madrid, ES); M. Boehm (Homburg/Saar, DE) 

08:30 Current standards and news in antihypertensive therapy. 249 

s. Laurent (Paris, FR) 

08:48 The concept of renal denervation. 250 

G. Bakris (Chicago, Us) 

09:06 Current status of renal denervation in hypertension. 251 

H. Krum (Melbourne, AU) 

09:24 Patient selection for renal denervation. 252 

F. Mahfoud (Hamburg, de) 

09:42 Renal denervation and heart failure: what is the evidence? 253 

M. Boehm (Homburg/saar, de) 


Management of co-morbidities in heart failure 

Joint Session with the Brazilian Society of Cardiology 

Chairpersons: J. Souza Neto (Fortaleza, BR); P. Ponikowski (Wroclaw, PL) 

08:30 Pulmonary disease: differential diagnosis and therapy. 254 

F.H. Rutten (Utrecht, NL) 

08:48 The cardio-renal syndrome. 255 


09:06 Liver dysfunction in heart failure. 256 

F. Bacal (sao Paulo, BR) 

09:24 How to optimize diabetes management in heart failure? 257 

M. Mamas (Manchester, GB) 

09:42 Obesity management in the heart failure patient: walk or cut? 258 

e.A. Bocchi (sao Paulo, BR) 

52


08:30 - 10:00 - Oral Abstracts Room Guarda 

Rapid Fire Session 1 

Chairpersons: G.M. Felker (Durham, US); M.F. Piepoli (Piacenza, IT) 

Flash presentations on research highlights: Aim / Methods / Results. 

discussions animated by two experts chairing the session. Posters of all presented abstracts will 

be on display the same day outside the room. 

08:30 Effects of serelaxin on blood pressure: results from the RELAX-AHF Trial 260 

M. Metra, J.R. Teerlink, G. Cotter, B.A. davison, G.M. Felker, G. Filippatos, 

B.H. Greenberg, P. Ponikowski, A.A. Voors, T. severin (Brescia, IT; san Francisco, 

durham, NC and san diego (CA), Us; Athens, GR; Wroclaw, PL; Groningen, NL; 

Basel, CH) 

08:35 Effects of ularitide on the endothelin and aldosterone system, cardiac 

troponins, and renal function in acute decompensated heart failure 261 

V. Mitrovic, H. Luess, P. seferovic, d. simeunovic, A. Ristic, s. Felix, M. Meyer, 

W. Forssmann (Bad Nauheim, Hannover and Greifswald, de; Belgrade, Rs) 

08:40 Beta-blockers and short-term mortality in patients with acute heart failure and 

chronic obstructive pulmonary disease 262 

J.T. Parissis, C. Andreoli, N. Kadoglou, I. Ikonomidis, K. Ntai, A. Mebazaa, 

G. Filippatos, M. Anastasiou-Nana, F. Follath (Athens, GR; Paris, FR; Zurich, CH) 

08:45 A retrospective observational study on the clinical outcomes in relation with 

serum sodium level in Asian patients hospitalized for heart failure 263 

J.J. Park, d.J. Choi, M.s. Kang, B.s. Yoo, J.J. Hwang, s.J. Lin, M.s. Wen, J. Zhang, 

J. Ge (seongnam, seoul and Wonju, KR; Taipei, TW; Beijing and shanghai, CN) 

08:50 Continuous versus intermittent loop diuretics infusion dosing in acute heart 

failure: effects on renal function, outcome and BNP levels 264 

A. Palazzuoli, A. Palazzuoli, G. Martini, B. Franci, M.s. Campagna, M. Pellegrini, 

M. Beltrami, G. Ruocco, R. Nuti (siena, IT) 

08:55 Bioimpedance vector analysis (BIVA) plus BNP in the accurate assessment of 

volume overload in the emergency department 265 

d.W. Kehl, P. Chowdhury, B. dieffenbach, R. Choudhary, N. Iqbal, 

e. Higginbotham, F. Khusro, P. Clopton, P. Taub, A. Maisel (san diego, Us) 

09:00 usefulness of non-invasive monitoring of the net lung impedance in chronic 

heart failure patients in out hospital clinic 266 

M. shochat, A. shotan, M. Kazatsker, I. dahan, I. shochat, A. Asif, L. Vasilenko, 

A. Frimerman, d. Blondheim, s. Meisel (Hadera, IL) 

09:05 Characterization of myocardial deformation in hypertrophic cardiomyopathy 

using speckle tracking: comparison with physiological hypertrophy 267 

H. Badran, M.F. elnoamany, M. Ayad, A. elshereef, A. Farhan, Y. Nassar, 

M. Yacoub (shebeen el-Koom and Cairo, eG; London, GB) 

53 

monday 

sessions

monday 

sessions 


08:30 - 10:00 - Oral Abstracts Room Guarda 

Rapid Fire Session 1 (continued) 

Chairpersons: G.M. Felker (Durham, US); M.F. Piepoli (Piacenza, IT) 

09:20 Non-Compaction cardiomyopathy. Outcome of patients with different left 

ventricular function and other risk stratification criteria to decide 

ICD implantation. 268 

N. Galizio, A. Palazzo, F. Robles, G. Carnero, A. Gargano, N. Martinenghi, 

X. Vallejos, M. Mysuta, J. Gonzalez (Capital Federal, AR) 

09:25 Pneumococcal/influenza vaccination, exercise prescription and diseasemanagement 

programme participation in PARADIGM-HF. 269 

J.J.V. Mcmurray, M. Packer, J. Gong, M. Lefowitz, A.R. Rizkala, J.L. Rouleau, 

V.C. shi, s.d. solomon, K. swedberg, M.R. Zile (Glasgow, GB; dallas, east 

Hanover, Boston and Charleston, Us; Montreal, CA; Gothenburg, se) 

09:30 Tricuspid regurgitation in a heart failure cohort: risk factors and prognostic 

implications 270 

R. dierckx, s. Verstreken, J. Bartunek, M. Goethals, M. Vanderheyden (Aalst, Be) 

09:35 Clinical outcomes of a large cohort of patients with low-gradient aortic 

stenosis despite preserved left ventricular ejection fraction 271 

M. Morosin, e. Fabris, M. Moretti, M. Merlo, B. Pinamonti, G. Barbati, 

A. Pappalardo, G. sinagra (Trieste, IT) 

09:40 Predictors of heart failure worsening after surgery for degenerative mitral 

regurgitation in patients with systolic dysfunction 272 

s. Boskovic, B. Obrenovic-Kircanski, B. Vujisic-Tesic, s. Micovic, P. Otasevic 

(Belgrade, Rs) 

09:45 Novel three dimensional echocardiographic guided optimization 

improves outcome in cardiac resynchronization therapy compared to 

electrocardiographic optimization - results of a randomized comparison 273 

C. sonne, L. Bott-Fluegel, s. Hauck, M. Hadamitzky, H. Lesevic, P. Wolf, C. Kolb 

(Munich and erding, de) 

09:50 An individual patient meta-analysis of randomized trials assessing the effects 

of CRT and CRT-D in heart failure in sinus rhythm with a prolonged QRS 

duration and left ventricular systolic dysfunction 274 

J.G.F. Cleland, W.T. Abraham, C. Linde, M.R. Gold, J.B. Young, J.C. daubert, 

L. sherfesee, G.A. Wells, A.s.L. Tang (Kingston Upon Hull, GB; Columbus, 

Charleston, Cleveland and Minneapolis, Us; stockholm, se; Rennes, FR; Ottawa 

and Vancouver, CA) 

09:55 Clinicians' ability to detect upcoming decompensations in patients with heart 

failure based on home telemonitoring data 275 

J. Caffarel, C. Bescos, A. Bonomi, H. Ter Horst, R. Bover, P. Cowburn, I. squire, 

C. Zugck, J. Cleland, P. schauerte (eindhoven, NL; Madrid, es; southampton, 

Leicester and Hull, GB; Heidelberg and Aachen, de) 

54



Gene therapy for heart failure: ready for the clinic? 

Chairpersons: T. Eschenhagen (Hamburg, DE); J. Molkentin (Cincinnati, US) 

08:30 Adeno-associated viruses: why are they cardiotropic? 276 

M. Giacca (Trieste, IT) 

08:48 Corrective gene therapy for monogenic myopathies. 277 

K. davies (Oxford, GB) 

09:06 Gene therapy for acquired heart failure: options and progress in translation. 278 

s. Pleger (Heidelberg, de) 

09:24 Barriers to translation: how to deliver a clinical gene therapy trial. 279 

J.-s. Hulot (Paris, FR) 

09:42 Antiarrhythmic positive inotropic gene therapy: a new paradigm for heart 

failure therapeutics. 280 

A. Lyon (London, GB) 


Late breaking trials 2 

Chairpersons: G.S. Filippatos (Athens, GR); B.M. Pieske (Graz, AT) 


This session will feature the latest breakthrough in clinical heart failure research. 

Consult session details in the Congress News, on your Mobile Application or on the Website! 

Trial Presentations of 10 minutes followed by a discussant review and questions from the 

audience and chairpersons for 5 minutes. 


Imaging in heart failure 2: update 2013 

Chairpersons: F.J. Pinto (Lisbon, PT); P. Nihoyannopoulos (London, GB) 

11:00 Standpoint: what should we expect from imaging? 295 

J. Holzmeister (Zurich, CH) 

11:15 Assessing systolic and diastolic function. 296 

O.A. smiseth (Oslo, NO) 

11:30 Quantification of volumes and muscle mass. 297 

J. schwitter (Lausanne, CH) 

11:45 Non-invasive assessment of hemodynamics. 298 

B. Borlaug (Rochester, Us) 

12:00 Imaging the microvasculature in heart failure. 299 

P.G. Camici (Milan, IT) 

12:15 Wrap up Echo, CT, MRI and PET: how to match technology with clinics. 300 

J.U. Voigt (Leuven, Be) 

55 

monday 

sessions

monday 

sessions 



Cardiac inotropes and beyond: update 2013 

Chairpersons: G. Hasenfuss (Göttingen, DE); F.K. Triposkiadis (Larissa, GR) 

11:00 Dobutamine and other catecholamines. 301 


11:10 Levosimendan: an update. 302 


11:20 PDE-3 inhibition. 303 

V.-P. Harjola (Helsinki, FI) 

11:30 Digoxin. 304 

M. Gheorghiade (Chicago, Us) 

11:40 New compounds: omecamtiv mercabil and others. 305 


11:50 Clinical perspective: how should inotropes be used today? 306 

J. Bauersachs (Hannover, de) 



Management of acute heart failure: 2013 update and perspectives 

Joint Session with the Portuguese Society of Cardiology, the Brazilian 

Society of Cardiology and the Spanish Society of Cardiology 

Chairpersons: D. Brito (Lisbon, PT); M.S. Nieminen (Helsinki, FI) 

11:00 Setting the stage: review of the ESC Acute Heart Failure guidelines. 308 


11:18 using diuretics: all the same? All different? 309 

J.L. Lopez-sendon (Madrid, es) 

11:36 Which vasodilator and when? 310 

M.s. Robalo Martins (Lisbon, PT) 

11:54 How to choose the right inotrope. 311 

J.T. Parissis (Athens, GR) 

12:12 When to use a balloon pump or an assist device? 312 

N. Clausell (Porto Alegre, BR) 

56


11:00 - 12:30 - Special Session Room Guarda 

What's new in Industry? 

Chairpersons: S.D. Anker (Berlin, DE); F. Ruschitzka (Zurich, CH) 


Industry representatives will present highlights of their current programme in heart failure 

research as well as any products in the pipeline. 

each presentation will be followed by a panel discussion. 

We encourage questions from the audience. 


oxidative stress in heart failure: mechanisms and treatment 

Chairpersons: A.M. Shah (London, GB); H. Post (Graz, AT) 

11:00 Mechanisms of mitochondrial ROS production in heart failure. 319 

C. Maack (Hamburg, de) 

11:18 Redox-regulation of cell death in heart failure. 320 

Junichi sadoshima (Newark, Us) 

11:36 Oxidative myocardial protein alterations. 321 

Z. Papp (debrecen, HU) 

11:54 Mitochondria and Wnt signaling: molecular mechanisms of heart failure. 322 

Issei Komuro (Tokyo, JP) 

12:12 From bench to bedside: mitochondrial-targeted antioxidants to treat 

cardiovascular diseases. 323 

H. szeto (New York, Us) 

57 

monday 

sessions

monday 

sessions 

monDAY 27 mAY 2013 - afternoon sessions 

12:45 - 14:00 - Satellite Symposium Room Evora 

Prevention of heart failure hospitalizations with management of pulmonary 

artery pressures: insights from the CHAMPIoN Trial 

Sponsored by CardioMEMS 

Chairpersons: M.R. Cowie (London, GB); F. Koehler (Berlin, DE) 

12:45 The HF epidemic in the Eu, standard of care, and implications for the future. 324 


13:00 CHAMPION trial update. 325 


13:15 The HF clinic of the future. 326 


13:30 Remote hemodynamic management of heart failure - Case studies: increase 

the understanding of the benefits and value of pressure-guided therapy in 

heart failure management. 327 


13:45 Q and A session with the panel. 


Reducing hospital readmissions for heart failure - Can galectin-3 help? 

Organised by Charité university Berlin and sponsored by an educational grant 

from BG Medicine & BioMérieux 

Chairpersons: G.S. Filippatos (Athens, GR); S.D. Anker (Berlin, DE) 



12:50 Reducing the burden of hospital readmissions for heart failure - Patient and 

health system perspectives. 330 


13:05 Predictors of hospital readmissions for chronic heart failure: an overview of 

serum biomarkers. 331 


13:20 use of biomarkers to reduce heart failure readmission rates: focus on galectin-3. 332 


13:35 Discussion. 

58



HFPEF: update 2013 

Chairpersons: D.L. Brutsaert (Kontich, BE); C.S.P. Lam (Singapore, SG) 

14:15 Pathophysiology. 334 

Z. Papp (debrecen, HU) 

14:33 Epidemiology. 335 

V.s. Ramachandran (Framingham, Us) 

14:51 Diagnosis. 336 

s. solomon (Boston, Us) 

15:09 Emerging therapies 337 


15:27 Controversial issues. 338 



New chronic heart failure medications at the horizon 

Heart Failure Management - Pharmacotherapy 

Chairpersons: S.D. Anker (Berlin, DE); C. o’Connor (Durham, US) 

14:15 Soluble guanylatecyclase inhibitors. 339 


14:27 Neprilysin inhibition. 340 

s. solomon (Boston, Us) 

14:39 PDE 5-Inhibition. 341 

M. Guazzi (san donato Milanese, IT) 

14:51 New MR antagonists. 342 


15:03 Ranolazine. 343 

M. senni (Bergamo, IT) 


59 

monday 

sessions

monday 

sessions 



How to manage valvular disease in heart failure 

Chairpersons: P. Ponikowski (Wroclaw, PL); o. Smiseth (oslo, No) 

Aortic stenosis and heart failure: diagnosis and management. 345 


Advanced heart failure and functional mitral regurgitation. 346 

s. Blankenberg (Mainz, de) 

Tricuspid valve insufficiency, pulmonary hypertension and Right Ventricular 

Failure. 347 

O. Alfieri (Brescia, IT) 

Discussions. 348 

A. Leite-Moreira (Porto, PT); J.R. Pepper (London, GB); W. schillinger (Göttingen, de); 

G. Hasenfuss (Gottingen, de) 


Update on myocarditis and pericarditis 

Chairpersons: E.V. Shlyakhto (St. Petersburg, RU); C. Tschoepe (Berlin, DE) 

14:15 Pathophysiology: virus, inflammation, rare causes. 349 

s. Pankuweit (Marburg, de) 

14:33 Diagnosis: imaging and endomyocardial biopsy. 350 

H.P. schultheiss (Berlin, de) 

14:51 Perimyocarditis: how to deal with it? 351 

A.d. Ristic (Belgrade, Rs) 

15:09 Management anti-inflammatory, antiviral, emergency therapies. 352 

C. Tschoepe (Berlin, de) 

15:27 (Recurrent) Pericarditis: workup and therapy! 353 

M. Imazio (Turin, IT) 

60 

FoCUS



Failing hearts and failing brains 

Chairpersons: G. Ertl (Würzburg, DE); M.G. Crespo-Leiro (La Coruna, ES) 

14:15 Pathophysiology: the heart-brain connection. 354 

G.M.C. Rosano (Rome, IT) 

14:30 Epidemiological considerations: heart failure vs. stroke. 355 

A. Ahmed (Birmingham, Us) 

14:45 Heart failure and stroke: adding insult to injury. 356 

W. doehner (Berlin, de) 

15:00 Cardiac hormones: impact on brain function? 357 

e.A. Jankowska (Wroclaw, PL) 

15:15 Heart failure and depression: room for anti-depressive therapy? 358 

C.e. Angermann (Würzburg, de) 

15:30 How does heart failure therapy impact on cognitive function? 359 

M. Lainscak (Golnik, sI) 


Amplifier and economizer in cardiac beta-adrenergic signaling 

Chairpersons: L. Neyses (Luxembourg, LU); J. Sadoshima (Newark, US) 

14:15 PDEs and signal termination upstream of PKA. 360 

R. Fischmeister (Chatenay-Malabry, FR) 

14:33 Phosphatases and signal termination downstream of PKA. 361 

A. el-Armouche (Göttingen, de) 

14:51 Oxidative activation of PKA and PKG. 362 

P. eaton (London, GB) 

15:09 cAMP-responsive triggering of PKA by anchoring proteins. 363 

e. Hirsch (Turin, IT) 

15:27 Antithetic regulation of histone deacetylases by PKA and CaMKII. 364 

J. Backs (Heidelberg, de) 

61 

monday 

sessions

monday 

sessions 



Meet the trialist: acute heart failure in 2013 

Heart Failure Management - Pharmacotherapy 

Chairpersons: S.D. Anker (Berlin, DE); P. Ponikowski (Wroclaw, PL) 

16:30 The problem of acute heart failure: from epidemiology to endpoints. 365 


16:40 The RELAX results on relaxin: how to explain the surprising mortality effect? 366 


16:50 The TRuE - acute heart failure programme with ularitide: lessons learned from 

RELAX for its rationale and design. 367 

M. Packer (dallas, Us) 

17:00 What now for omecamtiv? 368 


17:10 The importance of speed and avoidance of hypotension in treating acute 

heart failure – lessons from ASCEND-HF. 369 

C. O.Connor (durham, Us) 



Controversies in the management of heart failure 

Chairpersons: K. Dickstein (Stavanger, No); B.M. Massie (San Francisco, US) 

Chronic heart failure with refractory low-output. 371 


Congestive heart failure with diuretic resistance. 372 

G.M. Felker (durham, Us) 

Heart failure with preserved ejection fraction and pulmonary hypertension. 373 

C.s.P. Lam (singapore, sG) 


M. Gheorghiade (Chicago, Us); J.L. Lopez-sendon (Madrid, es); 

A. Mebazaa (Paris, FR); J.R. Pepper (London, GB); 

J.G.F. Cleland (Kinston Upon Hull, GB) 

62 

FoCUS



Heart failure in cardiomyopathies 

Chairpersons: L. Tavazzi (Cotignola, IT); H.P. Schultheiss (Berlin, DE) 

16:30 Specific heart muscle diseases: amyloid, sarcoid and Fabry heart disease. 375 

A. Keren (Jerusalem, IL) 

16:48 Left ventricular noncompaction. 376 

s. Pankuweit (Marburg, de) 

17:06 Arrhythmogenic right ventricular cardiomyopathy. 377 

C. Basso (Padua, IT) 

17:24 Hypertrophic cardiomyopathy: diagnostic workup and risk stratification. 378 

P.M. elliott (London, GB) 

17:42 Dilated cardiomyopathy: a practical approach towards diagnosis and therapy. 379 

P. seferovic (Belgrade, Rs) 


What you should know about exercise training 

Exercise Training 

Chairpersons: A.L. Clark (Kingston-Upon-Hull, GB); M. Emdin (Pisa, IT) 

16:30 What does exercise training do in heart failure? 380 


16:45 Results from clinical trials. 381 

M.F. Piepoli (Piacenza, IT) 

17:00 Mode of exercise training: interval, high intensity, resistance? 382 

M. Halle (Munich, de) 

17:15 Gender impact on exercise training? 383 

I. Pina (Bronx, Us) 

17:30 Exercise in heart failure with preserved ejection fraction. 384 

F. edelmann (Göttingen, de) 

17:45 Alternatives: anabolics, currents, suction? 385 

s. Von Haehling (Berlin, de) 

63 

monday 

sessions

monday 

sessions 


16:30 - 18:00 - Oral Abstracts Room Guimaraes 


Chairpersons: J. Sadoshima (Newark, US); C. Maack (Hamburg, DE) 




16:30 Identification of post-transcriptional regulators of autophagy in pathological 

cardiac remodeling and heart failure by a functional high-throughput screen 387 

P.A. da Costa Martins, e. Poels, N. Van den Akker, d. Molin, B. duygu, 

L.J. de Windt (Maastricht, NL) 

16:35 Left ventricular diastolic dysfunction in obese diabetic mice is attenuated by 

pharmacological inhibition of dipeptidyl peptidase IV 388 

A.s. Hervent, N. Hamdani, V. Matheeussen, M. demolder, I. de Meester, 

W.A. Linke, W.J. Paulus, G.W. de Keulenaer (Antwerp, Be; Amsterdam, NL; 

Bochum, de) 

16:40 Neuregulin-1 prevents the development of left ventricular hypertrophy, 

myocardial fibrosis and diastolic dysfunction in angiotensin-II treated mice 389 

A.-s. Hervent, L. Vandekerckhove, G.W. de Keulenaer (Antwerp, Be) 

16:45 Histone deacetylase 4 controls reactivation of ANP in heart failure by 

regulating rapid demethylation of H3K9 through association with SuV39H1 390 

M. Hohl, M. Wagner, J.C. Reil, L. Lehmann, A.M. Zimmer, M. Tauchnitz, J. Backs, 

M. Boehm, C. Maack (Homburg and Heidelberg, de) 

16:50 Titin phosphorylation deficit and high cardiomyocyte stiffness in an animal 

model of metabolic risk induced heart failure with preserved ejection fraction 391 

N. Hamdani, I. Falcao-Pires, A.P. Lourenco, C.P.M. Franssen, A.F. Leite-Moreira, 

W.J. Paulus, W.A. Linke (Bochum, de; Porto, PT; Amsterdam, NL) 

16:55 Reverse mode of the mitochondrial transhydrogenase during elevated cardiac 

afterload triggers NADPH oxidation and reactive oxygen species-dependent 

induction of apoptosis, necrosis and fibrosis 392 

A. Nickel, J.R. Loeffler, J.C. Reil, A. Von Hardenberg, M. Kohlhaas, J. Bonnekoh, 

A. Kazakov, I. Bogeski, M. Boehm, C. Maack (Hamburg, de) 

17:00 HDAC4 reduces pathological but stimulates physiological cardiac remodeling 393 

L.H. Lehmann, Z. Jebessa, M.M. Kreusser, A. Horsch, L. Frischbier, U. Oehl, 

H.J. Groene, H.A. Katus, J. Backs (Heidelberg, de) 

17:05 Ablation of mafbx/atrogin-1 blocks autophagy leading to restrictive 

cardiomyopathy and premature death 394 

T. Zaglia, G. Milan, A. Ruhs, M. Kruger, M. Franzoso, e. Bertaggia, P. Pesce, 

d. Glass, M. Mongillo, M. sandri (Padova, IT; Bad Nauheim, de; Cambridge, Us) 

17:10 Independent roles for PMCA1 and 4 in the development of left ventricular 

hypertrophy and failure 395 

N. stafford, M. Zi, M. shaheen, T.M. Mohamed, s. Cook, s. Prehar, L. Neyses, 

e.J. Cartwright (Manchester, GB) 

64




Chairpersons: J. Sadoshima (Newark, US); C. Maack (Hamburg, DE) 

17:25 Bendavia (MTP-131), a novel mitochondria-targeting peptide, reverses 

mitochondrial functional abnormalities in left ventricular myocardium of dogs 

with advanced heart failure 396 

H.N. sabbah, R.C. Gupta, s. Rastogi, M. Wang, K. Zhang (detroit, Us) 

17:30 Regulation of pathological cardiac remodeling following myocardial 

infarction: the role of miR-199b 397 

B. duygu, L. Philippen, G.J.J. silva, N. Bitsch, L.J. de Windt, 


17:35 Local cAMP dynamics in the SERCA2 signalling compartment studied by a 

targeted FRET biosensor in adult mouse cardiomyocytes 398 

J.U. sprenger, V.O. Nikolaev (Götttingen, de) 

17:40 Genetic deletion of phosphatase inhibitor-1 versus betablocker treatment in 

severe CaMKIIdeltaC-induced heart failure 399 

M. dewenter, s. Neef, C. Brammen, J.H. Brown, L.s. Maier, A. el-Armouche 

(Göttingen, de; Los Angeles, Us) 

17:45 The core function of calcineurin 400 

M. Czolbe, M. Muehlfelder, P. Nordbeck, L. seidlmayer, T. Williams, O. Ritter 

(Wuerzburg, de) 

17:50 Titin carbonylation increases cardiomyocyte resting tension in a rat model of 

heart failure with preserved ejection fraction 401 

J. Kalasz, N. Hamdani, e.T. Pasztor, I. Falcao-Pires, A. Lourenco, A.F. Leite-Moreira, 

W.A. Linke, W.J. Paulus, Z. Papp, A. Borbely (debrecen, HU; Amsterdam, NL; 

Porto, PT; Bochum, de) 

17:55 Decreased left ventricular capacitance is associated with a titin isoform shift 

and reduced titin phosphorylation in a porcine model of early heart failure 

with preserved ejection fraction. 402 

M. schwarzl, s. seiler, A. Alogna, N. Hamdani, W. Linke, J. Verderber, P. steendijk, 

B.M. Pieske, H. Post (Graz, AT; Bochum, de; Leiden, NL) 

65 

monday 

sessions

See you aT Esc congrEss 2013 

www.escardio.org/ESC2013 

67 

Bring your Heart Failure congress 

experience full circle by participating 

in ESC Congress 2013 

In Village 2, you will find a comprehensive 

overview of: 

• current management of heart failure 

• comorbidities and malignancy 

• physiological conditions 

• biomarkers in heart failure 

• devices and medical management in 

heart failure 

The programme provides highlights on the 

interaction between the heart and other vital 

organs, state-of-the art knowledge, latest updates 

and take home messages for the clinicians. 

Follow the “Guidelines into Practice” track for 

sessions on the practical implementation of the 

ESC Guidelines on Heart Failure 2012. 

For more information 

Visit the ESC-HFA stand B50 

AdVAnCE ProgrAmmE 

AVAilABlE onlinE 

www.escardio.org/ESC2013programme 

register before 31 may at 

www.escardio.org/ESC2013 

5 days of scientific sessions • 145 CV topics • 400+ ESC sessions • 27 000+ healthcare professionals from 150+ countries 

• 10 000 abstracts submitted • 130 industry sponsored sessions • 200 exhibiting companies • + unique & unlimited opportunities to network! 

ESC CongrESS 2013 

european Society of Cardiology 

20 500+ fans 

#eSCcongress2013 

12 000+ followers 

escardiodotorg 

EUROPEAN 

SOCIETY OF 

CARDIOLOGY ® 

tuesday 

sessIONs

tuesday 

sessions 

tuesDAY 28 MAY 2013 - morning sessions 

08:30 - 10:00 - Main Session Room Evora 

U-shape relationship in heart failure? 

Chairpersons: U. Laufs (Homburg, DE); M.R. Cowie (London, GB) 

08:30 Blood pressure and heart rate: what is optimal and how to reach it? 403 


08:45 HbA1c: how to target therapy of Type II diabetes in heart failure. 404 

A.L. Clark (Kingston Upon Hull, GB) 

09:00 BMI: losing weight or gaining it? 405 


09:15 Sodium (Na) in the diet of heart failure patients: what advice in 2013? 406 

I. Pina (Bronx, Us) 

09:30 Cholesterol and LDL: managing lipids in heart failure patients. 407 


09:45 Alcohol: a glass of red? 408 

s. Rosenkranz (Koln, de) 


What a busy clinician needs to know about hypertension 

Joint session with Japan 

Chairpersons: S.D. Anker (Berlin, DE); Mitsuaki Isobe (Tokyo, JP) 

08:30 Mechanisms of how hypertension causes heart failure. 409 

Issei Komuro (Tokyo, JP) 

08:48 Hypertension: diagnostic procedures and pitfalls. 410 


09:06 ACE-inhibitors vs ARBs in the first line therapy: is this still a question? 411 

Yoshihiko saito (Kashihara, JP) 

09:24 Multi-drug therapy of hypertension: state-of-the-art 2013. 412 


09:42 Emerging pharmacological and non-pharmacological therapies. 413 

C. Tschoepe (Berlin, de) 

68



HFA/ESC Cardiologists of Tomorrow session: the heart failure specialist of tomorrow 

Chairpersons: R. Fontes Carvalho (Porto, PT); V.S. Ramachandran (Framingham, US) 

08:30 Mentoring and training in heart failure specialisation. 414 

M.s. Nieminen (Helsinki, FI) 

08:42 Heart failure as a subspecialty in the united States. 415 

M. Jessup (Philadelphia, Us) 

08:54 How could it work in Europe? The HFA heart specialist curriculum. 416 

T.A. Mcdonagh (London, GB) 

09:06 Interventions and technologies for the new heart failure specialist. 417 


09:18 Cardiologists of Tomorrow: what do we expect from specialised heart failure 

training? 418 




Update on optimised pharmacological management in heart failure with 

reduced ejection fraction 

Heart failure Management - Pharmacotherapy 

Chairpersons: L. Neyses (Luxembourg, LU); M. Packer (Dallas, US) 

08:30 How to improve diuretic therapy? 420 

B. Pitt (Ann Arbor, Us) 

08:48 Combinations of RAAS, beta blockade and Ivabradine. 421 

K. swedberg (Gothenburg, se) 

09:06 How to deal with Class II recommendations. 422 


09:24 How to optimise medication for co-morbidities. 423 

V. Mareev (Moscow, RU) 

09:42 Whom to include into a heart failure management programme and how? 424 

T. Jaarsma (Norrkoping, se) 

69 

tuesday 

sessions

tuesday 

sessions 




Chairpersons: M.G. Crespo-Leiro (La Coruna, ES); J. Vanhaecke (Leuven, BE) 




08:30 New Treatment Option For INTERMACS >4 Heart Failure Patients: CircuLite 

SyNERGy System 425 

B. Meyns, F. Rega, A. Barbone, d. Ornaghi, M. struber, A. simon, e. Vitali 

(Leuven, Be; Rozzano, IT; Leipzig, de; Harefield, GB) 

08:35 Pre-operative risk factors for right ventricular assist device support after 

continuous-flow LVAD implantation 426 

d. Charisopoulou, s. Rahman Haley, A. simon, M.R. Cowie, N.R. Banner (London, GB) 

08:40 Coronary microvascular dysfunction is an independent predictor of the new 

onset of coronary epicardial stenosis in heart transplant patients 427 

F. Tona, G. Famoso, M. Previato, M. Fedrigo, e. Osto, s. Tellatin, G. Tarantini, 

A. Angelini, G. Gerosa, s. Iliceto (Padova, IT) 

08:45 Level of social support in heart failure patients - effects of caregivers 

participation in a simple national disease management programme 428 

T. Rywik, P. Kurjata, G. Broda, P. Leszek, M. Fedyk-Lukasik, R. Targonski, 

P. Kolodziej, W. Piotrowski, H. Rywik, J. Korewicki (Warsaw, Krakow, Olsztyn 

and siedlce, PL) 

08:50 ESC/ HFA Guidelines implementation in primary care patients with Heart 

Failure: the GuIDE-HF study. 429 

M. Nikolaou, G. Filippatos, J.T. Parissis, M. Papaconstantinou, A. Karavidas, 

P. Vardas (Athens and Heraclion, GR) 

08:55 Combined cardiac magnetic resonance and I-123 MIBG imaging improves risk 

stratification in patients evaluated for cardiac defibrillator implantation. 430 

P. Garcia-Gonzalez, O. Fabregat-Andres, J. estornell-erill, P. Cozar-santiago, 

M. Ferrando-Beltran, A. Cubillos-Arango, L. Higueras-Ortega, A. Valle-Munoz, 

J. Ferrer-Rebolleda, F. Ridocci soriano (Valencia and denia (Alicante), es) 

09:00 When a big drop is beneficial: the impact of the decrease in BNP in patients 

with heart failure 431 

d.A. Moreira, A. delgado, B. Rodrigues, B. Marmelo, L. Abreu, e. Correia, 

L. Nunes, O. santos (Viseu, PT) 

09:05 Increasing levels of gamma-glutamyltransferase predict survival in chronic 

heart failure - Data from the Austrian Heart Failure Registry (HIR-Austria) 432 

M. ess, G. Poelzl (Innsbruck, AT) 

09:10 Determinants of abnormal resting heart rate and chronotropic exercise 

response in advanced systolic heart failure - evidence for distinct 

pathophysiological mechanisms 433 

J. Benes, M. Kotrc, B.A. Borlaug, K. Lefflerova, P. Jarolim, B. Bendlova, A. Jabor, 

J. Kautzner, V. Melenovsky (Prague, CZ; Rochester, Us) 

70




Chairpersons: M.G. Crespo-Leiro (La Coruna, ES); J. Vanhaecke (Leuven, BE) 

09:15 Incidence description and costs of acute heart failure in France 434 

s. Bouee, B. detournay, C. Laurendeau, B. Kind (Bourg La Reine and 

Rueil Malmaison, FR) 

09:20 Inspiratory muscle training improves intercostal and forearm muscle blood 

flow and oxygenation in patients with chronic heart failure 435 

A.C. Nobrega, A. Moreno, M.s. Anna Junior, J.s. Lima, C.s. duarte, H. Villacorta 

Junior, G.A. Cunha, R. Castro, B. silva (Niteroi, BR) 

09:25 Cumulative adverse effects of anaemia and iron deficiency on mortality risk in 

chronic systolic heart failure 436 

M. Kaspar, P.U. Heuschmann, s. stoerk, F. Hammer, d. Berliner, G. Gueder, 

s. Brenner, G. Gelbrich, G. ertl, C.e. Angermann (Wuerzburg and Hannover, de) 

09:30 Percutaneous transfemoral management of severe secondary tricuspid 

regurgitation as a new heart failure tool: first experience in man 437 

K. stangl, V. stangl, M. Laule (Berlin, de) 

09:35 Low-flow, low-gradient aortic stenosis, but not impaired left ventricular 

systolic function per se predicts elevated mortality after transcatheter aortic 

valve implantation (TAVI) 438 

M. Puls, B. sobisiak, C. Jacobshagen, F. schoendube, G. Hasenfuss, R. seipelt, 

W. schillinger (Göttingen, de) 

09:40 Dysglycaemia in heart failure: diagnosed and undiagnosed diabetes and 

impaired glucose tolerance in the PARADIGM-HF. 439 

J.J.V. Mcmurray, M. Packer, J. Gong, M. Lefowitz, A.R. Rizkala, J.L. Rouleau, 

V.C. shi, s.d. solomon, K. swedberg, M.R. Zile (Glasgow, GB; dallas, east 

Hanover, Boston and Charleston, Us; Montreal, CA; Gothenburg, se) 

09:45 The effect of coenzyme Q10 on morbidity and mortality in chronic heart 

failure. Results from the Q-SyMBIO study. 440 

s.A. Mortensen, A. Kumar, P. dolliner, K.J. Filipiak, d. Pella, U. Alehagen, 

G. steurer, G.P. Littarru, F. Rosenfeldt (Copenhagen, dK; Amritsar, IN; Wien, AT; 

Warsaw, PL; Kosice, sK; Linköping, se; Ancona, IT; Victoria, AU) 

09:50 ACCESS-EuROPE phase I study: analysis of outcomes at 1 year in functional 

mitral regurgitation patients with reduced left ventricular ejection fraction 441 

U. schaefer, O. Franzen, H. Treede, J. Hausleiter, C. Butter, G.P. Ussia, H. sievert, 

G. Pedrazzini, W. schillinger, F. Maisano (Hamburg, Munich, Bernau bei Berlin, 

Frankfurt and Göttingen, de; Copenhagen, dK; Catania and Milan, IT; Lugano, CH) 

09:55 Discussion. 

71 

tuesday 

sessions

tuesday 

sessions 


11:00 - 12:30 - Special Session Room Evora 

Clinical Highlights of the Heart Failure Congress 2013 

Chairpersons: B.M. Pieske (Graz, AT); G.S. Filippatos (Athens, GR) 

experts will provide you with the most important take-home messages for you in 90 minutes. 

Heart Failure Congress 2013 in a nutshell! 

11:00 Biomarkers and imaging. 

H.P. Brunner-La Rocca (Maastricht, NL) 

11:15 Patient care and telemedicine. 

J. Riley (London, GB) 

11:30 Drug therapy. 

L.s. Maier (Gottingen, de) 

11:45 Heart failure with preserved ejection fraction. 

s. salomon (Boston, Us) 

12:00 Acute heart failure. 


12:15 Devices and interventions. 



Workshop on treatment development for muscle wasting and cachexia in 

chronic heart failure 

Chairpersons: P. Ponikowski (Wroclaw, PL); S. Adamopoulos (Athens, GR) 

Pathophysiology of muscle wasting in heart failure: results from pre-clinical 

and human studies. 449 

J. springer (Berlin, de) 

Anabolic/catabolic imbalance in heart failure: pathophysiologic and 

prognostic importance. 450 


Testosterone therapy for chronic heart failure patients. 451 

K.s. Channer (sheffield, GB) 

Treatment development for anabolics in chronic heart failure: relevant 

endpoints and safety considerations. 452 

G.M.C. Rosano (Rome, IT) 

Panel discussion. 453 

s.d. Anker (Berlin, de); A.J.s. Coats (Coventry, GB); B.M. Massie (san Francisco, Us); 

P. Ponikowski (Wroclaw, PL); R. Wachter (Goettingen, de) 

72



Non-pharmacological management of HFREF 

Chairperson: J.G.F. Cleland (Kingston Upon Hull, GB); A. Cohen-Solal (Paris, FR) 

11:00 Nutrition and PuFA: which evidence? 454 

M. Mamas (Manchester, GB) 

11:10 Salt restriction? 455 


11:20 Obesity management: from weight loss advice to gastric banding. 456 

W. doehner (Berlin, de) 

11:30 Physical activity and exercise training. 457 

A.L. Clark (Kingston Upon Hull, GB) 

11:40 Telemedicine and heart failure management programmes. 458 

F. Koehler (Berlin, de) 

11:50 Recommendations from the ESC 2012 Heart Failure Guidelines. 459 




Should I take my medicine? 

Chairpersons: E. Lambrinou (Nicosia, CY); T. Jaarsma (Norrkoping, SE) 

11:00 Beta-blockers: fatigue; sexual dysfunction; nightmares? 461 

G. ertl (Wuerzburg, de) 

11:18 Non-steroidal anti-inflammatory agents. 462 

A.W. Hoes (Utrecht, NL) 

11:36 Statin therapy in heart failure: risks versus benefits? 463 

T.A. Mcdonagh (London, GB) 

11:54 Medication perception and adherence. 464 

I. ekman (Gothenburg, se) 

12:12 Devices and telemedical interventions to improve adherence. 465 

U. Laufs (Homburg, de) 

73 

tuesday 

sessions

tuesday 

sessions 


11:00 - 12:30 - Special Session Room Guimaraes 

Basic & translational Science Highlights of the Heart Failure Congress 2013 

Chairpersons: C. Maack (Hamburg, DE); Z. Papp (Debrecen, HU) 

In this session, state-of-the-art basic science will be presented. Abstracts and speakers were 

selected on the basis of a peer-review process in order to identify presentations with high quality 

content of interest to a broader audience. Both clinicians and basic scientists are invited to join 

this session and get an excellent overview on contemporary basic research in the field of Heart 

Failure. 

11:00 Excitation-contraction coupling. 

F.R. Heinzel (Graz, AT) 

11:15 Energy metabolism. 

A.M. shah (London, GB) 

11:30 Cellular remodeling and signal transduction. 

e. Hirsch (Torino, IT) 

11:45 Extracellular matrix. 


12:00 New drug targets. 

L.J. de Windt (Maastricht, NL) 

12:15 Regeneration and stem cell therapy. 

T. eschenhagen (Hamburg, de) 

74

FEATuRED POSTER 

Featured Poster sessions 

The content of abstracts considered to be of special interest will be displayed in the 

form of a poster in a dedicated Featured Poster Area. 

Presenters will briefly discuss key points of their research with two moderators in 

front of an appreciative audience during official coffee breaks. Posters are available 

for consultation throughout the poster session. 

Research 

New Therapies 

75 

Interventions 

Knowledge 

featured 

posters

SATuRDAy AFTERNOON - FEATURED PoSTERS 

14:00 - 18:00 - Featured Posters Featured Poster Area 

Featured Poster Session 1 - Saturday 15:45 - 16:30 

Chairpersons: E.V. Shlyakhto (St. Petersburg, RU); J.T. Parissis (Athens, GR) 

Featured posters must be set-up between 13:30 - 14:00, removed between 18:00 - 18:30, to be 

on display between 14:00 - 18:00 in the designated Featured Poster Area. 

These abstracts were chosen for their outstanding quality and will be presented during the 

Featured Poster session between 15:45 - 16:30. 

Feasibility of slow-continuous-ultrafiltration by peripheral line: is it possible in 

real world? P472 

C. enjuanes Grau, N.R.B. Ribas Barquet Nuria, C.C.J. Comin Colet Josep, 

O.M.d. Merono duenas Oona, C.G.G. Garcia Garcia Cosme, 

s.R.B. Ruiz Bustillo sonia, L.G.L. Guillen Lopez Luisa, M.G.R. Garcia Rodriguez, 

J.B.C. Bruguera Cortada Jordi (Barcelona, es) 

Short-term intravenous infusion of a novel mitochondria-targeting peptide 

(Bendavia, MTP-131) improves left ventricular function in dogs with chronic 

advanced heart failure P473 

H.N. sabbah, M. Wang, K. Zhang, R.C. Gupta, s. Rastogi (detroit, Us) 

Bioelectrical impedance vector analysis and the risk of readmission in patients 

with acute heart failure P474 

H.C. stubbe, s. Ventura, C. Bonanad, B. Mascarell, L. Bondanza, J. sanchis, 

e. santas, J. Nunez (Valencia, es) 

Enhancing the quality of care in heart failure (the South East England 

enhancing Quality Programme) P475 

H.F. Mcintyre, s. Reid, L. Mcevoy, G. Baldock-Apps (Hastings, GB) 

Prognostic utility of high sensitive procalcitonin in systolic heart failure. P476 

C. Reichert, G. Gueder, d. Berliner, s. stoerk, G. ertl, C. Angermann, s. Brenner 

(Wuerzburg and Hannover, de) 

Specialist cardiology care improves outcomes for patients admitted with acute 

heart failure P477 

T.A. Mcdonagh, J.G.F. Cleland, s.M. Hardman, H.J. dargie (London, Hull and 

Glasgow, GB) 

Lung impedance-guided therapy of patients with chronic heart failure 

improves clinical outcome P478 

M. shochat, A. shotan, M. Kazatsker, A. Asif, I. dahan, I. shochat, L. Vasilenko, 

e. Noyman, T. sigalov, s. Meisel (Hadera, IL) 

The interaction between pulmonary hypertension and right ventricular 

function in acute decompensated heart failure P479 

d. Aronson, W. darawsha, A. Atamna, Z. Azzam (Haifa, IL) 

77 

featured 

posters

Featured 

posters 

SuNDAy MORNING - FEATURED PoSTERS 


Featured Poster Session 2 - Sunday 10:00 - 11:00 

Chairpersons: A. Lyon (London, GB); S. Heymans (Maastricht, NL) 





Cardiac fibroblast-secreted microRNAs mediating cardiomyocyte hypertrophy P480 

C. Bang, s. dangwal, s. Batkai, A. Zeug, M. Mayr, A. schmiedl, T. Thum 

(Hannover, de; London, GB) 

Renal sympathetic denervation suppresses ventricular substrate remodeling in 

a canine high-rate pacing model P481 

Q. Zhao, shengb. Yu, Jinpin. Xiao, Zixuan. dai, Xule. Wang, Congxi Huang (Wuhan, CN) 

Myocardial titin hypophosphorylation importantly contributes to heart failure 

with preserved ejection fraction in a rat cardiometabolic risk model. P482 

C. Franssen, N. Hamdani, I. Falcao Pires, A.P. Lourenco, C.A.C. Ottenheijm, 

W.A. Linke, A. Leite Moreira, W.J. Paulus (Amsterdam, NL; Porto, PT; Bochum, de) 

Proteomic analysis of right atrial remodelling in tachycardia-induced heart 

failure: insights into molecular mechanisms P483 

A. dietl, I. Winkel, R. deutzmann, J. schroeder, C. Jungbauer, P. schmid, 

M. Resch, G. Riegger, A. Luchner, C. Birner (Regensburg, de) 

Novel insights in hypertrophic cardiomyopathy (HCM) evaluation: mirs as 

biomarkers of HCM cardiac remodeling P484 

s. santos, V. Marques, A.C. Nunes, A.T. Freitas, M.R. Gouveia, M. Antunes, 

I.M. Carreira, I.M. Gaspar, C. Monteiro, A.R. Fernandes (Lisbon and Coimbra, PT) 

Cyclic GMP enhancing therapy promotes titin phosphorylation and corrects 

high cardiomyocyte passive stiffness in diastolic heart failure P485 

N. Hamdani, M.M. Redfield, W.A. Linke (Bochum, de; Rochester, Us) 

C21, a specific angiotensin(ang)II type 2 receptor agonist, downregulates LPSstimulated 

tissue factor procoagulant activity in human mononuclear cells. (w) P486 

C. Balia, s. Petrini, V. scalise, s. Cianchetti, A. Celi, R. Pedrinelli (Pisa, IT) 

Mechanical cell conditioning of subATDPCs for cardiac regeneration therapy P487 

A. Llucia-Valldeperas, B. sanchez, C. soler-Botija, d.O. Freytes, C. Prat-Vidal, 

s. Roura, J. Rosell-Ferrer, G. Vunjak-Novakovic, R. Bragos, A. Bayes-Genis 

(Badalona and Barcelona, es; New York, Us) 

Experimental mild hypothermia potentiates pulmonary vasoconstriction 

during endotoxemia in pigs. P488 

M. schwarzl, s. seiler, A. Alogna, B. Zirngast, s. Huber, H. Maechler, P. steendijk, 

B.M. Pieske, H. Post (Graz, AT; Leiden, NL) 

Long-term levosimendan treatment improves systolic function and myocardial 

relaxation in mice with cardiomyocyte-specific disruption of the SERCA2 gene P489 

V. Hillestad, F. Kramer, s. Golz, A. Knorr, K.B. Andersson, G. Christensen 

(Oslo, NO; Wuppertal, de) 

78

SuNDAy AFTERNOON - FEATURED PoSTERS 


Featured Poster Session 3 - Sunday 15:45 - 16:30 

Chairpersons: M.F. Piepoli (Piacenza, IT); G. Hindricks (Leipzig, DE) 





Evaluation of the efficacy and costs impact of a telemonitoring and 

teleintervention trough videoconference program for patients with chronic 

heart failure: a randomized controlled trial P490 

C. enjuanes Grau, J.C.C. Comin Colet Josep, J.V.R. Verdu Rotellar Jose Maria, 

G.G.R. Gonzalez Tobledo Gina, P.R.R. Ruiz Rodriguez Pilar, A.L.A. Linas Alonso, 

C.I.d. Ivern diaz Consol, J.B.C. Bruguera Cortada Jordi (Barcelona, es) 

Pre-operative renal parameters in patients indicated to long-term ventricular 

assist device implantation - when we should be afraid of acute renal failure 

requiring renal replacement therapy? P491 

M. Holek, J. Kettner (Prague, CZ) 

Systematic review of bridging to heart transplantation with long-term 

continuous flow left ventricular assist devices P492 

s. Pettit, A. Japp, N. Hawkins, R. Gardner, s. Haj-Yahia, J. Mcmurray, M. Petrie 

(Liverpool, edinburgh and Glasgow, GB) 

Trimetazidine in the management of chronic heart failure in patients with 

mechanical prostheses of aortic valve: a randomized, case-control study P493 

I.R. Gaisin, A.s. Gazimzyanova (Izhevsk, RU) 

How many heart failure patients admitted to secondary care fulfil ESC 

guideline criteria for cardiac resynchronisation therapy? P494 

d.H. Brahmbhatt, R. Prasad, V. Nayar, N. Hiari, M.R.d. Belham, d.P. dutka, 

P.J. Pugh (Cambridge, GB) 

A multiparametric echocardiographic approach to enhance patient selection 

for CRT incorporating myocardial substrate characterization P495 

A.C. Kydd, F.Z. Khan, L.M. Mccormick, L.M. Ring, M.s. Virdee, d.P. dutka 

(Cambridge, GB) 

Prognostic impact of QRS axis deviation in patients treated with cardiac 

resynchronization therapy P496 

L. Perrotta, R. Bani, G. Ricciardi, P. Pieragnoli, L. di Biase, A. Natale, A. Valleggi, 

M. emdin, G. Mascioli, L. Padeletti (Florence, Pisa and Bergamo, IT; Austin, Us) 

Dyspnea relief with serelaxin-treatment in patients with acute heart failure in 

the RELAX-AHF trial: the earlier the better? P497 

J.R. Teerlink, M. Metra, G. Cotter, B.A. davison, G.M. Felker, G.M. Filippatos, 

B.H. Greenberg, P. Ponikowski, A.A. Voors, e. Unemori (san Francisco, durham, 

NC, san diego and san Carlos, CA, Us; Brescia, IT; Athens, GR; Wroclaw, PL; 

Groningen, NL) 

79 

featured 

posters

Featured 

posters 

MONDAy MORNING - FEATURED PoSTERS 


Featured Poster Session 4 - Monday 10:00 - 11:00 

Chairpersons: T.A. McDonagh (London, GB); M.F. Piepoli (Piacenza, IT) 





Playing exergames by heart failure patients P498 

L. Verheijden Klompstra, T. Jaarsma, A. stromberg (Norrkoping and Linkoping, se) 

Communicating prognosis and end-of-life to heart failure patients: heart 

failure nurses' perspectives P499 

L. Hjelmfors, T. Jaarsma, J. Martensson, M. Friedrichsen, A. stromberg (Linkoping 

and Jonkoping, se) 

Person-centered care influences the belief in medication in patients with 

chronic heart failure P500 

K. dudas, L.-e. Olsson, K. swedberg, A. Wolf, I. ekman (Gothenburg, se) 

Predictors for appetite among patients with chronic heart failure P501 

C. Andreae, A. stromberg, K. Arestedt (Linköping and Kalmar, se) 

Medical yoga compared to hydrotheraphy training in patients with heart 

failure - a randomised pilot study P502 

e. Hagglund, I. Hagerman, A. stromberg (stockholm and Linkoping, se) 

Phone-call consultations in a heart failure unit P503 

B. Gonzalez, R. Cabanes, L. Cano, J. Lupon, M. Arenas, C. Blasco, M. de Antonio, 

A. Urrutia, M. domingo, A. Bayes-Genis (Badalona, es) 

Perceived needs of supportive care in patient-partner dyads affected by heart 

failure P504 

M. Liljeroos, s. Agren, T. Jaarsma, A. stromberg (Linkoping, se) 

In-hospital variation of dyspnea scores in patients with acute heart failure 

versus exacerbation of chronic obstructive pulmonary disease P505 

e. Tzourou, M. Nikolaou, K. Paravolidakis, J.T. Parissis, s. Nikolakopoulou, 

s. Gaitani, M. Anastasiou-Nana, J. Lekakis, G. Filippatos (Athens, GR) 

Self-care skills of heart failure patients and association with hospital 

readmission rates P506 

A.C. Linn, K.O. Azzolin, e.N. souza (Porto Alegre, BR) 

Clinical validation of nursing diagnosis sexual dysfunction in outpatients with 


A.C. Cavalcanti, V.A. silva, W.A. Martins, e.T. Mesquita, J.M.V. Pereira, F. Melo, 

R. souza, G.C. Vieira, I. Vasconcellos, R. santana (Niteroi, BR) 

80

MONDAy AFTERNOON - FEATURED PoSTERS 


Featured Poster Session 5 - Monday 15:45 - 16:30 

Chairpersons: A. Cohen-Solal (Paris, FR); L. Tavazzi (Cotignola, IT) 





Decrease of elevated PCWP is not accompanied by a benefit in mid- and longterm 

survival in CHF P508 

C. Kapelios, J. Terrovitis, e. Kaldara, A. Ntalianis, e. Repasos, C. Pantsios, 

V. sousounis, T. sfakianaki, Z. Margari, J. Nanas (Athens, GR) 

Prognostic significance of high-sensitivity troponin-T in patients with 

suspected chronic heart failure P509 

J.G.F. Cleland, J. Zhang, A. Torabi, B. dicken, F. Keshavarzi, R. dierckx, A. shoaib, 

P. Pellicori, K.M. Goode, A.L. Clark (Kingston Upon Hull, GB) 

Prognosis in heart failure in the era of beta-blockers: role of severe exercise 

intolerance assessed by peak oxygen consumption P510 

G. Cattadori, P. Agostoni, e. salvioni, U. Corra, G. Parati, A. di Lenarda, 

M. Piepoli, G. sinagra, M. emdin, M. Metra (Milan, Veruno, Trieste, Piacenza, Pisa 

and Brescia, IT) 

Adherence to heart failure therapy and outcome: a population based study P511 

J.L. Yeong, s.A. Ogston, C. Hall, d. Heather, d.H. elder, A.M. Choy, 

A.d. struthers, C.C. Lang (dundee, GB) 

Lack of anaerobic threshold identification is associated with poor prognosis in 


e. Battaia, P.G. Agostoni, M. Giovannardi, M.A. Cicoira, G. Limongelli, R. La Gioia, 

A.B. scardovi, C. Passino, A. Mezzani, R. Belardinelli (Milano, Verona, Napoli, Bari 

(Cassano delle Murge), Roma, Pisa, Veruno and Ancona, IT) 

Successful long-term weight loss improves left ventricular diastolic function, 

physical performance and quality of life in severe obesity P513 

s. Fenk, A. Baessler, e. Rousseva, C. strack, M. Manka, G. schmitz, G. Riegger, 

T. Loew, C. Lahmann, M. Fischer (Regensburg and Munich, de) 

Cardiopulmonary exercise testing in idiopathic dilated cardiomyopathy: 

prognostic role of VE/VCO2 and percent-predicted peak VO2 P514 

A. Iorio, A. di Lenarda, e. Zambon, e. Berton, M. Merlo, e. salvioni, G. Cattadori, 

M. Contini, P. Agostoni, G. sinagra (Trieste and Milan, IT) 

Basic grounding of prognosis and medical prevention of postoperative heart 

remodeling in patients with ischemic cardiomiopathy P515 

V.M. shipulin, V.A. Kazakov, A.A. Lezhnev, s.L. Andreev, V.H. Vaizov, s.s. Gutor, 

I.V. suhodolo (Tomsk, RU) 

81 

featured 

posters

Featured 

posters 

TuESDAy MORNING - FEATURED PoSTERS 


Featured Poster Session 6 - Tuesday 10:00 - 11:00 

Chairpersons: R. Doughty (Auckland, NZ); R. Latini (Milan, IT) 





Predictors of NT-proBNP response in primary care patients with heart failure 

and NT-proBNP guided therapy. P516 

H. erntell, K. swedberg, L. Jorgensen, U. dahlstrom, H. Persson (stockholm, 

Gothenburg, södertälje and Linkoping, se) 

Gene polymorphism of brain natriuretic peptide in patients with chronic heart 

failure P517 

e.N. Berezikova, s.d. Mayanskaya, s.N. shilov, A.T. Teplyakov, A.V. efremov, 

I.d. safronov, M.G. Pustovetova, A.A. Popova, N.F. Yakovleva, J.U.J.U. Torim 

(Novosibirsk, Kazan and Tomsk, RU) 

High-sensitive troponin I after acute cardiac decompensation - distribution of 

baseline values and prognostic significance P518 

J. Wallenborn, s. stauffenberg, s. stoerk, d. Berliner, P. Heuschmann, G. ertl, 

C. Angermann (Hannover and Würzburg, de) 

Prognostic value of plasma amino-terminal pro-brain natriuretic peptide in 

out-patients with suspected heart failure: a decade of experience in a single 

centre P519 

J.G.F. Cleland, J. Zhang, P. Pellicori, P. Callan, R. Jibran, T. Mabote, R. Antony, 

s. Parsons, K.Y. Wong, A.L. Clark (Kingston Upon Hull, GB) 

Multi-marker risk score for mortality in older patients with decompensated 

chronic heart failure (w) P520 

C. Bjurman, J. Jensen, O. Hammarsten, M.L.X. Fu (Gothenburg, se) 

Impact of malnutrition in very elderly patients with acute decompensated 


M. shigekiyo, A. Okada, K. Takeichi, T. shiraishi, A. Hirono, K. Tamura (Tokushima, JP) 

Rica score: model of risk assessment in heart failure P522 

A.P. Bohlen delgado, B. Rodrigues, d. Moreira, B. Marmelo, e. Correia, P. Gama, 

O. santos (Viseu, PT) 

Prevalence and differential prognostic significance of anaemia and iron 

deficiency in decompensated heart failure P523 

F. Hammer, M. Kaspar, s. stoerk, d. Berliner, G. Gueder, s. Brenner, G. Gelbrich, 

G. ertl, P.U. Heuschmann, C.e. Angermann (Wuerzburg and Hannover, de) 

Expression levels of select mRNA triads are predictive of response to 

beta-blocker therapy in patients with reduced ejection fraction heart failure P524 

d.P. Kao, L.e. epperson, A. Karimpour-Fard, e.M. Gilbert, B.d. Lowes, L.e. Hunter, 

M.R. Bristow (denver, salt Lake City and Omaha, Us) 

Cystatin C correlates with alpha-1-microglobulin, neutrophil gelatinaseassociated 

lipocalin and BNP in patients after heart transplantation P525 

L. Hoskova, J. Franekova, I. Malek, P. secnik, J. Pirk, J. Kautzner, O. szarszoi, 

A. Jabor (Prague, CZ) 

82

MODERATED POSTER SESSION 1 

New this year 

Moderated Poster sessions will be organised over 2 half days. Make the most of the 

2 coffee breaks to interact with the presenters! 

Moderated Poster Session 1 

From saturday 25 May 14:00 - 18:00 & sunday 26 May 08:00 - 12:30. 

These sessions provide a visual display of research highlights with a maximum of 

viewing time for of the research and peer to peer interaction. A very popular platform 

where our community truly comes together to meet and exchange knowledge 

throughout the different categories: 

• Basic science 

• Clinical research 

• Clinical cases 

The following posters will be on display for the entire duration of the congress! 


• Clinical Forum: Late Breaking trials, Clinical trials, Late Breaking Research 

Clinical & Basic science… 

Come and interact with the presenters! 

Research 

New Therapies 

83 

Interventions 

Knowledge 

MODERATED 

pOsTER sEssiOn 1

moderated poster session 1 - sATuRDAy 14:00 TO sunDAy 12:30 

Moderated Poster Session 1 - Saturday 14:00 to Sunday 12:30 

85 

Poster Area 

New this year 

Posters will be hosted and sessions will be two half-days long: meet the presenters, interact, 

exchange and join the visiting experts! 

Clinical - Acute Heart Failure 

Clinical experience in daily practice with Tolvaptan in patients hospitalized for heart 

failure and refractory hyponatremia. P526 

N. salterain Gonzalez, A. esteban Fernandez, M. Garcia Lopez, J.J. Gavira Gomez 

(Pamplona, es) 

Analysis of the efficacy and complications associated with use of intraaortic balloon 

pump in an acute coronary care unit P527 

s. secades, e. Velasco, J.P. Florez, e. Fernandez, V. Barriales, M. Martin, e. diaz, F. Pun, 

e. Capin, J.L. Lambert (Oviedo, es) 

Heart failure cause blood transfusions after cardiac surgery P528 

V. sanchez, C. Pons, M. Puccini, O. Londono (Barcelona, es) 

Survival and characteristics of patients undergoing rescue cardiac resynchronisation 

therapy in cardiac intensive care P529 

s. Honarbakhsh, V.L. simpkin, M.R. Griffiths, s. Price, R.K. sharma, M.R. Cowie, A. Vazir 

(London, GB) 

Evaluation of the effectiveness of in-hospital treatment of chronic heart failure 

patients during exacerbation by non-invasive net lung impedance monitoring during 

during admission P530 

M. shochat, A. shochat, M. Kazatsker, A. Asif, I. dahan, I. shochat, Y. Levy, L. Vasilenko, 

d. Blondheim, s. Meisel (Hadera, IL) 

OPeRA-HF Study Design (Monitoring Arm): An observational study to assess 

and predict the in-patient course, risk of re-admission and mortality for patients 

hospitalised for or with heart failure P531 

A. shoaib, K.M. Goode, A. Crundall-Goode, G. Geleijnse, J.J.G. de Vries, e. Robson, 

K. dobbs, K. Wong, A.L. Clark, J.G.F. Cleland (Hull, GB; eindhoven, NL) 

Mechanical ventilation in patients with acute heart failure: invasive or non-invasive? P532 

F. Caetano, I. Almeida, A. Fernandes, I. Patricio, P. Mota, A. Botelho, A. Leitao-Marques 

(Coimbra, PT) 

Sildenafil for a treatment in patients with Chronic Lung disease in an acute stage P533 

V. sanchez, P. esteve, M.L. Perez, O. Londono sanchez (Barcelona, es) 

Prognostic value of echocardiography and treatment with ventricular assist devices in 

fulminant myocarditis P534 

s. secades, C. Corros, M. Martin, J.M. de La Hera, B. diaz, V. Barriales, e. Fernandez, 

e. diaz, e. Capin, J.L. Lambert (Oviedo, es) 

Prehospital treatment of pulmonary edema- a 6 year study P535 

s. Lourenco, J. Figueira-Coelho, Z. Neves, s. Lino (Lisbon, PT) 

Hemodynamic improvement following levosimendan treatment in acute myocardial 

infarction complicated by cardiogenic shock patients treated with primary 

percutaneous coronary intervention and intra-aort P536 

M. Pennacchi, M. Mancone, L. Lucisano, N. Bruno, N. salvi, R.e. stio, B. Brasolin, 

s. Calcagno, G. sardella, F. Fedele (Rome, IT) 

MODERATED 

pOsTER sEssiOn 1

MODERATED 

pOsTER sEssiOn 1 


Descriptive study of the pharmacological management for rate control in patients 

with atrial fibrillation (af) admitted to an internal medicine department. P537 

C. Capin sampedro, e. Capin sampedro, e.M. Benito Martin, s. secades Gonzalez, 

L. Garcia Perez (Oviedo, es) 

Pulmonary artery stiffness in patients with heart failure P538 

F.Q. Huang, T.T. Le, L. Zhong, R.s. Tan (singapore, sG) 

The Killip-Kimbal classification- is it still useful in our age of widespread primary 

coronary intervention? P539 

d.A. Moreira, B. Rodrigues, J. Pipa, L. Nunes, O. santos (Viseu, PT) 

Cost of hospitalisation of heart failure in a developing economy P540 

A. Mbakwem, N. Ajoku, A. Okobi (Lagos, NG) 

Outcome of cardiopulmonary resuscitation by Systolic Blood Pressure at admission 

in patients with in-hospital heart failure; data from Romanian Acute Heart Failure 

Syndromes (RO-AHFS) Study P541 

O. Chioncel, A. Ambrosy, d. Vinereanu, s. Bubenek, d. Filipescu, A. Petris, L. Antohi, 

C. Macarie, M. Gheorghiade (Bucharest and Iasi, RO; stanford and Chicago, Us) 

Descriptive study of pharmacological management of atrial fibrillation (AF) and heart 

failure (HF) in patients admitted to an internal medicine department (IMD) P542 

C. Capin sampedro, M.L. Gallego Villalobos, M.L. Garcia Perez, M.L. Barreiro Perez 

(Oviedo, es) 

Religiosity and quality of life in patients with heart failure P543 

F.d.C. Cruz, A.C.A. Nussbaum, V.s. Issa, s.F. Ayub, G.e. Conceicao, F. Bacal, e.A. Bocchi 

(sao Paulo, BR) 

Acute heart failure due to scorpion envenomation. P544 

A. Tounsi, Leila. Abid, dorra. Abid, Mabrou Bahloul, Anis Chaari, Mourad Hentati, 

samir Kammoun, Mounir Bouaziz (sfax, Tn) 

Differences among patients with atrial fibrillation (af) admitted for heart failure with 

or without accompanying thyroid disorders P545 

C. Capin sampedro, e.M. Benito Martin, M.L. Barreiro Perez, A. Renilla Gonzalez, 

M.L. Garcia Perez (Oviedo, es) 

Do beta-blockers improve long-term prognosis of elderly patients with ischemic heart 

disease presenting as acute heart failure? P546 

s.-J. Joo, J.-H. Choi, s.-Y. Kim, K.-s. Kim, K.-H. Ryu (Jeju and dongtan, KR) 

Acute heart failure due to traumatic brain injury P547 

Ahmed Tounsi, Leila. Abid, Mabrou Bahloul, Anis Chaari, dorra Abid, Mourad Hentati, 

samir Kammoun, Mounir Bouaziz (sfax, Tn) 

Comparison of muscle strength between different clinical pathologies: heart failure, 

familial amyloidotic polyneurophathy and fibromyalgia P548 

B. Fernandes, R. Pinto, M.H. santa Clara, A. Abreu, M. Carrolo, M.T. Tomas, M. Goncalves, 

s. silva, P. Cunha, M. Oliveira (Lisbon, PT) 

Relationship between systemic venous congestion and renal function in patients with 

acute heart failure. P549 

M. Koide, H. Miura, K. Miyazaki, G. Hamano, H. Kitada, H. Abe, K. Hirooka, Y. Koretsune, 

H. Kusuoka, Y. Yasumura (Osaka, JP) 

The distribution of changes in weight and pulmonary artery pressure leading to 

worsening heart failure P550 

R. Wariar, K. Beck, G. Herro, R.J. sweeney, F.R. Gilliam, d. Menachemi, Y. Rozenmann, 

H. sievert, M. Vanderheyden, U.C. Hoppe (st Paul and Arkansas, Us; Holon, IL; 

Frankfurt, de; Aalst, Be; salzburg, AT) 

86


Association between obesity and clinical characteristics in patients with acute 


M. Matsushita, A. shirakabe, N. Hata, Y. Yamamoto, H. Okazaki, M. Tsurumi, K. Tomita, 

T. shinada, s. Yokoyama, K. Mizuno (Chiba and Tokyo, JP) 

High urine osmolality on admission predicts better prognosis in patients with acute 

heart failure syndrome P552 

s. Koyama, Y. sato, H. Inazumi, T. sawa, Y. Tanada, H. Fujiwara, Y. Takatsu (Amagasaki, JP) 

Early changes in ventricular-arterial coupling in acutely decompensated systolic heart 

failure: an arterial tonometry and echocardiography study P553 

e. Berthelot, O. Brault Meslin, N. Bihry, P. Assayag, A. Cohen-solal, d. Logeart (Paris and 

Le Kremlin-Bicetre, FR) 

The correlations of serum phosphorus and left ventricular mass, function and 

congestive heart failure in a General Hospital in Thailand P554 

W. Wichitkosoom (Udonthani, TH) 

Relationship between red blood cell distribution width on admission and heart failure 

in very elderly patients with acute myocardial infarction P555 

A. Renilla Gonzalez, e. diaz, J. Rozado, M. Barreiro, I.A. Pichel, V. Barriales (Oviedo, es) 

Comparison of the diagnostic and prognostic values of B-type and atrial-type 

natriuretic peptides in acute heart failure P556 

M.-F. seronde, e. Gayat, d. Logeart, J. Lassus, s. Laribi, R. Boukef, F. sibellas, J.M. Launay, 

A. Cohen-solal, A. Mebazaa (Besançon, Paris and Lyon, FR; Helsinki, FI; Monastir, TN) 

Acute heart failure precipitated by acute coronary syndrome - patient characteristics, 

management and survival P557 

T. Tarvasmaki, V.P. Harjola, J. Tolonen, K. siirila-Waris, M.s. Nieminen, J. Lassus (Helsinki, FI) 

Assessment of hypertonic stress in young men basing on the data of blood pressure 

daily monitoring P558 

V. dyakonyuk, V. Tashchuk, s. Grechko (Chernivtsi, UA) 

Clinical characteristics of patients with atrial fibrillation (AF) admitted to an internal 

medicine department P559 

C. Capin sampedro, e. Capin sampedro, M.L. Martin Fernandez (Oviedo, es) 

Clinical - Diagnosis 

Do frail elderly with screen-detected diagnosis of heart failure have a worse prognosis 

as compared to other frail elderly? P560 

K.P. Wagenaar, A.W. Hoes, Y. Van Mourik, L.C.M. Bertens, F.H. Rutten (Utrecht, NL) 

Implantable sensors measure physiologic response to activity during activities of daily 

living P561 

J. Boehmer, Y. Zhang, K. Beck, R. sweeney (Hershey and st Paul, Us) 

utility of serial high-sensitive Troponin T measures with the incident of heart failure in 

acute coronary syndrome P562 

J.G. sanchez Ramos, I. Almansa Valencia, P. Toledo Frias, F. Burillo Gomez, 

s. Martinez Huertas, e. Moreno escobar, G. Moreno Terribas, P. Martin de La Fuente, 

J. Caballero Borrego, C. Correa Vilches (Granada, es) 

The optimal cut-points of NT-proBNP for detecting acute heart failure in Chinese 

dyspnoeic inpatients P563 

Q. duan, d.Y. Zhang, s. Qin (Chongqing, CN) 

The effect of dobutamine stress on left ventricular outflow tract gradients in 

hypertensive patients with basal septal hypertrophy (w) P564 

N. Haq, F.Y. Yalcin (Baltimore, Us) 

87 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Sexual dysfunction in patients with chronic heart failure (CIBIS-ELD Study) P565 

e. Tahirovic, T. Trippel, V. Tscholl, L. Musial-Bright, d. Jahandar Lashki, s. Inkrot, 

d. Obradovic, W. doehner, W. Haverkamp, H.-d. duengen (Berlin, de) 

Application of the Seattle Heart Failure Model in Latin American population with 

idiopathic, ischemic and Chagasic etiologies P566 

G.V. Guimaraes, M.M. Fernandes-silva, A.C. Tavares, I.s. Teixeira-Neto, R.e. Castro, 

s.A. Ferreira, V.s. Issa, P.R. Chizzola, N. Carvas Junior, e.A. Bocchi (sao Paulo, BR) 

Pulmonary ultrasound "Comet Tail" artefact in heart failure patients with preserved 

systolic function P567 

M. Tsverava, d. Tsverava (Tbilisi, Ge) 

Clinical - Arrhythmias and treatment 

Safety and efficacy of warfarin versus aspirin in patients with heart failure and sinus 

rhythm: a meta-analysis of phase III randomized controlled trials P568 

L.V. Paiva, R. Providencia, A.C. Faustino, s. Barra, P. dinis, F. Caetano, I. Almeida, 

A.M. Botelho, A. Leitao-Marques (Coimbra, PT) 

Autonomic function in adolescent patients with non-sustained ventricular tachycardia 

according to heart rate variability (HRV). P569 

Y. Kikuchi (Tochigi, JP) 

T peak-T end interval and severe ventricular arrhythmia in patients with atrial 

fibrillation and heart failure P570 

G. Gheorghe, A. Cristea, A. Liteanu, d. Arama, A. Hodorogea, I.T. Nanea (Bucharest, RO) 

Patients in coma vigile reveal a breakdown in fractal organization of the heart rate 

variability P571 

N. scherbakov, N. ebner, M. Knops, s. Von Haehling, W. doehner (Berlin, de) 

Clinical - Atrial fibrillation 

CHADS2 and CHA2DS2-VASc scores are not inferior to ejection fraction and left atria 

size for predicting cardiovascular mortality in non-valvular atrial fibrillation P572 

A. Faustino, R. Providencia, L. Paiva, A. Fernandes, J. Trigo, A. Botelho, F. Caetano, 

I. Almeida, M. Costa, A. Leitao-Marques (Coimbra, PT) 

Influence of a functional classes of heart failure on HAS-BLED score levels and the 

incidence of hypocoagulation/bleedings P573 

N.U. Zakirov, R.d. Qurbanov, d.B. Irisov, T.Z. Ganiyev (Tashkent, UZ) 

Low negative predictive value of D-Dimer test for detectiong left atrial appendage 

thrombi in Egyptian patients with valvular Atrial Fibrillation (w) P574 

A. Al-Habbaa, A. Al-Amin, M. ezzat, A. Gazar, M. Mansour (Cairo, eG) 

Assessment of ECHO parameters in with patients with arrhythmia recurrence after 

3-D radiofrequency ablation of atrial fibrillation P575 

A.V. Ardashev, e. Zhelyakov, e. dolgushina, A. Konev, V. Ardashev (Moscow, RU) 

usefulness of brain natriuretic peptide (BNP) for evaluating left ventricular filling 

pressure in patients with atrial fibrillation P576 

J. Ahn, d.H. Kim, T.H. Kim (Gumi, KR) 

Vitamin K antagonist therapy for atrial fibrillation in very elderly patients with heart 

failure in real clinical practice P577 

A. Mateescu, M. Vintila, M. Baluta, M.M. Vintila (Bucharest, RO) 

Can preoperative therapy with ACE inhibitors prevent atrial fibrilation after coronary 

artery bypass grafting P578 

A. Boskovic, N. Belada, s. dragnic (Podgorica, Me) 

88


Left ventricular hypertrophy as a predictor of incident atrial fibrillation and the effect 

of hypertension in the Suita Study: an urban cohort study P579 

Y. Kokubo, W. shimizu, M. Watanabe, s. Kamakura, A. Kada, K. Kawanishi, Y. Miyamoto 

(suita, JP) 

Clinical - Cancer/Cardiotoxicity 

Left heart remodelling one year after adjuvant treatment with trastuzumab in women 

with positive human epidermal growth factor type 2 receptor (HER-2) breast cancer. P580 

G. Piotrowski, L. Bodnar, R. Gawor, P. strzelecki, M. Majzner, d. Timler, P. Potemski, 

Z. Gawor (Lodz and Warsaw, PL) 

Cardiotoxicity of cyclophosphamide: A formula to predict a safe dose of anticancer 

agents for neoadjuvant therapy of breast cancer P581 

M. Arao, M. sekine, Y. Kitahara, K. Mizuno (Tokyo, JP) 

Cardiotoxic anticancer agents induce heart failure with preserved ejection fraction 

(HF-PEF): a pathophysiologic study of altered cardiac mechanics P582 

M. Arao, M. sekine, Y. Kitahara, K. Mizuno (Tokyo, JP) 

Survival of chemotherapy-induced cardiomyopathy in the last two decades P583 

A. Fornaro, G. Castelli, M. Ciaccheri, B. Tomberli, I. Olivotto, G.F. Gensini (Florence, IT) 

Early diagnosis of cardiotoxicity by anticancer therapy with pulsed wave tissue 

doppler imaging: detection of the cut-off value of myocardial systolic velocity P584 

F. Maramao, Y. Conde, I. sperduti, F. Rulli (Rome, IT) 

Clinical - Cardiomyopathy 

An analysis of heart rate recovery in hypertrophic cardiomyopathy P585 

V. Patel, C.H. Critoph, M. Finlay, B. Mist, P. Lambiase, P.M. elliott (London, GB) 

Symptoms in hypertrophic cardiomyopathy: what are the predictors? P586 

C.e. Correia, d. Moreira, C. Cabral, O. santos, J.s. Cardoso (Viseu and Porto, PT) 

The relation between the dimensions of the left atrium and the mass index of the left 

ventricle in hypertensive heart diseases as possible determinants of heart failure P587 

s. Pajovic, s. Lazic, d. Celic, B. Lazic, R. stolic (Gracanica, Rs) 

Late gadolinium enhancement in the right ventricular septal insertion: a finding with 

prognostic value in hypertrophic cardiomyopathy? P588 

A. Lebreiro, e. Martins, M. Vasconcelos, T. Pinho, A. sousa, A. Madureira, M. Campelo, 

s. Amorim, J. silva-Cardoso, M.J. Maciel (Porto, PT) 

Apical rocking in septal asymmetric hypertrophic cardiomyopathy: a new marker 

assessing ventricular function P589 

C. sousa, A. Goncalves, I. Rangel, A.s. Correia, A. Lebreiro, e. Martins, J.C. silva-Cardoso, 

F. Macedo, M.J. Maciel (Porto, PT) 

Results of catheter cblation of atrial fibrillation in hypertrophic cardiomyopathy - 

comparison between primary and secondary hypertrophy P590 

A. Muessigbrodt, J. Kosiuk, e. Koutalas, s. Pastromas, s. Richter, A. Bollmann, G. Hindricks 

(Leipzig, de) 

Myocardial scar on cardiovascular magnetic resonance imaging predicts adverse 

outcome in adults with non-ischaemic dilated cardiomyopathy P591 

C.M. Plymen, s.e. Piper, J. Hilton, R. Rajani, e. Nagel, G.s. Carr-White, s.s. Kapetanakis 

(London, GB) 

Assessment of baroreflex regulation depended on the humoral changes P592 

s.s. davirova, N.A. Kurbanov, T.A. Abdullaev (Tashkent, UZ) 

89 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Prognosis assessment with cardiac magnetic resonance imaging in familial dilated 

cardiomyopathy P593 

s.M. Leite, e. Martins, T. Pinho, A. Madureira, M.B. Campelo, s. Amorim, B. Moura, 

J. silva Cardoso, M.J. Maciel (Porto, PT) 

ultrastructural findings of cardiomyocytes in early phase of dilated cardiomyopathy as 

a predictor of the prognosis P594 

T. saito, K. Asai, s. sato, e. Yamamoto, H. Takano, M. Yasutake, K. Mizuno (Tokyo, JP) 

Galectin-3, soluble ST-2 protein and echocardiographic parameters in clinically stable 

dilated cardiomyopathy patients P595 

C.A. Wojciechowska, W. Jachec, e. Romuk, A. Gala, d. Kawecki, K. Krzemien-Wolska, 

G. Kubiak, e. Nowalany-Kozielska (Zabrze, PL) 

Reverse ventricular remodeling after pharmacological therapy in idiopathic dilated 

cardiomyopathy- prevalence and prognosis P596 

s.M.R. Amorim, M. Campelo, e. Martins, B. Moura, J. silva-Cardoso, M.J. Maciel 

(Porto, PT) 

Trimetazidine therapy in patients with dilated cardiomyopathy and congestive 


N. Al-shawabkeh (Amman, JO) 

Clinical features of cardiac involvement of myasthenia gravis P598 

s. Hirose, T. Kato, M. Inoko, s. Kumagai, e. Minamino, A. Ozaki, s. Matsumoto, R. Nohara 

(Osaka, JP) 

In-hospital prognosis of stress cardiomyopathy P599 

V. Ribeiro, M. Vasconcelos, F. Melao, e. Ferreira, G. Malangatana, M.J. Maciel (Porto and 

Matosinhos, PT) 

Malignant arrhythmias in peripartum cardiomyopathy P600 

M. Yahalom, M. Jabaren, L. Ilan-Bushari, e. Rosner, Y. drori, Y. Turgeman (Afula, IL) 

Cardioembolism as the initial manifestation of left ventricle noncompaction P601 

C. sousa, A. Goncalves, T. Pinho, I. Rangel, M. Paiva, A.J. Madureira, F. Macedo, 

M.J. Maciel (Porto, PT) 

Coxsackie-adenovirus receptor (CAR) in patients with cardiomyopathy of 

inflammatory and non-inflammatory etiology P602 

e.M. Gupalo, L.I. Buryachkovskaya, M.A. Naumova, P.V. Chumachenko, N.A. Mironova, 

s.P. Golitsyn (Moscow, RU) 

Association of ratio of eicosapentaenoic acid to arachidonic acid (EPA/AA) with the 

washout rate of tc-99msestamibi in patients with cardiomyopathy P603 

M. Wakasa, K. Kajinami, M. Kitayama, Y. Kawai, H. Akao, N. Fujioka, H. Aoki, 

K. Fujibayashi, K. Tanabe, W. Fujita (Ishikawa, JP) 

Hemodynamic response to volume expansion and TIPS in cirrhotic patients with 

refractory ascites: lack of evidence of a relevant cirrhotic cardiomyopathy P604 

C. Falletta, d. Fili', C.M. Hernandez Baravoglia, G. di Gesaro, C. Mina', F. Tuzzolino, 

A. Luca, F. Clemenza, C. scardulla, J. Bosch (Palermo, IT; Barcelona, es) 

High risk of severe cardiac adverse events in patients with mitochondrial 

m.3243A>G mutation P605 

d. duboc, K. Wahbi, P. Laforet, O. Varenne, s. Weber, T. stojkovic, A. Behin, B. eymard 

(Paris, FR) 

Mitochondrial changes in patients with dilated cardiomyopaty and myocarditis P606 

A. Pawlak, M. Fronczak-Baniewicz, M. Przybylski, K. Gil, O. Mozenska, A. Michalek, 

A.M. Nasierowska-Guttmejer, R.J. Gil (Warsaw, PL) 

90


Global assessment of left ventricle longitudinal strain in patients after acute 

myocarditis: going further in left ventricular function P607 

M. Paiva, A. Goncalves, F. Melao, C. sousa, I. Rangel, e. Martins, A. Madureira, F. Macedo, 

T. Pinho, M.J. Maciel (Porto, PT) 

Coronary microvascular disfunction in patients with acromegaly: a hint for their 

increased cardiovascular risk P608 

s. Tellatin, P. Maffei, G. Famoso, F. dassie, C. Martini, e. Osto, R. Vettor, s. Iliceto, F. Tona 

(Padova, IT) 

Alcoholic cardiomyopathy - an insight from Liptov region in Slovakia. Final results of 

4-years follow-up. P609 

P. Kycina, J. Murin (Lipt.Mikulas, Bratislava, sK) 

Left ventricular filling pressure estimated by echocardiography is a significant 

predictor of survival in patients with systemic light chain amyloidosis treated with 

autologous stem cell transplant P610 

L.M. Nelson, P. Gimsing, F. Gustafsson (Copenhagen, dK) 

Risk stratification for clinical outcomes and death in patients with cardiomyopathy P611 

A.K. Kurlianskaya, T.L. denisevich, M.I. Belskaya (Minsk, BY) 

Risk stratification of patients with cardiac amyloidosis by magnetic resonance imaging P612 

N.R. Pugliese, A. del Franco, A. Barison, A. Giannoni, G. Vergaro, M. Lombardi, 

M. emdin, G.d. Aquaro (Pisa, IT) 

Clinical - Cardio-renal syndrome 

Clinical correlates of renal arterial resistance index, a marker of cardiorenal syndrome P613 

F. Monitillo, M.M. Ciccone, M. Iacoviello, A. Puzzovivo, A. doronzo, V. Antoncecchi, 

G. Citarelli, V. Paradies, N. Corrieri, s. Favale (Bari, IT) 

Adaptive servo ventilation improves cardio-renal function and prognosis in heart 

failure patients with Chronic Kidney Disease and Sleep-Disordered Breathing P614 

Y. Takeishi, T. Owada, A. Yoshihisa (Fukushima, JP) 

Beta-blockers in the treatment of heart failure with preserved systolic function in 

patient with renal dysfunction P615 

O.V. soya, O.V. Kuryata, A.O. Miroshnichenko (dnipropetrovsk, UA) 

The features of cardiohemodynamic parameters, markers of kidney dysfunction and 

immune inflammation in patients with chronic heart failure and chronic kidney disease P616 

I. Mykhailova, L. Lapshina, G. Tytova, P. Kravchyn, V. Zolotaikina (Kharkiv, UA) 

Which laboratory parameter is the best predictor of the short-term survival of 

ambulatory patients with systolic heart. P617 

s. Longo, L. sargento, M. satendra, N. Lousada, R. Palma dos Reis (Lisbon, PT) 

Acute heart faillure: Cardiorenal Syndrome and its relation with hepatic alterations P618 

A. Fernandes, I. Almeida, F. Caetano, J. Trigo, P. Mota, A. Leitao Marques (Coimbra, PT) 

Prognostic value of urine NGAL in patients with acute kidney injury and 

decompensated heart failure P619 

A. Klimenko, s. Villevalde, M. efremovtseva, Z. Kobalava (Moscow, RU) 

State of renal tubuloepithelial system in patients with chronic heart failure P620 

U. Kamilova, I. Alikulov, Z. Rasulova (Tashkent, UZ) 

Assessment of paradoxical improvement in renal function defined by a decreased 

concentration of serum creatinine despite heart failure worsening in patients with 

mild-to-moderate heart failure P621 

H. Kataoka (Oita, JP) 

91 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Clinical features, in-hospital and 1-year mortality of patients with acute heart failure 

and severe renal dysfunction. Data from the Italian Registry IN-HF outcome. P622 

G. Cioffi, A. Mortara, F. Oliva, d. Lucci, M. senni, G. Cacciatore, A. Chinaglia, L. Tarantini, 

M. Metra, L. Tavazzi (Trento, Monza, Milano, Florence, Bergamo, Rome, Turin, Belluno, 

Brescia and Cotignola, IT) 

Fluid loss, venous congestion and worsening renal function in acute decompensated 


d. Aronson, Z. Abassi, e. Allon, A.J. Burger (Haifa, IL; Cincinnati, OH, Us) 

Clinical - Co-morbidities 

Long-term prognostic value of estimated glomerular filtration rate calculated with the 

new CKD-EPI-creatinin-Cystatin C equation in chronic heart failure P624 

e. Zamora, J. Lupon, M. de Antonio, J. Vila, J. Penafiel, A. Galan, A. Urrutia, B. Gonzalez, 

M. domingo, A. Bayes-Genis (Badalona and Barcelona, es) 

Co-morbidities and heart failure related therapies: do they contribute to anabolic 

deficiencies in men with systolic heart failure? P625 

e. Kalicinska, K. Wojtas, J. Majda, W. doehner, s. Von Haehling, W. Banasiak, 

B. Ponikowska, s.d. Anker, P. Ponikowski, e.A. Jankowska (Wroclaw, PL; Berlin, de) 

The impact of chronic obstructive lung disease on outcomes of chronic heart failure P626 

G. Kozdag, e. emre, G. ertas, I. Yilmaz, K. Karauzum, Y. Akay, T. sahin, M. Cetin, H. ekren, 

d. Ural (Kocaeli, Istanbul, Tekirdag and erzincan, TR) 

Face mask oxygen benefits on hypoxemia and cardiovascular side effects during 

colonoscopy in mild to moderate heart failure (HF) patients P627 

A.I. suceveanu, I.R. Parepa, L. Mazilu, A. suceveanu, F. Voinea, d. Catrinoiu (Constanta, RO) 

FACE: a prospective multicentre observational cohort study in patients with 

chronic heart failure (HF) and central sleep apnoea (CSA) treated with adaptive 

servoventilation (ASV) P628 

T. damy, R. Tamisier, P. Levy, J.-M. davy, L. Morin, M.-P.d.ortho, J.-L. Pepin 

(Creteil, Grenoble, Montpellier, saint Priest and Paris, FR) 

Nutritional status and prognostic value in advanced Heart Failure P629 

M.L. Talavera, M.I. somoza, L.e. Favaloro, C. Nino, P. Nicolao, M. Peradejordi, M. Carballo, 

L. Favaloro, A.M. Bertolotti, R.R. Favaloro (Buenos Aires, AR) 

Acute hemodynamic effects of a therapy with adaptive servoventilation in patients 

with heart failure compared to healthy volunteers P630 

J. spiesshoefer, J. Heinrich, R. Lehmann, C. efken, B. Koerber, T. Bitter, H. Fox, 

d. Horstkotte, O. Oldenburg (Bad Oeynhausen, de) 

Right and left heart hemodynamics of heart failure patients with nocturnal 

Cheyne-Stokes respiration P631 

O. Oldenburg, T. Bitter, C. Piper, H. Fox, B. Koerber, Z. dimitriadis, P. Netz, d. Horstkotte 

(Bad Oeynhausen, de) 

Acute hemodynamic effects of hyperventilation in healthy volunteers P632 

J. spiesshoefer, B. Koerber, J. Heinrich, R. Lehmann, C. efken, T. Bitter, P. Netz, 

d. Horstkotte, O. Oldenburg (Bad Oeynhausen, de) 

Features of water molecules diffusion in the cerebral cortex of the patients with the 


N.s.A. Akimova, Y.G.s. shvarts, T.V.M. Martynovich, d.G.P. Persashvily (saratov, RU) 

Frequency and outcomes of hyponatremic patients with heart failure hospitalized 

in a university emergency hospital P634 

C.C. diaconu, L.A. Balaceanu, B. Paraschiv, e. Badila, d. Bartos (Bucharest, RO) 

92


Gender-related differences in laboratory tests and precipitating factors in patiens with 


d. Glavas, K. Novak, B. Jurcevic Zidar, d. Milicic, s. Polic (split and Zagreb, HR) 

The application of oral iron and epoetin-alpha in CHF and anemia patients caused by 

dilated cardiomyopathy for the 1 and 3-month follow-up P636 

I.A. Choi, T.A. Abdullaev, B.U. Mardanov (Tashkent, UZ) 

Relation between comorbidities and use of evidence based therapies in patients with 

in-hospital heart failure; data from the IHHF RO study P637 

e.-L. Antohi, d. dobreanu, d. Vinereanu, G. Tatu-Chitoiu, d. deleanu, C. Macarie, 

O. Chioncel (Bucharest and Targu Mures, RO) 

Respiratory muscle trainings reduce frequency of pneumonia in patients with NyHA 

class III-IV heart failure P638 

e.A. Kolesnikova, G.P. Arutyunov, A.K. Rylova, N.V. Rylova, V.I. Lobzeva (Moscow, RU) 

Thyroid dysfunction in heart failure patients included to the Heart Failure Pilot survey 

in Poland. P639 

K. Bury, A. Furman, J. drozdz, G. Opolski, P. Ponikowski, L. Polonski, P. Rozentryt, 

e. Jankowska, R. szelemej, J. Nessler (Krakow, Lodz, Warsaw, Wroclaw, Zabrze and 

Walbrzych, PL) 

Andropausal syndrome in men with systolic chronic heart failure P640 

M. Tkaczyszyn, K. Nega, M. Lopuszanska, A. szklarska, s. Von Haehling, W. doehner, 

W. Banasiak, s.d. Anker, P. Ponikowski, e.A. Jankowska (Wroclaw, PL; Berlin, de) 

Clinical - Cytokines and inflammation 

A trial of micronutrient supplementation in patients with heart failure P641 

N. Mckeag, M.C. Mckinley, J.V. Woodside, M.T. Harbinson, P.P. Mckeown (Belfast, GB) 

Cytokine profile, lipid metabolism and morphometric parameters obese women with 


A. Koryagina, A.V. Petrischeva, L.M. Vasilts (Perm, RU) 

The relationship of cytokine, myocardial antibodies and disease severity at patients 

with dilated cardiomyopathy P643 

N.A. Kurbanov, T.A. Abdullaev, s.s. davirova, I.A. Choi (Tashkent, UZ) 

Relation between the expression of peroxisome proliferator-activated receptor gamma 

and inflammation as a predictor of heart failure development in patients with 

ischemic heart disease after coronary P644 

I. Wojtkowska, J.A.s. siedlecki, J. Janas, Z. Juraszynski, A. Tysarowski, M. Marona, 

L. Greszata, J. Rozanski, J. stepinska (Warsaw, PL) 

Clinical - Valvular heart disease 

EuroScore and heart failure development late after surgery for degenerative mitral 

regurgitation in patients with systolic dysfunction P645 

s. Boskovic, P. Otasevic, B. Vujisic-Tesic, B. Obrenovic-Kircanski, s. Micovic, I. stojanovic 


To study the effect of sildenafil in patient recovery with high pulmonary artery pressure P646 

A.U.M. Ahmed (Karachi, PK) 

Heart failure and left ventricular remodelling after aortic valve replacement during 

1 year follow-up period P647 

A. Zhadan, O. Romanenko, O. Boyagina (Kharkiv, UA) 

Two-year outcomes after trancatheter aortic valve implantation P648 

J. Mancio, d. Caeiro, M. Oliveira, A. Albuquerque, L. simoes, V. Gama (Vila Nova de Gaia, PT) 

93 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



New-onset atrial fibrillation after transcatheter aortic valve implantation: incidence, 

predictive factors and prognostic value P649 

J. Mancio, R. Fontes-Carvalho, d. Caeiro, M. Oliveira, A. Albuquerque, L. simoes, V. Gama 

(Vila Nova de Gaia, PT) 

Effects of meldonium for ischemic chronic heart failure with preserved systolic 

function and aortic valve stenosis in the elderly patients P650 

Y. Kushnir, O. Mytrokhina, O. Kuryata, O. soya (dnipropetrovsk, UA) 

Clinical - Devices/Artificial heart/CRT/ICD 

Hemodynamic crt optimization employing the QuickOpt algorithm: are the resulting 

avds and vvds longer than empiric? P651 

I. seifert, V. Puetz, d. schmitz, F.H. Gueldner, O. Bruder, C.K. Naber (essen, de) 

Impact of chronic kidney disease in CRT effectiveness and long-term outcomes P652 

L. Leite, L.d. elvas, s. Lazaro, A.R. Ferreira, J. Ferreira, N. Antonio, J. Cristovao, 

M. Ventura, M. Pego (Coimbra, PT) 

Pulmonary vascular resistence in patients with severe left ventricular dysfunction P653 

T. Minarik, M. Fedorco, M. Taborsky (Ostrava and Olomouc, CZ) 

What additional benefits does resynchronization therapy bring to patients with 

implantable cardioverter defibrillator? P654 

M.J. sousa, P. Rodrigues, d. Anjo, B. Brochado, C. Roque, R. Hipolito, V. Lagarto, P. Vieira, 

J. silveira, s. Torres (Porto, PT) 

Cardiac resynchronization therapy in very old people: complications, events and 

benefits of the implant. P655 

e. Cruz Berlanga, M. Cortes (Madrid, es) 

Our CRT (cardiac resynchronisation therapy) experience - Is enough being done to 

block heart failure in India? P656 

H.-K. Bali, K.K. Chattree, H.K.C. Chauhan, C.P. shukla (Mohali, IN) 

Does left atrial early negative strain predict outcome after cardiac resynchronization 

therapy? P657 

N. Moreira, F. soares, R. Teixeira, N. Antonio, R. Martins, L. elvas, N. Ribeiro, M.J. Ferreira, 

M. Pego (Coimbra, PT) 

Prognostic impact of discordant versus concordant left bundle branch block in heart 

failure patients undergoing cardiac resynchronization therapy P658 

A. Valleggi, G. Vergaro, L. Perrotta, G. Mascia, G. Ricciardi, P. Pieragnoli, C. Passino, 

G. Mascioli, M. emdin, L. Padeletti (Pisa, Florence and Brescia, IT) 

The first implant of a cardiac resynchronization therapy/defibrillation system using a 

robotic approach P659 

s. Amraoui, P. Ritter, L. Labrousse, s. Ploux, M. Haissaguerre, P. Bordachar 

(Bordeaux-Pessac, FR) 

Indexed maximal left atrial volume predicts response to cardiac resynchronization 

therapy P660 

A. Malagoli, L. Rossi, F. Franchi, M.F. Piepoli, V. Malavasi, e. Casali, M.G. Modena, 

G.Q. Villani (Piacenza and Modena, IT) 

Long-term results after cardiac resynchronization therapy with or without surgical 

revascularization in patients with ischemic heart failure and left ventricle dyssynchrony P661 

A. Romanov, e. Pokushalov, s. Artemenko, N. shirokova, A. Karaskov, s. Mittal, 

J.s. steinberg (Novosibirsk, RU; New York, Us) 

Cardiac resynchronisation therapy improves anaemia of chronic disease in heart failure P662 

e.s.P. Lee, L. edmunds, s. Oliver, Z. Yousef (Cardiff, GB) 

94


Telemonitoring in heart failure - is there a need to target high-risk populations and 

optimize background standards of care? P663 

V. Voon, M.T. Ledwidge, N. edwards, L. Lawlor, B. Travers, d. Kelly, R.O. Hanlon, 

K.M. Mc donald (dublin, Ie) 

Health social network in cardiology: "My Health" project P664 

e. Lima Medina, s. Marina Ribeiro de Miranda, O. Gomes Loques Filho, C. Tinoco 

Mesquita (Niteroi, BR) 

Not all systematic reviews are systematic: a meta-review of the quality of current 

systematic reviews and meta-analyses for remote monitoring in heart failure. (w) P665 

R.A. Clark, A. Conway, s.C. Inglis, M. Horton-Breshears, J.G.F. Cleland 

(Brisbane, Queensland and sydney, AU; Hull, GB) 

Three months educational remote telemonitoring in elderly patients with heart failure 

reduces hospitalizations for acute heart failure at one year: a randomized trial. P666 

R. sabatier, G. Coutance, A. Belin, C. Biannic, P. Loiselet, G. Pradere, L. Michel, 

J.J. Parienti, G. Grollier (Caen, Cricqueboeuf, Cherbourg, Flers and saint-Lo, FR) 

Predictors of mortality and complications associated with use of intraaortic balloon 

pump counterpulsation P667 

s. secades, e. Velasco, J.P. Florez, e. Fernandez, M. Martin, V. Barriales, e. diaz, e. Capin, 

F. Pun, J.L. Lambert (Oviedo, es) 

Atrial fibrillation predicts increased hospitalizations in patients with advanced heart 

failure supported with a Heart Mate II P668 

K. Rossing, K. sander, P.s. Olsen, P.B. Hansen, s. Boesgaard, F. Gustafsson 

(Copenhagen, dK) 

Impact of physical exercise testing on inflammatory markers in continuous flow LVAD 

patients. P669 

P. Ganslmeier, H.-J. schneider, M. Gietl, M. Foltan, d. Camboni, C. diez, M. Hilker, s. Hirt, 

C. schmid (Regensburg, de) 

Health status and psychological distress in patients with a left ventricular assist device 

and their partners: a comparative study P670 

C.J. Brouwers, J. denollet, K. Caliskan, N. de Jonge, Q. Young, A. Kaan, J. Kealy, 

C. Cannon (Tilburg, Rotterdam and Utrecht, NL; Vancouver, CA) 

Health status, anxiety and depression in heart failure patients after heart 

transplantation versus left ventricular assist device implantation P671 

C.J. Brouwers, J. denollet, K. Caliskan, N. de Jonge, Q. Young, A. Kaan, J. Kealy, 

C. Cannon, s.s. Pedersen (Tilburg, Rotterdam and Utrecht, NL; Vancouver, CA) 

Can pre-operative levels of common inflammation markers predict occurrence of 

infectious complications after long-term ventricular assist device implantation? P672 

J. Kettner, M. Holek (Prague, CZ) 

Extension of an assist device program is not associated with increased risk P673 

J. Garbade, e.M. Langenstroth, H.B. Bittner, s. Lehmann, M. strueber, M.A. Borger, 

F.W. Mohr, M.J. Barten (Leipzig, de) 

Model for determination reference lung impedance for non-invasive monitoring of 

chronic heart failure patients in outpatient clinic P674 

M. shochat, A. shotan, M. Kazatsker, Y. Levy, I. dahan, I. shochat, A. Asif, A. Frimerman, 


Intrathoracic impedance monitoring: sensitivity for different definitions of heart failure 

events and correlation with mortality P675 

R. dierckx, R. Houben, M. Goethals, J. Bartunek, s. Verstreken, M. de Proft, e. Boel, 

W. Timmermans, F. de Pauw, M. Vanderheyden (Aalst, Be; Maastricht, NL) 

95 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Efficacy and safety of cardiac rehabilitation in patients with implantable cardioverter 

defibrillators and cardiac resynchronization therapy P676 

B. Brochado, M. santos, d. Anjo, P. Rodrigues, M.J. sousa, s. Viamonte, J.P. Fernandes, 

H. Carvalho, L. Gomes, s. Torres (Porto, PT) 

Percutaneous left ventricular partitioning therapy in ischemic heart faulire P677 

M. Banovic, V. Vukcevic, M. Ostojic, d. Bacic, V. dedovic, d. Zamaklar, P. seferovic 


Clinical - Surgery 

Surgical management of functional mitral valve regurgitation in heart failure patients P678 

J. Garbade, J. seeburger, B. Pfannmueller, M. Vollroth, d. Merk, M. Misfeld, M.A. Borger, 

F.W. Mohr (Leipzig, de) 

Results of surgical treatment of hydatid cysts of the heart P679 

s. Mleyhi, J. Ziadi, N. Triki, R. denguir, M. Hakim, s. Ben Omrane, T. Kalfat, A. Khayati 

(Tunis, TN) 

undersized mitral annuloplasty with asymmetric ring for non-ischemic mitral 

regurgitation P680 

L. dell'angela, G. Gatti, M. Bollini, A. Poletti, L. dreas, F. Negri, F. Cettolo, B. Pinamonti, 

G. sinagra, A. Pappalardo (Trieste, IT) 

Clinical - Heart transplantation 

Favorable effect of add everolimus to valganciclovir prophylaxis for cytomegalovirus 

infection after heart transplantation P681 

s. secades, B. diaz, J.L. Lambert, M.J. Bernardo, O.C. Cimadevilla, M. Martin, V. Barriales 

(Oviedo, es) 

Intra-aortic balloon pump in managing acutely decompensated candidates to heart 

transplantation: successful bridge to transplant and long-term survival P682 

L. Potena, F. Vagnarelli, V. Manfredini, G. Norscini, A. Amabile, G. Magnani, F. Grigioni, 

A. Marzocchi, G. Melandri, A. Branzi (Bologna, IT) 

Low incidence of cellular rejection after cardiac transplantation. P683 

I. Malek, L. Voska, L. Hoskova, M. Hegarova, M. Podzimkova, Z. dorazilova, J. Pirk 

(Prague, CZ) 

Evaluation of the xenodiagnosis in patients awaiting heart transplant P684 

F.d.C. Cruz, M. Avila, B. Biseli, s.F. Ayub, F. Bacal, e.A. Bocchi (sao Paulo, BR) 

Assessment of the metabolic profile in heart transplantation patients. Is there any 

difference among chagasic and non-chagasic patients? P685 

B. Biselli, J.P. escalante, A.C.A. santos Nussbaum, M.s. Avila, M.B. Ulhoa, 

s.M. Ayub-Ferreira, G.e. Conceicao-souza, V.s. Issa, e.A. Bocchi, F. Bacal (sao Paulo, BR) 

use of proliferation signal inhibitors in heart transplantation. P686 

M. Avila samuel, B. Biselli, M.B. Ulhoa Junior, A. santos Nussbaum, J.P. escalante, 

F.G. Mercondes-Braga, s.M. Ayub-Ferreira, s.M. Brandao, F. Bacal, e.A. Bocchi 


Mortality risk factors in heart transplant patients P687 

J. Ljubas, B. skoric, M. Cikes, I. skorak, d. Bozic, T. Bubalo, d. Milicic (Zagreb, HR) 

May echocardiographic imaging of the right ventricle have a role in diagnosing acute 

cellular rejection after heart transplantation P688 

e. simsek, s. Nalbantgil, M. Zoghi, d. Nart, H. Kemal, C. engin, T. Yagdi, M. Ozbaran 

(Batman and Izmir, TR) 

96


Coronary microvascular remodeling and coronary flow reserve in heart transplant 

patients: a correlation study of pathological and clinical features P689 

F. Tona, M. Fedrigo, B. schiavon, G. Famoso, C. Castellani, s. Tellatin, G. Gerosa, 

G. Thiene, s. Iliceto, A. Angelini (Padova, IT) 

Routine transthoracic echocardiogram evaluation of potential heart donor during the 

process of brain death diagnosis: impact for the heart transplantation program P690 

s.N.R.s. Falcao, J.d. Ribeiro Filho, J.L.A.A. Falcao, W.A. silva, A.A. Braga, J.e. Costa Filho, 

J. Rolim, J.A.C. Mejia, J.d. souza Neto (Fortaleza, BR) 

Clinical - Disease management programmes 

Effectiveness of HeartNetCare-HF, a heart failure disease management program, in 

the real-world setting P691 

s. stoerk, F. Gietzen, s. Kerber, B. Gebhard, V. Holzendorf, s. Brenner, G. Gueder, 

M. Hanke, G. Gelbrich, G. ertl (Würzburg, Bad Neustadt an der saale and Leipzig, de) 

The evolution of a community heart failure service in the Waikato, New Zealand: 

the first year P692 

e. Gibbons, A.J. Bell, V. Gibbons, G. devlin, R. Fisher, K. Buswell, M. davis, R. Lawrenson 

(Hamilton, Auckland and Te Kuiti, NZ) 

The contribution of hospital medical treatment in optimization of drug therapy in 

patients with systolic heart failure: the status in 2012. P693 

A. Yurchenko, M. Trukshina, M. sitnikova, e. Lyasnikova, e. shlyakhto (st. Petersburg, RU) 

Heart Failure Clinics (HFC) overview using the Grading of Recommendations, 

Assessment, Development and Evaluation (GRADE) system. P694 

N. Gonzalez-Jaramillo, C. saldarriaga (Medellin, CO) 

Telemonitoring as bridge to discharge in advanced heart failure P695 

J. Gupta, T. Fletcher, T. Larcombe, T. Gupta (Walsall and Oxford, GB) 

"RESPIRATE" project: a HF co-management programme between HF specialist and 

general practitioner P696 

P. Rocca, P. Neri, A. Locatelli, B. Casiraghi, M.T. Villa, M. Pisoni, M. Tespili, V. Giudici 

(seriate, IT) 

Clinical course and palliative care needs for in patients with end-stage heart failure or 

chronic obstructive pulmonary disease are similar: a multicentre observational registry P697 

e.d.elia, R. de Maria, A. deales, F. Humar, R. Pozzi, M. Ugolini, s. Gasparini, A. Cassi, 

M. Frigerio, A. Gavazzi (Bergamo, Milano, Ancona, Trieste, Orbassano and Pesaro, IT) 

Improving quality of life in heart failure - results of the national educational study P698 

T. Rywik, P. Kurjata, G. Broda, R. Targonski, M. Fedyk-Lukasik, W. Piotrowski, P. Leszek, 

H. Rywik, J. Korewicki (Warsaw, Olsztyn and Krakow, PL) 

Clinical - Diuretics 

Diuretics in acute heart failure: is there a better strategy? P699 

F. Caetano, I. Almeida, A. Fernandes, P. Mota, A. Botelho, A. Leitao-Marques (Coimbra, PT) 

Comparative efficacy of furosemide and torasemide in patients with various forms of 

cardiomyopathies P700 

B.U. Mardanov, T.A. Abdullaev, Y.R. Akhmatov (Tashkent, UZ) 

Clinical - Drug therapy, other 

Heart failure and central sleep apnea: the impact of non-invasive ventilation P701 

V.H. Pereira, M. Fernandes, J. Guardado, J. Portugues, I. Machado, C. duraes, 

M.J. Guimaraes, F. Canario-Almeida, A. Lourenco (Guimarães, PT) 

97 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Hyperkalemia in elderly patients with chronic heart failure P702 

L. Mathe, e.G.Y. Ban (Tirgu-Mures, RO) 

Clinical and pharmacoeconomic aspects of trimetazidine MB in patients with chronic 


T. Morozova, s. Rikova, e. Ivanova (Moscow, RU) 

Myocardial stress and collagenolisis markers dynamics depending on average diurnal 

heart rate in patients with chronic heart failure during ivabradine therapy P704 

N. Koziolova, A. Chernyavina, M. surovtseva (Perm, RU) 

Repeated levosimendan infusions in patients with refractory heart failure P705 

M. Frigerio, A. Verde, e. Ammirati, F. Macera, V. Pacher, F.G. Oliva, F.M. Turazza (Milan, IT) 

Effect of treatment by the direct renin inhibitor on the echocardiographic parameters 

in patients with diastolic dysfunction P706 

M.I. Voevoda, K.Y. Nikolaev, Z.G. Bondareva, I.V. Arutunyan (Novosibirsk, RU) 

Heart failure in younger patients: the Meta-analysis Global Group in Chronic Heart 

Failure (MAGGIC) P707 

C. Wong, N.M. Hawkins, M.C. Petrie, C.A. Ariti, K. Poppe, N. earle, G.A. Whalley, 

I.B. squire, R.N. doughty, J.J.V. Mcmurray (Glasgow, Liverpool, London and Leicester, GB; 

Auckland, NZ) 

Correction of hemodynamic by telmisartan and torasemid in hypertensives with heart 

failure and hyperinsulinemia P708 

M.A. Orynchak, O.M. sheremeta (Ivano-Frankivsk, UA) 

Audit of heart failure patients using ESC guidelines for heart rate optimization P709 

M. Baig, J. Boardman, J. sajjid, R. Potluri, R. Carty, s. Mushawar, B. Irwin (Bury, GB) 

Audit of Ivabradine use in heart failure clinic using ESC Guidelines 2012 P710 

M. Baig, J. Boardman, J. sajjid, R. Potluri, R. Carty, s. Mushawar, B. Irwin (Bury, GB) 

Interaction of left bundle branch block on heart rate and ivabradine in patients with 


J.-C. Reil, M. Robertson, I. Ford, J. Borer, M. Komajda, K. swedberg, L. Tavazzi, M. Boehm 

(Hamburg, de; Glasgow, GB; New York, Us; Paris, FR; Gothenburg, se; Catignola, IT) 

Short- and long-term effects of nocturnal oxygen therapy on sleep apnea in chronic 


P. Bordier, s. Orazio (Pessac, FR) 

Early addition of ivabradine shortens carvedilol uptitration and improves exercise 

capacity in patients with chronic heart failure P713 

A.e. Bagriy, e.V. shchukina, s.I. Malovichko, A.V. Prikolota (donetsk, UA) 

The change of the proportion of patients with indication for ivabradin treatment in 

the effect of optimal therapy in systolic heart failure P714 

B. Muk, M. dekany, B. szabo, B. Ancsin, T. Borsanyi, M. Vamos, d. Vagany, G.Z. duray, 

R.G. Kiss, N. Nyolczas (Budapest, HU) 

Ivabradine treatment blunts dobutamine-induced increase in heart rate in patients 

with acute decompensated heart failure: a comparative study with beta-blocker therapy P715 

Y. Cavusoglu, K.U. Mert, A. Nadir, F. Mutlu, e. Gencer, T. Ulus (eskisehir, TR) 

Clinical - Beta blockers 

Beta-blockers: which is the target? dose or heart rate? P716 

F. Gomes, M. Casal Moura, M. Carvalho, F. silva, O. Laszczynska, J.P. Araujo, M. Alvelos, 

J. Pimenta, A. Azevedo, P. Bettencourt (Porto, PT) 

98


Beta-blockers attenuate ST-elevation in patients presenting with ST-elevation 

myocardial infarction P717 

s.M. Leite, J. Rodrigues, C. sousa, M. Vasconcelos, A. Goncalves, e. Martins, s. Amorim, 

J. silva Cardoso, M. Campelo, M. Julia Maciel (Porto, PT) 

Prevalence and characteristics of patients with chronic heart failure and indication to 

ivabradine treatment after optimization of beta-blocker therapy: a single center 

experience P718 

d. Robba, G. Caretta, L. Bettari, s. Frattini, L. Moschini, s. Verde, G. di Tano, s. Pirelli 

(Cremona, IT) 

Clinical - Renin-angiotensin-aldosterone antagonists 

Communicating with general practitioners regarding renal monitoring in patients 

with chronic heart failure, are we doing well? P719 

A. Al-Mohammad, M.Z. Kanaan, J. Bashforth, d. Barnett, A. Birchall, M. Warriner, 

N. Buckley, V. Watt, L.O.toole (sheffield, GB) 

Occurrence of graft re-stenoses after CABG in hypertensive CAD patients receiving 

ACE-inhibitors and ATII-receptors antagonists P720 

M.N. dolzhenko, s. Potashev, Y. Luchinskaya, L. Konoplyanik (Kiev, UA) 

Clinical - Haemodynamics and peripheral circulation 

If inhibitor Ivabradine does not modify augmentation index in patients with heart 

failure of ischemic etiology P721 

Y.M. Lopatin, T.H. Temirsultanova (Volgograd, RU) 

Chronic total occlusion in non-infarct related artery as a determinant of elevated 

NT-pro BNP levels in acute coronary syndrome patients without previous history 

of heart failure P722 

M. stachura, P.J. Kwasiborski, G.J. Horszczaruk, R. Ryczek, A. Cwetsch (Warsaw, PL) 

Effect of environmental temperature on hemodynamics according to 

echocardiography measurement in patients with heart failure. heartcycle (FP 216695) 

European union 7th framework programme P723 

A. Torabi, T. Mabote, R. Antony, K. Wong, J.M. Weston, A. shoaib, J. Zhang, s. Parsons, 

B. dicken, J.G.F. Cleland (Hull, GB) 

Haemodynamic effects of light exercise at different temperatures in chronic heart failure P724 

T. Mabote, A. Torabi, R. Antony, A. shoaib, Y.A. Agha, R. dierckx, s. Parsons, P. Pellicori, 

A.L. Clark, J.G.F. Cleland (Hull, GB) 

Disturbance of macrocirculation and microcirculation: relation with risk factors, left 

ventricular function and duration of disease in patient with chronic heart failure and 

type 2 diabetes mellitus P725 

A.A. shchendrygina, Y.N. Belenkov, e.V. Privalova, Y.A. danilogorskaya, e.A. Zheleznykh 

(Moscow, RU) 

Exercise Training influence on periphery in HF patients using near-infrared spectroscopy P726 

I.s. Teixeira Neto, A.C. Tavares, M. Morita, J. Roque, R.e. Castro, e.A. Bocchi, 

G.V. Guimaraes (sao Paulo, BR) 

Clinical - Hormones/neurohumoral regulation 

Impairment of heart rate variability circadian profile in patients with heart failure P727 

M.s. deshko, N.F. Pobivantseva, V.A. snezhitskiy, e.s. Pelesa, N.V. shpak 

(Grodno and Brest, BY) 

99 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Effects of cholecalciferol supplementation in patients with low vitamin d levels and 

chronic heart failure (a randomized double blind controlled trial) P728 

s. scarlini, F. Turrini, L. Roli, C. Mussi, M. Bertolotti, T. Trenti, P. Loria, M. Bondi (Modena, IT) 

Changes of sex hormones levels in patients with heart failure P729 

A. Kuchmin, d. Cherkashin (st-Petersburg, RU) 

Clinical - Metabolism/diabetes mellitus 

Paraoxonase 1 Gene (Gln192-Arg) polymorphism and the risk of coronary artery 

disease in type 2 diabetes mellitus P730 

M.F. elnoamany, A. dawood, R. Azmy, M. elnajjar (shebeen el-Koom, eG) 

Microalbuminuria is correlated with the presence of early right ventricular diastolic 

dysfunction in type 1 diabetes patients P731 

d. Levisianou, d. Beldekos, G. Tsiaousis, e. Fousteris, V. dragoumanos, C. Verras, 

A. dimitriadou, s. Handanis, A. Melidonis, s. Foussas (Piraeus, GR) 

Relationship between abdominal obesity and platelet indices in patients with 

congestive heart failure P732 

A. Furman, K. Bury, P. Rostoff, J. Nessler (Krakow, PL) 

Some features of immunoreactivity in patients with acute myocardial infarction and 

diabetes mellitus P733 

A.G. Nikishin, s.Y. Abdullayeva, M.M. Pirnazarov, N.T. Yakubbekov, T.A. Nurbaev 

(Tashkent, UZ) 

Impaired insulin resistance in systolic heart failure differs from diastolic heart failure P734 

N. scherbakov, M. Knops, M. Bauer, C. Misgeld, T. scabo, A. Toepper, s. Von Haehling, 

s.d. Anker, H.-d. duengen, W. doehner (Berlin, de) 

Differential optimal glycemic values in diabetic and non diabetic patients with acute 

heart failure. Data from the Italian IN-HF Outcome registry P735 

A. Mortara, F. Oliva, G. Cacciatore, A. Chinaglia, A. di Lenarda, d. Lucci, M. Metra, 

M. senni, A. Maggioni, L. Tavazzi (Monza, Milan, Rome, Turin, Trieste, Florence, Brescia, 

Bergamo and Cotignola, IT) 

Clinical - Imaging, other 

Effects of multiple cardiovascular risk factors on myocardial perfusion SPECT imaging 

in patients with normal coronary angiography findings P736 

I. Peovska, M. Vavlukis, N. Kostova, e. srbinovska, M. Otljanska, F. Arnaudova (skopje, MK) 

B1-adrenoreceptor polymorphisms in heart failure patients and its relationship to 

cardiac I123-MIBG and carvedilol treatment response P737 

s.M. Miranda, s.d. Moscavitch, s.B. Pereira, R.A. Freitas, J.C. de Azevedo, L.R. Messias, 

R.C. Rodrigues, e.T. Mesquita, G.s. Ribeiro, C.T. Mesquita (Niteroi and Rio de Janeiro, BR) 

Prognostic assessment by myocardial perfusion-gated SPECT in patients with left 

bundle-branch block P738 

V. Ribeiro, T. Vieira, e. Martins, J.G. Pereira, M.J. Maciel (Porto, PT) 

The differential diagnosis of an ischemic cardiomyopathy from a dilated 

cardiomyopathy: the results of positron emission tomography P739 

d.V. Ryzhkova, V.s. Pavlova, L.N. Maslov (st-Petersburg and Tomsk, RU) 

SPECT/CT in determination of choice of revascularization in patients with congestive 


I. Rjabceva, G. Krumina, A. Kalvelis (Riga, LV) 

100


Cardiac abnormalities in cirrhotic patients before liver transplantation (tx): evaluation 

of a Turkish large liver transplantation single center cohort P741 

N. Arat Koc, M. Akyildiz, B. dilekci, O. demirozu, C. Ciftci, Y. Tokat (Istanbul, TR) 

Transient myocardial edema in heavy-user asymptomatic cocaine addicts after drug 

withdrawal P742 

A. del Franco, N.R. Pugliese, A. Gabutti, M. Meini, C. Passino, M. Lombardi, G.d. Aquaro, 

M. emdin (Pisa, IT) 

Long term prognostic value of late gadolinium enhancement by cardiovascular 

magnetic resonance in patients with heart failure secondary to non-ischemic dilated 


J. Rodriguez Capitan, J.M. Garcia-Pinilla, I. Ruiz-Zamora, e. Rueda-Calle, 

L. Morcillo-Hidalgo, J. Robledo-Carmona, J.J. Gomez-doblas, e. de Teresa-Galvan 

(Málaga, es) 

Diagnostic contribution of cardiac magnetic resonance imaging and outcome in 

patients with acute chest pain, elevated cardiac enzymes and culprit-free angiograms. P744 

d. Kawecki, B. Morawiec, C. Wojciechowska, J. Jojko, M. Basiak, B. Przywara-Chowaniec, 

e. Nowalany-Kozielska (Zabrze and Katowice, PL) 

The impact of n terminal pro B natriuretic peptide (NT pro BNP) on number needed 

to screen for heart failure by echocardiography. Prospective observational comparative 

study. P745 

M. Al Barjas, R. Morris, d. Nair, J. davar (London, GB) 

Ejection fraction of the left atrium and left ventricle systo-diastolic function in systolic 

heart failure. 2D-Strain study P746 

M. satendra, L. sargento, s. Longo, N. Lousada, R. Palma dos Reis (Lisbon, PT) 

Right ventricular dysfunction worst mid-term prognosis in systolic heart failure. 

24 months follow-up P747 

L. sargento, M. satendra, s. Longo, N. Lousada, R. Palma dos Reis (Lisbon, PT) 

Echocardiographic and lung ultrasound characteristics in ambulatory patients with 

dyspnea or prior heart failure P748 

e. Platz, d. Hempel, e. Pivetta, J. Rivero, s.d. solomon (Boston, Us; Mainz, de) 

Dyssynchrony should be measured from a single heart beat P749 

O. Khaleva, J. Zhang, A.L. Clark, J.G.F. Cleland, K. Wong (Hull, GB) 

Aortic valve area assessment by 3D flow: can we dodge error measurements of left 

ventricle outflow tract? P750 

M. Paiva, C. Vieira, F. Islas, J.A. Agustin, P. Marcos Alberca, J.J. Gomez diego, 

J. Rodrigo Lopez, C. Almeria, M. Garcia Fernandez, L. Perez de Isla (Porto and Braga, PT; 

Madrid, es) 

Salutatory association of alcohol and ventricular function is limited to moderate 

systolic dysfunction (w) P751 

H. Yousaf, K.A. Ammar (Milwaukee, Us) 

Interest of study of left ventricular function by 2D strain in acute coronary syndrome 

without ST elevation P752 

N. Mouine, M. Raissouni, A. Chaib, A. Bouzerda, M. sabry, I. Asfalou, A. Boukili, e. Zbir, 

A. Benyass (Rabat, MA) 

Global longitudinal strain as a potential prognostic marker in patients with chronic 


I. Rangel, A. Goncalves, C. sousa, J. Rodrigues, F. Macedo, J. silva-Cardoso, M.J. Maciel 

(Porto, PT) 

101 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Difference of left and right ventricular dimensions and left and right atrial dimension 

in patients with and without right ventricular myocardial infarction P754 

V.A. Andova, e.s.K. srbinovska-Kostovska, L.J.G.I. Georgievska-Ismail, P.Z. Zafirovska, 

M.M. Miletic (skopje, MK) 

Correlation of leucocytes count in the development of congestive heart failure in 

patients with acute myocardial infarction P755 

M. Isailovic-Kekovic, P. Kekovic (Prokuplje, Rs) 

Right Ventricular Outflow Tract Systolic Excursion, a noninvasive load-independent 

index of right ventricular function P756 

N. Moreno, A. Pereira, A. silva Castro, R. Pontes dos santos, R. sousa, R. Carvalho, 

M. Pires, A. Andrade, P. Pinto (Penafiel, PT) 

Clinical - Biomarkers 

NT-pro-BNP and compliance of the right ventricle predict pulmonary performance P757 

d. Popovic, M. Ostojic, M. Petrovic, B. Vujisic-Tesic, B. Popovic, M. Banovic, A. Kocijancic, 

A. Arandjelovic, P. seferovic, s. damjanovic (Belgrade, Rs) 

Amino-terminal Pro-B-type natriuretic peptide and high sensitive Tpoponin T levels in 

patients with acute decompensated heart failure P758 

d. Koshkina, A.A. skvortsov, V.P. Masenko, s.N. Tereschenko (Moscow, RU) 

Impact of obstructive sleep apnea on aortic elastic properties and left ventricular 

functions in hypertensive and normotensive patients: Correlation with brain 

natriuretic peptide levels P759 

M.F. elnoamany, A. dawood, M. elhabashy, Y. Khalil (shebeen el-Koom, eG) 

Diagnostic value of NT-proBNP in children with chronic heart failure P760 

e. Arkhipova, O. Zharova, e. Basargina, N. Mayanskiy (Moscow, RU) 

Influence of renal failure on correlation of NTproBNP with grading of heart failure P761 

A. Rieth, J. Pons-Kuehnemann, M. Krpuljevic, V. Mitrovic, C.W. Hamm (Bad Nauheim and 

Giessen, de) 

Age-related alteration of risk profile, inflammatory response, and angiographic 

findings in patients with acute coronary syndrome P762 

H. Badran, M.F. elnoamany, T. Khalil, M. ezz eldin (shebeen el-Koom, eG) 

Assessment of QRS duration and presence of fragmented QRS in patient with Behcet 

disease P763 

M.R. sayin, I. Akpinar, Y.C. Gursoy, s. Kiran, N. eris Gudul, T. Karabag, R. Koca, M. Aydin 

(Zonguldak, TR) 

Cardiac dysfunction in pauci symptomatic HIV patients: a meta-analysis in the Highly 

Active Antiretroviral Therapy era. (w) P764 

e. Cerrato, F.d.ascenzo, G. Biondi-Zoccai, W. Grosso Marra, s. Frea, G. Quadri, P. Omede', 

C. Moretti, F. Gaita (Turin and Rome, IT) 

Albuminuria, diastolic dysfunction and left ventricular hypertrophy - adding adverse 

prognosis P765 

A. Baptista, C. Ferreira, P. Magalhaes, P. Mateus, s. silva Carvalho, A. Matias, N. Vilas 

Boas, I. Moreira (Vila Real, PT) 

The prognostic value of neopterin concentration in patients with advanced heart failure P766 

s. demir, V. Yuksekdag, A. Tosu, M. selcuk, Z. Karakaya (Adana and Van, TR) 

use of cardiorenal biomarker in early follow-up acute heart failure rislk evaluation P767 

J. Tolonen, J.P.e. Lassus, K. siirila-Waris, T. Tarvasmaki, K. Pulkki, K. Peuhkurinen, 

M.s. Nieminen, V.-P. Harjola (Helsinki, FI) 

102


uric acid: a new therapeutic target in chronic heart failure? P768 

A. Ramalho, d. silva, C. Jorge, A. Magalhaes, R. Placido, M. Menezes, I. Pinheiro, 

I. Portela, A. Nunes diogo, d. Brito (Lisbon, PT) 

NT-proBNP level: a predictor of noninvasive pressure support ventilation success in 

acute heart failure? P769 

A. Camoes, A.s. Corredoura, M. Monteiro (Lisbon, PT) 

The main mechanism of destabilization coronary heart disease compatible with 

chronic obstructive pulmonary disease P770 

V.K. Tashchuk, T.M. Amelina, O.s. Polyanska, O.I. Gulaga (Chernivtsy, UA) 

Red cell distribution width (RDW), a novel prognostic marker in heart failure patients 

in comparison to BNP and uric acid P771 

e. straburzynska-Migaj, e. Ciesiolka, L. Chmielewska-Michalak, H. Popiak, s. Grajek 

(Poznan, PL) 

Iron deficiency status irrespectively of anaemia: a predictor of unfavourable outcome 

in chronic heart failure patients P772 

I. Rangel, A. Goncalves, C. sousa, s. Leite, M. Campelo, e. Martins, s. Amorim, B. Moura, 

J. silva-Cardoso, J. Maciel (Porto, PT) 

Factors associated with quality of life in patients with suspected heart failure P773 

J. Zhang, J.G.F. Cleland, B. dicken, I. sunderji, s. Parsons, R. dierckx, A.L. Clark (Hull, GB) 

The association between total cholesterol at admission and mortality in patients 

hospitalized for heart failure: an analysis of the RO-AHFS registry P774 

O. Chioncel, A.P. Ambrosy, d. Vinereanu, s. Bubenek, d. deleanu, A. Petris, 

M. Vaduganathan, s. Greene, C. Macarie, M. Gheorghiade (Bucharest and Iasi, RO; 

stanford, Boston and Chicago, Us) 

Adrenomedullin has a strong long-term prognostic value in decompensated chronic 


d. silva, A. Magalhaes, C. Jorge, A.R. Ramalho, N. Cortez-dias, C. Calisto, C. Pascoa, 

A. Castro Lopes, A. Nunes diogo, d. Brito (Lisbon, PT) 

Prognostic significance of microalbuminuria in acute myocardial infarction as a marker 

of heart failure and inflammation P776 

d. stanojevic, s. Apostolovic, R. Jankovic-Tomasevic, s. salinger-Martinovic, 

d. djordjevic-Radojkovic, M. Pavlovic, M. damjanovic (Nis, Rs) 

Matrix metalloproteinase-2 predicts cardiovascular outcomes in heart failure patients 

diagnosed in an outpatient clinic P777 

L. sanchis, R. Andrea Riba, C. Falces, M. sitges, F. Perez-Villa, M. sabate, M. Heras, 

J. Brugada (Barcelona, es) 

Clinical value of matrix metalloproteinase-9 in assessing severity of acute heart failure 

in ST elevation myocardial infarction patients P778 

T. Pecherina, V. Kashtalap, O. Barbarash (Kemerovo, RU) 

Endothelin and ANP: prognostic value in patients with acute myocardial infarction P779 

C. Jorge, N. Cortez-dias, A. Magalhaes, C. Calisto, R. Placido, A. Ramalho, s. Robalo 

Martins, M. Fiuza, F.J. Pinto, A. Nunes diogo (Lisbon, PT) 

Predictors of abnormal chemoreflex sensitivity to hypoxia and hypercapnia in chronic 


G. Mirizzi, A. Ripoli, A. Giannoni, G. Vergaro, F. Bramanti, G. Iudice, A. del Franco, 

N.R. Pugliese, M. emdin, C. Passino (Pisa, IT) 

103 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Cystatin C is an independent predictor of long-term mortality in decompensated 


C. Jorge, d. silva, N. Cortez-dias, A. Magalhaes, A. Ramalho, R. Placido, I. Portela, 

M.J. Gomes, A. Nunes diogo, d. Brito (Lisbon, PT) 

Leptin: biomarker for heart failure in acute coronary syndrome? P782 

C. Ferreira, A. Baptista, P. Magalhaes, s. Leao, P. Mateus, s. Carvalho, A. Ferreira, 

P. Fontes, I. Moreira, C. Caldas (Covilhã and Vila Real, PT) 

The change of cystatin-c during the treatment of decompensated heart failure is 

a predictor of short term prognosis P783 

H. Inazumi, Y. sato, s. Koyama, Y. Tanada, M. Kawashima, H. Fujiwara, Y. Takatsu 

(Amagasaki and Kyoto, JP) 

Circulating level of hepatocyte growth factor in patients with a comorbidity of heart 

failure and diabetes mellitus type 2 P784 

T. Kochegura, P. Makarevich, A. Ovchinnikov, L. Gigunova, Y.e. Lakhova, F. Ageev, 

Y.e. Parfyonova (Moscow, RU) 

Soluble st2 differentiates hypertensives with or without left ventricular hypertrophy 

from those with heart failure P785 

d.B. Ojji, s. Lecour, L. Lacerda, O.M. Adeyemi, L.H. Opie, s. Karen (Abuja, NG; 

Cape town, ZA) 

Relationship between Galectin-3 Levels and Aldosterone Antagonist use in Heart 

Failure: Analysis from the HF-ACTION Study P786 

M. Fiuzat, G.M. Felker, P. shulte, M. Neely, K. Adams, M. donahue, W. Kraus, I. Pina, 

d. Whellan, C.M.O.connor (durham, NC, Chapel Hill, New York and Philadelphia, Us) 

Independent association of plasma soluble klotho with prognosis in heart failure P787 

P. Rozentryt, J. Niedziela, R. Partyka, e. Kawecka, J. Nowak, L. Polonski, d. Kokocinska, 

s. Von Haehling, W. doehner, s.d. Anker (Zabrze and Katowice, PL; Berlin, de) 

Red blood cell distribution width is longitudinally associated with mortality and 

incident anemia in heart failure patients P788 

L. Bondanza, J. Nunez, J. sanchis, P. Merlos, G. Minana, C. Castillo, C. Bonanad, 

B. Mascarell, V. Pedrosa, F.J. Chorro (Valencia, es) 

Fibroblast growth factor-23 is associated with disease severity in patients with stable 


C. Trenkler, J. Kliebhan, M. ess, P. Wuertinger, A. Griesmacher, s. Kaser, M. Frick, G. Poelzl 

(Innsbruck, AT) 

In-hospital and 30 days predictive value of Worsening Renal Function (WRF) and 

Galectin 3 (Gal 3) in patients with acute heart failure in emergency department. P790 

B. de Berardinis, B. Zancla, L. Magrini, H.K. Gaggin, G. salerno, P. Cardelli, J.J. Januzzi, 

s. di somma (Rome, IT; Boston, Us) 

Clinical - Nursing 

Barriers and facilitators to self-care management: a systematic review of qualitative 

studies P791 

s. siabani, s. R Leeder, P.M. davidson, s. siabani (sydney and sydney Thecnology sydney, 

AU; kermanshah, IR) 

Long term improvement of functional capacity after short term physiotherapy in 

patients with chronic heart failure P792 

d. smidi (Amsterdam, NL) 

104


Determinants of sodium intake among Dutch heart failure patients P793 

J. Boyne, L. Verberne, M. Castermans, L. Moors, N. Feij, J. Jans, M. Beijer, A. Bree, 

C. Hoving (Maastricht, NL) 

End of life care in patients included in a nurse-led heart failure unit: quality of medical 

and psychological care to the patient and to the family. P794 

M. Nebot, J. Gonzalez-Costello, N. Manito, A. Requena, M.J. Barbosa, s. Asensio, 

J. Roca, P. Manas, J. salazar, A.R. Cequier (L'Hospitalet de Llobregat and Barcelona, es) 

Patient satisfaction with the medical care received after inclusion in a nurse-led heart 

failure unit P795 

M. Nebot, J. Gonzalez-Costello, N. Manito, M.J. Barbosa, A. Requena, s. Asensio, 

J. Roca, J. salazar, M. Gracida, A.R. Cequier (L'Hospitalet de Llobregat and Barcelona, es) 

Effectiveness of a nurse-led clinic in Riyadh in implementing and adhering to 

international heart failure management guidelines P796 

R. Odeh, e. Fadel, M.B. Bdeir, T. Conboy (Riyadh, sA) 

Clinical - Population studies 

Clinical characteristics and outcome of heart failure and captagon amphetamine use: 

an observational prospective study P797 

A. elasfar (Riyadh, sA) 

Prevalence of patients with NyHA class II and LVEF < 30% among chronic heart 

failure population in France P798 

M. Galinier, F. Beygui, e. Vicaut, L. Imekraz (Toulouse, Caen and Paris, FR) 

Clinical characteristics, management, and outcomes of patients with high risk chronic 

heart failure referred to a heart failure clinic in Saudi Arabia P799 

A. elasfar, K.F. Alhabib, Z. Alharfi, M.A. Youssef (Riyadh, sA) 

Screening of cardiovascular risk in female employees from state government P800 

I.P. Borges, V.F.M. Marcolla, M.L.F. silva, s. simoes, A.C.B. souza, T.s. spritzer, P.P.s. Ferreira 

(Rio de Janeiro, BR) 

Register of patients, hospitalized due to acute decompensation of chronic heart failure 

(CHF): clinical picture and treatment P801 

N. Bylova, O.O. Berejnaya, e.M. slepneva, G.P. Arutynov (Moscow, RU) 

Hybrid coronary revascularization: a case series P802 

J.d.R. duarte Rodrigues, M.V. Mariana Vasconcelos, R.R. Rui Rodrigues, 

s.M.L. sergio Machado Leite, M.A. Mario Amorim, M.C. Manuel Campelo, 

J.P.N. Jose Pedro Nunes, J.C.s. Joao Carlos silva, P.P. Paulo Pinho, 

M.J.M. Maria Julia Maciel (Porto, PT) 

Prognostic impact of patients with acute heart failure in summer P803 

Y. Yamamoto, A. shirakabe, N. Hata, N. Kobayashi, T. shinada, K. Tomita, M. Tsurumi, 

M. Matsushita, H. Okazaki, K. Mizuno (Chiba and Tokyo, JP) 

Heart failure in very elderly patients admitted to a cardiology department P804 

P. Carrilho-Ferreira, A.C. Rocha, A. Magalhaes, R. Placido, A.R. Ramalho, 

M. Nobre Menezes, C. Jorge, d. silva, A. Nunes diogo, d. Brito (Lisbon, PT) 

Congestive heart failure as a cause of rehospitalization and death after acute coronary 

syndromes in the contemporary era: 5-year follow-up of an unselected cohort P805 

F. Vagnarelli, G. Norscini, L. Cinti, s. Nanni, F. semprini, G. Bugani, A. Corsini, A. Branzi, 

G. Melandri (Bologna, IT) 

105 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Differences in the clinical presentation, pharmacological treatment and outcome 

between men and women in the 12 months follow-up in the Polish Population of 

Heart Failure Pilot Survey. P806 

J. Nessler, K. Bury, G. Opolski, L. Polonski, J. drozdz, e. Mirek-Bryniarska, P. Rozentryt, 

M. Zembala, M. Broncel, P. Ponikowski (Krakow, Warsaw, Zabrze, Lodz, Cracow and 

Wroclaw, PL) 

Aiming high in evidenced-based heart failure pharmacotherapy - are the guidelines 

right? P807 

s.M. Guentner, G. Gueder, s. Brenner, M. Hanke, G. ertl, C.e. Angermann, s. stork 

(Würzburg, de) 

High prevalence of unrecognized heart failure among elderly patients presenting with 

shortness of breath on exertion to the general practitioner P808 

e.e.s. Van Riet, F.H. Rutten, A. Limburg, M.J. Landman, A.W. Hoes (Utrecht and 

Amersfoort, NL) 

Heart failure after acute myocardial infarction: evidence from a cohort of more than 

800,000 Italian patients P809 

F. seccareccia, C. Greco, s. Rosato, P.d.errigo, A. Maraschini, G. Badoni (Rome, IT) 

Prevalence, outcome, and echocardiographic characteristics of different QRS 

morphologies in patients referred with suspected heart failure P810 

A. Joseph, P. Pellicori, J. Zhang, A. Bennett, s. Parsons, R. dierckx, K. Goode, A.L. Clark, 

J.G.F. Cleland (Hull, GB) 

Clinical - Psychosocial/ethical concepts 

Education programmes reveal a scant level of knowledge of patients on anticoagulant 

therapies P811 

F. Roubille, C. Roubille, F. Leclercq, J.L. Pasquie, J.M. davy, d. delseny (Montpellier, FR) 

Type D personality subscales influence long term survival in Chronic Heart Failure 

patients P812 

M. Nikolaou, J.T. Parissis, T. Katsoulas, G. sakkas, P. Rafouli-stergiou, e. stylianaki, 

s. sothiriou, e. Rentoukas, G. Filippatos, M. Anastasiou-Nana (Athens, GR) 

Predictive value of the shorter 2-item patient health questionnaire in heart failure 

patients P813 

s.M. Piepenburg, s. stoerk, G. Gelbrich, B. Warrings, G. ertl, H. Faller, C.e. Angermann 


Clinical - Exercise testing 

Treadmill versus cycle ergometer cardiopulmonary exercise testing in patients with 

chronic heart failure in the beta-blocker era P814 

M. Morita, F. Bacal, R.e. Castro, L. Cruz, J.F.C. Belli, J. Roque, I.s. Teixeira-Neto, P. Chizzola, 

e.A. Bocchi, G.V. Guimaraes (sao Paulo, BR) 

Effect of left atrial volume index and pulse wave velocity on early systolic blood 

pressure response to exercise P815 

J.O. Jeong, J.H. Park, s.A. Jin, s.J. Park, J.H. Park, s.W. Choi (daejeon, KR) 

Influence of pulmonary hypertension and right ventricular dysfunction on functional 

exercise capacity in systolic heart failure patients P816 

M. satendra, L. sargento, C. sousa, s. Longo, A. Arsenio, N. Lousada, R. Palma dos Reis 

(Lisbon, PT) 

106


How active are patients with heart failure and implantable cardioverter-defibrillator - a 

pilot study P817 

A. Kisko, L. dernarova, J. Kmec, A. Hudakova, M. Jakubikova, T. santova, d. Magurova, 

A. sulicova, M. Mroskova (Presov, sK) 

Influence of functional capacity and anthropometric parameters in medium-term 

prognosis after acute coronary syndrome P818 

R.M. duarte Faria, M. Ponte, N. Bettencourt, R. Fontes de Carvalho, F. sampaio, 

J. Caldas, A. Rodrigues, M. Teixeira, L. simoes, V. Gama (Vila Nova de Gaia, PT) 

Prognostic value of maximal oxygen consumption in patients with dilated 


M. satendra, L. sargento, A. Arsenio, C. sousa, s. Longo, N. Lousada, R. Palma dos Reis 

(Lisbon, PT) 

Biovaribility, minimal important difference and change of the 6-minute walk test in 


T. Taeger, F.H. Wians, R. Cebola, H. Froehlich, H.A. Katus, L. Frankenstein 

(Heidelberg, de; dallas, Us) 

A new method for evaluation of ventilatory efficiency in heart failure patients P821 

P. Gargiulo, A. Apostolo, e. Gondoni, e. salvioni, M. Contini, P. Palermo, s. Farina, 

C. Vignati, s. Olla, P.G. Agostoni (Milan, IT) 

Diabetes patients with a hypertensive response to exercise have exercise intolerance P822 

T. sugimoto, M. Ootsuji, K. sato, K. Moriwaki, M. Horiguchi, T. Takamura, s. sakabe, 

T. seko, K. Bettou, A. Kasai (Ise, JP) 

Clinical - Prognosis 

From heart failure to highly unsaturated fatty acids deficiency P823 

P. Alter, H. Rupp (Marburg, de) 

Prognostic value of heart rate at discharge in patients hospitalized for decompensated 

heart failure and systolic dysfunction P824 

R.M. Christodorescu, d. darabantiu, s. dragan (Timisoara and Arad, RO) 

Prognostic value of gender in elderly patients with severe ventricular dysfunction P825 

M. Cortes Garcia, I. Hernandez, P. Avila, e. de La Cruz, J.A. Palfy, A.M. Romero, 

J.A. Franco, M.A. Navas, M.A. Orejas, J. Farre (Madrid, es) 

ultrafiltration and survival of patients with refractory to medical treatment congestive 


L.G. Mircheva, Y.T. Yotov, A.A. Angelov, A.R. Kisheva, O.G. Kunchev (Varna, BG) 

T(-786)C polymorphism of endothelial nitric oxide synthase is associated with poor 

endothelium-mediated vasodilatatory response and worse clinical prognosis in 

chronic systolic heart failure P827 

I.d. Mazur, N.G. Gorovenko, L.G. Voronkov, I.A. shkurat (Kyiv, UA) 

Can tissue hemoglobin oxygen saturation predict decompensation in advanced heart 

failure patients? P828 

C. Marques, M. Castelo Branco (Covilhã, PT) 

Prognostic model for 2-year survival of heart failure patients with systolic dysfunction 

using every-day variables P829 

B.N.K. Kanazirev, J.G.T. Georgieva, M.s.d. dimova (Varna, BG) 

Multidisciplinary programs: how import is the management of patients with heart failure P830 

R. Rodrigues, L. Rassi, L. Mendes, J.F. santos, s. Correia, A. Lourenco, N. Fonseca, 

L. soares (setubal, PT) 

107 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Copeptin is a long-term predictor of mortality and rehospitalization for 

decompensated chronic heart failure P831 

d. silva, C. Jorge, A. Magalhaes, A.R. Ramalho, N. Cortez-dias, R. Placido, C. Calisto, 

I. Portela, A. Nunes-diogo, d. Brito (Lisbon, PT) 

Predictive value of glomerular filtration rate and microalbuminuria in patients with 


s. djordjevic, M. Krotin, V. Bisenic, s. Raspopovic, N. Ninkovic, s. Banicevic, s. Hinic, 

M. Zaja (Belgrade, Rs) 

Prognostic impact of Bundle Branch Block (BBB) on presenting electrocardiogram in 

patients with left ventricular systolic dysfunction following acute myocardial infarction P833 

L. savic, I. Mrdovic, M. Asanin, M. Matic, R. Lasica (Belgrade, Rs) 

Differences of long-term prognostic factors in chronic kidney disease patients 

according to dialysis P834 

s. Lee, H. Yun, L. Jung, e. Kim, W. Kim, J. Ko (Jeonju, KR) 

Characteristics nad long-term survival in 1000 patients with advanced heart failure. 

A single center experience. P835 

P. Lesny, M. Luknar, I. Varga, P. solik, I. soosova, s. Wimmerova, e. Goncalvesova 

(Bratislava, sK) 

Glasgow prognostic score: also valid in acute coronary syndromes? P836 

C. sousa, J. Rodrigues, I. Rangel, A. Goncalves, R. Lopes, A. Lebreiro, A. sousa, e. Martins, 

M. Campelo, M.J. Maciel (Porto, PT) 

Clinical outcomes of heart failure among patients with in-hospital cardiac arrest: 

from J-RCPR study P837 

T. sasaoka, Mitsuaki Isobe, N. Yonemoto, H. Yokoyama, H. Nonogi (Tokyo, suita, Osaka 

and shizuoka, JP) 

The music therapy on patients with heart failure and acute myocardial infarction; 

11-year experience P838 

P. Mitrovic, B. stefanovic, A. Paladin, M. Radovanovic, N. Radovanovic, d. Rajic, G. Matic, 

A. Novakovic, Z. Vasiljevic (Belgrade, Rs) 

Ascending aorta size and outcome in heart failure: a reflection of biological aging? P839 

I. Gotsman, A. shauer, d.R. Zwas, A. Keren, C. Lotan, d. Gilon (Jerusalem, IL) 

The obesity paradox: impact of body mass index in acute coronary syndrome P840 

C. Ferreira, P. Mateus, H. Ribeiro, s. Carvalho, A. Ferreira, I. Moreira 

(Covilhã and Vila Real, PT) 

Red cell distribution width in acute heart failure - a cost-effective prognostic marker P841 

P. Torres Ramalho, C. dias, J. Rema, P. Lourenco, F. Frioes, M. Alvelos, P. Bettencourt 

(Porto, PT) 

The association between Triglycerides at admission and mortality in patients 

hospitalized for heart failure: an analysis of the RO-AHFS Registry P842 

A. Ambrosy, O. Chioncel, d. Vinereanu, s. Bubenek, d. deleanu, d. Filipescu, 

M. Vaduganathan, s. Greene, C. Macarie, M. Gheorghiade (stanford, Boston and 

Chicago, Us; Bucharest, RO) 

Association between type-2 diabetes mellitus and post-discharge outcomes in heart 

failure patients: findings from the RICA registry P843 

F.J. Carrasco sanchez, R. Gomez-Huelgas, F. Formiga-Perez, A. Conde-Martel, 

J. Carles-Trullas, J.I. Perez-Calvo, P. Bettencourt, M. Montero (Huelva, Malaga, 

L’Hospitalet de Llobregat, Barcelona, Las Palmas de Gran Canaria, Girona, Zaragoza and 

Cordoba, es; Porto, PT) 

108


Clinical - Pathophysiology 

Analysis of blood flow velocity waveforms from the retro-bulbar circulation detects 

differences between heart failure patients and controls. (w) P844 

K. Lyons, A. Mccann, A. Millar, C. Bleakley, G.e. Mcveigh, M.T. Harbinson (Belfast, GB) 

Elevated neopterin is associated with disease severity and prognosis in chronic heart 

failure P845 

P. Lika, C. Trenkler, M. ess, M. Frick, G. Weiss, G. Poelzl (Innsbruck, AT) 

Depression correlates with right amygdala damage in heart failure patients P846 

K. sairafian, J.A. Ogren, P.M. Macey, R. Kumar, G.C. Fonarow, M.A. Hamilton, 

R.M. Harper, M.A. Woo (Los Angeles, Us) 

Clinical - Pulmonary hypertension 

Adrenomedullin in pulmonary arterial hypertension: a valuable parameter in 

prognostic stratification P847 

P. Carrilho-Ferreira, N. Cortez-dias, A.R. Ramalho, R. Placido, M. Nobre Menezes, C. Jorge, 

C. Calisto, s. Robalo Martins, F.J. Pinto, A. Nunes diogo (Lisbon, PT) 

Features of treatment of acute myocardial infarction patients with moderate 

pulmonary hypertension P848 

N.T. Yakubbekov, A.G. Nikishin, T.A. Nurbaev, s.Y. Abdullaeva, M.s. Hasanov 

(Tashkent, UZ) 

Right heart failure and clinical deterioration: the study of idiopathic pulmonary arterial 

hypertensive patients P849 

J. Grapsa, I. Z Cabrita, G. durighel, d. dawson, d.O.regan, W. Gin-sing, L. sge Howard, 

s. Jr Gibbs, P. Nihoyannopoulos (London, GB) 

Phosphodiasterase inhibitors in pulmonary hypertension secondary to left ventricular 

dysfunction and highly elevated pulmonary wedge pressure: is it safe? P850 

d. Murninkas, T. Hasin, I. Mats, V. Yaari, J. Zusmam, T. Ben Gal (Petach Tikva, IL) 

A hemodynamic study of pulmonary arterial hypertension in patients with chronic 

hemolytic anemia P851 

G.e. derchi, C. dessi, P. Bina, M.-e. Lai, e. Cassinerio, A. Quarta, I. Tartaglione, M. Melis, 

A. Piga, G.L. Forni (Genoa, Cagliari, Milan, Brindisi, Naples, Nuoro and Turin, IT) 

Clinical - Right ventricular function 

The role of right ventricular systolic function on long-term outcome in patients with 

newly diagnosed systolic heart failure. P852 

C. Chrysohoou, C. Antoniou, J. Kotroyiannis, G. Metallinos, J. Andreou, G. siasos, s. Brili, 

d. Tousouls, C. Pitsavos, C. stefanadis (Athens, GR) 

Myocardial acceleration during isovolumic contraction, an independent afterload 

index of right ventricular contractile function P853 

A. Pereira, N. Moreno, A. Castro, R. santos, R. sousa, R. Carvalho, M. Pires, d. Araujo, 

P. Pinto (Penafiel, PT) 

Pulmonary embolism with and without acute heart failure: what makes the 

difference? Data from Romanian registry for pulmonary thromboembolism (RO-TEP) P854 

A.O. Petris, G. Tatu-Chitoiu, A. Nechita, C. Pop, M. Vladoianu, L. Petrescu, L. Vida-simiti, 

d. Tint, d. Cimpoesu (Iasi, Bucharest, Arad, Targoviste, Timisoara, Cluj Napoca and 

Brasov, RO) 

Not all heart failure is the same: the comparison of echocardiographic parameters 

affecting response to exercise in left and right ventricular failure P855 

M. Jasiewicz, K. Ptaszynska, A. szpakowicz, M. Knapp, W.J. Musial, K.A. Kaminski 

(Bialystok, PL) 

109 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Clinical - Left ventricular function 

Diastolic dysfunction of the left ventricle in dialysis patients P856 

d. Loncar, M. Tabakovic, d. Hadzovic, A. Jasarevic, e. Brkic, e. smajic (Tuzla, BA) 

Central hemidynamics, myocardial function abd lift heat remodelling in postinfarction 

patients with non-alcoholic fatty liver disease P857 

M.N. dolzhenko, s. Potashev, L. Konoplyanik, Y. Luchinskaya, Y. Lymar (Kiev, UA) 

Left ventricular diastolic disfunction is associated with shortened telomere length in 

elderly patients with diabetes. P858 

d. Akasheva, O.N. Tkacheva, I.d. strazhesko, e.V. Plokhova, A.s. Kruglikova, 

e.N. dudinskaya, N.V. Kokshagina, s.A. Boytsov (Moscow, RU) 

Late left ventricular systolic dysfunction in patients with acute myocarditis: 

echocardiographic and cardiac magnetic resonance predictors P859 

F. Melao, M. Paiva, T. Pinho, A. Goncalves, A. Madureira, e. Martins, F. Macedo, 


Diastolic heart failure P860 

M. Miljkovic, d.V. Vasic, d.G.P. Golubovic Petrovic (Aleksinac, Rs) 

Deterioration of LV systolic function in patients (PTS) treated with antibradycardic 

pacemakers (PM) and right ventricular (RV) stimulation: can it be predicted by 

LV-function at the time of implant? P861 

M. ebert, T. Blum, C. Maring, C. Restle, J. stockinger, T. Arentz, d. Kalusche 

(Freiburg - Bad Krozingen, de) 

Clinical - Hypertension/LV hypertrophy 

Geometerical changes of left ventricle left ventricle hypertrophy in hypertensive 

patients with and without diabetes mellitus P862 

M. saranovic, s. saranovic (Bar, Me) 

Effect of complex on clinical and functional parameters in the case of hypertension 

with diabetes diseases patients P863 

A. Isabekova, A. Rakisheva (Almaty, KZ) 

Left ventricular hypertrophy in hypertensive patients, comparison of Cardiac Magnetic 

Resonance and echocardiographic analysis of morphological and functional 

LV-parameters. P864 

A. Brzozowska-Czarnek, A. Urbanik (Krakow, PL) 

The effect of diastolic functional reserve and systolic functional reserve on stroke 

volume by passive leg elevation in hypertensive patients P865 

s.J. Rhee, s.N. shin, J.J. Choi, C.O. Choi, s.J. Kim, N.J. Yoo, J.W. Jeong (Iksan, KR) 

Clinical - HFpEF - Heart failure with preserved ejection fraction 

Survival in ambulatory heart failure patients with preserved ejection fraction, 1999-2011 P866 

J.M.O. Arnold, P. Liu, M.-H. Leblanc, J.G. Howlett, A. Ignaszewski, A. Kaan, M. edmonds, 

M. Winkler, P. Luehr, e. estrella-Holder (London, Ottawa, Quebec, Calgary, Vancouver, 

edmonton, Kelowna and Winnipeg, CA) 

Comparison of Clinical Characteristics of Patients with Heart Failure with Preserved 

and Reduced Ejection Fraction in Singapore versus New Zealand P867 

R. santhanakrishnan, G.d. Gamble, L.H. Ling, M. Lund, G. devlin, R. Troughton, 

A.M. Richards, R.N. doughty, C.s.P. Lam (singapore, sG; Auckland, Hamilton and 

Christchurch, NZ) 

Prevalence and prognosis of heart failure with preserved ejection fraction P868 

C.M. Carlsen, L. Kober, O.W. Nielsen (Copenhagen, dK) 

110


Arrhythmias predictors in hypertensive patients with heart failure with preserved 

ejection fraction P869 

M.V. Krestjyaninov, V.I. Ruzov (Ulyanovsk, RU) 

Anemia in heart failure with preserved ejection fraction P870 

M. Lezha, A. Gjata, e. Petrela (Tirana, AL) 

Association between atrial fibrillation and outcomes in patients with heart failure and 

preserved ejection fraction: finding from the RICA registry P871 

M. Montero Perez Barquero, J.M. Cepeda Rodrigo, A. Urrutia de diego, F. Formiga Perez, 

A. Conde Martel, B. Roca Villanueva, J.C. Trullas Vila, J.M. Cerqueiro Gonzalez, 

M.F. davila Ramos, F.J. Carrasco sanchez (Córdoba, Orihuela. Alicante, Badalona. 

Barcelona, Las Palmas de Gran Canaria, Castellon de la Plana, Olot. Gerona, Lugo, 

santa Cruz de Tenerife and Huelva, es) 

Recent prior heart failure hospitalization is associated with risk of clinical events in 

patients with reduced and preserved ejection fraction in the CHARM trials P872 

N. Bello, A.s. desai, J.J.V. Mcmurray, C. Granger, s. Yusuf, K. swedberg, M.A. Pfeffer, 

s. solomon (Boston and durham, NC, Us; Glasgow, GB; Hamilton, CA; Gothenburg, se) 

Diastolic dysfunction is associated with tissue Doppler longitudinal systolic dysfunction 

in patients with diastolic heart failure P873 

U. Yuksek, H. duygu, Z. Akyildiz, U. Kocabas, N. Kahya eren, R. Berilgen, C. Nazli, 

O. ergene (Kastamonu and Izmir, TR) 

Diastolic stress test in diagnosis of heart failure with preserved ejection fraction in 

patients with arterial hypertension P874 

d. Pilant, V. Lollini (Vitebsk, BY) 

Heart failure with preserved ejection fraction after mitral valve surgery P875 

J. Gupta, H. Zafar, T. Fletcher, T. Gupta (Walsall and Oxford, GB) 

Epicardial fat volume is inversely correlated with the degree of diastolic dysfunction 

and outcome in patients with heart failure with preserved ejection fraction P876 

G. Karakus, C. Tufaro, B. Marzluf, d. Bonderman, J. Babayev, s. Pfaffenberger, G. Maurer, 

J. Mascherbauer (Istanbul, TR; Vienna, AT) 

Adherence to guidelines is underestimated in women with chronic heart failure, 

regardless of ejection fraction P877 

A. Klabnik, J. Murin (Hospital Banovce and University Hospital Bratislava, sK) 

Plasma lysyl oxidase levels (pLOX-L) correlate with estimated left ventricular filling 

pressures and plasma galectine-3 in patients with stage C heart failure with preserved 

ejection fraction (HFPEF) P878 

B. Munoz Calvo, A. Villa Martinez, V. Victor Palomares, N. Lopez Andres, F. Roman Garcia, 

V. Nadador Patino (Alcala de Henares, es; Vandœuvre-Les-Nancy, FR) 

Clinical - Gene and cell therapy 

Structural polymorphism of angiotensin-converting enzyme gene at patients with 

dilated cardiomyopathy of uzbek nationality P879 


Polymorphism gene angiotensinogen M235T with clinical, structural and functional 

indexes of the heart in patients with chronic heart failure P880 

O. Krasnova, O. Krasnova (st. Petersburg, RU) 

111 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Clinical - Vascular biology, other 

The circulating endothelial progenitor cells decreased in patients with 

angiographically significant coronary artery diseases and chronic heart failure P881 

K.A. Khmelnitskaya, e.V. shlyakhto (st. Petersburg, RU) 

Subclinical Vascular disease in patients with Erectile Dysfunction: Correlation with 

High Sensitivity C-Reactive Protein Levels P882 

M.F. elnoamany, A. dawood (shebeen el-Koom, eG) 

Role of tirofiban in acute ST-elevation myocardial infarction in combination with 

reduced dose of streptokinase P883 

d.R. Alradhi (sanaa, Ye) 

Basic - EC coupling, arrhythmias and atrial fibrillation 

Angiotensin II increases arrhythmogenity of diastolic Ca2+ leak in murine and human 

cardiomyocytes P884 

M. sacherer, s. Ljubojevic, s. sedej, M. sereinigg, P. stiegler, e. Bisping, e.M. Moerth, 

K. Groschner, B.M. Pieske, F.R. Heinzel (Graz, AT) 

Cardiomyocyte contractile and calcium handling breakdown at high stimulation 

frequencies in post-myocardial infarction heart failure is reversed by exercise training P885 

O.J. Kemi, A. Johnston, M. dunne, G.L. smith (Glasgow, GB) 

IP3 mediated mitochondrial Ca uptake regulates mitochondrial metabolism P886 

L.K. seidlmayer, J. Kuhn, O. Ritter (Wurzburg, de) 

Aldosterone reduces left atrial contractile function P887 

J.-C. Reil, M. Tauchnitz, M. Oberhofer, M. Hohl, G.-H. Reil, P. steendijk, M. Boehm, P. Lipp, 

H.R. Neuberger (Hamburg and Oldenburg, de; Leiden, NL) 

Arterial hypertension accelerates rhythm instability and atrial remodeling in a porcine 

model of atrial fibrillation. P888 

M. schwarzl, A. Alogna, d. Zweiker, s. Huber, J. Verderber, G. Antoons, B.M. Pieske, 

A. Lueger, H. Post (Graz, AT) 

Chronic hypertension induces atrial remodeling during normal sinus rhythm in a 

porcine model of hypertensive heart disease. P889 

G. Jin, M. schwarzl, s. Huber, A. Alogna, P. schoenleitner, P. Wakula, F.R. Heinzel, 

B.M. Pieske, H. Post, G. Antoons (Graz, AT) 

Basic - miRNAs and genetics 

Inhibition of miR-148a results in accelerated dilated cardiomyopathy P890 

L.e. Philippen, e. dirkx, N. Lopez-Andres, N. Bitsch, P.A. da Costa Martins, L.J. de Windt 

(Maastricht, NL; Vandœuvre-Les-Nancy, FR) 

Identification of regulated microRNAs by the endothelial transcription factor GATA2 P891 

d. Hartmann, J. Fiedler, T. Thum (Hannover, de) 

MicroRNA signatures in left ventricular hypertrophy P892 

M. swinnen, H. Hermans, s. Vandenwijngaert, P. Pokreisz, e. Caluwe, H. Gillijns, 

F. Van de Werf, K.d. Bloch, s. Janssens (Leuven, Be; Boston, Us) 

Expression of PITX2 transcription factor is re-activated in heart failure: evidence from 

the pig model and patient samples P893 

M. Torrado, d. Franco, F. Hernandez-Torres, N. domenech, M.G. Crespo-Leiro, 

A. Castro-Beiras, A. Mikhailov (La Coruna and Jaen, es) 

112


High-risk genetic polymorphism associated with cardiovascular events following 

ischemic heart disease in a Portuguese population P894 

M. Mendonca, s. Gomes, A. Pereira, B. silva, H. Cafe, M. Rodrigues, A.I. Freitas, s. Freitas, 

d. Pereira, R. Palma dos Reis (Funchal and Lisbon, PT) 

The impact of genetic testing versus heart failure symptomatology on the health 

status and psychological distress of patients with non-compaction cardiomyopathy P895 

C.J. Brouwers, W.J. Kop, K. Caliskan, J. Roeters Van Lennep, e. sijbrands, s.s. Pedersen 

(Tilburg and Rotterdam, NL) 

GSTM1 null genotype is associated with increased risk of chronic heart failure among 

smokers P896 

N. Jankovic, d.V. simic, s. Radovanovic, N. Mujovic, M. Marinkovic, B. Parapid, s. Mrdja, 

A. Kocijancic, V. Kovacevic, P.M. seferovic (Belgrade, Rs) 

MiR-21 mediates interstitial fibrosis in cardiac allograft by supporting monocyte to 

fibroblast transition P897 

s.K. Gupta, J. Fiedler, L.V. Aelst, C. Falk, s. Heymans, T. Thum (Hannover, de; 

Maastricht, NL) 

Basic - Inflammation 

Simultaneous detection of multiple viruses and bacteria by both electron microscopy 

and immunohistochemistry techniques suggests a role for co-infection in dilated 


M.L. Higuchi, s.A.P. Palomino, M.M. Reis, s. Mangini, e.A. Bocchi, P.M. Pomerantzeff, 

A.I. Fioreli, R. Kalil Filho (sao Paulo, BR) 

Lipoxins: a new biomarker in chronic heart failure? P899 

M. Reina-Couto, J. Carvalho, M.J. Valente, L. Vale, J. Afonso, M. Morato, F. Carvalho, 

P. Bettencourt, T. sousa, A. Albino-Teixeira (Porto, PT) 

Induction, histomorphologic and molecular analysis of acute myocarditis in the Lewis 

rat in order to determine molecular targets suitable for imaging purposes P900 

P. Panjwani, V. Boivin (Wuerzburg, de) 

Myocardial fibrosis development in an angiotensin ii induction model is exacerbated 

by intravenous immunoglobulin P901 

A. Falkenham, N.L. Rosin, A. Gareau, M.J.H. sopel, T.d.G. Lee, J.F. Legare (Halifax, CA) 

Age-related fibrosis and the effects of collagen cross-linking reduction with lysyl 

oxidase inhibition P902 

N. Rosin, M.J. sopel, A. Falkenham, T. Myers, T.G.d. Lee, J.F. Legare (Halifax, CA) 

Iron deficiency and endothelial dysfunction in patients with 2 type of cardiorenal 

syndrome. P903 

N. Ryndina, G. Tytova, P. Kravchun (Kharkiv, UA) 

Basic - Vascular 

Cardiomyocite and microvascular endothelial cell remodelling and hibernation in 

hypertension as risk factor for heart failure P904 

O. Barnett, Y. Kyyak (Lviv, UA) 

Myocardial remodelling in arterial hypertension as predictor of myocardial infarction 

and heart failure P905 

O. Barnett, Y. Kyyak (Lviv, UA) 

Cardiac cell hibernation in acute and chronic aneurism wall: dedifferentiation or 

degeneration? P906 

O. Barnett, Y. Kyyak, H. Kyyak (Lviv, UA) 

113 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



Hyperoxia causes reversible pulmonary vasoconstriction in human arteries P907 

P. Ariyaratnam, M. Loubani, R. Bennett, s. Griffin, A. Morice (Hull, GB) 

Echocardiographic assessment of the impact of exercise training at different time 

points of the development of experimental pulmonary arterial hypertension P908 

N. Moreno, d. Moreira-Goncalves, C. shmidt, A. Bovolini, T. Henriques-Coelho, 

A. Leite-Moreira (Porto, PT) 

Neuregulin-1 treatment reduces right ventricular dysfunction in pulmonary arterial 

hypertension P909 

P. Mendes-Ferreira, R. Adao, C. Maia-Rocha, A.P. Lourenco, A. Meireles, I. Falcao-Pires, 

G.W. de Keulenaer, A.F. Leite-Moreira, C. Bras-silva (Porto, PT; Antwerp, Be) 

Divergent mechanisms of hydrogen-peroxide evoked vascular effects in isolated 

systemic and coronary arterioles P910 

V. Csato, A. Toth, A. Koller, I. edes, Z. Papp (debrecen and Pécs, HU) 

Mechanisms of orthostatic insufficiency in patients with severe heart failure P911 

O.V. Mamontov, A.V. Kozlenok, A.O. Conradi, e.V. shlyakhto (st. Petersburg, RU) 

Enhancement of coronary flow in mice hearts using new MAH3HCL P912 

P. Haller, J. Krynicka, M. Kreibich, e. dzilic, G. Brunhofer, M. Hintersteininger, K. Trescher, 

C.H. studenik, T. erker, B.K. Podesser (Vienna, AT) 

Basic - Cardiomyopathies and LV remodeling 

Neuregulin-1 prevents the development of dilated cardiomyopathy but not 

atherosclerosis in mice with type-1 diabetes and hypercholesterolemia P913 

L. Vandekerckhove, A.-s. Hervent, G.W. de Keulenaer (Antwerp, Be) 

Methylenetetrahydrofolate reductase gene polymorphism, obesity and 

hypercholesterolemia in patients with heart failure and arterial hypertension P914 

d. shorikova, e. shorikov, V. Tashchuk (Chernivtsy, UA) 

Influence of air pollution upon myocardial remodeling P915 

A.M. Oliveira, F. Ramires, K.C.B. Fonseca, V.M. salemi, F.G. Pessoa, F. Fernandes, 

P. saldiva, C. Mady (sao Paulo, BR) 

unfolded protein response in hypertrophic cardiomyopathy P916 

L. Gu, G. Gao, s. Kasturirangan, C. Rutledge, s. day, s.C. dudley (Chicago and Ann 

Arbor, Us) 

Electron lucent serum microparticles are related with heart failure in chagas disease P917 

M.A.R.T.I.N.s. Reis, M.L. Higuchi, R.N. Ikegami, J.T. Kawakami, B. Ianni, J.J. Pereira, 

M.H. santos, s. Mangini, e.A. Bocchi, R. Kalil Filho (sao Paulo, BR) 

Archaeal DNA and heart failure in chagasic patients P918 

M.L. Higuchi, R.N. Ikegami, J.T. Kawakami, M.M. Reis, M.H.H. santos, V. Issa, s. Mangini, 

e.A. Bocchi, R. Kalil Filho (sao Paulo, BR) 

Co-infection in chagasic patients with heart failure P919 

M.L. Higuchi, M.M. Reis, s. Mangini, s.A.P. Palomino, J.T. Kawakami, M.H.H. santos, 

R. Kalil Filho, e.A. Bocchi (sao Paulo, BR) 

Evidence that a familial DCM mutation uncouples troponin I phosphorylation from 

calcium sensitivity, blunts the lusitropic response and generates symptoms of heart 

failure under stress P920 

R. Wilkinson, P. Vikhorev, W. song, s.B. Marston (London, GB) 

114


Basic - Stem cells 

Experimental therapy of heart failure with mesenchyme stem cells P921 

A. Zhuiko, V. Kardash, A. Bulgak, T. Vladimirskaya, A. Zhernosechenko, Y. Isaikina, 

V. Terekhov (Minsk, BY) 

Effect of a cell-based bioactive smart patch after myocardial infarction in swine. P922 

C. Galvez-Monton, C. Prat-Vidal, B. sanchez-Terrones, A. Guasch, V. Puig-sanvicens, 

I. diaz-Guemes, F.M. sanchez-Margallo, C.e. semino, R. Bragos, A. Bayes-Genis 

(Badalona, Barcelona and Caceres, es) 

Molecular machinery regulating angiogenesis is common to umbilical cord 

blood-derived mesenchymal stem cells and mature endothelial cells P923 

s. Roura, J.R. Bago, C. Galvez-Monton, J. Blanco, A. Bayes-Genis (Badalona and 

Barcelona, es) 

Canonical NF-kB signaling pathway functionally links mammalian Target Of 

Rapamycin (mTOR) kinase to Bnip3 suppression and cell survival of ventricular myocytes P924 

L.A. Kirshenbaum, R. dhingra (Winnipeg, Canada, CA) 

Detection of soluble bag3 and anti-bag3 antibodies in chronic heart failure patients P925 

M. Mirra, M. de Marco, G. Vitulano, N. Virtuoso, R. de Rosa, A. Gigantino, A. Falco, 

F.d.auria, M.C. Turco, F. Piscione (salerno and Naples, IT) 

Basic - Extracellular matrix, fibrosis 

Mineralocorticoid receptor antagonists modulate galectin-3 cardiac expression in 

chronic heart failure. P926 

J. sanchez-Mas, A. Lax, M.C. Asensio-Lopez, G. santarelli, s. Abenza, L. Caballero, 

M.T. Perez-Martinez, M.J. Fernandez-del Palacio, M. Valdes, d.A. Pascual-Figal 

(Murcia, es) 

Pharmacological activation of soluble guanylate cyclase attenuates fibrosis and 

chronic heart failure in experimental diabetic cardiomyopathy P927 

T. Radovits, C. Matyas, A. Olah, B. Nemeth, L. Hidi, e. Birtalan, s. Korkmaz, G. Kokeny, 

G. szabo, B. Merkely (Budapest, HU; Heidelberg, de) 

Galectin-3 and cardiac remodeling in an animal model of myocardial infarction P928 

A. Lax, M.C. Asensio-Lopez, J. sanchez-Mas, M.J. Fernandez-del Palacio, L. Caballero, 

G. santarelli, s. Abenza, M.T. Perez-Martinez, M. Valdes, d.A. Pascual-Figal (Murcia, es) 

Cardiac effects of leptin in rats, the potential role of galectin-3 P929 

e. Martinez, M. Miana, R. Jurado-Lopez, M. Valero-Munoz, M.V. Bartolome, s. Ballesteros, 

M. Luaces, A. Briones, N. Lopez-Andres, V. Cachofeiro (Madrid, es; 

Vandœuvre-Les-Nancy, FR) 

Syndecan-4 regulates myocardial stiffness in response to mechanical stress by 

regulating extracellular matrix composition through myofibroblast differentiation P930 

K.M. Herum, I.G. Lunde, B. skrbic, W.e. Louch, A. Hasic, I. sjaastad, A. Unger, W.A. Linke, 

M.F. Gomez, G. Christensen (Oslo, NO; Bochum, de; Malmö, se) 

Serum levels of Galectin-3 in end-stage heart failure and after heart transplantation P931 

N. suarez, e. Barge Caballero, M.J. Paniagua Martin, R. Marzoa Rivas, Z. Grille Cancela, 

J. Rodriguez Garrido, s. Chavez Leal, N. domenech Garcia, A. Castro Beiras, 

M.G. Crespo-Leiro (A Coruña, es) 

Proteomics analysis of cardiac extracellular proteins reveals oxidation of pentraxin 3 as 

novel biomarker for survival in sepsis P932 

F. Cuello, U. Mayr, X. Yin, M. Marshall, I. drozdov, P. Willeit, M. shankarhari, 

M. Terblanche, A.M. shah, M. Mayr (Hamburg, de; London and Cambridge, GB) 

115 

MODERATED 

pOsTER sEssiOn 1

MODERATED 



A crosstalk between cardiotrophin-1 and ST-2s, two key molecules in cardiovascular 

fibrosis and dysfunction P933 

N. Lopez-Andres, L. Calvier, e. Rousseau, J. diez, F. Zannad, P. Rossignol (Pamplona, es; 

Vandoeuvre-Les-Nancy, FR) 

Clinical Cases 

Acute coronary syndrome presenting with severe pulmonary edema due to papillary 

muscle rupture of the anterior mitral leaflet demending urgent mvr and cabg P934 

s.K. Kaeva, M.M. Miletic, H.P. Pejkov, V.A. Andova, e.s. shehu, s.P. Paljoskovska-Jordanova 

(skopje, MK) 

Extracorporeal membrane oxygenation in the multi-disciplinary intensive treatment of 

cardiogenic shock secondary to acute myocarditis P935 

A. Fontana, A. Vincenzi, F. Formica, L. Avalli, A. Ciro', A. Frattola, F. Achilli (Monza, IT) 

Acute pulmonary thromboembolism caused by prolonged oral contraceptive therapy: 

case report P936 

M. Boshev, s. Kedev, M. Otljanska, F. Arnaudova-dezulovik, s. Paljoskovska-Jordanova 

(skopje, MK) 

Long-term noninvasive monitoring by lung impedance of chronic heart failure 

patients in the out-patient clinic P937 

M. shochat, A. shotan, M. Kazatsker, A. Asif, I. dahan, I. shochat, L. Vasilenko, Y. Levy, 


The time course of the evolution of pulmonary congestion and edema during ST 

elevation Myocardial Infarction P938 

M. shochat, A. shotan, M. Kazatsker, A. Asif, I. dahan, I. shochat, Y. Levy, L. Vasilenko, 

T. sigalov, s. Meisel (Hadera, IL) 

Comparison of the predictive values of NT-proBNP and lung impedance 

measurements in the course of BNP-guided treatment of CHF patients P939 

M. shochat, A. shotan, M. Kazatsker, A. Asif, I. dahan, I. shochat, Y. Levy, L. Vasilenko, 

e. Noyman, s. Meisel (Hadera, IL) 

Acute left ventricular dysfunction due to diffuse anterior descendent coronary artery 

spasm P940 

J. Mancio, R. Faria, s. Bernardino, M. Marques, d. Caeiro, M. Oliveira, A. Albuquerque, 

L. simoes, V. Gama (Vila Nova de Gaia and Famalicão, PT) 

Heart failure and muscular dystrophy: a case of success P941 

R. Rodrigues, L. Rassi, J.F. santos, L. Mendes, C. sa, N. Fonseca, L. soares (setubal, PT) 

Noncompaction cardiomyopathy combined with four other cardiac abnormalities, 

what are the odds? P942 

d. Zizek, M. Jan, M. Cvijic, R. Zbacnik, M. Kozelj (Ljubljana, sI) 

Arrhythmogenic right ventricular cardiomyopathy with left ventricular involvement: 

the important contribution of magnetic resonance imaging P943 

I. Rangel, M. Vasconcelos, A. sousa, C. sousa, C. Frutuoso, R. Mota-Garcia, A. Madureira, 

M. Campelo, M.J. Maciel (Porto, PT) 

Prevention of right heart failure post left ventricle assit device implantation by 

Phosphodiesterase 5 inhibitor P944 

R. Hamdan, A. Al Zein, C. Najjar, P. Nassar, F. Ali, M. Harb, F. Housseiny, M. Issa, M. Chaar, 

M. saab (Beirut, LB) 

Suicide by disconnection of left ventricular assist device P945 

C. Nadarajah, I. Weichert (Ipswich, GB) 

116


Clinical outcomes of device treatment of fulminant myocarditis; a series of case reports P946 

M. Masumura, T. sasaoka, T. Fujiwara, H. Arai, Mitsuaki Isobe (Tokyo, JP) 

Successful radiofrequency ablation therapy for refractory ventricular tachycardia in a 

patient with left ventricular assist device P947 

G. Romano, G. di Gesaro, G. sgarito, U. Giordano, C. Mina, C. Ruperto, F. Clemenza, 

C. scardulla (Palermo, IT) 

The combined strategy in patient with angiodysplasia andLleft Ventricular Assist 

Device thrombosis. P948 

G. di Gesaro, G. Romano, C.M. Hernandez Baravoglia, C. Falletta, A. Amaducci, 

R. Baglini, F. Clemenza, C. scardulla (Palermo, IT) 

Coronary artery abnormalities- case report P949 

s. Paljoskovska Jordanova, M. Otljanska, M. Boshev, s. Kaeva (skopje, MK) 

Heart failure as an initial manifestation of antiphospholipid syndrome P950 

K.Y. Juarez escobar, J.e. Cruz, J. Vargas Penafiel, M. Jimenez Cruz, J. Gomez Leon, 

A. Lara Olivares, R.U.B.e. Baleon esponoza (Mexico, city, MX) 

Superiority of combined 6-minute walking test and echocardiography versus 

cardiopulmonary exercise testing in predicting mortality in the elderly with all-cause 


A.B.s. scardovi, d.M.R. de Maria, A. Ferraironi, R.R. Ricci, P.A.B. Boccanelli, G.C. Carboni 

(Rome and Milan, IT) 

Carotid body resection in chronic systolic heart failure: first-in-man case report P952 

P. Niewinski, d. Janczak, A. Rucinski, P.A. sobotka, Z.J. engleman, P. Jazwiec, s. Tubek, 

e.A. Jankowska, W. Banasiak, P. Ponikowski (Wroclaw, PL; New York, Us) 

Chronic treatment of postcapillary pulmonary hypertension out-of-proportion with 

monthly levosimendan infusions P953 

A. Fontana, A. Vincenzi, A. Ciro', A. Frattola, e. Negro Cusa, e. Vigano', P. Cagnan, 

A. santi, G. Trocino, F. Achilli (Monza, IT) 

Fatal acute right heart failure in gastric cancer patients P954 

s.H. seol, s.e.O. Gwang-Won, K.I.M. dong-Kie, K.I.M. Ki-Hun, s.O.N.G. Pil-sang, 

K.I.M. doo-Il, K.I.M. dong-soo, s.e.O. Jeong-sook, K.I.M. dae-Kyeong, J.A.N.G. Jae-sik 

(Busan, KR) 

A challenging case of newly diagnosed primum atrial septal defect with severe 

pulmonary hypertension in a 70 year old P955 

M.M. Alqaseer, A.s. Aithan, M. saleem, A. Jelani (Al Ahsa, sA) 

Asymptomatic but irreversible: a missed chance of preventing right ventricular failure P956 

F. Valente, L. Marta, d. severino, C. Costa, M. Alves, I. Monteiro (santarem, PT) 

A case of diastolic heart failure with prominent pulmonary arterial wedge V waves not 

associated with the presence and severity of mitral regurgitation P957 

C. Chrysohoou, s. Vaina, C. Tentolouris, C. Pitsavos, C. stefanadis (Athens, GR) 

Deformation imaging for long-term follow-up in a young patient with acute myocarditis P958 

A.O. Ciobanu, s. Mihaila, M. Cinteza, d. Vinereanu (Bucharest, RO) 

33 year-old male with Desmin-related restrictive cardiomyopathy P959 

J. stepniewski, G. Kopec, P. Wilkolek, P. Rubis, B. sobien, P. Podolec (Krakow, PL) 

117 

MODERATED 

pOsTER sEssiOn 1


New this year 




From sunday 26 May 14:00 - 18:00 & Monday 27 May 08:00 - 12:30. 













Research 

New Therapies 

119 

Interventions 

Knowledge 

MODERATED 

pOsTER sEssiOn 2

MODERATED pOsTER sEssiOn 2 - sunDAy 14:00 TO MOnDAy 12:30 

Moderated Poster Session 2 - Sunday 14:00 to Monday 12:30 

121 

Poster Area 

New this year 



Clinical - Acute heart failure 

ultrafiltration: a new therapeutic option for uK patients with end-stage heart failure P960 

P.J. Cowburn, J. Masters, s.d. duckett, d. Kelly (southampton and Basingstoke, GB) 

The rationale and design of the Acute Treatment with Omecamtiv Mecarbil to Increase 

Contractility in Acute Heart Failure (ATOMIC-AHF) study: a phase 2, cohort study of a 

novel cardiac myosin activator P961 

J.R. Teerlink, G.M. Felker, J.J.V. Mc Murray, J.B. Kim, B. Knusel, L. Lei, F.I. Malik, 

s.M. Wasserman (san Francisco, durham, NC, Thousand Oaks, CA and 

south san Francisco, Us; Glasgow, GB) 

Immediate administration of tolvaptan prevent the exacerbation of acute kidney injury 

in patients with acute heart failure P962 

A. shirakabe, N. Hata, T. shinada, K. Tomita, M. Tsurumi, H. Okazaki, Y. Yamamoto, 

N. Kobayashi, K. Asai, K. Mizuno (Chiba Hokusoh Hospital, Nippon Medical school and 

Tokyo, JP) 

Long term effects of Levosimendan therapy in patients with cardiogenic shock P963 

I. Katsytadze, e. Amosova, I. Prudkyi, O. Gerula, N. shishkina (Kyiv and Kiev, UA) 

Left-sided heart failure and inotropic agents use are independent predictors of 

worse outcome in patients presenting with acute myocardial infarction treated by 

thrombolytic therapy P964 

W. Jomaa, s. Hamdi, M. Chakroun, T.R. Trimech, K. Ben Hamda, F. Maatouk 

(Monastir, TN) 

Body mass index and in-hospital treatment strategies in acute heart failure patients. P965 

J.T. Parissis, K. Fountoulaki, I. Ikonomidis, K. Ntai, A. Mebazaa, G. Filippatos, 

M. Anastasiou-Nana, F. Follath (Athens, GR; Paris, FR; Zurich, CH) 

Seizing impaired body fluid distribution in heart failure - an application for body 

impedance spectroscopy? P966 

T. Trippel, A. stahn, V. Tscholl, e. Tahirovic, M. Lainscak, G. Loncar, L. Musial-Bright, 

F. Krackhardt, W. Haverkamp, H.-d. duengen (Berlin, de; Golnik, sI; Belgrade, Rs) 

Specific nursing care in patients after cardiac surgery operated by supporting from 

intra aortic balloon pump /IABP. P967 

N. Negrieva (sofia, BG) 

Outcome of acute heart failure management by cardiologists and non-cardiologist 

physicians P968 

Y.C. Lau, Q. Aleem, T. Hamid, J. Mcdonald, K. Balachandran, R. singh (Cardiff, Blackburn 

and Wigan, GB) 

Estimating the need for therapeutic procedures of high complexity in a cardiac care 

unit of a referral cardiovascular centre P969 

G. Binaghi, M. Lilliu, A. Pani, A. Pilleri, C. Pinna, G. scorcu, e. serra, L. Valentino, 

C. Caredda, M. Porcu (Cagliari, IT) 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Tolvaptan in hyponatremic patients with heart failure: initial experience P970 

L. Martinez-dolz, Y. Rodriguez-de Munoz, I.J. sanchez Lazaro, L. Almenar-Bonet, 

M. Rodriguez-serrano, J. Melero-Ferrer, e. Rosello-Lleti, M. Portoles-sanz, M. Rivera-Otero, 

A. salvador-sanz (Valencia, es) 

Clinical and prognostic implications of serum copper in acute heart failure P971 

I. Alexanian, J.T. Parissis, s. Athanaselis, L. Pappas, G. Gavrielatos, C. Michas, A. sideris, 

d. Kremastinos, M. Anastasiou-Nana, G. Filippatos (Athens, GR) 

Determinants and impact of acute heart failure complicating ST-elevation acute 

myocardial infarction on long-term outcome in patients treated with primary 

percutaneous coronary intervention P972 

d. Matic, G. stankovic, d. Milasinovic, M. Asanin, s. stankovic, I. Mrdovic, M. Marjanovic, 

N. Antonijevic, V. Vukcevic, P. seferovic (Belgrade, Rs) 

Trends in hospitalized patients with systolic heart failure in Korea: clinical 

characteristics, therapies and outcomes : a result from 3 Korean heart failure registry P973 

B.s. Yoo, K.H. Choe, s.H. Lee, J.W. Oh, s.M. Kang, e.s. Jeon, d.J. Choi, K.H. Ryu 

(Wonju and seoul, KR) 

Heart failure in native valve infective endocarditis: characteristics and prognosis P974 

M. Hassine, F. Ben Amor, A. elloumi, Z. dridi, F. Betbout, H. Gamra (Monastir, TN) 

Echocardiographic index of myocardial stunning predicts recovery of left ventricular 

systolic function after primary coronary angioplasty P975 

d. sharif, A. sharif-Rasslan, A. shefer, N. Makhul, A. Hassan, U. Rosenschein (Haifa, IL) 

High plasma glucose level as precipitating factor for readmission in ADHF P976 

B.B. siswanto, d. suprobo, P. Bustanul, R. surarso, N. Hersunarti (Jakarta, Id) 

Is muscle strength different in cardiac heart failure according to left ventricular 

dysfunction? P977 

B. Fernandes, R. Pinto, M.H. santa Clara, A. Abreu, M. Carrolo, M.T. Tomas, M. Goncalves, 

s. silva, P. Cunha, M. Oliveira (Lisbon, PT) 

Changes in serum potassium concentration in hospitalized heart failure patients P978 

U. Campia, M. Triggiani, H. subacius, J. Butler, R. Mentz, L. Lupi, M. Vanduganathan, 

A. Maggioni, M. Gheorghiade, s. Nodari (Chicago, Atlanta and durham, NC, Us; 

Brescia, IT) 

Cardiovascular reactivity to psychological stress in heart failure patients. Preliminary 

results P979 

G. Pena-Popoca, L. Castillo-Martinez, V. Pelaez-Hernandez, J.I.A. Orea-Tejeda, 

C. Figueroa-Lopez, B. Marquez-Zepeda, L. Tellez-Olvera, A. Montanez-Orozco, 

G. Ortiz-suarez (Mexico, MX) 

Secondary versus primary acute heart failure in the ALARM-HF database P980 

M.B. Yilmaz, J. Parissis, e. Gayat, M. Nikolaou, F. Follath, A. Mebazaa (sivas, TR; 

Athens, GR; Paris, FR; Zurich, CH) 

Predictors of rehospitalization in patients with decompensated chronic heart failure P981 

T. Zaninovic Jurjevic, L. skorup, A. Ruzic, N. Jurjevic, K. Bazdaric, s. Glavas, L. Zaputovic, 

Z. Mavric (Rijeka, HR) 

use of beta-blockers in elderly patients with acute heart failure and depressed left 

ventricular systolic function P982 

s.-J. Joo, J.-H. Choi, s.-Y. Kim, K.-s. Kim, K.-H. Ryu (Jeju and dongtan, KR) 

122


Gender-related differences in patients hospitalized with acute heart failure in Internal 

Medicine. Results from the Rica Registry P983 

A. Conde-Martel, F. Formiga, J.I. Perez-Calvo, J. Casado, J.C. Trullas, O. Aramburu, 

F.J. Carrasco, P. Bettencourt, L. Manzano, M. Montero (Las Palmas de Gran Canaria, 

Barcelona, Zaragoza, Madrid, Girona, seville, Huelva and Cordoba, es; Porto, PT) 

Clinical presentation of heart failure patients P984 

M.T. Rahman, A.A.s. Majumder (dhaka, Bd) 

Predictors of rehospitalization at six months in Tunisian patients admitted for acute 


s. Hamdi, M. Chakroun, W. Jomaa, W. selmi, T. Trimech, A. Hamzaoui, K. Ben Hamda, 

F. Maatouk (Monastir, TN) 

Preoperative peak velocity of tricuspid regurgitation as well as E/e ratio are related 

to development of postoperative congestive heart failure in asymptomatic patients 

undergoing orthopedic surgery P986 

s. Lee, e. Kim, H. Yun, L. Jung, W. Kim, J. Ko (Jeonju, KR) 

Features of heart failure in patients aged over 75 years P987 

s. Hamdi, M. Chakroun, W. Jomaa, T. Trimech, W. selmi, A. Hamzaoui, K. Ben Hamda, 

F. Maatouk (Monastir, TN) 

Gender differences on the impact of physical activity to left ventricular systolic 

function in elderly patients with an acute coronary event P988 

C. Chrysohoou, P. Aggelopoulos, M. Zaromytidou, C. Zisimos, V. Metaxa, s. Vaina, s. Brili, 

C. Pitsavos, d. Tousoulis, C. stefanadis (Athens, GR) 


Predictors of anaemia-development in patients with chronic heart failure: Results from 

the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF) P989 

N. ebner, M. Valentova, C. Krause, T. Bekfani, A. sandek, s.d. Anker, W. doehner, 


Tissue Doppler imaging (TDI) diastolic left ventricular (LV) pattern in elderly patients 

with mitral inflow E/A ratio < 1.0 P990 

K.A. Bagrii, L.s. Kholopov, O.V. samoilova, O.A. Prikolota, e.V. schukina (donetsk, UA) 

NT-proBNP in assessing of the rehabilitation phase after myocardial infarction. P991 

A. Tsokolov, I. Novak, V. senchili (Kaliningrad, RU) 

Tuberculous pericardial effusion in an immunocompetent patient, a case report P992 

L. Marta, M. Alves, N. Cabanelas, F. Valente, d. durao, M. Peres, I. Monteiro, 

G. Ferreira da silva (santarem, PT) 

One year experience of a dedicated heart failure diagnostic clinic P993 

I.A. Fazal, s.K. Bhagra, G.A. Macgowan, J.s. skinner (Newcastle upon Tyne, GB) 

Cutoff values of procalcitonin and c-reactive protein to differentiate acute heart failure 

from pneumonia in patients with acute dyspnea P994 

H. Kasem, R. Rashad, A. Abozeid, M.A. Abdelhamid (Cairo, eG) 

Validation of impedance cardiography with invasive measurements of haemodynamic 

parameters in patients with advanced heart failure P995 

M. sokolski, R. Zymlinski, J. Biegus, P. siwolowski, s. Nawrocka, J. szachniewicz, 

W. Banasiak, e.A. Jankowska, P. Ponikowski (Wroclaw, PL) 

how reliable and accurate are clinical measurements of jugular venous pressure? 

A report from the SICA-HF study P996 

s. Parsons, P. Pellicori, A. Bennett, A. Rigby, R. dierckx, B. dicken, T. Mabote, A. Joseph, 

M. Prapa, J.G.F. Cleland (Hull, GB) 

123 

MODERATED 

pOsTER sEssiOn 2

MODERATED 




The safety and efficacy for the Smarttouch Catheter in the Treatment of Symptomatic 

Paroxysmal Atrial Fibrillation P997 

H. Benhalla, C. sorea, L. deroy (Brussels, Be) 

Cardioversion for atrial fibrillation on the new novel oral anticoagulants - safety and 

concerns P998 

s.K. Mubarak, R.B. Pharithi, M. Ashfaq, R. Kelly, C.P. Malone, C. Fortune, d.J. Mc Caffrey 

(dublin, Ie) 

Does a previous stroke change the anticoagulation rate in atrial fibrillation patients? P999 

N. diaconu, A. Grosu, C. Gratii, V. Racila, G. Pavlic (Chisinau, Md) 

Outcomes of catheter ablation of ventricular tachycardia in arrhythmogenic right 

ventricular dysplasia/cardiomyopathy P1000 

J. Huang, X.H. Fang, X.Z. Zhan, Y.M. Xue, Q.H. Zhang, C.H. Chen, T. Liu, s.L. Wu 

(Guangzhou, CN) 


Predictors of diastolic dysfunction in atrial fibrillation: role of cardiac fibrosis and 

arterial stiffness P1001 

e. shantsila, C.W. Khoo, s. Krishnamoorthy, A. shantsila, A.d. Blann, G.Y.H. Lip 

(Birmingham, GB) 

Is a heart failure a frequent complication in patient with atrial fibrillation and 

subclinical thyroid dysfunction? P1002 

C. Gratii, N. diaconu, A. Grosu, V. Racila (Chisinau, Md) 

Prediction of future atrial fibrillation in patients with heart failure P1003 

N.G. Campbell, e. Cantor, V. sawhney, C. demartini, M. dhinoja, I. diab, M.J. earley, 

s. sporton, L.C. davies, R.J. schilling (London, GB) 

ECHO and ECG predictors of arrhythmia recurrence after an index 3-D radiofrequency 

ablation of Afib. Results of 3 years of follow-up P1004 

A. Ardashev, e. dolgushina, e. Zhelyakov, A. Konev, V. Ardashev (Moscow, RU) 

Perioperative amiodarone as a prophylaxis against atrial fibrillation in patients with 

heart failure after coronary artery bypass grafting P1005 

N. Kovacevic-Kostic, B. Obrenovic-Kircanski, B. Orbovic, R. Karan, M. Velinovic, P. Mitrovic, 

M. Vranes (Belgrade, Rs) 

Heart failure-an additional factor for cognitive disturbances in patients with atrial 

fibrillation P1006 

N. diaconu, A. Grosu, C. Gratii, V. Racila, G. Pavlic (Chisinau, Md) 

Atrial fibrillation in an internal medicine ward: 1-year follow-up study P1007 

A.M. Antunes, s. Guerreiro Castro, A. Chipepo, F.G. Magalhaes, M. silva, H. Gruner, 

A.M. Ferreira, M. Ventura, V. Riscado (Lisbon, PT) 


Management of patients with heart failure and neoplasia - a new challenge P1008 

R.T. Martins, F.G. Magalhaes, A.M. Antunes, s. Guerreiro Castro, M. silva, e. Patarata, 

A.P. Freitas, H. Gruner, M. Ventura, V. Riscado (Lisbon, PT) 

Left atrium in women with positive human epidermal growth factor type 2 receptor 

(HER-2) treated with trastuzumab in adjuvant setting. P1009 

G. Piotrowski, R. Gawor, P. strzelecki, M. Majzner, d. Timler, P. Potemski, Z. Gawor 

(Lodz, PL) 

124


Wearable cardioverter defibrillator use in patients with chemotherapy-induced 

cardiotoxicity P1010 

N. Bianco, s. szymkiewicz (Pittsburgh, Us) 

Silent risk? Cardiovascular risk factor control and stage B heart failure in survivors of 

breast cancer treated with anthracyclines. P1011 

G. Murtagh, T. Lyons, L. Geraghty, J. Ballot, e.O.connell, M. Ledwidge, G. Gullo, 

J. Walshe, J. Crown, K.M. Mcdonald (dublin, Ie) 

Cardiac safety of trastuzumab emtansine (T-DM1), a novel cancer drug linking 

trastuzumab to a chemotherapeutic agent for early-stage HER2-positive breast cancer P1012 

T. suter, L. Gianni, I. Krop, N. Xu, M. smitt, C. dang (Bern, CH; Milan, IT; Boston, south 

san Francisco and New York, Us) 

Clinical - Cardiomyopathies 

Individualization of angiotensin ii beta-blocker treatment in patients with hypertrophic 


s. Komissarova, N.N. Chakova, e.V. Krupnova, s.s. Niyazova, P. Mikhalenko, 

N.V. Chebotaryova (Minsk, BY) 

Geometerical changes of left ventricle in hypertensive patients and visceral adiposity 

as risk factor P1014 


Papillary muscle mass and area predict left ventricular hypertrophy in hypertrophic 


M. Vasconcelos, A. Lebreiro, e. Martins, J. silva Cardoso, A.J. Madureira, I. Ramos, 


Relationship of mechanical dyssynchrony to QT interval prolongation in hypertrophic 


H. Badran, M.F. elnoamany, G. soltan, M. ezzat, M. elsedi, R. Abdelfattah, M. Yacoub 

(shebeen el-Koom, eG; London, GB) 

Chronic heart failure in patients with hypertrophic cardiomyopathy, clinical and 

genetic characteristics P1017 

V.Y. Kaplunova, Y.N. Belenkov, e.V. Privalova, N.V. Khabarova, G.A. shakaryants 

(Moscow, RU) 

Sphericity Index as a predictor of outcomes in patients with heart failure P1018 

R. sharma, P. Manokar, s. Thanikachalam (Chennai, IN) 

Long-term natural history of Idiopathic Dilated Cardiomyopathy: changing mortality 

over the last 30 years and early prognostic stratification. The heart muscle disease 

registry. P1019 

M. Merlo, A. Pivetta, B. Pinamonti, M. Zecchin, d. stolfo, G. Barbati, A. di Lenarda, 

G. sinagra (Trieste, IT) 

Comparison of the results of cardiac magnetic resonance in patients with 

inflammatory cardiomyopathy with clinical data and the endomyocardial biopsy. P1020 

A.A. safiullina, M.A. shariya, O.U. Narusov, s.N. Tereshchenko (Moscow, RU) 

Prognostic predictors of outcomes in patients with non-ischemic dilated 


T. Vaikhanskaya, I. sidorenko, L. Gul, Z. Bogush (Minsk, BY) 

The immune system of dilated cardiomyopathy patients, depending on the severity of 



125 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Right ventricular and atrial functions in patients with non-ischemic dilated 


A. Cincin, K. Tigen, T. Karaahmet, C. dundar, B. Ozben, A. Guler, M. Bulut, Y. Basaran 

(Istanbul, TR) 

Time-dependent variability of ICD indications in patients with newly diagnosed 

idiopathic dilated cardiomyopathy after optimization of medical treatment. A single 

center, long-term follow-up study P1024 

A. Pivetta, M. Merlo, M. Zecchin, C. Lutman, G. Barbati, d. Gregori, A. di Lenarda, 

G. sinagra (Trieste and Padova, IT) 

Takotsubo Cardiomyopathy: the mysteries underlying a broken heart P1025 

P. Rodrigues, M. santos, d. Anjo, M.J. sousa, B. Brochado, P. Palma, s. Torres (Porto, PT) 

Diagnostic significance of intraoperative biopsies of left ventricular myocardium in 

patients with ischemic cardiomyopathy P1026 

V.A. Kazakov, V.M. shipulin, I.V. suhodolo, s.s. Gutor (Tomsk, RU) 

Discovering camouflaged fabry disease in left ventricular hypertrophy P1027 

A. Baptista, C. Ferreira, P. Magalhaes, P. Mateus, s. silva Carvalho, A. Matias, 

N. Vilas Boas, I. Moreira (Vila Real, PT) 

Impact of obesity on survival and New york Heart Association Functional Class in 

patients with systolic heart failure P1028 

A. Taiyem, M.B. Bdeir, T. Conboy (Riyadh, sA) 

Prevalance of viral nucleic acids detected using real-time PCR in endomyocardial 

biopsy specimens, blood samples from the ventricle and peripheral blood in patients 


A. Pawlak, M. Przybylski, O. Mozenska, K. Gil, K.J. Byczkowska, W. Grajkowska, R.J. Gil 

(Warsaw, PL) 

Characterization and long-term outcome of hypertensive dilated cardiomyopathy. 

A distinct phenotype of hypertensive heart disease? P1030 

A. Iorio, B. Pinamonti, M. Bobbo, M. Merlo, L. Massa, G. Faganello, G. Barbati, 

A. di Lenarda, G. sinagra (Trieste, IT) 

Prognosis of symptomatic patients with noncompaction cardiomyopathy during 

mid-term follow up P1031 

J. salazar Mendiguchia Y Garcia, J. Gonzalez Costello, M. Gracida, J. Roca elias, N. Manito, 

A.R. Cequier (Barcelona, es) 

High flow-mediated vasodilatation predicts pulmonary edema in liver transplant 

patients P1032 

s.-M. Chen, C.-L. Chen, H.-T. Chai, C.-C. Yong, H.-W. Hsu, Y.-F. Cheng, M. Fu, Y.-T. Huang, 

C.-L. Hang (Kaohsiung and Taoyuan, TW) 

Is taking health functional food beneficial for cardiovascular symptoms? (w) P1033 

M.s. shin, B.R. Kim, s.J. Park, s.W. Han, I.M. Chung, d.J. Choi (Incheon, seoul and 

seongnam, KR) 

Pregnancy with peripartum cardiomyopathy: characteristics, predictors and maternofetal 

outcome in a tertiary care hospital. P1034 

A. Tounsi, dorra Abid, Leila. Abid, Nizar Ketata, dolira Louati, Kais Chaabene, Feten Triki, 

Mourad Hentati, Med Guermazi, samir Kammoun (sfax, Tn) 

Global longitudinal strain: a marker of functional and electrical involvement in 

myotonic dystrophy type 1? P1035 

C. sousa, A. Goncalves, e. Martins, I. Rangel, A.s. Correia, M. Paiva, T. Pinho, 

J.C. silva-Cardoso, F. Macedo, M.J. Maciel (Porto, PT) 

126


Our first year in a familiar cardiomyopathy consult P1036 

I. Rilo Miranda, J.R. Beramendi Calero, K. echegaray Ibanez, M. Telleria Arrieta, 

M. Castillo Judez, I. solla Ruiz, I. Villanueva Benito, J. echeverria Oses, N. Garrido Asenjo, 

F. de La Cuesta Arzamendi (san sebastian, es) 

Ventricular-arterial coupling and arterial stiffness in patients with amyloidosis P1037 

I. Goncharov, V. Rameev, R. Akhmetov, V. Moiseev (Moscow, RU) 

Immunosuppressive treatment for myocarditis: a meta-analysis P1038 

C. Lu, H. Chen, F. Qin, Y.F. Yan, T. Liu, J. Li (Chengdu, CN) 


Serial central venous saturations during ultrafiltration can predict acute kidney injury 

in acutely decompensated heart failure patients P1039 

V.L. simpkin, G. Tavazzi, A. Ludman, P. Marino, d. Alexander, s. Price, M. Griffiths, 

R. sharma, M.R. Cowie, A. Vazir (London, GB; Pavia, IT) 

Intravenous loop diuretics versus isolated ultrafiltration for acutely decompensated 

heart failure: systematic review and metaanalysis P1040 

R. de Vecchis, C. Ariano, C. esposito (Naples, IT) 

B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: 

choosing the optimal heart failure marker in patients with impaired kidney function P1041 

L. Jafri, W.K. Kashif, J.T. Tai, I.s. siddiqui, A.H.K. Khan, F.G. Ghani (Karachi, PK) 

Correction of chronic heart failure in patients with the renocardiac syndrome P1042 

N. demikhova, M.A. Vlasenko (sumy and Kharkiv, UA) 

Impact of acute and persistent kidney injury in patients with acute decompensated 


s. Okino, J. sugioka, A. Ikeda, J. Maekawa, s. Ichikawa, N. Kuroiwa, s. Okamoto, 

s. Fukuzawa, M. Inagaki (Funabashi, JP) 

Assessment of the correlation between heart remodelling process and kidney function 

state in the patients with chronic heart failure P1044 

U. Kamilova, Z. Rasulova, I. Alikulov, J. Ismailova (Tashkent, UZ) 

Impact of vascular access on myocardial function in patients with end-stage renal 

disease P1045 

L. Mendes, A. Natario, J.F. santos (setubal, PT) 

Renal resistance index: a new marker of cardiorenal syndrome independently 

associated to heart failure progression P1046 

V. Antoncecchi, M.M. Ciccone, M. Iacoviello, A. Puzzovivo, A. doronzo, F. Monitillo, 

G. Citarelli, N. Corrieri, V. Paradies, s. Favale (Bari, IT) 

Risk factors of the worsening renal function in patients with acute heart failure treated 

with carperitide P1047 

H. Miura, K. Miyazaki, G. Hamano, M. Koide, H. Abe, K. Hirooka, Y. Koretsune, 

H. Kusuoka, Y. Yasumura (Osaka, JP) 

Cardiorenal syndrome (chronic tip2) in decompesated cardiomyopathy: diuretics 

resistens and sensitive to ultraflitration-case report P1048 

F. Arnaudova, s. Jovanova, M. Otljanska, s. Kedev, M. Bosev (skopje, MK) 

127 

MODERATED 

pOsTER sEssiOn 2

MODERATED 




Lower intestinal blood flow und more severe gastrointestinal symptoms in patients 

with chronic heart failure and cardiac cachexia compared to patients without 

cachexia and healthy control subjects P1049 

A. sandek, J. Bauditz, A. swidsinski, M. Valentova, W. schroedl, A. Watson, H. Lochs, 

s. Von Haehling, s.d. Anker, W. doehner (Berlin and Leipzig, de; Norwich, GB) 

The heart rate in coronary artery disease patients: impact of cardiac rehabilitation P1050 

B. Brochado, M. santos, d. Anjo, P. Rodrigues, M.J. sousa, s. Viamonte, J.P. Fernandes, 

H. Carvalho, L. Gomes, s. Torres (Porto, PT) 

Impact of HIV infection in cardiac deformation P1051 

L. Mendes, d. silva, C. Miranda, L.L. Bernardino, J.F. Pocas (setubal, PT) 

Anemia and heart failure: a systematic review P1052 

I. Lakatamitou, F. Kalogirou, e. Lambrinou (Limassol, CY) 

Co-morbidities frequencies in chronic heart failure patients with and without atrial 

fibrillatian P1053 

s. Jovanova, F. Arnaudova dezhulovikj, M. Gjerakaroska, M. Nakovska (skopje, MK) 

Impact of depressive symptoms on functional capacity measured with six minute 

walking test in elderly patients with coronary artery disease: the role of age P1054 

A. Pratesi, A. Foschini, F. Orso, A.G. Marella, N. Bartoli, I. Bracali, e. Mossello, F. Tarantini, 

N. Marchionni, s. Baldasseroni (Florence, IT) 

Bone mineral density and oxidative stress in patients with heart failure P1055 

I. Knyazkova, A.N. Bilovol, A.I. Tsygankov (Kharkov, UA) 

Influence of body composition on accuracy of renal function estimation in patients 

with chronic heart failure P1056 

K. Trobec, M. Kerec Kos, M. Lainscak (Golnik and Ljubljana, sI) 

The influence of anaemia on biomarkers and clinical presentation in patients with 

congestive heart failure P1057 

B. stojcevski, V. Celic, B. Pencic-Popovic, A. Andric, A. Majstorovic, A. sljivic, s. Backovic, 

V. Vukomanovic (Belgrade, Rs) 

Peripheral arterial disease in an internal medicine department: a 5-year experience P1058 

s. Leal, F.G. Magalhaes, s. Guerreiro Castro, A.M. Antunes, M. silva, R. Martins, 

H. Gruner, M. Ventura, V. Riscado (Lisbon, PT) 

Depression among elderly patients with heart failure in hospital settings: how to 

predict its occurrence? P1059 

L.G. Mircheva, Y.T. Yotov (Varna, BG) 

Prevalence and characteristics of sleep apnea syndrome in patients with stable heart 

failure P1060 

A. Ghrairi, H. Bouraoui, B. Trimeche, M. Ben Romdhane, A. Mahdhaoui, s. ernez, 

G. Jeridi (sousse, TN) 

Effect of nutritional intervention on the renal function of patients with chronic kidney 

disease and heart failure P1061 

L. Tellez-Olvera, L. Castillo-Martinez, J.I.A. Orea-Tejeda, B. Marquez-Zepeda, 

Y. Lopez-Ramirez, A. delgado-Perez, A. Montanez-Orozco, G. Ortiz-suarez (Mexico, MX) 

Impact of hypertension after myocardial infarction with ST elevation according to 

diastolic dysfunction P1062 

e. Cambronero Cortinas, M.J. Corbi Pascual, A. Gomez Perez, M. Barambio Ruiz, 

J.C. Garcia Lopez, J. salas Nieto, J.M. Jimenez Mazuecos, J. Navarro Cuartero, 

I. Lopez Neyra, C. Llanos Guerrero (Albacete, es) 

128


Nutritional status in heart failure patients with coexisting kidney disease P1063 

Y. Lopez-Rodriguez, J.I.A. Orea-Tejeda, L. Castillo-Martinez, A. delgado-Perez, 

A. Montanez-suarez, G. Ortiz-suarez, L. Tellez-Olvera, B. Marquez-Zepeda (Mexico, MX) 

Impact of acute kidney injury after transcatheter aortic valve implantation in patients 

with aortic stenosis with CoreValve prosthesis P1064 

A.J. Munoz Garcia, e. Munoz Garcia, M. Munoz Garcia, M.F. Jimenez Navarro, 

A.J. dominguez Franco, J.H. Alonso Briales, J.J. Gomez doblas, J.M. Hernandez Garcia, 

e. de Teresa Galvan (Malaga and Jaén, es) 

Prevalence of comorbidities in ambulatory patients with chronic heart failure and their 

impact on exercise capacity P1065 

M. Valentova, A. sandek, C. Krause, N. ebner, T. Bekfani, J. Murin, W. doehner, 

s.d. Anker, s. Von Haehling (Berlin, de; Bratislava, sK) 

Deadly heart failure in rheumatoid arthritis patients according to the autopsy data P1066 

N. dostanko, K. Chizh, V. Yagur, T. Zibalova (Minsk, BY) 

Clinical - Cytokines inflammation 

Enhanced levels of CD16 positive monocyte numbers in chronic heart failure patients 

the role of epigenetic mechanisms. P1067 

K. Kaminski, M. Moniuszko, M. Rusak, M. Jasiewicz, K. Ptaszynska Kopczynska, 

e. Waszkiewicz, A. Lisowska, B. Galar, A. Bodzenta Lukaszyk, W. Musial (Bialystok, PL) 

Effect of rosuvastatin on indicators of systemic inflammation in ischemic heart 

remodeling. P1068 

Y. Bochenina, G.e. Kuznetsov (Orenburg, RU) 

Hyperuricemia may predict poor prognosis of chronic heart failure in patients older 

than 75 years of age without advanced renal impairment. P1069 

Y. Mitsuke, H. Tsutani, R. Nakaya, s. Nishikawa (Fukui, JP) 


Heart failure in patients with infectious endocarditis: predictors and prognosis P1070 

P. Carrilho-Ferreira, J. Rodrigues dos santos, C. Jorge, d. silva, A.R. Ramalho, 

M. Nobre Menezes, N. Cortez-dias, M.J. Metrass, M.G. Lopes, A. Nunes diogo 

(Lisbon, PT) 

Infective endocarditis complicated by acute heart failure: clinical course and prognosis 

(Tunisian experience). P1071 

A. Tounsi, dorra Abid, Leila. Abid, Hassen Ajmi, Malek Akrout, Med Abdennadher, 

Feten Triki, Mourad Hentati, Imed Frikha, samir Kammoun (sfax, Tn) 

NyHA class and the ejection fraction as predictors of survival after aortic valve 

replacement in octogenarians P1072 

M. strachinaru, P. Wauthy, A. sanoussi, C. stefanidis, M. Morissens, I. Jousten, I. Costescu, 

e. Catez, O. Pavel (Brussels, Be) 

Mid-term results of transcatheter aortic valve implantation: data from a single center 

study P1073 

A.e. Komlev, R.s. Akchurin, T.e. Imaev, M.A. saidova, I.s. Medvedeva (Moscow, RU) 

Heart failure symptoms at presentation continue to influence outcomes in aortic 

stenosis despite advances in medical treatment P1074 

e. Minamino, T. Kato, Y. saji, K. Ueyama, M. Inoko, e. Tada, K. Nagao, R. Nohara 

(Osaka, JP) 

129 

MODERATED 

pOsTER sEssiOn 2

MODERATED 




Peak oxygen consumption score improves with echocardiographic biventricular 

device optimisation P1075 

V. Cobb, M. Thomas, s. ellery, s. Jewell, L. Lee, R. James, s.O.nunain, d. Hildick-smith 

(London and Brighton, GB) 

Prognostic value of red blood cell distribution width (RDW) in heart failure patients 

undergoing ICD-CRT implantation P1076 

B. surial, B. schaer, M. Potocki, 0. Pfister (Basel, CH) 

Indication for cardiac resynchronisation therapy on the grounds of mechanical 

dyssynchrony in patients with cardiomyopathy and narrow QRS P1077 

A.K. Kurlianskaya, d.V. Romanovskiy, U.P. Ostrovskiy, T.A. Troyanova, T.L. denisevich 

(Minsk, BY) 

The effect of upgrade from dual chamber ICD to Cardiac resynchronisation therapy 

and defibrillator upon ventricular arrhythmia burden P1078 

K. Guha, A. Morley-smith, H.O. savage, T. Mcdonagh, R. sharma (London, GB) 

using 2-chamber pacemakers for cardioresynchronization therapy in patients with 

permanent atrial fibrillation P1079 

I. Repnikov, d. Perchatkin, e. sautova, e. Maslova, T. Novikova (st. Petersburg, RU) 

Cardiac resynchronization therapy in advanced heart failure patients: does a gender 

difference in response to CRT exist? P1080 

M.T. Petrovic, M. Petrovic, B. Vujisic-Tesic, G. Milasinovic, d. Trifunovic, M. Zivkovic, 

M. Boricic, M. Tesic, I. Petrovic, P. seferovic (Belgrade, Rs) 

A cardiac resynchronization therapy method to augment ventricular contraction using 

polymer based actuators and mitral regurgitation control devices over pacing 

wire- Investigational Results P1081 

M. Arokiaraj, L. Guerrero, R. Levine, I. Palacios (Pondicherry, IN; Boston, Us) 

Echocardiographic evaluation of right ventricular dysfunction and non-LBBB pattern 

on ECG in patients undergoing cardiac resynchronization therapy P1082 

s. salinger, Z. Perisic, T. Kostic, M. Pavlovic, T. stanojlovic, s. Apostolovic, N. Krstic, 

N. Bozinovic, P. Cvetkovic, d. stanojevic (Nis, Rs) 

Assessment of myocardial perfusion and metabolism by radionuclide imaging in 

patients with heart failure undergoing to cardiac resynchronisation therapy P1083 

Y. Lishmanov, s. Minin, Y. saushkina, I. efimova, d. Lebedev (Tomsk, RU) 

Advanced cardiac heart failure and Cardiac Resynchronization Therapy. Prevalence, 

causes and outcome of patients with epicardial lead implantation. P1084 

A. Palazzo, N. Galizio, H. Fraguas, N. Martinenghi, F. Robles, G. Carnero, A. Gargano, 

X. Vallejos, M. Mysuta, J. Gonzalez (Buenos Aires, AR) 

Do short av delays and long vv delays favour atrial fibrillation in heart failure patients? P1085 

V. Puetz, I. seifert, d. schmitz, F.H. Gueldner, C.K. Naber, O. Bruder (essen, de) 

Pre- and per-procedural predictors of cardiac resynchronization therapy response, 

assessed by CMR P1086 

s. Amraoui, H. Cochet, A. denis, s. Ploux, P. Ritter, M. Haissaguerre, P. Bordachar 

(Bordeaux-Pessac, FR) 

Optimization of cardiac resynchronization therapy: the role of ECG P1087 

V. Lebedeva, T. Lubimceva, M. Trukshina, d. Lebedev (st. Petersburg, RU) 

130


Although CRT-Ds do not improve quality of life in patients with AF as those with 

SR, AV Node Junction ablation could lead to a better outcome: A meta-analysis of 

randomized and observational trials P1088 

C. Maniotis, C. Andreou, P. dimitriou, C. Papadopoulos, T. Zografos, K. Chantziara, 

A.G. Manolis, Z.s. Kyriakides (Athens, GR) 

Implantable electrical devices in the real world: the experience of an outpatient heart 

failure clinic P1089 

J.C. duarte Rodrigues, C.s. Carla sousa, s.M.L. sergio Machado Leite, F.M. Filipa Melao, 

R.M.G. Raquel Mota Garcia, s.A. sandra Amorim, e.M. elisabete Martins, 

M.C. Manuel Campelo, J.s.C. Jose silva Cardoso, M.J.M. Maria Julia Maciel (Porto, PT) 

Excessive use of CRT-D instead of CRT-P in systolic heart failure P1090 

N. Nyolczas, G.Y. Marton, M. dekany, B. szabo, B. Muk, T. Borsanyi, B. Ancsin, G. duray, 

M. Vamos, R.G. Kiss (Budapest, HU) 

Long-term prognosis and arrhythmic risk in patients with cardiac resynchronization 

therapy with a defibrillator and left ventricular ejection fraction >35% by cardiac 

magnetic resonance P1091 

O. Fabregat Andres, P. Garcia-Gonzalez, B. Bochard-Villanueva, A. Valle, 

J. estornell-erill, R. Paya, V. Palanca, A. Quesada, s. Morell, F. Ridocci-soriano 

(Valencia and denia, es) 

Educative telemedicine reduces the severity of rehospitalizations for acute heart failure 

in an elderly population: post-hoc analysis of SEDIC study. P1092 

G. Coutance, A. Belin, C. Biannic, J.J. Parienti, P. Loiselet, L. Michel, G. Pradere, P.U. 

Milliez, G. Grollier, R. sabatier (Caen, Cricqueboeuf, Cherbourg and saint-Lo and Flers, FR) 

Diurnal variations in thoracic fluid status using bio-impedance during low and high 

salt intake in patients with heart failure. HeartCycle (FP7-216695) European union 7th 

framework programme. P1093 

R. Antony, A. Torabi, J. Weston, J. Zhang, T. Mabote, P. Pellicori, R. dierckx, A. Rigby, 


CAD system to assess the patients HF severity on a three levels scale and dependence 

of the system performance from the BNP P1094 

G. Guidi, M.C. Pettenati, e. Iadanza, M. Milli, F. Pavone (Firenze, IT) 

Exploring the impact of telemonitoring on prescription of guideline-recommended 

heart failure medication P1095 

R. dierckx, T. Mabote, J. Zhang, P. Pellicori, s. Parsons, R. Antony, P. Atkin, C. Whitehead, 

K. Goode, J.G.F. Cleland (Hull and York, GB) 

Extracorporeal mMembrane Oxigenation in a Coronary Care unit: Initial Experience P1096 

M. Ponte, d. Caeiro, A. dias, R. Faria, A. Albuquerque, P. Fernandes, V. Gama 

(Vila Nova de Gaia, PT) 

Mechanical circulatory support, emergency procedures and education of community 

services P1097 

J. Vierecke, A. stepanenko, e. Potapov, T. Krabatsch, R. Hetzer (Berlin, de) 

Bridge to transplant using paracorporeal ventricular assistance device in patients with 

dilated chagasic cardiomyopathy P1098 

J.R. Fernandes, J.C. Mejia, J.d. souza Neto, G.G. Vasconcelos, B.M. Carvalho, 

M.L. Pinheiro, R.C. santos, s.N.R.s. Falcao, M.s.Q. Farias, V.L.M.P. Pessoa (Foraleza-Ceara, BR) 

Sexual dysfunction in patients supported with left ventricular assist device and 

patients after heart transplant. P1099 

T. Hasin, V. Yaari, d. Murninkas, T. Jaarsma, s. Bar Yosef, B. Medalion, T. Ben Gal 

(Petah Tikva, IL; Linkoping, se) 

131 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Longitudinal assessment of myocardial viability and left ventricular function in patients 

supported by a left ventricular assist device P1100 

d. Gupta, H. skali, J. Rivero, P. Campbell, G. Couper, M. Givertz, M. Mehra, M. di Carli, 

s. solomon, M. Pfeffer (Boston, Us) 

Low intrathoracic impedance can predict increased b-type natriuretic peptide instead 

of optivol alert: Momotaro study P1101 

Y. Okamoto, s. Fujii, H. Tasaka, M. Kubo, A. Watanabe, N. Nishii, Y. Tsushima, K. Kadota, 

K. Mitsudo, H. Ito (Okayama and Fukuyama, JP) 

A pilot study on the feasibility of heart failure medical management based on daily 

monitoring of pulmonary subclinical congestion with ReDS technology in outpatient 

set up P1102 

T. Ben Gal, O. Amir, d. Rappaport, K. Rekant, P.B. Adamson, s. Anker, J.G.F. Cleland, 

T. Jaarsma, W.T. Abraham (Petah Tikva, Haifa and Netanya, IL; Oklahoma City and 

Columbus, Us; Berlin, de; Hull, GB; Linköping, se) 

Physical activity of 836 patients with implanted ICD and CRT-D devices P1103 

V.M. Conraads, M.A. spruit, F. Braunschweig, M.R. Cowie, L. Tavazzi, M. Borggrefe, 

M. Hill, s. Jacobs, B. Gerritse, d.J. Van Veldhuisen (Antwerp, Be; Horn, Maastricht 

and Groningen, NL; stockholm, se; London, GB; Cotignola, IT; Mannheim, de; 

Minneapolis, Us) 

The Parachute device in patients with ischaemic heart failure: outcomes at 6 months P1104 

M. Petrie, M. Thomas, M. Costa, C. Nienaber, H. Ince, e. erglis, W.T. Abraham 

(Glasgow and London, GB; Cleveland and Ohio, Us; Rostock, de; Riga, LV) 


SVR management hn chronic heart failure P1105 

W.A. Walid A Abukudair, M.F. Rajab, A.A. Arnous, M.M.H. Al Najjar, H.C. Pasha, 

A.A. Ajam, Y.N. Nusir (Jeddah, sA) 

Prolonged heart insufficiency in the early postoperative period predicts worse long 

term survival in patients with left ventricle systolic dysfunction undergoing mitral 

valve repair P1106 

A. drohomirecka, P. Litwinski, P. Kolsut, N. Buraya, L. Wielocha, H. Pawlowska, 

K. Pelewicz, T. Zielinski, J. Rozanski, M. Kusmierczyk (Warsaw, PL) 

Isolated repair for tricuspid regurgitation: is right heart failure a justified fear? P1107 

G. Faerber, M. diab, W. Bothe, T. doenst (Jena, de) 


Primary graft failure after heart transplantation: risk factors analysis and long term 

results P1108 

M. Ribezzo, M. Boffini, d. Ricci, G. Rovero, R. Bonato, M. Attisani, d. Pasero, M. Rinaldi 

(Turin, IT) 

Correlation between pre-transplant Immuknow and post-transplant infection and 

rejection: a longitudinal perspective P1109 

e. Andrikopoulou, V.A. Amin, P.J.M. Mather (Philadelphia, Us) 

Prognostic value of pulmonary hemodynamic parameters in cardiac transplant 

candidates P1110 

M. sobieszczanska-Malek, J. Korewicki, T. Zielinski (Warszawa, PL) 

132


Central hemodynamics in patients from the waiting list of heart transplantation in 

north-west Russia P1111 

P.A. Fedotov, M.Y. sitnikova, A.e. Bautin, s.V. datsenko, M.A. Bortsova, s.V. Urina, 

e.V. shlyakhto (st. Petersburg, RU) 

Characterization of potential donors to cardiac transplantation in the city of Fortaleza, 

Brazil P1112 

V.L. Pessoa, A.A. Braga, R.s. Florencio, W.M. Barroso, N.s.V. Lacerda, s.B. Ribeiro, 

M.s.B. Gomes, J.R. Fernandes, J.d. souza Neto, G.G. Vasconcelos (Fortaleza, BR) 

Different hemodynamic profile of ischemic and non-ischemic heart transplant 

candidates. P1113 

P. Rubis, J. stepniewski, M. Kostkiewicz, A. Lesniak-sobelga, M. szuksztul, M. Olszowska, 

P. Podolec (Krakow, PL) 

Definitive treatment of supraventricular tachycardia mediated by a hidden lateral 

accessory pathway on a transplanted heart P1114 

J. souza Neto, J.R. Fernandes, G.G. Vasconcelos, R.s. Florencio, V.L.M.P. Pessoa, 

J.R. Andrade Junior, F. Tavora, R.C. santos, s.N. Falcao, J.A.C. Mejia (Fortaleza, BR) 

Clinical and surgical determinants of mortality after cardiac transplantation P1115 

V. Ribeiro, F. Melao, s. Amorim, A.C. Araujo, J. Pinheiro Torres, J. silva Cardoso, P. Pinho, 


Assessment of metabolic profile after conversion from cyclosporine to tacrolimus in 

heart transplantation P1116 

B. Biselli, J.P. escalante, M.s. Avila, A.C.A. santos Nussbaum, M.B. Ulhoa, 

s.M. Ayub-Ferreira, P.R. Chizzola, F.d. Cruz, e.A. Bocchi, F. Bacal (sao Paulo, BR) 

Type B natriuretic peptide as a rejection predictor in heart transplantation P1117 

F.d.C. Cruz, V.I. Issa, s.A. Ferreira, G.e. Conceicao, F. Bacal, e.A. Bocchi (sao Paulo, BR) 


Functional capacity benefits of cardiac rehabilitation after acute coronary syndrome 

are sustained in time and independent of left ventricle systolic function P1118 

C. sousa, A. Rocha, I. Rangel, A. Goncalves, F. Melao, J. Rodrigues, A.s. Correia, 

V. Araujo, F. Parada-Pereira, M.J. Maciel (Porto, PT) 

Prescription rates and dosage of heart failure medication varies dramatically at 

discharge in patients hospitalized for heart failure compared to outpatient treated P1119 

K. Ablasser, V. Platzer, s. Heller, G. stoschitzky, A. schmidt, B. Pieske, F. Fruhwald 

(Graz, AT) 

usefulness of educational program in patients with heart failure P1120 

Z. Gasimov, A. Bakhshaliyev, T. Jahangirov, M. Hajiyev, M. Kocharli, s. Gahramanova, 

G. dadashova (Baku, AZ) 

How to select and individualize management plans for every chronic heart failure 

patient P1121 

d.N. Naghi, M.A. Abdelmoneim, W.A. Abukhudair, M.M.H. Al Najjar (Jeddah, sA) 

Management of patients with heart failure using education or education & yelephone 

or telephone in Cyprus (MEETTinCy) trial. Preliminary results. P1122 

e. Lambrinou, F. Kalogirou, A. Protopapas, e. Papathanassoglou, V. Barberis, P. sourtzi, 

C. Lemonidou, N. Middleton (Limassol and Nicosia, CY; Athens, GR) 

Nurse-based educational intervention in a heart failure unit improves outcomes in 

self-care , quality of life and depression of high-risk patients with chronic heart failure P1123 

s. Lopez Fernandez, M. Puga-Martinez, M. Jimenez-Fernandez, N. Herrera-Gomez, 

R. Melgares-Moreno (Granada, es) 

133 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Cost-effectiveness of long-term disease management program in heart failure: results 

from the REMADHE trial P1124 

e.A. Bocchi, F. Cruz, s. Brandao, G. Guimaraes, F. Bacal, V.s. Issa, P. Chizzola, G. souza, 

s.M.A. Ferreira (sao Paulo, BR) 

Hospital-based heart failure care program in a cohort of elderly spanish patients: 

what is changing? P1125 

J.A. satue, s. Gonzalo Pascua, J. Marrero Frances, J.C. Belinchon Paraiso, 

A. Perez Martin, L. Horrillo sanchez, A. sanmartin Prado, P. Talavera Calle, 

A. Zapatero Gaviria (Fuenlabrada, es) 

Adherence of patients with chronic heart failure to medical recommendations P1126 

T. Murataliev, Y.N. Nekludova, V.K. Zventsova, A.A. Okunova, s.Y. Muhtarenko 

(Bishkek, KG) 

up-to date-cardiovascular risk management based on complex prognosis information 

system integrated with famous prognostic scores: SCORE, PROCAM, FRAMINGHAM P1127 

T. Pecherina, V. Kashtalap, O. Barbarash (Kemerovo, RU) 


Effects of high dose allopurinol on clinical outcome, cardiac function, quality of life 

and effort capacity in patients with symptomatic chronic heart failure P1128 

A.M. Iliesiu, A.L. Campeanu, d. dusceac, A. Cristea, G. Uscoiu, T. Nanea (Bucharest, RO) 

Short-term effects of additional therapy in patients with cardiomyopathies P1129 

M.Y. saburov, B.U. Mardanov, T.A. Abdullaev, I.A. Choi (Urgench and Tashkent, UZ) 

Poor response to antiplatelet therapy is related to altered pharmacogenetics of 

clopigogrel and fibrinogen P1130 

Y.A. Arutinova, I. Koksheneva, T. sofoterova, B. sandukhadze, s. Matskeplishvili 

(Moscow, RU) 

Interest of ivabradine in a real-life population of heart failure patients P1131 

s. Perna, L. Coldea-Agoston, d. Petrovai (Meaux, FR) 

Heart rate in heart failure patients with systolic dysfunction and optimal 

neurohumoral blockade: is still there a place for improvement? P1132 

R. Rodrigues, L. Rassi, L. Mendes, J.F. santos, s. Correia, A. Lourenco, s. Mateus, 

N. Fonseca, L. soares (setubal, PT) 

Effect of folic acid supplementation in patients with chronic heart failure P1133 

I. sudano, A.J. Flammer, F. enseleit, T.F. Luscher, F. Ruschitzka, G. Noll (Zurich, CH) 

Integrating the management of elevated resting heart rate in a specialist tertiary 

centre heart failure clinic P1134 

O.M. demir, K. darragh, T. Pakrashi, L. Fallon, H. Pryce-Hawkins, R.K. sharma, 

A. Vazir, s.K. Prasad, M.R. Cowie, A.R. Lyon (London, GB) 

Effects of oral administration of L-Carnosine and exercise training in patients with 

chronic heart failure and severe left ventricular dysfunction P1135 

C. Lombardi, V. Carubelli, A.I. Castrini, V. Lazzarini, F. Quinzani, M. Magatelli, e. Pezzotti, 

F. Guidetti, M. Adamo, M. Metra (Brescia, IT) 

Changes in parameters of central blood pressure in congestive heart failure with 

preserved systolic function and hypothyroidism. P1136 

F.T. Ageev, F.T. Ageev, Z. Blankova, e.M. seredenina, e.M. seredenina, A.G. Ovchinnikov, 

A.G. Ovchinnikov, O.Y. Ryabceva, O.Y. Ryabceva (Moscow, RU) 

Ivabradin added to the therapy improves left ventricular diastolic dysfunction after 

surgical revascularisation - preliminary data of echocardiographic evaluation P1137 

d. Panayotova, M. slavov, Y. Radulova, Y. Krasnaliev, P.L. Panayotov (Varna, BG) 

134


Evaluation of omacor efficiency in patients with chronic heart failure P1138 

U. Kamilova, C.H. Abdullaeva, I. Alikulov (Tashkent, UZ) 

Inotropes in acute decompensated heart failure: are there differences? P1139 

I. Campos Moreira de Almeida, F. Caetano, A. Fernandes, P. Mota, A. Leitao-Marques 

(Coimbra, PT) 

Effects of levosimendan and dobutamine on systolic time intervals in patients with 

acute decompensated heart failure P1140 

Y. Cavusoglu, A. Nadir, K.U. Mert, e. Gencer, F. Mutlu, T. Ulus (eskisehir, TR) 

Pharmacokinetics of drugs in cachexia of chronic disease: a systematic review P1141 

K. Trobec, M. Kerec Kos, s. Von Haehling, J. springer, s. Anker, M. Lainscak (Golnik and 

Ljubljana, sI; Berlin, de; Rome, IT) 

Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: 

insights from the SHIFT study P1142 

L. Tavazzi, K. swedberg, M. Komajda, M. Boehm, J.s. Borer, M. Lainscak, I. Ford 

(Cotignola, IT; Gothenburg, se; Paris, FR; Hamburg, de; New York, Us; Golnik, sI; 

Glasgow, GB) 

Impact of nitrates use on the prognosis of patients with heart failure P1143 

s. Moreira da silva, L. Nogueira-silva, M. Couto, J. Urbano, J. Pimenta, O. Laszczynska, 

P. Bettencourt (Porto, PT) 


Determinants of non-introduction of beta-blockers in heart failure with systolic 

dysfunction. P1144 

M. Carvalho, M. Casal Moura, F. Gomes, F. silva, O. Laszczynska, R. Pimentel, M. Alvelos, 


Beneficial effect of higher dose of beta-blocker in Korean heart failure patients with 

systolic dysfunction P1145 

K.H. Ryu, s.W. Han, s.H. Kim, W.J. shim, B.s. Yoo, Y.J. Kim, H.s. Kim, K.K. Hwang, 

d.J. Choi, M.s. shin (seoul, Wonju, daegu, Cheongju, seongnam and Incheon, KR) 

Dynamics of echocardiographic parameters in patients with systolic heart failure and 

Arg389Gly beta1-adrenergic receptor gene polymorphism P1146 

M. Udovychenko, I. Rudyk (Kharkiv, UA) 


Impact of valsartan on endothelial function, renal function parameters in patients 

with heart failure: comparison to enalapril P1147 

K. Gyamdjyan, M. Maximov, V. Kukes (Moscow, RU) 

Mineralocorticoid receptor antagonism in patients with coronary artery disease and 

preserved ejection fraction - a randomized, double-blind trial P1148 

A. Flammer, I. sudano, F. enseleit, T.F. Luscher, G. Noll, F. Ruschitzka (Zurich, CH) 


Condition of intercellular collagen matrix and demping (shock-absorbing) function of 

arterial wall depending on average diurnal heart rate in patients with chronic heart 

failure P1149 

N. Koziolova, A. Chernyavina, M. surovtseva (Perm, RU) 

Ventricular-arterial coupling is associated with NT-proBNP in stable patients with heart 

failure and reduced ejection fraction P1150 

R. Akhmetov, s. Villevalde, A. safarova, V. Moiseev (Moscow, RU) 

135 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Endothelial dysfunction with photopletysmography comparison between heart failure 

patients with preserved vs reduced ejection fraction P1151 

A. Montanez-Orozco, G. Ortiz-suarez, L. Castillo-Martinez, J.I.A. Orea-Tejeda, 

L. Figuerola-Chaparro, O. Infante-Vazquez, R. Martinez-Memije, A. Ricalde-Alcocer, 

J. dorantes-Garcia, R. Narvaez-david (Mexico City, MX) 

usefulness of impedance cardiography in predicting beneficial effects of cardiac 

rehabilitation in patients with heart failure P1152 

P. Krzesinski, G.G. Gielerak, e. Piotrowicz, J.J. Kowal, R. Piotrowicz (Warsaw, PL) 

Effects of Waon therapy on hemodynamics, autonomic nervous activity, vascular 

endothelial function and oxidative stress in patients with chronic heart failure P1153 

C. Noda, T. Masuda, M. Kawano, Y. ebina, A. Igarashi, K. Kamiya, N. Hamazaki, 

s. Niwano (sagamihara, JP) 

Clinical - Hormones 

The value of cortisol at admission to the cardiac intensive care unit P1154 

V.H. Pereira, M.J. Fernandes, J. Guardado, J. Portugues, I. Machado, A. Pereira, 

F. Canario-Almeida, F. Ferreira, A. Lourenco (Guimarães, PT) 

Comparative effects of cardiac rehabilitation on autonomic nervous system in 

coronary artery disease patients with and without left ventricular dysfunction P1155 

T. silva, A. Abreu, P. Rio, M. Nogueira, J. Labandeiro, N. santos, T. Alves, I. Carlos, 

M. Oliveira, R. Cruz Ferreira (Lisbon, PT) 

Stress-axis hormonal predictors of the global diastolic function P1156 

d. Popovic, M. Ostojic, M. Petrovic, B. Vujisic-Tesic, M. Banovic, B. Popovic, A. Kocijancic, 

A. Arandjelovic, P. seferovic, s. damjanovic (Belgrade, Rs) 

Clinical - Metabolism/diabetes mellitus 

Left ventricular diastolic function in patients with diabetes mellitus: association with 

leukocyte telomere length P1157 

e.V. Plokhova, d.U. Akasheva, O.N. Tkacheva, I.d. strazhesko, A.s. Kruglikova, 

e.N. dudinskaya, N.V. Kokshagina, s.A. Boytsov (Moscow, RU) 

The predictive value of soluble ST2 in the new onset left ventricular diastolic 

dysfunction in type 2 diabetes P1158 

e. Fousteris, G. Tsiaousis, V. dragoumanos, s. Tzerefos, A. Angelidi, s. Matsagos, 

I. Protopsaltis, A. Theodosis-Georgilas, A. Melidonis, s. Foussas (Piraeus, GR) 

Serum adiponectin levels in patients with coronary artery disease P1159 

M.F. elnoamany, I. Abdelfattah, A. dawood, A. Kamal, s. Zahran (shebeen el-Koom, eG) 

Statins in diabetes mellitus patients with normal BP, preserved LVEF and high 

NT-proBNP as a marker of subclinical metabolic cardiomyopathy. A 2-year prospective 

study in Constanta County, Romania. P1160 

I.R. Parepa, L. Mazilu, A.I. suceveanu, A. suceveanu, d. Catrinoiu (Constanta, RO) 

Impact of diabetes mellitus on cardiac sympathetic innervation in patients with heart 

failure. A iodine-123 meta-iodobenzylguanidine (I123MIBG) scintigraphic study P1161 

s. Paolillo, G. Rengo, G. Pagano, T. Pellegrino, G. savarese, L. Petraglia, R. Formisano, 

d. Leosco, A. Cuocolo, P. Perrone-Filardi (Naples, IT) 


Heart failure patients with dynamic stenosis of the inferior vena cava, comparison 

with a healthy population P1162 

J.e. Herrera (Porlamar, Ve) 

136


Is baseline 123 I-MIBG heart-mediastinum rate a predictor of VO2 changes after 

cardiac resynchronization? P1163 

A. Abreu, L. Oliveira, H. santa Clara, M. Mota Carmo, M. Goncalves, C. Fondinho, P. Rio, 

e. Oliveira, M. Oliveira, R. Ferreira (Lisbon, PT) 

Association between measurements of body composition and other prognostic 

variables in patients with chronic heart failure: a report from SICA-HF P1164 

s. Prapa, P. Pellicori, A. Kallvikbacka-Bennett, A. Joseph, s. smith, s. Rimmer, P. Costanzo, 

J. Warden, A.L. Clark, J.G.F. Cleland (Hull, GB) 

The use of Gated Myocardial Perfusion SPECT for cardiac resynchronization therapy 

and identification of responders through prediction of left ventricular remodeling. P1165 

M. Kostkiewicz, W. szot, A. Lesniak-sobelga, P. Podolec (Krakow, PL) 

The rule of single-photon emission computed tomography to diagnose coronary 

disease in heart failure patients with reduced left ventricle ejection fraction P1166 

L. Rassi, R. Rodrigues, s. Goncalves, P. Amador, L. Mendes, J. santos, s. Correia, 

s. Mateus, A. Lourenco, L. soares (setubal, PT) 

Fibrosis as possible risk factor in patients with heart failure P1167 

V. sanchez, s. Lopez, M. Cabre, O. Londono sanchez (Barcelona, es) 

Papillary muscle abnormalities in a hypertrophic cardiomyopathy population: 

a cardiovascular magnetic resonance study P1168 

M. Vasconcelos, A. Lebreiro, e. Martins, J. silva Cardoso, A.J. Madureira, I. Ramos, 


Diagnostic value of dobutamine stress Doppler tissue imaging in diabetic patients 

with suspected coronary artery disease P1169 

M.F. elnoamany, H. Badran, T. Khalil, A. Kamal, A. serag, R. Yaseen 

(shebeen el-Koom, eG) 

Left atrio-ventricular matching in patients with heart failure with different filling pattern P1170 

F.Q. Huang, L. Zhong, R.s. Tan (singapore, sG) 

Left ventricular deformation and the mid-term prognosis in systolic heart failure. P1171 

L. sargento, s. Longo, M. satendra, N. Lousada, R. Palma dos Reis (Lisbon, PT) 

dP/dt: Additive or redundant parameter in the assessment of left ventricular function 

by echocardiography? P1172 

M. Castro, M. santos, J. Abecasis, H. dores, M.s. Carvalho, C. Machado, I. Rosario, 

R. Ribeiras, M.J. Andrade, M. Mendes (Lisbon, PT) 

Nt-proBNP and systo-diastolic function in systolic heart failure patients P1173 


Contractile reserve in patients with dilatative cardiomyopathy using 3D speckle 

tracking, basal and mid segments are important P1174 

s. Ulbrich, K.M. sveric, U. Richter, R.H. strasser, B. ebner (dresden, de) 

Is the mitral e/e' ratio a reliable predictor of left ventricular diastolic function in 

patients with heart failure? P1175 


Multimodality echocardiography as a predictor of death in patients with left 

ventricular systolic dysfunction P1176 

L. sargento, M. satendra, s. Longo, N. Lousada, R. Palma dos Reis (Lisbon, PT) 

The role of echocardiography and cardiac magnetic tomography in the evaluation 

of the role of electrocardiogram in the clinical assessment of patients with corrected 

tetralogy of Fallot. P1177 

s.A. Mouratoglou, G. Giannakoulas, V. Kamperidis, Z. Pappa, d. Parcharidou, d. Kristo, 

s. Hatjimiltiadis, H. Karvounis, I. styliadis (Thessaloniki, GR) 

137 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Is Duchenne dilated cardiomyopathy different than idiopathic? A comparative 

echocardiographic study P1178 

s.A. Mouratoglou, V. Kamperidis, G. Giannakoulas, L. Mantziari, d. Kristo, Z. Pappa, 

H. Karvounis, I. styliadis (Thessaloniki, GR) 

Ventricular septal rupture complicating subacute myocardial infarction P1179 

L. Marta, M. Alves, M. Peres, M. da Costa, s. Martins, s. Prata, I. Monteiro, 

G. Ferreira da silva (santarem and Lisbon, PT) 


The impact of n terminal pro B natriuretic peptide (NT pro BNP) on echocardiography 

referrals in secondary care clinics. prospective comparative study P1180 

M. Al Barjas, R. Morris, d. Nair, J. davar (London, GB) 

Natriuretic peptides as markers of congestive heart failure in elderly patients with 

multiple myeloma P1181 

e. Yurova, s.V. semochkin (Moscow, RU) 

Diagnostic value of nt-probnp in identifying impaired coronary flow reserve in 

asymptomatic moderate or severe aortic stenosis P1182 

M. Banovic, B. Vujisic-Tesic, s. Bojic, d. Trifunovic, I. Nedeljkovic, d. Popovic, M. Petrovic, 

P. seferovic (Belgrade, Rs) 

NT-proBNP serum level is an independent predictor of intima-media thickness of the 

common carotid artery in asymptomatic patients of a primary prevention study P1183 

L.Z. Kiss, R. Vadas, Z. Bagyura, P. soos, B. Merkely, Z. szelid (Budapest, HU) 

Prognostic value of low brain natriuretic peptide (BNP) in stable systolic heart failure P1184 

F. Gomes, F. Cunha, L. Nogueira-silva, M. Amorim, R. Pimentel, O. Laszczynska, 

J. Pimenta, F. Frioes, A. Azevedo, P. Bettencourt (Porto, PT) 

Left ventricular remodeling and immune inflammation in patients with Q-wave 


K.M. Amosova, A. Bezrodny, I.I. Gorda, I.V. dankevich (Kiev, UA) 

Is there a difference in inflammatory response after cardiac resynchronization in 

ischemic heart failure? P1186 

A. Abreu, M. Mota Carmo, H. santa Clara, T. Pinheiro, P. Rio, M. selas, P. Cunha, 

M. Oliveira, M. Nogueira da silva, R. Ferreira (Lisbon, PT) 

Prognostic value of NT-proBNP levels in patients with infectious endocarditis: 

a 12-year longitudinal study P1187 

P. Carrilho-Ferreira, J. Rodrigues dos santos, d. silva, A. Magalhaes, R. Placido, 

A.R. Ramalho, M. Nobre Menezes, M.J. Metrass, M.G. Lopes, A. Nunes diogo (Lisbon, PT) 

Relationship between prognostic indicators (RDW, VO2peak, NT-proBNP) and annual 

mortality of patients with systolic chronic heart failure living in the north-western 

Russia. P1188 

L.V. Prokopova, M.Y. sitnikova, P.A. Fedotov, T.A. Lelyavina, e.V. shlyakhto 

(st. Petersburg, RU) 

NT-proBNP: prognostic marker in patients with ST-segment elevation acute myocardial 

infarction? P1189 

P. Carrilho-Ferreira, N. Cortez-dias, C. Jorge, A. Magalhaes, R. Placido, d. silva, 

s. Robalo Martins, M. Fiuza, P. Canas da silva, A. Nunes diogo (Lisbon, PT) 

Value NT-proBNP level changes under the influence of therapy on prognosis chronic 

heart failure patients P1190 

s. shalaev, e. Mezhonov (Tyumen, RU) 

138


In-hospital prognostic value of first fasting glucose measurement in patients with 

acute coronary syndromes P1191 

A. Castro, A. Pereira, N. Moreno, R. santos, M.C. Queiros, P. Pinto (Penafiel, PT) 

B-type natriuretic peptide-guided therapy vs. conventional care in outpatients with 

chronic heart failure: a retrospective cohort study P1192 

R. de Vecchis, G. di Biase, C. Ariano, A. Fusco, C. Cioppa, A. Giasi, s. Cantatrione 

(Naples and somma Vesuviana, IT) 

NT-proBNP and diabetes mellitus as predictive factors of clinical outcome in patients 

with acute heart failure- one year follow up P1193 

B. stojcevski, B. Pencic-Popovic, V. Celic, M. Pavlovic-Kleut, s. Backovic, A. Andric, 

A. Majstorovic, A. sljivic, M. Tadic (Belgrade, Rs) 

Humoral markers imbalance and relationship to myocardial remodeling in patients 

with congestive heart failure P1194 

L.G. sahakyan, A.A. sanosyan, A.R. davtyan, H.s. sisakyan (Yerevan, AM) 

Renin levels are associated with adverse prognosis in decompensated heart failure, 

regardless modulation of the renin-angiotensin-aldosterone system P1195 

A. Magalhaes, d. silva, N. Cortez-dias, C. Jorge, A. Ramalho, R. Placido, C. Pascoa, 

A.J. Pedro, A. Nunes diogo, d. Brito (Lisbon, PT) 

Role of biomarkers to identify individuals with silent cardiac disease to help improve 

primary prevention P1196 

Y. elrakshy, A.F. Fayed (Alexandria, eG) 

Differential white blood cell count influences outcomes in patients with acute 

decompensated systolic heart failure P1197 

M.B. Yilmaz, H. Gunes, A.U. Uslu, H. Kaya, B. Aydin, T. erdogan, C. Kucur, O.O. Turgut 

(sivas, TR) 

Clinical performance of VIDAS Galectin-3: predictive value for mortality and 

hospitalization in a multinational trial in heart failure. P1198 

M.A. Vernet, F. Apple, B.C. Handy, P. Venge, Y. Guo, s. dufoix-Cusin, B. Incaurgarat, 

M. Hausmann (Marcy l'etoile, FR; Minneapolis, Houston and Waltham, Us; Upssala, se) 

Exploring relationship between changes in NT-proBNP and renal function in patients 

with suspected heart failure using structural equation modelling P1199 

J. Zhang, P. Pellicori, T. Mabote, R. Antony, A. shoaib, A. Torabi, K. Wong, A.L. Clark, 


OPCAB results in early systolic function improvement in patients with recent acute 

coronary syndrome: biomarker links P1200 

O. Mirolyubova, O.L.G.A. Mirolyubova (Arkhangelsk, RU) 

The state of beta-receptors and adenylate-cyclase activity of the erythrocyte 

membranes in the with chronic heart failure P1201 

U. Kamilova, T. Alieva (Tashkent, UZ) 

Effects of high dose allopurinol on serum uric acid, oxidative stress and inflammatory 

biomarkers in patients with chronic heart failure P1202 

A.L. Campeanu, A. Iliesiu, G. Uscoiu, d. dusceac, A. Cristea, d. Marta, e. Moldoveanu 

(Bucharest, RO) 

Plasma levels of neutrophil gelatinase-associated lipocalin and hypoxia inducible 

factor-1 alpha in pediatric heart failure: relation to the etiology and severity of heart 

failure P1203 

M.s.K. Tawfeek, d.M. Raafat, N.K. Idris, s.s. Abdelrehim, d.A. Fouad (Assiut, eG) 

139 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Galectin-3: correlation with nitrosative stress and inflammation in patients with 


e.A. Medvedeva, Y.V. shchukin, e.I. seleznev, I.I. Berezin, L.N. slatova (samara, RU) 

Determining the prognostic value of red cell distribution width and carbohydrate 

antigen 125 in acute decompensated heart failure patients P1205 

M.Y. Liu, H. Zhang, W. Zhu, X.M. Yang, H. shen, M. Wei (shanghai, CN) 

Do patients with heart failure have equal response of endothelial function as patients 

without heart failure to exercise training? P1206 

M. deljanin Ilic, s. Ilic, G. Kocic, R. Pavlovic, V. stoickov, d. Marinkovic, V. Ilic (Niska Banja 

and Nis, Rs) 

Screening for heart failure in frail elderly with dyspnoea or reduced exercise tolerance: 

which blood tests have added value beyond the clinical assessment? P1207 

Y. Van Mourik, M.J.M. Cramer, M.J. Landman, J.B. Reitsma, L.C.M. Bertens, 

K.G.M. Moons, A.W. Hoes, F.H. Rutten (Utrecht and Amersfoort, NL) 

Red blood cell distribution width and peripheral blood cells parameters in patients 

with heart failure and a reduced ejection fraction vs heart failure with "preserved" 

ejection fraction P1208 

L. Malinova, L. Akhmadullina (saratov, RU) 

Relation between renal function, fluid status and inferior vena cava parameters in 

ambulatory patients with heart failure and chronic kidney disease P1209 

d. Torres, G. Parrinello, J.M. Testani, s. Paterna, M. Bellanca, F. Cuttitta, G. Licata 

(Palermo, IT; New Haven, Connecticut, Us) 

Ferritin and outcome in patients with heart failure without anemia P1210 

J.C. Arevalo-Lorido, J. Carretero-Gomez, M. Montero Perez-Barquero, A. Armengou Arxe, 

O. Aramburu Bodas, A. Muela Molinero, J. Casado Cerrada, L.M. Ceresuela eito, 

J.I. Perez Calvo, F. Formiga Perez (Zafra, Cordoba, Girona, sevilla, Leon, Coslada (Madrid), 

L'Hospitalet de LLobregat, Zaragoza and L'Hospitalet de Llobregat, es) 


Are predictors of health-related quality of life in pulmonary arterial hypertension 

different for women and men? P1211 

L.A. Matura, A. Mcdonough, d.L. Carroll (Philadelphia, Lowell and Boston, Us) 

Nursing consultation for heart transplantation in Ceara, Brazil P1212 

V.L. Mendes de Paula Pessoa, I.C. Lacerda, T.M. Magalhaes Moreira, 

M.V. Cavalcante Guedes, L.F. silva, R.s. Florencio, A.A. Braga, W.M. Barroso, 

J.R. Fernandes, J.d. souza Neto (Fortaleza, BR) 

Cardiovascular risk screening of female adolescents students from vocational high 

school: a cross-sectional study P1213 

V. de Freitas Marcolla (Rio de Janeiro, BR) 

Design and development of common heart failure medication titration guidelines for 

nurses in Spain P1214 

M.J. Oyanguren Artola, R. Peraira, M.J. Bernardo, C. Bravo, L. Cano, d. Fernandez Asensi, 

L.L. Garcia Garrido, A. Linas Rodriguez, M. Nebot Margalef, A. Recio Platero 

(Bilbao, Madrid, Oviedo, Lleida, Barcelona, Girona and Valladolid, es) 

Rating of self-care heart failure patients treated at a specialized clinic P1215 

A.C. Cavalcanti, C.s. Arruda, G.C.A. Vieira, A.s. Nunes, V.A. silva, B.s. scofano, F. Mello, 

B. Lins, J.M.V. Pereira, M.R. Lopes (Niteroi, BR) 

140


Can a facilitated model improve evidence-based practice for heart failure in primary 

care? P1216 

M.C. deaton, L. Burey, M. spence, K. Wild, J. Thomas (Manchester, salford and Greater 

Manchester, GB) 

Development of a nursing intervention program via tablet PC for remotely monitored 

patients with a cardiac device to manage heart failure P1217 

A. Umeda, H. Iizuka, M. suzuki, T. Inoue (Tokyo and Kamogawa, JP) 


Frequency of risk factors and aetiologies for heart failure in Saudi Arabia: A Hospital- 

Based Study P1218 

A. elasfar (Riyadh, sA) 

Depressive symptoms in patients with advanced heart failure attending a South 

African public hospital P1219 

M.e. Lokker, L. Gwyther, P. Magona, J. Riley, L. Van Zuylen, A. Van der Heide, R. Harding 

(Rotterdam, NL; Cape Town, ZA; London, GB) 

Analyze of nutritional risk screening performed during stationary rehabilitation of 

patients with decreased systolic function of left ventricle (LVEF

MODERATED 



Heart failure awareness in Germany P1228 

L. Musial-Bright, e. Tahirovic, s. Inkrot, F. edellmann, R. Wachter, s. Pankuweit, 

F. Krackhardt, s. stoerk, W. Haverkamp, H.-d.- duengen (Berlin, Göttingen, Marburg and 

Wurzburg, de) 

COMmmunity Project for cardiovAscular Risk Evaluation and prevention in stage A/B 

Heart Failure (COMPARE-HF): Is the intervention effective in very high risk patients 

over one year follow up? P1229 

s. Horgan, J. Gallagher, e.O.connell, V. Voon, d. Kerins, C. Vaughan, C. Watson, 

J. Baugh, K. Mcdonald, M. Ledwidge (dublin and Cork, Ie) 

Impact of day, month, and hour of admission on inpatient outcomes in 949,907 

hospitalizations for congestive heart failure P1230 

d.P. Kao, C.K. Mcilvennan, R.L. Page, R.L. Page, J. Lindenfeld (denver, Us) 

Remodeling of the left ventricle in patients with coronary artery disease and 

preserved left ventricular ejection fraction in a population-based study in one of the 

mountainous regions of Azerbaijan P1231 

N.R. Ismayilova (Baku, AZ) 

Risk factors for cardiovascular disease in students P1232 

J.s. Nurkovic (Novi Pazar, Rs) 


Female chronic heart failure: clinical and structural-functional peculiarities of 

cardiovascular system, microcirculation and psychosomatic state, therapeutic 

approach, treatment effectiveness increas P1233 

K.e. Klester elena, L.V. Luchev Valerii, L.R. Lihachev Rodion, K.K. Klester Karolina 

(Barnaul, RU) 

PHQ -9 screening for depression in hospitalized patients with heart failure P1234 

T. suzuki, T. shiga, K. Nishimura, J. Ishigooka, N. Hagiwara (Tokyo, JP) 

Heart failure in sub-saharan africa: a scoping review P1235 

A. Ramsay, e. Grant, s. Murray (edinburgh, GB) 

Gender differences in treatment in latin american patients with heart failure P1236 

N. Gonzalez-Jaramillo, C. saldarriaga (Medellin, CO) 

A comparison of coping, self-management and quality of life in heart failure patients 

with reduced and preserved ejection fraction P1237 

J. Gallagher, C.C. Lewis, L. Mcgarrigle, C. Mchugh, M. Heverin, F. doyle, N. Pender, 

B. Mcadam (dublin, Ie) 


Evaluation of valvular heart disease by exercise echocardiography - experience in one 

centre P1238 

d.C.H.s. Neves, J. Chin, C. Cotrim, I. Joao, P. Fazendas, A. Almeida, I. Cruz, B. stuart, 

H. Pereira (Almada, PT) 

Prognostic value of a positive exercise treadmill testing in asymptomatic coronary 

artery disease patients. P1239 

M. santos, d. Anjo, P. Rodrigues, M.J. sousa, B. Brochado, s. Viamonte, P. Fernandes, 

A. Barreira, s. Cabral, s. Torres (Porto, PT) 

Peak oxygen consumption measured during exercise correlates with post-exercise 

heart rate recovery in patients with chronic heart failure P1240 

A. Gwizdala, e. straburzynska-Migaj, T. Krauze, R. Ochotny, s. Grajek, P. Guzik 

(Poznan, PL) 

142


Acute effects of inspiratory muscle training on hemodynamic variables in patients 


L.d. Marchese, M. Quintao, L. Brandao, s. Bernardez, W.A. Martins, K. dias, 

e.T. Mesquita, s. Chermont (Teresopolis and Niteroi, BR) 

Twice-weekly neuromuscular electrical stimulation in patients with congestive heart 

failure: a pilot study P1242 

M.C.B. sacilotto, C.F.R. Lavagnoli, e.s.B.O. severino, K.A.s. Vilarinho, L.M. silveira-Filho, 

P.P.M. Oliveira, O. Petrucci (Campinas, BR) 

Depression and cardiac prognosis following acute coronary syndrome P1243 

F. Melao, A. Rocha, A.s. Correia, V. Ribeiro, M. Paiva, I. Rangel, C. sousa, V. Araujo, 

F. Parada-Pereira, M.J. Maciel (Porto, PT) 

Test-retest repeatability of cardiopulmonary exercise test parameters in patients with 

cardiac or respiratory disease P1244 

A.J. Barron, N. dhutia, A.d. Hughes, d.P. Francis, R. Wensel (London, GB) 

Importance of early physical activity after surgical revascularisation in patients with 

poor left ventricular function (w) P1245 

M. Krstic, M. deljanin - Ilic, I. Nikolic - Pavlovic, d. Petrovic (Niska Banja, Rs) 

Hemodynamics responses from the six-minute walk test in patients with heart failure 

assessed by impedance cardiography P1246 

s. Chermont, M.M.P. Quintao, L. Marchese, s. Lindemberg, L. Brandao, L. Mello, 

s. Bernardez, W.A. Martins, e.T. Mesquita (Niteroi and Teresopolis, BR) 


Features of arterial wall stiffness at different maintaining of patients with congestive 


N.A. Kosheleva, A.P. Rebrov (saratov, RU) 

Prognosis of outpatients with ambulatory diagnosis of heart failure P1248 

L. sanchis, R. Andrea Riba, C. Falces, M. sitges, F. Perez-Villa, M. sabate, M. Heras, 


The prognosis of Gypsy patients with heart failure and acute myocardial infarction P1249 

P. Mitrovic, B. stefanovic, Z. Vasiljevic, M. Radovanovic, N. Radovanovic, d. Rajic, 

G. Matic, A. Novakovic (Belgrade, Rs) 

Different evolution patterns of clinical response to cardiac ressynchronization therapy P1250 

N. Cabanelas, M. Oliveira, M. Nogueira da silva, P.s. Cunha, A. Lousinha, B. Valente, 

L. Branco, A. Galrinho, R. Pimenta, R. Ferreira (santarém and Lisbon, PT) 

Moderate to severe heart failure follow up after CRT: negative prognostic markers P1251 

M. Nogueira, A. Abreu, H. santa-Clara, L. Oliveira, M. Goncalves, M. selas, M. Carmo, 

P. Cunha, R. soares, R. Ferreira (Lisbon, PT) 

Does home telemonitoring reduce mortality and if so, is it just due to better 

guideline-treatment? P1252 

R. dierckx, T. Mabote, J. Zhang, R. Antony, P. Pellicori, s. Parsons, B. dicken, A. shoaib, 

K. Goode, J.G.F. Cleland (Hull, GB) 

Influence of established prognostic factors on long-term outcome in a cohort of 107 

patients with systolic heart failure P1253 

M.s. Annabi, F. Mezni, s. Mzoughi, R. dahmeni, B. Jdaida, A. Haggui, d. Lahidheb, 

N. Hajlaoui, W. Fehri, H. Haouala (Tunis, TN) 

Inability to prescribe beta-blockers is associated with worse prognosis in clinical practice P1254 

M. Casal Moura, F. Gomes, F. Carvalho, F. silva, O. Laszczynska, M. Amorim, M. Alvelos, 


143 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Low-frequency component of heart rhythm variability and prognosis of patients with 


N.A. Kosheleva, A.P. Rebrov (saratov, RU) 

Spironolactone use before hospital readmission provides a better outcome in elderly 

patients with heart failure P1256 

M.M. Baluta, A.d. Mateescu, e. Panaitescu, M.M. Vintila (Bucharest, RO) 

Predictors of improvement in ejection fraction in very old patients with left ventricular 

systolic dysfunction P1257 

M. Cortes Garcia, I. Hernandez, e. de La Cruz, P. Avila, A.M. Romero, J.A. Palfy, 

M.A. Navas, J.A. Franco, M. Rey, J. Farre (Madrid, es) 

Impact of chronic kidney disease on 5-year mortality in patients with left ventricular 

systolic dysfunction following ST-elevation myocardial infarction P1258 

L. savic, I. Mrdovic, M. Asanin, M. Matic, G. Krljanac, J. Perunicic (Belgrade, Rs) 

The relative prognostic importance of renal function measures in chronic heart failure P1259 

B. szabo, B. Muk, B. Ancsin, M. dekany, J. Restum, Z. Puspoki, R.G. Kiss, N. Nyolczas 

(Budapest, HU) 

Heart Faillure in context of Infective endocarditis: predictive factors an short term 

prognosis P1260 

B.F.L. Marmelo, A.P. delgado, d. Moreira, B.F. Rodrigues, P.L.C. Ferreira, J. Oliveira santos 

(Viseu, PT) 

Bioelectrical impedance vector analysis and the risk of 1-year mortality in patients with 

acute heart failure. P1261 

B. Mascarell, s. Ventura, C. Bonanad, L. Bondanza, G. Minana, A. Mollar, P. Merlos, 

M. Olivares, J. sanchis, J. Nunez (Valencia, es) 

Long-term prognosis of medically treated chronic heart failure patients with functional 

mitral regurgitation P1262 

V.N. Larina, B.B. Bart (Moscow, RU) 

Predictive value of flow-mediated dilation normalization in heart failure P1263 

F. Tarro Genta, e. eleuteri, P.L. Temporelli, F. Comazzi, M. Tidu, Z. Bouslenko, F. Bertolin, 

C. Vigorito, P. Giannuzzi, F. Giallauria (Turin, Veruno and Naples, IT) 

Long-term prognosis of patients with reduced left ventricular ejection fraction after 

the hospitalization for acute heart failure P1264 

M. Felsoci, J. Parenica, J. spinar, P. Widimsky, A. Linhart, J. Vitovec, J. Vaclavik, Z. Coufal, 

F. Malek, J. Jarkovsky (Brno, Prague, Olomouc and Zlin, CZ) 

ABO and Rhesus D blood groups in patients with chronic heart failure: impact on 

clinical outcome P1265 

I. Gotsman, d.R. Zwas, A. Keren, C. Lotan, d. Admon (Jerusalem, IL) 

Are myopericarditis and perimyocarditis benign myopericardial inflammatory 

syndromes? Results from a multicenter prospective cohort study. P1266 

M. Imazio, A. Brucato, A. Barbieri, F. Ferroni, s. Maestroni, G. Ligabue, A. Chinaglia, 

d. Cumetti, G. della Casa, R. Belli (Torino, Bergamo and Modena, IT) 

Prognostic value of left atrial function measured with cardiac magnetic resonance in 

out-patients with suspected heart failure P1267 

P. Pellicori, A. Joseph, J. Zhang, e. Lukaschuk, C. Bourantas, H. Loh, A.L. Clark, 


144


Clinical - Pathopysiology 

Relations between endothelial dysfunction and renal function in patients with heart 

failure P1268 

K. Gyamdzhyan, M. Maximov, V. Kukes (Moscow, RU) 

Parathyroid hormone is associated with markers of bone metabolism and disease 

severity in chronic heart failure P1269 

J. Kliebhan, C. Trenkler, M. ess, P. Wuertinger, A. Griesmacher, s. Kaser, M. Frick, G. Poelzl 

(Innsbruck, AT) 


Right atrium in pulmonary arterial hypertension: the forgotten prognostic determinant P1270 

A. Magalhaes, J. silva Marques, s. Goncalves, R. Placido, A. Ramalho, C. Jorge, d. silva, 

s. Martins, A. Nunes diogo (Lisbon, PT) 

Estimation of pulmonary artery distensibility index in patients with pulmonary artery 

hypertension. P1271 

A.V. Kazimli, A.V. Ryzkov, N.s. Goncharova, A.V. Beresina, A.V. Naymushin, O.M. Moiseeva 


The relationship of pulmonary hypertension and diastolic dysfunction in patients with 

systolic heart failure P1272 

s.H. seol, s.e.O. Gwang-Won, s.O.N.G. Pil-sang, K.I.M. dong-Kie, K.I.M. Ki-Hun, 

K.I.M. doo-Il, s.e.O. Jeong-sook, J.I.N. Han-Young, J.A.N.G. Jae-sik, K.I.M. dong-soo 

(Busan, KR) 

Reliability of right ventricular myocardial isovolumic relaxation time as a predictor of 

pulmonary hypertension P1273 

M.F. elnoamany, A. dawood, T. Khalil, M. elhabeeby (shebeen el-Koom, eG) 

Interaction between pulmonary hypertension and diastolic dysfunction in an elderly 

heart failure population- a sub analysis of the TIME-CHF trial P1274 

V. Van empel, B.A. Kaufmann, A.M. Bernheim, K. Goetschalckx, s.Y. Min, s. Muzzarelli, 

P. Buser, s. Kiencke, M.T. Maeder, H.P. Brunner-La Rocca (Melbourne, AU; Basel, 

Bruderholz and st. Gallen, CH; Maastricht, NL) 

Bisoprolol efficacy in patients with chronic heart failure and pulmonary hypertension 

due to systolic dysfunction P1275 

O.V. Koshlataya, e.s. Atroschenko, I.s. Karpova, s.P. solovei (Minsk, BY) 


Right ventricular dysfunction and left ventricular systo-diastolic function by 2D-strain 

in patients with dilated cardiomyopathy P1276 


Right ventricular function in asymptomatic type 2 diabetic patients: a conventional 

and tissue doppler echocardiographic imaging study. P1277 

W. Ammar, H. el Hosssary, M. Abdel Ghani, s. Abdallah (Cairo, eG) 

Radionuclide assessment right ventricle dysfunction in pulmonary embolism patients P1278 

Y. Lishmanov, K. Zavadovsky, d. Ryzhkova (Tomsk and st. Petersburg, RU) 

Clinical probability scores and right ventricular dysfunction in pulmonary 

thromboembolism, is there any correlation? P1279 

d.A. Moreira, A. delgado, B. Rodrigues, B. Marmelo, L. Nunes, O. santos (Viseu, PT) 

Early changes in right ventricle after trastuzumab treatment P1280 

B. Kilicaslan, O. Ozdogan, I. susam, M. Aydin, H. dursun, C. ekmekci (Izmir, TR) 

145 

MODERATED 

pOsTER sEssiOn 2

MODERATED 




Microalbuminuria in acute myocardial infarction as a predictor of left ventricular 

dysfunction P1281 

A. Baptista, C. Ferreira, P. Magalhaes, P. Mateus, s. silva Carvalho, A. Matias, N. Vilas 

Boas, I. Moreira (Vila Real, PT) 

Myocardial performance index in patients with left ventricular systolic dysfunction: 

conventional method versus Doppler tissue imaging P1282 

M.F. elnoamany, H. Badran, I. Abdelfattah, T. Khalil, M. salama (shebeen el-Koom, eG) 

Performance of the transversally orientated myocardial fibers was depressed in 

patients with aortic regurgitation of ischemic origin compared to patients with AR of 

nonischemic origin P1283 

N.V. Nranyan (Yerevan, AM) 

The genetics of glycaemic control and heart failure are inter-twined P1284 

H.M. Parry, L.A. donnelly, N.R. Van Zuydam, A.s.F. doney, d.H. elder, A.d. Morris, 

C.N.A. Palmer, C.C. Lang (dundee, GB) 

Left ventricular deformation and functional capacity in mild to moderate hypertension P1285 

A. Majstorovic, V. Celic, B. Pencic-Popovic, A. sljivic, M. Tadic, M. Pavlovic-Kleut, A. Andric, 

B. stojcevski, s. Backovic, I. Ilic-djordjevic (Belgrade, Rs) 

Early effects of heart rate control with ivabradine in combination with metoprolol 

compared with metoprolol uptitration on global and longitudinal LV functions, 

NT-proANP in Q-MI patients with EF


Plasma testosterone concentration in men with heart failure and preserved ejection 

fraction (HFPEF): associations with clinical variables and prognostic relevance P1293 

P. Pellicori, J. Hobkirk, M. Prapa, R. Antony, R. dierckx, B. dicken, T. Mabote, A.L. Clark, 


Pulmonary hypertension in heart failure with preserved ejection fraction associated 

with atrial dyssynchrony: a haemodynamic study P1294 

J.-C. eicher, A. Mathe, G. Laurent, J.-L. Philip, O. Barthez, G. Berteaux, J.-e. Wolf 

(dijon, FR) 

Relationship of NT-proBNP to systolic and diastolic function in HFpEF: Findings from 

the PARAMOuNT trial P1295 

A. shah, e. Kraigher-Krainer, B. Pieske, M. Zile, A. Voors, T. Bransford, M. Lefkowitz, 

M. Packer, J. Mcmurray, s. solomon (Boston, Charleston, east Hanover and dallas, Us; 

Graz, AT; Groningen, NL; Glasgow, GB) 

Characterization of heart failure with preserved ejection fraction in a Hispanic 

population P1296 

e. silva, J.J. Villasmil, C.e. esis, M.J. Bracho, e.s. Clavell, G.e. Calmon (Maracaibo, Ve) 

Left ventricular-arterial coupling in HFpEF and HFrEF shows no discontinuity P1297 

P.L.M. Kerkhof, J.K.-J. Li, J.Y. Kresh, G.R. Heyndrickx (Amsterdam, NL; Piscataway and 

Philadelphia, Us; Aalst, Be) 

Differences in functional status in patients with heart failure and reduced ejection 

fraction compared to patients with preserved ejection fraction with and without 

anemia and iron deficiency. P1298 

N. ebner, T. Bekfani, M. Valentova, A. sandek, s.d. Anker, W. doehner, s. Von Haehling 

(Berlin, de) 

Risk factors for heart failure rehospitalization in patients with preserved ejection 

fraction : Comparison between preserved ejection fraction and reduced ejection 

fraction. P1299 

M. setoguchi, Y. Hashimoto, Mitsuaki Isobe (Tokyo and Kamogawa, JP) 

Positive dynamics of left ventricle diastolic function parameters with effective 

antiarrhythmic treatment in patients with atrial fibrillation P1300 

O. Miller, A. Tarasov, O. Reynbakh, U. Pozdnyakov, s. Luchinsky, V. doschitsyn, I. dik, 

I. Belyaeva (Novosibirsk, Moscow and Zhukovsky, RU) 

Elevated plasma galectin-3 levels (GAL-3 L) correlate with echocardiographic 

parameters of diastolic dysfunction (DD) in patients with stable heart failure with 

preserved ejection fraction (HFpEF) P1301 

B. Munoz Calvo, A. Villa Martinez, V. Victor Palomares, N. Lopez Andres, F. Roman Garcia, 

V. Nadador Patino (Alcala de Henares, es) 

A conceptual paradigm of heart failure with preserved ejection fraction and systems 

biology approach P1302 

e.T. Mesquita, A.J.L. Jorge, C.V. souza Junior, J.P. Cassino (Niteroi, BR) 

Clinical - Cellular biology 

Mobilization of endothelial progenitor cells induced by physical exercise in patients 

with heart failure P1303 

P. Wieczorek, W. Wojakowski, M. Kazmierski, M. Kotowski, B. Machalinski, J. Ciosek, 

A. Filipecki, M. Tendera (Katowice and szczecin, PL) 

147 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Clinical - Metabolism/Ischaemia/Reperfusion/Preconditioning 

Changing characteristics, management and outcome in patients admitted with acute 

coronary syndrome in a tertiary hospital. Observations from 1996 to 2010 P1304 

F. Melao, e. Martins, V. Ribeiro, C. sousa, I. Rangel, s. Amorim, M. Campelo, M.J. Maciel 

(Porto, PT) 

Gemetic, clinic, angiographic, procedure technique and follow-up of percutaneous 

coronary intervention evaluation: polymorphisms, major events and restenosis. P1305 

I.P. Borges, R. Andrade, e.C.s. Peixoto, R.T.s. Peixoto, V.F.M. Marcolla (Rio de Janeiro, BR) 

Scope of age extremes: comparison between presentation, treatment and occurrence 

of heart failure in acute coronary syndrome P1306 

A. damasio, A. santos, B. Picarra, M.R. Celeiro, A. Bento, J. Aguiar (Évora, PT) 

Acute coronary syndrome and multivessel disease: culprit only versus multivessel 

revascularization P1307 

M.J. sousa, J. silveira, d. Anjo, P. Rodrigues, M. santos, B. Brochado, N. Antunes, A. Luz, 

H. Carvalho, s. Torres (Porto, PT) 

Epidemiology, management and outcome in acute coronary syndromes of 

octogenarians: the EuRHOBOP study in Portugal P1308 

F. Melao, M. Pereira, V. Ribeiro, s. Oliveira, C. Araujo, I. subirana, J. Marrugat, P. dias, 

A. Azevedo (Porto, PT; Barcelona, es) 

Endothelial dysfunction is an independent predictor of new-onset heart failure in 

coronary artery disease patients P1309 

Y. Matsue, A. Mizukami, W. Nagahori, M. Ohno, M. suzuki, A. Matsumura, Y. Hashimoto, 

M. Yoshida (Kamogawa and Tokyo, JP) 

Basic - EC coupling 

Sex-related differences in acute heart failure due to ventricular fibrillation in old rats: 

implication of electrical coupling protein, connexin-43. P1310 

N. Tribulova, J. Radosinska, V. Knezl, J. slezak, L. Urban, A. Vachulova, R. Hatala 

(Bratislava, sK) 

Doxorubicin side effects on cyclic AMP signalling and calcium handling in the heart P1311 

M. Mazevet, A. Llach-Martinez, J.P. Benitah, P. Mateo, M.C. Vozenin, A.M. Gomez, 

e. Morel (Chatenay-Malabry and Villejuif, FR) 

Sex-specific ventricular transcriptional profiles and calcium current densities in patients 


G. Kararigas, C. e Molina, H. summer, P. e Molina, I. Julia, I. Baczko, s. Golz, R. Hetzer, 

V. Regitz-Zagrosek (Berlin and Wuppertal, de; Barcelona, es; szeged, HU) 

Myofilament changes in doxorubicin-induced dilated cardiomyopathy P1313 

I. Falcao-Pires, P. Goncalves Rodrigues, C. Barros, d. Miranda-silva, N. Hamdani, 

W. Linke, A.F. Leite-Moreira (Porto, PT; Bochum, de) 

Calcium-sensitizing effects of OR-2828 in permeabilized cardiomyocytes P1314 

L. Nagy, s. szilagyi, P. Pollesello, I. edes, Z. Papp (debrecen, HU; espoo, FI) 

Early alterations of nucleoplasmic Ca2+ signalling in cardiac hypertrophy P1315 

s. Ljubojevic, s. Radulovic, s. sedej, M. sacherer, J. Kockskaemper, B. Pieske (Graz, AT; 

Marburg, de) 

148



The biological variability of circulating cytokines from healthy people: a potential 

reference for measuring inflammatory mediators in heart failure patients P1316 

R. Altara, M.H.M. Hessel, M. Manca, H.P. Brunner - La Rocca, A.P.M. Gorgels, 

J.J.R. Hermans, B.J.A. Janssen, W.M. Blankesteijn (Maastricht, NL) 

Acute exercise-induced variation in monocyte subsets in patients with chronic heart 

failure P1317 

e. Van Craenenbroeck, A. Van Craenenbroeck, K. Van Ackeren, L. scheurweghs, 

N. Possemiers, P. Beckers, C. Vrints, V. Conraads (Antwerp, Be) 

Adiponectin and type 2 diabetes in ischemic heart failure: what is the relationship? P1318 

A. Foschini, A. Pratesi, F. Orso, A. Antenore, G. Lonetto, N. Bartoli, A.G. Marella, 

M. Monami, N. Marchionni, s. Baldasseroni (Florence, IT) 

Proinflammatory cytokines and abnormalities of cardiac structures and diastolic 

function in woman with abdominal obesity. P1319 

e. Bazhenova, O. Belyaeva, A. Berezina, N. Korelskaya, T. Naneishvili, d. Kolodina, Y. Kurt, 

O. Berkovich, e. Baranova, e. shlyakhto (st. Petersburg, RU) 

Macrophages dictate the progression and manifestation of hypertensive heart disease 

in rat P1320 

d. Kain, C. Yagil, N. Landa-Rouben, Y. Yagil, J. Leor (Tel Aviv and Ashkelon, IL) 

Cardiac expression and shedding of the transmembrane heparan sulphate 

proteoglycan syndecan-4 is induced by innate immune signalling, affecting 

inflammation and heart failure progression P1321 

M.e. strand, K.M. Herum, Z.A. Rana, B. skrbic, e.T. Askevold, C.P. dahl, M. Vistnes, 

I. sjaastad, G. Christensen, I.G. Lunde (Oslo, NO) 

Effect of cardiac resynchronization therapy on natriuretic peptide and inflammatory 

markers P1322 

A.M. soldatova, V.A. Kuznetsov, T.N. enina, P.V. shebeko, A.Y.U. Rychkov, T.I. Petelina, 

N.N. Melnikov (Tyumen, RU) 

Different neurohormonal and inflammatory pattern in acute CRS respect to AHF 

patients with preserved renal function P1323 

A. Palazzuoli, G. Ruocco, M. Beltrami, M. Pellegrini, B. Franci, M.s. Campagna, R. Nuti, 

C. Ronco (siena and Vicenza, IT) 

Basic - Metabolism 

CardioNet: A human metabolic network suited for the study of cardiomyocyte 

metabolism P1324 

A. Karlstaedt, d. Fliegner, G. Kararigas, H. sanchez Ruderisch, V. Regitz-Zagrosek, 

H.G. Holzhuetter (Berlin, de) 

The effect of high fat diet on cardiac structure and myocardial metabolism regulation 

in the absence of interleukin 6. P1325 

K. Kaminski, T. Bonda, M. sokolowska, M. dziemidowicz, B. szynaka, M.M. Winnicka, 

W.J. Musial (Bialystok, PL) 

Myocardial abnormalities induced at early and late stage of hypertension are 

attenuated by omega-3 fatty acids. P1326 

J. Radosinska, B. Bacova, T. Benova, V. Knezl, J. Zurmanova, T. soukup, e. Goncalvesova, 

J. slezak, N. Tribulova (Bratislava, sK; Prague, CZ) 

The role of hydrogen sulfide in mitochondrial dysfunction and heart function 

disturbances of spontaneously hypertensive rats P1327 

N.A. dorofeyeva, V.F. sagach (Kiev, UA) 

149 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



Is the type of hypertrophy predictable by the stimulus-specific reaction of 

mitochondrial function? P1328 

M. schwarzer, A. schrepper, M. schoepe, P.A. Amorim, T. doenst (Jena, de) 

Triheptanoin diet alleviates hypertrophy and diastolic dysfunction and preserves 

cardiac glucose oxidation in rats with pressure overload P1329 

T.d. Nguyen, Y. shingu, P.A. Amorim, M. schwarzer, T. doenst (Jena, de; Hokkaido, JP) 

Basic - Cardiac remodeling and hypertrophy 

Left ventricular hypoinnervation is an early event in response to pressure overloadinduced 

myocardial remodelling P1330 

s. sedej, J. schipke, A. schmidt, H. Post, B. Pieske, C. Muehlfeld (Graz, AT; Hannover, de) 

Functional improvement of isoproterenol-induced cardiac failure by apelin-12 and its 

analog P1331 

s.V. Lakomkin, V.V. Gramovich, O.N. Vyborov, e.V. Lukoshkova, V.L. Lakomkin, 

N.A. Undrovinas, A.A. Abramov, s.N. Tereschenko, V.P. shirinsky, V.I. Kapelko 

(Moscow, RU) 

Protective effects of exercise before and after myocardial infarction on cardiac 

remodelling P1332 

s.L. Puhl, Y.d. devaux, A.M. Mueller, H.K. Kilter, d.R.W. Wagner, M.B. Boehm, C.M. Maack 

(Homburg and Cologne, de; Luxembourg, LU) 

Cardiospecific nNOS overexpression is protective in Chagas cardiomyopathy P1333 

J. strasen, P. Nordbeck, M. Czolbe, M. Muehlfelder, s. Olivares Flores, T. Williams, O. Ritter 


Antiplatelet therapy modulates contractile function of right ventricular cardiomyocytes 

in a rat model of post-ischemic heart failure P1334 

A. Kovacs, J. Kalasz, e.T. Pasztor, s.K. sanganalmath, N.s. dhalla, Z. Papp, J. Barta 

(debrecen, HU; Winnipeg, CA) 

Features of structural reorganization of a myocardium of rats-females with an 

experimental heart failure at melatonin introduction P1335 

Y. Liskova, s.P. salikova, A.A. stadnikov (Orenburg and st. Petersburg, RU) 

Identification of serum biomarkers that reflect progressive cardiac remodelling P1336 

C.J. Watson, P. Collier, I. Tea, s. Horgan, M. Ledwidge, K. Mcdonald, J. Baugh (dublin, Ie) 

The relation between left atrial size and left ventricular function in patients after 


V. stoickov, s. Ilic, M. deljanin Ilic, L.J. Nikolic, M. stoickov (Nis and Niska Banja, Rs) 

Basic - Diastolic function 

Impaired diastolic adaptation to stretch in the hypertrophic rat heart with diastolic 


A.L. Pires, P. Goncalves-Rodrigues, d. Moreira-Goncalves, C. Moura, R. Ladeiras-Lopes, 

C. sena, I. Falcao-Pires, R. seica, A.L. Leite-Moreira (Porto and Coimbra, PT) 

Serum amyloid P-component: a novel biomarker and potential treatment for diastolic 

dysfunction and heart failure P1339 

s. Horgan, C. Watson, P. Collier, M. Ledwidge, K. Mcdonald, J. Baugh (dublin, Ie; 

Cleveland, Us) 

Diastolic dysfunction in early stages of murine model of dilated cardiomyopathy P1340 

U. Tyrankiewicz, T. skorka, M. Jablonska, A. Osiak, K. Jasinski, M. Gonet, A. Osip, K. Byk, 

s. Chlopicki (Krakow, PL) 

150


Time constant of relaxation of the left ventricle (taudmx) measured by diamix 

technique is a major determinant of both systolic and diastolic function P1341 

A. selaru, R. Tecuceanu, I. stoian, C. Macarie (Bucharest, RO) 

New echocardiographic technique allows evaluation of the diastolic function in 

patients with atrial fibrillation by measuring the time relaxation constant and atrial 

filling pressure P1342 

A. selaru, R. Tecuceanu, I. stoian, C. Macarie (Bucharest, RO) 

Adiponectin, interleukin-1 receptor antagonist and diastolic dysfunction in patients 

with arterial hypertension. P1343 

e. Kiseleva, N. Krukov, M. Ginzburg (samara, RU) 

Basic - Miscellaneous, hemodynamics, imaging, techniques 

Correlation between multi register-noninvasive device hemodynamic variables vs 

intraverticular and aortic pressures in hemodynamic laboratory P1344 

L. Figuerola-Chaparro, A. Montanez-Orozco, G. Ortiz-suarez, L. Castillo-Martinez, 

J.I.A. Orea-Tejeda, O. Infante-Vazquez, R. Martinez Memije, B. Becerra Luna, 

d. Aguilar-de La Torre, A. Ricalde-Alcocer (Mexico City, MX) 

Visualization of myocardial ischemia injury development over time in rats using 

multimodal high-field MRI P1345 

P. Nordbeck, d. Weber, K.H. Hiller, P.M. Jakob, G. ertl, W.R. Bauer, O. Ritter 

(Würzburg, de) 

Influence of heart failure severity on the autoregulation of cerebral circulation and 

manifestation of convulsive readiness P1346 

M. Mamalyga (Moscow, RU) 

Mild hypothermia improves mixed venous oxygen saturation during experimental 

reductions of cardiac power output in pigs. P1347 

A. Alogna, M. schwarzl, s. Huber, H. Maechler, P. steendijk, B. Pieske, H. Post (Graz, AT; 

Leiden, NL) 

Basic - Stem cells 

Effects of age, sex and diabetes on cardiac stem cells characteristics and left 

ventricular remodeling in patients with ischemic heart disease. P1348 

d.d.amario, A.M. Leone, A. Lombardo, A. Iaconelli, M.B. Giannico, F. Graziani, 

C. smaldone, M. Massetti, F. Crea (Rome, IT) 

Cardiac stem cells can be isolated and characterized from 3d-electroanatomic guided 

endomyocardial biopsies in a preclinical animal model. P1349 

d.d.amario, A.M. Leone, C. smaldone, M.L. Narducci, G. Pelargonio, F. Perna, 

A. Amodeo, F. Inzani, M. Massetti, F. Crea (Rome, IT) 

Development of a new 3D cell-based bioactive patch for myocardial infarction: 

a pilot study in swine P1350 

C. Prat-Vidal, C. Galvez-Monton, V. Puig-sanvicens, B. sanchez-Terrones, A. Guasch, 

I. diaz-Guemes, F.M. sanchez-Margallo, R. Bragos, C.e. semino, A. Bayes-Genis 

(Badalona, Barcelona and Caceres, es) 

Comparison of properties of c-kit positive cardiac stem cells in different parts of the 

myocardium from patients with ischemic heart failure P1351 

K. dergilev, K. Rubina, V. sysoeva, R. Akchurin, V. Tkachuk, Y.e. Parfyonova (Moscow, RU) 

151 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



The impact of cardiovascular diseases and diabetes mellitus type 2 on paracrine 

activity and angiogenic properties of human adipose tissue derived stromal/stem cells P1352 

N.A. dzhoyashvili, A.Y. efimenko, N.I. Kalinina, R.s. Akchurin, e.V. Parfyonova 

(Moscow, RU) 

Cardiomyocte cell cycle induction improves the survival in pressure overload induced 

heart failure. P1353 

K. Toischer, M. Huenlich, W. Zhan, s.P. Reuter, L.s. Maier, s. sossalla, L.J. Field, 

G. Hasenfuss (Göttingen, de; Indianapolis, Us) 

Basic - Extracellular matrix, fibrosis 

Role of Neutrophil Gelatinase Associated Lipocalin (NGAL) in cardiovascular 

remodeling induced by aldosterone P1354 

A. Tarjus, s. el Moghrabi, C. Latouche, P. Rossignol, F. Zannad, N. Farman, 

N. Lopez-Andres, F. Jaisser (Paris and Vandœuvre-Les-Nancy, FR; Pamplona, es) 

Indapamide induces prevention of myocardial fibrosis in spontaneous hypertension rats P1355 

A. Barta, O. Pechanova, s. Kojsova, L. Jendekova, P. Babal, P. Janega (Bratislava, sK) 

Phosphodiesterase 2 activates myofibroblast formation and CTGF synthesis in cardiac 

fibroblasts and augments stiffness in engineered connective tissue P1356 

C. Vettel, s. Laemmle, J. emons, s. ewens, C. Cervirgen, K. Wittkoepper, C.M. Wuertz, 

s. Lutz, W.H. Zimmermann, A. el-Armouche (Göttingen, de) 

The MMP9/TIMP1 ratio might rule out the hemodynamic relevance of tenascin-c P1357 

d. santer, K. Trescher, F. Nagel, J. Krynicka, K. Kaun, M. Krssak, B.K. Podesser (Vienna, AT) 

Hypoxia alters the DNA methylation profile of cardiac fibroblasts via HIF-1a regulation 

of DNA methyltransferases: implications on cardiac fibrosis P1358 

C.J. Watson, P. Collier, R. Neary, I. Tea, M. Ledwidge, K. Mcdonald, J. Baugh (dublin, Ie) 

The proteolysis activity influence on ischemic heart failure formation and progression P1359 

O. Koval, A. skoromna (dnipropetrovsk, UA) 

Differential glycosylation of the novel biomarker leucine-rich alpha 2-glycoprotein 

(LRG) in heart failure - potential application to improve diagnostic accuracy P1360 

N. Glezeva, K. Mcdonald, M. Ledwidge, J. Baugh, C. Watson (dublin, Ie) 


Cardiogenic shock due to opiates and propofol infusion. Should we take caution 

using these drugs? P1361 

A. Renilla Gonzalez, J. Rozado, e. diaz, I.A. Pichel, M. Barreiro, B. diaz-Molina, 

J.L. Lambert (Oviedo, es) 

Age and sex-related differences in processes of care and mortality among patients 

with incident heart failure P1362 

A. Nakano, s.P. Johnsen, M.L. svendsen, K. egstrup (Aarhus and svendborg, dK) 

Infective endocarditis with acute heart failure, petechie and absscessus of splean P1363 

B. Orbovic, B. Ivanovic, s. Matic (Belgrade, Rs) 

Heart failure and arrhythmias in a patients with cardiac inflitration of chronic myeloid 

leukaemia: rapid recovery with chemotherapy P1364 

N. Arat Koc, s. Guvenc, B. dilekci, T. ece, M. Arat (Istanbul, TR) 

Changes in sleep disordered breathing with heart failure decompensation 

(fluid overload) P1365 

J. spiesshoefer, J. Heinrich, T. Bitter, d. Horstkotte, O. Oldenburg (Bad Oeynhausen, de) 

152


Sudden cardiac tamponade: a rare presenting manifestation of a systemic 

inflammatory disease P1366 

F. Valente, L. Marta, d. severino, C. Costa, M. Alves, M.L. Pitta, V. Martins, A. Francisco, 

I. Monteiro (santarem, PT) 

Diagnostic challenges: is histopathology enough? P1367 

K. Kodziszewska, P. Leszek, M. Pronicki, W. Grajkowska, T. Zielinski (Warsaw, PL) 

Cardiogenic shock after traumatic coronary hematoma P1368 

B. Biselli, M.B. Ulhoa, B.L.R. Faillace, F.A. Pinton, J.P. escalante, F. Bacal, V.s. Issa, 

s.M. Ayub-Ferreira, P.A. Lemos-Neto, e.A. Bocchi (sao Paulo, BR) 

Heart failure due to effusive-constrictive pericarditis: a rare complication of a frequent 

disease P1369 

L. Rassi, R. Rodrigues, P. Amador, s. Goncalves, L. Mendes, J. santos, s. Correia, 

s. Mateus, R. Caria, L. soares (setubal, PT) 

Obstructive left atrial myxoma mimicking congestive heart failure P1370 

e. Kaczmarska, Z. dzielinska, C. Kepka, M. demkow (Warsaw, PL) 

Ischemic dilated cardiomyopathy without late gadolinium enhancement P1371 

e. Cambronero Cortinas, M.J. Corbi Pascual, A. Gomez Perez, J.G. Cordoba soriano, 

R. Fuentes Manso, A. Tercero Martinez, C. Llanos Guerrero, J. Navarro Cuartero, 

I. Lopez Neyra, d. Prieto Mateos (Albacete, es) 

A case of the rapid reversal of tachycardia-induced cardiomyopathy associated with 

atrial flutter P1372 

T. Kurushko, V. Halianishcha, T. Vaikhanskaya, I. sidorenko (Minsk, BY) 

Peripheral embolization secondary to atrial fibrillation P1373 

T. Kovacevic-Preradovic, M. Kozic, Z. Janjic, d. Uncanin, M. Grujicic, B. stanetic, A. Janjic, 

s. Vlaisavljevic, s. srdic, d. Trninic (Banja Luka, BA) 

Atrial fibrillation induced cardiomyopathy: an uncommon yet reversible cause of 

cardiogenic shock P1374 

A. Tralhao, s. Madeira, J. Ferreira, A. Ventosa, C. Aguiar, M. Trabulo, P. Adragao, 

M. Mendes (Carnaxide, PT) 

Pentavalent Antimonials Compounds and Doxorubicin: potentiation of cardiotoxicity? P1375 

W.A. Martins, C.A. Tiradentes, C. Martins, R.C.M. Almeida, M.L. Ribeiro, e.N. silva, 

A.C.d. Cavalcante (Niteroi, BR) 

Metastatic hepatocellular carcinoma: an unusual cause of right heart failure P1376 

A. Tounsi, Malek Akrout, dorra Abid, Leila Abid, Zied Chaari, Med Abdennadher, 

Feten Triki, Mourad Hentati, Imed Frikha, samir Kammoun (sfax, Tn) 

Cardiac resynchronization therapy in a patient with noncompaction cardiomyopathy. P1377 

A. Villa Martinez, B. Munoz Calvo, V. Victor Palomares, F. Roman Garcia, V. Nadador 

Patino (Alcala de Henares (Madrid), es) 

Dectection of nocturnal Cheyne-Stokes respiration and its effective treatment using a 

novel cardiac resynchronization device P1378 

H. Fox, G. Noelker, K.J. Gutleben, T. Bitter, d. Horstkotte, O. Oldenburg 


Intrathoracic impedance monitor alarm in a patient with cardiac resynchronization 

therapy and advanced lung carcinoma P1379 

M. Cvijic, d. Zizek, B. Antolic, I. Zupan (Ljubljana, sI) 

153 

MODERATED 

pOsTER sEssiOn 2

MODERATED 



The Janus face of pacemakers; early biventricular pacemaker upgrade in case of LVEF 

>35% could improve pacemaker induced heart failure P1380 

Z. Bari, M. Vamos, G. szabo, B. Ancsin, B. szabo, T. Borsanyi, R.G. Kiss, G.Z. duray, 

N. Nyolczas (Budapest, HU) 

Importance of additional echocardiographic parameters in selecting a CRT responder 

patient P1381 

J. Taleski, B. Zafirovska, L. Poposka, e. srbinovska (skopje, MK) 

A case of chronic myocardial rupture P1382 

e. Cambronero Cortinas, M.J. Corbi Pascual, V. Hidalgo Olivares, A. Gomez Perez, 

R. Fuentes Manso, G. Aldamiz echevarria Castillo, s. Beltrame Tomatis, M. Barambio Ruiz, 

J. Cuartero Navarro, d. Prieto Mateos (Albacete, es) 

Extensive myocardial infarction leading to severe heart failure requiring heart 

transplantation in patient with myocardial bridge P1383 

A. drohomirecka, A. Tarnowska, K. Kozar-Kaminska, M. Piotrowska, J. Wisniewska, 

T. Zielinski (Warsaw, PL) 

Visceral leishmaniasis in heart transplant patient: a diagnosis to consider P1384 

s.M.G. Mayordomo Gomez, J.M.M.C. Montero Cabezas, C.G.N. Granda Nistal, 

B.G.A.d. Garcia- Aranda dominguez, J.M.M.N. Molina Martin de Nicolas, 

B.R.A. Rubio Alonso, B.d.A. diaz Anton, e.P.G.M. Garcia Martin, L.V.T. Villagraz Tecedor, 

L.B.A. Blazquez Arroyo (Madrid, es) 

Sudden death caused by malignant cardiac lymphoma in a transplanted heart P1385 

J.J. Parra Fuertes, T. Anton Bravo, s. Mayordomo Gomez, R. salgado Aranda, 

B. diaz Anton, J.M. Montero Cabezas, e.P. Garcia Martin, A. Miguel Gutierrez, 

J. Molina Martin de Nicolas, R. Martin Asenjo (Madrid and Mostoles, es) 

Clinical example of good responder patient with postoperative pericardial constriction 

treated with tolvaptan P1386 

T. sugimoto, K. Mori, K. sato, K. Moriwaki, M. Horiguchi, T. Takamura, s. sakabe, T. seko, 

A. Kasai (Ise, JP) 

Monthly levosimendan infusions in the treatment of advanced heart failure: the net 

clinical benefit beyond simple palliative care P1387 

A. Fontana, A. Vincenzi, A. Ciro', A. Frattola, e. Vigano', P. Cagnan, A. santi, F. Achilli 

(Monza, IT) 

154


New this year 




From Monday 27 May 14:00 - 18:00 & Tuesday 28 May 08:00 - 12:30. 













Research 

New Therapies 

155 

Interventions 

Knowledge 

MODERATED 

pOsTER sEssiOn 3

MODERATED pOsTER sEssiOn 3 - MOnDAy 14:00 TO TuEsDAy 12:30 

Moderated Poster Session 3 - Monday 14:00 to Tuesday 12:30 

157 

Poster Area 

New this year 



Clinical - Acute heart failure 

Inotropes in acute heart failure, possible implications of inappropriate use: data from 

the new Italian Registry IN-HF Outcome P1388 

A. Mortara, F. Oliva, M. Metra, G. Cacciatore, A. Chinaglia, A. di Lenarda, M. senni, 

R. Urso, A. Maggioni, L. Tavazzi (Monza, Milan, Brescia, Rome, Turin, Trieste, Bergamo, 

Florence and Cotignola, IT) 

Sex-specific acute heart failure phenotypes and treatment results from PROTECT P1389 

s. Meyer, P. Van der Meer, C.M.O.connor, G. Cotter, B.A. davison, J.G.F. Cleland, 

H.L. Hillege, A.A. Voors (Groningen, NL; durham, Us; Hull, GB) 

Antagonists of aldosterone in acute myocardial infarction with acute heart failure P1390 

V.K. Tashchuk, O.I. Gulaga, O.s. Polyanska (Chernivtsy, UA) 

Cost of pharmacological therapy in heart failure and heart transplantation 

outpatients: effects of age, etiology and functional class P1391 

s.M.G. Brandao, V.s. Issa, s.M.A. Ferreira, s. storer, V.G. santos, P.R. Chizzola, 

G.e.C. souza, Bacal Fernando, G.G. Veiga, e.A. Bocchi (sao Paulo, BR) 

Prediction of body weight reduction by tolvaptan in acute decompensated heart failure P1392 

M. Fukunami, M. Hori, M. Matsuzaki, T. Izumi (Osaka, Ube and sagamihara, JP) 

Living longer or with optimal quality of life: preferences of heart failure patients in 

daily clinical practice P1393 

I.H. Kraai, K.M. Vermeulen, M.L.A. Luttik, T. Hoekstra, T. Jaarsma, H.L. Hillege 

(Groningen, NL; Norrkoping, se) 

Non-invasive Ventilation for Acute Cardiogenic Pulmonary Edema in the Emergency 

Department: Southeast Asian experience P1394 

R.C.C. Wong, M. Carteciano, J. Tang, J. Lee, I. Ibrahim (singapore, sG) 

Efficacy of repeated infusions of levosimendan in patients with chronic heart failure P1395 

N. Bruno, M. Mancone, A. Cinque, P. scarparo, M. Pagliaro, B. Brasolin, F. Fedele 

(Rome, IT) 

Prediction of acute effect on urine output of a novel diuretics tolvaptan in patients 

with decompensated heart falure P1396 

M. Fukunami, M. Hori, M. Matsuzaki, T. Izumi (Osaka, Ube and sagamihara, JP) 

Bioelectrical impedance vector analysis predicts the direction and intensity of 

creatinine changes following administration of intravenous loop diuretics in acute 


s. Ventura, C. Bonanad, B. Mascarell, G. Minana, L. Bondanza, P. Merlos, J. sanchis, 

F.J. Chorro, e. Nunez, J. Nunez (Valencia, es) 

Prevalence of different types of sleep-disordered breathing in acute decompensated 


O. Oldenburg, T. Bitter, J. spiesshoefer, H. Fox, B. Koerber, Z. dimitriadis, P. Netz, 

d. Horstkotte (Bad Oeynhausen, de) 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



use of non-invasive continuous hemodynamic monitoring in decompensated heart 

failure P1399 

M. Villaca Lima, M.e. Ochiai, J.N. Cardoso, K.R. Vieira, M.N. Cardoso, e.C.O. Brancalhao, 

A.C.P. Barretto (sao Paulo, BR) 

Impact of gender in the management and mortality of acute heart failure patients P1400 

M. Reina-Couto, J. Rema, s. silva, F. Frioes, J. Pimenta, A. Azevedo, P. Bettencourt 

(Porto, PT) 

Relationship between systolic pulmonary artery pressure and adverse outcomes in 

acute descompensated heart failure P1401 

I. Rilo Miranda, J.R. Beramendi Calero, s. Garcia, I. Barrio, A. escobar, 

K. echegaray Ibanez, M. Telleria Arrieta, I. Villanueva Benito, I. solla Ruiz, 

F. de La Cuesta Arzamendi (san sebastian and Bilbao, es) 

Occurrence of heart failure in patients with non - St- elevation acute coronary 

syndrome P1402 

A. damasio, A. santos, B. Picarra, M.R. Celeiro, A. Bento, J. Aguiar (Évora, PT) 

Heart failure in octogenarians with acute coronary syndrome: the EuRHOBOP study 

in Portugal P1403 

F. Melao, M. Pereira, V. Ribeiro, s. Oliveira, C. Araujo, J. Vila, J. Marrugat, P. dias, 

A. Azevedo (Porto, PT; Barcelona, es) 

Predictors of cardiogenic shock in patients with acute st-elevation myocardial infarction P1404 

A.R. santos, B. Picarra, A.F. damasio, M. Celeiro, A. Bento, J. Aguiar, R.N.s.C.A. spc 

(Évora, PT) 

Impaired hemodynamics and liver dysfunction in acute heart failure. P1405 

J. Biegus, R. Zymlinski, M. sokolski, s. Nawrocka, P. siwolowsk, J. szachniewicz, 

e.A. Jankowska, G. Cotter, W. Banasiak, P. Ponikowski (Wroclaw, PL; durham, NC, Us) 

Heart rate variability to psychological stress in decompensated heart failure P1406 

J.I.A. Orea-Tejeda, V. Pelaez-Hernandez, L. Castillo-Martinez, G. Pena-Popoca, 

C. Figueroa-Lopez, G. Ortiz-suarez, A. Montanez-Orozco, Y. Lopez-Ramirez, 

A. delgado-Perez, B. Marquez-Zepeda (Mexico, MX) 

Predictors of cardiogenic shock in st-elevation and non-ST-elevation myocardial 

infarction: are they different? P1407 

A.R. santos, B. Picarra, A.F. damasio, M. Celeiro, A. Bento, J. Aguiar, R.N.s.C.A. spc 

(Évora, PT) 

Cardiogenic shock in non-st-elevation myocardial infarction: impact in prognosis and 

predictors P1408 

B. Picarra, A.R. santos, A.F. damasio, M. Celeiro, A. Bento, J. Aguiar, R.N.s.C.A. spc 

(Évora and Portugal, PT) 

Prognosis of acute heart failure with reduced and preserved ejection fraction, is there 

any difference after all? P1409 

M. Proenca, I. Araujo, R. Cardiga, F. Marques, s. Augusto, s. Jesus, A. Leitao, C. Fonseca, 

F. Ceia (Lisbon, PT) 

The effect of the glucose-insulin-potassium solution on the p-wave dispersion of the 

heart failure patients P1410 

s. ercan, M. Oylumlu, M. Oylumlu, s. soydinc, V. davutoglu (Gaziantep and 

diyarbakir, TR) 

Depressive disorders in acute heart failure P1411 

G. Tytova, O. Liepieieva, P. Kravchun (Kharkiv, UA) 

Echocardiographic predictor of postoperative acute heart failure after spine surgery P1412 

T.H. Kim, J. Moon (seoul and Incheon, KR) 

158


The biological variability of sST2, a novel serum biomarker for heart failure P1413 

A. Wu, J. snider (san Francisco and san diego, Us) 

Presenting symptoms and changes in heart and respiratory rate and blood pressure in 

the first 24 hours after admission in patients admitted with heart failure P1414 

A. shoaib, A. Raza, M. Waleed, A. djahit, X. Kassianides, J. Zhang, T. Mabote, A. Torabi, 


In the era of BNP measurement, which symptoms and signs have independent 

prognostic value in patients with acute decompensated heart failure? P1415 

C.e. Jackson, I.K. Tsorlalis, R.C. Myles, J.R. dalzell, V. Bezlyak, I. Ford, s.M. Cobbe, 

R.s. Gardner, M.C. Petrie, J.J.V. Mcmurray (Glasgow, GB) 

Heart Failure Post Ischemic Heart Disease: The role of pulse wave velocity P1416 

M. Mendonca, A. Pereira, s. Gomes, B. silva, A.C. sousa, s. Borges, M. Rodrigues, 

C. Freitas, d. Pereira, R. Palma dos Reis (Funchal and Lisbon, PT) 

Prognostic value of red blood cell distribution in acutely decompensated chronic heart 

failure patients with deteriorated and preserved systolic function P1417 

L.R. Tumasyan, K.G. Adamayn (Yerevan, AM) 

I123-MIBG prognostic value in a selected patients population with idiopathic 

cardiomyopathy candidate to AICD implant: a pilot study. P1418 

G. scrima, G. Bertuccio, F. Rabajoli, G. Canavese, M. Imazio, e. Brscic, 

M.T. spinnler (Moncalieri and Turin, IT) 

Elevated serum lactate is a marker of organ hypoperfusion and indicates poor 

prognosis in acute heart failure P1419 

R. Zymlinski, J. Biegus, M. sokolski, N. Nawrocka, P. siwolowski, J. szachniewicz, 

G. Cotter, e.A. Jankowska, W. Banasiak, P. Ponikowski (Wroclaw, PL; durham, NC, Us) 

Acute kidney injury and worsening kidney function predict outcomes of acute heart 

failure patients P1420 

G. Berra, N. Garin, A.s. Janot-Berthier, A. Perrier, P.Y. Martin, s. Carballo (Geneva, CH) 


Heart rate reduction and improvement of NyHA class during uptitration of 

beta-blockers for heart failure independently predict mortality P1421 

H.-d. duengen, s. Inkrot, e. Tahirovic, L. Musial-Bright, T. Trippel, V. Tscholl, F. Krackhardt, 

W. Haverkamp, s. Apostolovic, G. Gelbrich (Berlin and Wurzburg, de; Nis, Rs) 

use of natriuretic peptides to screen for cardiac dysfunction in older patients with 

type-2 diabetes mellitus. a report from sica-diabetes study (fp7/2007-2013/ 241558) P1422 

P. Pellicori, H. Fazlalizadeh, s. Nichols, J. Zhang, A.L. Clark, R. Raghunath, M. Hancocks, 

B. saveliych, J. Warden, J. Cleland (Hull, GB) 

Role of serum procalcitonin and high sensitivity C-reactive protein in distinguishing 

cardiac from pulmonary causes in patients with acute shortness of breath P1423 

M. Abdelhamid, H. Heshmat, A. Abozeid, R. Rashad (Cairo, eG) 

Pulmonary arterial systolic acceleration time in diagnosis of heart failure with 

preserved systolic function P1424 


Analysis of the metabolomic profile of a healthy blood donor cohort and comparison 

with the heart failure metabolomic fingerprint. P1425 

M. Biagioli, P. Pantaleo, L. Tenori, C. Luchinat, X. Hu, C. Lippi, F. Biagini, C. Gironi, 

B. Alterini, G.F. Gensini (Florence, IT) 

159 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Health-related quality of life in patients with heart failure/risk factors of heart failure 

and renal dysfunction P1426 

G. Cherian, H.-d. duengen, e. Tahirovic, L. Musial-Bright, s. Inkrot, T. Trippel, 

F. Krackhardt, W. Haverkamp, R. Wachter, C. Herrmann-Lingen (Berlin and 

Göttingen, de) 

Soluble prorenin receptor in chronic heart failure patients P1427 

d. Obradovic, G. Loncar, T. Trippel, N. sekularac, e. Tahirovic, R. Wachter, M. Lainscak, 

W. Haverkamp, R. dechend, H.-d. duengen (Berlin and Göttingen, de; Belgrade, Rs; 

Golnik, sI) 

QT peak dispersion correlated with LV size and mass in patients with chronic heart 

failure, but not to the amount of scar present P1428 

O. Khaleva, N. sherwi, e. Lukaschuk, M. Borovickova, A. Joshi, H. Loh, C. Bourantas, 

A.L. Clark, J.G.F. Cleland, K. Wong (Hull, GB) 


Severe myocardial fibrosis in hcm is associated with high risk for future arrhythmic 

events P1429 

C. Prinz, J. Vogt, R. Lehmann, F. Van Buuren, N. Bogunovic, d. Horstkotte, L. Faber 


Prognostic value of cardiac arrhythmias in elderly patients with chronic heart failure P1430 

s. Garkina, d. duplyakov, e. Adonina (samara, RU) 

Pacemakers dysfunction as a factor of heart failure progression P1431 

L. Kardashevska, I.s. Mikhailichenko, T.V. Turovskaya (donetsk, UA) 

Risk factors for inducible sustained ventricular tachycardia at electrophysiological 

testing in patients with mild left ventricular systolic due to chronic Chagas disease P1432 

R. Bestetti, A. Cardinalli Neto, e.F. silva, R.P. Lima, A.M. Lorga Filho 

(sao Jose do Rio Preto, BR) 


Left ventricular flow pressure and NT-proBNP level in atrial fibrillation patients P1433 

G.V. dzyak, L.I. Vasilyeva, L.V. sapozhnychenko, O.s. Kalashnykova (dnipropetrovsk, UA) 

The value of left atrial volumes and CHADSVASc scoring as predictors of recurrence of 

stroke in patients with no previous documented atrial fibrillation: A Saudi experience P1434 

M.M. Alqaseer, A.K. Alqarni, Y. Alawi, H. elsamiri, M.M. Mowla, A. Jelani (Al Ahsa, sA) 

Comparative assessment of the efficacy of antiarrhythmic therapy in patients with 

chronic heart failure and concomitant type 2 diabetes mellitus complicated by atrial 

fibrillation P1435 

G. Qadjiyev (Baku, AZ) 

Revisiting the prognosis of atrial fibrillation in heart failure P1436 

F.A. Cunha, M. Couto, A.L. silva, R. Pimentel, J. Pimenta, s. silva, P. Lourenco, A. Azevedo, 

F. Frioes, P. Bettencourt (Porto, PT) 

Ventricular rate versus rhythm control and vascular function in atrial fibrillation P1437 

A. Flammer, d. Hurlimann, R. Chenevard, F. enseleit, I. sudano, F. duru, T.F. Luscher, 

G. Noll, F. Ruschitzka (Zurich, CH) 

Thromboembolic risk and related treatment in elderly patients with atrial fibrillation 

and advanced heart failure from rural areas P1438 

A.d. Mateescu, M.M. Baluta, M.M. Vintila (Bucharest, RO) 

160


B-type natriuretic peptide, von Willebrand factor and oxidised low density lipoprotein 

are predictors of heart failure development in patients with atrial fibrillation P1439 

M. Polovina, T. Potpara, M. Licina, M.C. Ostojic (Belgrade, Rs) 

The correlation between pressure gradient on tricuspid valve regurgitation and 

cardiac function in patients with atrial fibrillation and systolic dysfunction P1440 

J.P. Park, H.M. Choi, s.e. Lee, J.Y. Rhew, L.I.M. Jh, J.O.H.N. sh, d.Y. Lee, J.e. song, 

H.J. Nam (Jeonju, Ks; Jeonju and seoul, KR) 


Hematopoietic cell transplantation (HCT) therapy and the risk heart failure 

development P1441 

s. Rispler, I. Henig, H. sholy, H. Hammerman, Z. Abassi, d. Aronson, T. Zuckerman 

(Haifa, IL) 

Optimal timing of cardiac function monitoring for early detection of subclinical 

doxorubicin cardiotoxicity P1442 

W.B. Chung, H.J. Youn, J.s. Yu, J.Y. Kim, Y.s. Choi, C.s. Park (seoul, KR) 

Significance of value of biomarkers troponine I and NT-proBNP in evaluation of 

potential cardiotoxicity of Trastuzumab in patients with HER2 positive breast cancer P1443 

Z. Zdrale (Belgrade, Rs) 

Cardioprotective effects of seapolynol (polyphenol purified from ecklonia cava) 

against adriamycin-induced cardiomyopathy in an animal rat model P1444 

H.K. Jeon, d.H. Lee, H.J. Youn, H.C. shin (Uijeonbu and seoul, KR; seatle, Us) 

Global longitudinal strain is an early marker of systolic dysfunction during anticancer 

therapy P1445 

Y. Vasyuk, e. shkolnik, V. Nesvetov, L. shkolnik, G. Varlan (Moscow, RU) 

Predictors of cardiotoxicity in breast cancer: value of speckle-tracking analysis P1446 

A. Magalhaes, N. Cortez-dias, d. silva, M. Menezes, L. santos, A.L. Costa, A.R. sousa, 

L. Costa, A. Nunes diogo, M. Fiuza (Lisbon, PT) 

Clinical - Cardiomyopathy 

Echocardiographic particle image velocimetry in diastolic dysfunction due to 

hypertrophic cardiomyopathy P1447 

C. Prinz, R. Lehmann, B. Jurczak, F. Van Buuren, N. Bogunovic, d. Horstkotte, L. Faber 


The left atrial phasic functions and the relationship with plasma n-terminal pro-b-type 

natriuretic peptide in patients with hypertrophic cardiomyopathy P1448 

K.A.M.I.L. Tuluce, s.e.L.C.e.N. Yakar Tuluce, O.G.U.Z. Yavuzgil, e.L.N.U.R. Isayev, 

s.A.N.e.M. Nalbantgil, F.I.L.I.Z. Ozerkan (Izmir, TR) 

Signal averaged electrocardiogram and risk stratification in hypertrophic 

cardiomyopathy: how useful? P1449 

C.e. Correia, d. Moreira, C. Cabral, O. santos, J.s. Cardoso (Viseu and Porto, PT) 

Increased circulating mesencymal stem cells in patients with hypertrophic 

cardiomyopathy: correlation with left ventricular mass index P1450 

M. Marketou, F. Parthenakis, N. Kalyva, C.H. Pontikoglou, s. Maragkoudakis, e. Zacharis, 

A. Patrianakos, e. Papadaki, P. Vardas (Heraklion, GR) 

Serum levels of BNP in hypertrophic cardiomyopathy: correlation with symptoms, 

image findings and biomarkers of fibrosis P1451 

A. Lebreiro, e. Martins, I. Falcao-Pires, T. Pinho, A. Madureira, A. sousa, M. Campelo, 

s. Amorim, J. silva-Cardoso, M.J. Maciel (Porto, PT) 

161 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Genotype-phenotype correlation in hypertrophic cardiomyopathy P1452 

A. Castella, R. spoladore, R.d.amato, s. Benedetti, C. di Resta, M. Ferrari, I. Olivotto, 

P.G. Camici (Milan and Florence, IT) 

Dilated cardiomyopathy in Becker Muscular Dystrophy (a case report) P1453 

P.C. Ines, J.d.A. Magno, R.C. Manuel, A.V. Aquino (Quezon city, PH) 

Diagnosis of dilated cardiomyopathy. Results of the registry of dilated cardiomyopathy 

in the Russian Federation. P1454 

e. Alaeva, s.N. Tereshchenko, O.Y. Narusov, A.G. Kochetov (Moscow, RU) 

Rosuvastatin in dilated cardiomyopathy: a double blind, randomised trial of efficacy 

and safety P1455 

K. Broch, e.T. Askevold, e. Gjertsen, R. Mo, W. stueflotten, J. Andreassen, R. svendsmark, 

s. Aakhus, P. Aukrust, L. Gullestad (Oslo, drammen and Trondheim, NO) 

Determinants of reverse remodeling in idiopathic dilated cardiomyopathy P1456 

s.M.R. Amorim, B. Moura, e. Martins, M. Campelo, T. Pinho, J. silva-Cardoso, M.J. Maciel 

(Porto, PT) 

Evolution of left ventricular sphericity index in Idiopathic Dilated Cardiomyopathy: 

clinical and prognostic implications P1457 

d. stolfo, M. Merlo, B. Pinamonti, G. Barbati, A. di Lenarda, G. sinagra (Trieste, IT) 

Prognostic value of plasma protein levels for the recovery of LVEF in patients suffering 

from DCM P1458 

C. Pop, K. Weitmann, M. Feig, N. Jehmlich, V. dhople, s. Felix, U. Volker, F. Loghin, 

e. Hammer (Cluj-Napoca, RO; Greifswald, de) 

Eficacy and safety of ivabradin treatment in patients with dilated cardiomyopathy P1459 

s.H. Chumburidze, L. Khosroshvili, G. shelia (Tbilisi, Ge) 

Longitudinal development of left ventricular diastolic dysfunction in patients with type 

2 diabetes P1460 

L. Venskutonyte, C. Jarnert, L. Ryden, B. Kjellstrom (stockholm, se) 

Evaluation of myocardial gadolinium kinetics at magnetic resonance imaging for the 

diagnosis of cardiac amyloidosis P1461 

N.R. Pugliese, A. del Franco, A. Barison, A. Giannoni, G. Vergaro, M. Lombardi, 

M. emdin, G.d. Aquaro (Pisa, IT) 

Effect of heart rate control on mortality in patients with heart failure P1462 

e.W. Alameen, I. Farah, A. Tayiem, M.B. Bdeir (Riyadh, sA) 

Impact of chemotherapy with anthracyclines in systolic and diastolic left ventricular 

function in patients with breast cancer P1463 

N. Marques, N.Tavares, I. Jesus (Faro, PT) 

Spironolactone in patients with heart failure: friend or foe? P1464 

M. Khateeb, T. Conboy, M.B. Bdeir (Riyadh, sA) 

Survival of patients with Chagas versus non Chagas Cardiomyopathy in a heart failure 

clinic P1465 

F.d.C. Cruz, J.P. escalante, s.F. Ayub, V.s. Issa, F. Bacal, e.A. Bocchi (sao Paulo, BR) 

Relationships between T- wave alternation, ventricular tachyarrhythmias and left 

ventricular reverse remodeling in patients with dilated cardiomyopathy after cardiac 


T. Vaikhanskaya, I. sidorenko, L. Gul, A. Makeyeva (Minsk, BY) 

The thyrotoxic cardiomyopathy. Problems in diagnosis, treatment and prevention P1467 

I.Tudose (Chisinau, Md) 

162


Effects of hypoxic adaptation on the exercise intolerance and the adaptation reserves 

level in patients with ischemic cardiomyopathy P1468 

T. dubovik, L. Gelis, L. Rachok (Minsk, BY) 

Cardiopulmonary exercise testing in idiopathic dilated cardiomyopathy: influence of 

diastolic disfunction and tissue doppler imaging parameters P1469 

e. Zambon, A. Iorio, e. Berton, C. Carriere, A. Pantano, G. Barbati, M. Bobbo, e. Abate, 

A. di Lenarda, G. sinagra (Trieste, IT) 

Prevalence of anemia in a Saudi population with CHF P1470 

R. Odeh, d.R. Bdeir, T. Conboy (Riyadh, sA) 

Hypertrophic cardiomyopathy and Noonan Syndrome: an association to remember P1471 

C. sousa, e. Martins, A. sousa, B. Moura, I. Rangel, M. Campelo, s. Amorim, 

J. silva Cardoso, M.J. Maciel (Porto, PT) 

Coronary microvascular dysfunction in patients with advanced liver cirrhosis: the 

missing piece of the puzzle for understanding cirrhotic cardiomyopathy? P1472 

G. Famoso, e. Ferrazzi, M. senzolo, G. segato, F. Folino, s. Tellatin, P. Burra, P. Angeli, 

s. Iliceto, F. Tona (Padova, IT) 

Anti-inflammatory approach for treatment of viral induced cardiomyopathy P1473 

A.M. saleh, M. Haykal, H. Negm, M. shalaby, M. Fayez, A. Matsumori (Coburg, de; 

Cairo, eG; Tokyo, JP) 

Do the women with left breast cancer undergoing combined treatment with 

chemotherapy and radiation have a worse systolic or diastolic left ventricular function? P1474 

N. Marques, N. Tavares, I. Jesus (Faro, PT) 


Incremental prognostic role of renal arterial resistance index as marker or renal 

dysfunction in heart failure outpatients P1475 

A. doronzo, M.M. Ciccone, M. Iacoviello, A. Puzzovivo, F. Monitillo, V. Antoncecchi, 

G. Citarelli, V. Paradies, N. Corrieri, s. Favale (Bari, IT) 

The relationship of cardiac structure, diastolic and systolic function with glomerular 

filtration rate and urinary albumin excretion in chronic heart failure P1476 

e. Reznik, G.e. Gendlin, G.I. storozhakov (Moscow, RU) 

The prognostic implications of vascular access methods for chronic intermittent 

ultrafiltration, in end-stage heart failure patients with cardiorenal syndrome P1477 

e. Repasos, J. Terrovitis, e. Kaldara, A. Ntalianis, M. Marougas, C. Kapelios, V. sousounis, 

T. sfakianaki, J. Boletis, J. Nanas (Athens, GR) 

Cardio-renal anaemia syndrome in an internal medicine department P1478 

C. Goncalves, M. silva, s. Guerreiro Castro, R. Martins, F.G. Magalhaes, A.M. Antunes, 

H. Gruner, M. Ventura, V. Riscado (Lisbon, PT) 

Cardiorenal syndrome- when markers crossroad P1479 

M. Teodoru, I. Manitiu, A. Teodoru (sibiu, RO) 

Lose of independence of chroninc kidney disease in extreme heart failure patients: 

a prospective observation study in CGMH heart failure center P1480 

M.H. Lin, C.H. Yu (Taoyuan, TW) 

The cardio renal syndrome: a Moroccan experience for risk factors and prognostic P1481 

H. Benhalla, H. Najih, R. Habbal (Casablanca, MA) 

Endothelial dysfunction is associated with the cardiorenal syndrome in Asian patients 


s.L. Lim, R.W.O.N.G. R santhanakrishnan T P Ng, P.s.d. Yeo, d.s.I.M. F Jaufeerally, 

G. Leong, H.Y. Ong, P.C.H.A.I. A Low, L.H. Ling, A.M. Richards, C.s.P. Lam (singapore, sG) 

163 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Epidemiological characteristics of patients with heart failure and cardio-renal anemia 

association. P1483 

J. Ramirez, C. saldarriaga, N. Gonzalez-Jaramillo (Medellin, CO) 

Plasma Neuthrophil Gelatinase associated Lipocalin (NGAL) predict worsening renal 

function and outcome in patients with acute decompensated heart failure P1484 

M. Beltrami, A. Palazzuoli, G. Ruocco, M. Pellegrini, B. Franci, C. Ronco, R. Nuti (siena 

and Vicenza, IT) 

Effects of plasma contraction on changes in the serum creatinine concentration under 

conventional therapy for worsening of heart failure P1485 

H. Kataoka (Oita, JP) 


Geographical variation in the prevalence and severity of anaemia in PARADIGM-HF. P1486 

J.J.V. Mcmurray, M. Packer, J. Gong, M. Lefowitz, A.R. Rizkala, J.L. Rouleau, V.C. shi, s.d. 

solomon, K. swedberg, M.R. Zile (Glasgow, GB; dallas, east Hanover, Boston 

and Charleston, Us; Montreal, CA; Gothenburg, se) 

Changes of the cerebral cortex of the patients with chronic heart failure P1487 

N.s.A. Akimova, Y.G.s. shvarts, T.V.M. Martynovich (saratov, RU) 

Pulse-transit-time derived blood pressure monitoring: validation in heart failure 

patients undergoing adaptive servoventilation therapy P1488 

J. spiesshoefer, J. Heinrich, T. Bitter, d. Horstkotte, O. Oldenburg (Bad Oeynhausen, de) 

Depression, anxiety and health-related quality of life in heart failure patients: 

a pilot study P1489 

V. Pelaez-Hernandez, J.I.A. Orea-Tejeda, C. Figueroa-Lopez, L. Castillo-Martinez, 

G. Pena-Popoca, Y. Lopez-Rodriguez, L. Tellez-Olvera, A. Montanez-Orozco, 

G. Orti-suarez, A. delgado-Perez (Mexico, MX) 

Epicardial fat as early vascular damage predictor in patient with metabolic syndrome P1490 

J. drapkina (Moscow, RU) 

Periodic limb movements and arterial stiffness in moderate-to-severe heart failure P1491 

L. Korostovtseva, Y.U. sviryaev, e. Moguchaya, Y.U. sazonova, K. Malikov, N. Zvartau, 

A. Kozlenok, s. Kozlova, A. Konradi, e. shlyakhto (st. Petersburg, RU) 

Sleep apnea prevalence in acute myocardial infarction patients with preserved left 

ventricular systolic function and systolic dysfunction P1492 

O. Ludka, R. stepanova, M. Vyskocilova, L. Galkova, M. Mikolaskova, M. Belehrad, 

J. Kostalova, T. Mikusova, T. Kara, J. spinar (Brno, CZ; Minnesota, Us) 

Treating iron deficiency in heart failure evaluation (TIDE-HF) P1493 

d. Hipperson, s. Piper, N. Chanakira, J. decourcey, C. Plymen, G. Amin-Youssef, 

T. Mc donagh (London, GB) 

The prevalence of anemia in chronic heart failure and associated factors P1494 

M. Lezha, A. Gjata, e. Petrela (Tirana, AL) 

Bone mineral density in chronic heart failure patients P1495 

V.N. Larina, B.B. Bart, T.N. Raspopova (Moscow, RU) 

Impact of diastolic dysfunction in patients with myocardial infarction with ST elevation P1496 

e. Cambronero Cortinas, M.J. Corbi Pascual, J.M. Jimenez Mazuecos, A. Gomez Perez, 

M. Barambio Ruiz, J.G. Cordoba soriano, d. Prieto Mateos, J. Cuartero Navarro, 

F.M. salmeron Martinez (Albacete, es) 

Clinical characteristics and outcomes of patients with heart failure hospitalized in 

a university emergency hospital P1497 

C.C. diaconu, L.A. Balaceanu, B. Paraschiv, e. Badila, d. Bartos (Bucharest, RO) 

164


Association of gender based difference with heart failure outcome in patients with 

heart failure and anemia P1498 

N. Haq, s.M. Mukharjee, A.C. Chibungu, R.Z. Ziegelstein (Baltimore, Us) 

Prevalence of pre-diabetes among non diabetic heart failure patients. P1499 

M. Mohan, C. Lang (dundee, GB) 

Relation of iron deficiency and exercise tolerance in asian heart failure patients with 

reduced ejection fraction P1500 

R.C.C. Wong, T.J. Yeo, A.M. Richards, d. sim, d. Yeo, F.R. Jaufeerally, P. Chai, G. Leong, 

H.Y. Ong, C. Lam (singapore, sG) 

Exercise capacity in patients with heart failure and COPD P1501 

B. diaz Molina, M. Iscar, J.L. Lambert, C.A. Quezada, A. Renilla, e. Benito, s. secades, 

M.J. Bernardo (Oviedo, es) 

Haemoglobin deficit versus glomerular filtration rate: the better predictor of mortality 

in patients admitted with decompensated heart failure. P1502 

G. doolub, J. dwight (Oxford, GB) 

Parameters of cardiac function in cardiac cachexia: are we aware of right heart failure? P1503 

M. Valentova, s. Von Haehling, C. Krause, N. ebner, T. Bekfani, W. doehner, J. Murin, 

s.d. Anker, A. sandek (Berlin, de; Bratislava, sK) 


Left ventricular systolic and diastolic functions in subjects with a bicuspid aortic valve 

without significant valvular dysfunction P1504 

M. demir (Bursa, TR) 

Single center experience with percutaneous edge-to-edge mitral valve repair in high 

risk patients P1505 

T. sturmberger, C. ebner, H.J. Nesser (Linz, AT) 

Acute heart failure in the pregnant patient with a mechanical valve prosthesis: 

characteristics and outcome in a tertiary care Tunisian hospital P1506 

A. Tounsi, dorra Abid, Leila Abid, Nizar Ketata, Feten Triki, Malek Akrout, souad Mallek, 

Mourad Hentati, samir Kammoun (sfax, Tn) 

Long-term prognosis of patients with infectious endocarditis: a 12-year longitudinal 

study P1507 

P. Carrilho-Ferreira, J. Rodrigues dos santos, A. Magalhaes, C. Jorge, R. Placido, 

M. Nobre Menezes, d. silva, M.J. Metrass, M.G. Lopes, A. Nunes diogo (Lisbon, PT) 

Predictors of in-hospital mortality in patients with infectious endocarditis: a 12-year 

longitudinal study P1508 

P. Carrilho-Ferreira, J. Rodrigues dos santos, N. Cortez-dias, C. Jorge, A. Magalhaes, 

R. Placido, A.R. Ramalho, M.J. Metrass, M.G. Lopes, A. Nunes diogo (Lisbon, PT) 

Single center experience with the mitraclip system in patients after cardiac 

resynchronization therapy and persistent significant mitral regurgitation and heart 

failure symptoms P1509 

C. ebner, T. sturmberger, W. Tkalec, J. Aichinger, H.J. Nesser (Linz, AT) 


MRI assessment of mechanical dyssynchrony in patients with heart failure and narrow 

QRS P1510 

s. Amraoui, M. sohal, Z. Chen, e. sammut, P. Bordachar, A. Rinaldi, G. Carr-White 

(Bordeaux-Pessac, FR; London, GB) 

165 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Predictors of super-response to cardiac resynchronization therapy P1511 

N. Cabanelas, M. Oliveira, M. Nogueira da silva, P.s. Cunha, J. Feliciano, B. Valente, 

A. Lousinha, s. santos, R. Ferreira (santarém and Lisbon, PT) 

Emprovement of left and right ventricular function in patients with cardiac 


G. savenkova, s. Krivolapov, s. Popov (Tomsk, RU) 

Subjective and objective diagnostic parameter correlation in patients 12 months after 

cardiac resynhronization therapy P1513 

M.V. Vikmane, O.s. semjonova, A.L. Lejnieks, O.K. Kalejs (Riga, LV) 

Resynchronization with left ventricular pericardial electrode - is it clinically superior 

and better at improving ejection fraction? P1514 

M. Fernandes, V.H. Pereira, V. sanfins, V. Monteiro, B. Rodrigues, F. Canario-Almeida, 

J. Portugues, I. Quelhas, P. Pinho, A. Lourenco (Guimaraes and Porto, PT) 

Influence of chronic renal failure in reverse remodeling and prognosis of patients 

undergoing cardiac resynchronization therapy P1515 

B. Picarra, M.J. Ferreira, N. Cabanelas, A.R. santos, B. Valente, M. Oliveira, P. Cunha, 

M.N. silva, s. santos, R. Ferreira (Évora, Lisbon and santarem, PT) 

Cardiac resynchronization therapy with or without an implantable cardioverterdefibrillator: 

an insight from real world patients. P1516 

M. santos, d. Anjo, P. Rodrigues, M.J. sousa, B. Brochado, P. Vieira, C. Roque, V. Lagarto, 

s. Cabral, s. Torres (Porto, PT) 

CRT and atrial fibrillation: 3- year follow-up P1517 

V. Lebedeva, T. Lubimceva, M. Trukshina, d. Lebedev (st. Petersburg, RU) 

CRT-D: what about renal function, ventricular arrhythmias and worsening heart failure? P1518 

P. Giordano, C. Alderighi, M.R. Ferraro, N. scelza, T. Cellamaro, M. Lancioni, L. Rondinini, 

R. Mariotti (Pisa, IT) 

Cardiac Resynchronization Therapy in heart failure patients with atrial fibrillation: is it 

worth it? P1519 

P. Rodrigues, C. Roque, d. Anjo, M.J. sousa, B. Brochado, M. santos, A. Pinheiro-Vieira, 

H. Reis, V. Lagarto, P. Palma (Porto, PT) 

Effect of persistent renal impairment on mortality in cardiac resynchronization therapy 

patients with nonischemic heart failure P1520 

K. Tsukamoto, A. suzuki, T. shiga, K. Arai, K. ejima, T. suzuki, T. Manaka, K. Ashihara, 

M. shoda, N. Hagiwara (Tokyo, JP) 

Myocardial dyssynchrony at patients with heart failure: features of development and 

correction P1521 

A.I. Chesnikova, A.Y. Fishman (Rostov-on-don and Moscow, RU) 

Which parameters can predict worsening in heart failure in patients with home 

monitoring? P1522 

B. Urbanek, M. Chudzik, J.K. Wranicz (Lodz, PL) 

Non invasive detection of haemodynamic effects of environmental temperature in 

chronic heart failure. HeartCycle (FP 216695) European union 7th framework 

programme P1523 

T. Mabote, A. Torabi, R. Antony, R. dierckx, A. shoaib, s. Parsons, B. dicken, P. Pellicori, 


Prevention of heart failure with telemedicine P1524 

G. Vasoncelos, M.e.J. Camargo, L.R. Oliveira (Fortaleza, BR) 

166


Predictive value of future ventricular arrhythmic risk in patients with chronic heart 

failure from annual remote telemonitoring P1525 

J.A. Richardson, C. Hayward, A. Khanna, O. Williams, V. Markides, T. Wong, R.K. sharma, 

J.R. Clague, M.R. Cowie, A.R. Lyon (London, GB) 

Implantation of continuous-flow left ventricular assist devices: analysis of 42 patients 

with INTERMACS profiles 1-4 P1526 

A. Medressova, M. Murzagaliyev, R. Kaliyev, R. salov, N. smagulov, s. dzhetybayeva, 

s. Andossova, Y. Kuatbayev, s. Bekbossynov, Y. Pya (Astana, KZ) 

Detection of regional myocardial functions by echocardiography may contribute 

to the differential diagnosis of right ventricular dysfunction occurring during LVAD 

optimization P1527 

N. Arat Koc, e. Pektok, T. demirozu, C. Ciftci, N. Yazicioglu, s. Kucukaksu (Istanbul, TR) 

Extended biventricular assist device support as a bridge to heart transplantation in a 

low organ donation environment. A single centre experience P1528 

A. Gkouziouta, G. Karavolias, N. Kogerakis, L. Louca, P. sfirakis, s. Adamopoulos 

(Athens, GR) 

Immediate postoperative hemodynamic predictors of right ventricular failure after 

HeartMate II implantation P1529 

J. Cordtz, J.C. Nilsson, P.B. Hansen, K. sander, P.s. Olsen, s. Boesgaard, F. Gustafsson 

(Copenhagen, dK) 

Neurohormone kinetics in patients after planned and emergency VAD implantation P1530 

N. Maroz-Vadalazhskaya, I. Russkikh, M. Kaljadka, Y. seljun, d. Krachak, Y. Ostrovski 

(Minsk, BY) 

Increasing pump speed during exercise improves peak oxygen consumption in heart 

failure patients supported with continuous-flow left ventricular assist device- a doubleblind 

randomized study. P1531 

M. Holme Jung, P.B. Hansen, K. sander, P.s. Olsen, s. Boesgaard, K. Rossing, 

F. Gustafsson (Copenhagen, dK) 

The use of dabigatran etexilate as first line anticoagulation therapy in patients with a 

left ventricular assist device P1532 

C. Kapelios, J. Terrovitis, e. Kaldara, A. Ntalianis, V. sousounis, M. Tsamatsoulis, s. Vakrou, 

L. Katsaros, C. Charitos, J. Nanas (Athens, GR) 

Ventricular arrhythmia, ICD therapy and sudden cardiac death among patients with 

CRT from CuBIC Registry P1533 

Y. Okamoto, s. Fujii, H. Tasaka, K. Inoue, K. Ando, K. Kadota, T. Kimura, T. Isshiki, 

K. Mitsudo, M. Nobuyoshi (Okayama, Osaka, Kokura, Kyoto and Tokyo, JP) 

Non-invasive monitoring of patients with heart failure by objective indices of dyspnea P1534 

s. Rispler, Y. Tsibulsky, H. Hammerman, A. Landesberg (Haifa, IL) 

Pacemakers patients perception of daily life activities and medical follow up a French 

survey P1535 

W. Amara, s. Chaggour, H. salih, A. el Hraiech, J. Taieb, G. Glerici, F. Guennem, 

A. dompinier, B. Lahitton, K. Gacem (Montfermeil, Avignon, Aix en Provence, 

st Pierre, Chateauroux, Annecy, dax and Cholet, FR) 


Heart failure in native valve infective endocarditis: prognosis and results after surgical 

treatment P1536 

B. Obrenovic-Kircanski, B. Parapid, R. Karan, N. Kovacevic-Kostic, G. stojanovic, 

M. Velinovic, M. Vranes, P. djukic (Belgrade and Arandjelovac, Rs) 

167 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Prevention of heart failure by coronary artery bypass grafting in patients with 

previous myocardial infarction P1537 

s. Petrovic-Nagorni, s. Ciric-Zdravkovic, d. stanojevic, M. Pavlovic, M. Zivkovic, 

s. Apostolovic, G. Koracevic, s. dakic (Nis, Rs) 

EuroSCORE in patients with preoperative heart failure P1538 

B. Mihajlovic, N. Cemerlic-Adjic, s. Nicin, K. Pavlovic, s. dodic, B.B. Mihajlovic, 

M. Cankovic, L. Velicki, M. Fabri (sremska Kamenica, Rs) 

Surgical restoration of dyskinetic anteroapical left ventricular aneurysm supported 

with multi-slice computed tomography: update of single center experience P1539 

N. solowjowa, A. Penkalla, M. dandel, M. Pasic, R. Hetzer, C.H. Knosalla (Berlin, de) 


Lowering pulmonary wedge pressure after heart transplantation: the effect on 

pulmonary arterial compliance and resistance P1540 

R. Baptista, s. Costa, F. Franco, L. Goncalves, d. Prieto, M. Baptista, e. sola, M. Pego, 

M. Antunes (Coimbra, PT) 

Interplay between pulmonary iypertension and donor-recipient matching in the risk 

for early mortality and complications after heart transplantation P1541 

V. Manfredini, L. Potena, C. Lonetti, M. Masetti, s. Martin-suarez, F. Coccolo, F. Grigioni, 

C. Rapezzi, A. Branzi, G. Arpesella (Bologna, IT) 

TPMT heterozygote heart transplant recipients treated with azathioprine are at an 

increased risk for rejection (w) P1542 

J. Liang, J. Geske, B. Boilson, W. Kremers, R. Weinshilboum, N. Pereira (Rochester, Us) 

Predictors of unfavorable prognosis after orthotopic heart transplantation P1543 

e.d. Kosmacheva, N.V. Kizhvatova, e. Gordeeva, V.A. Porhanov, M.R. Bahchoyan 

(Krasnodar, RU) 

Allograft pathology in patients transplanted in a reference center, including cases of 

Chagas cardiomyopathy P1544 

J.d. souza, A.F. Torres, J.A. Mejia, J.R. Fernandes, G.G. Vasconcelos, V. Pessoa, F. Tavora 

(Fortaleza, BR) 

Analysis of survival time and etiologies of base disease in recipients of heart transplants P1545 

F.d.C. Cruz, A.C.A. Nussbaum, V.s. Issa, s.F. Ayub, P. Chizzola, G.e. Conceicao, F. Bacal, 


Significance of BNP examination in adult patiens with transposition of great arteries 

(TGA) after Mustard or Senning correction in the childhood reffered as heart 

transplant candidates. P1546 

M. Hegarova, A. Jabor, J. Vrbska, Z. dorazilova, J. Pirk, I. Malek (Prague, CZ) 

Characteristics of patients in the wait list for heart transplantation at a hospital in Sao 

Paulo, during the past 19 years P1547 

F.d.C. Cruz, A.C.A. Nussbaum, A.I. Fiorelli, F. Bacal, e.A. Bocchi (sao Paulo, BR) 

Heart transplantation and metabolic syndrome: which calcineurin inhibitor most 

promotes its development? P1548 

L. Martinez-dolz, d. domingo Valero, I. sanchez-Lazaro, L. Almenar-Bonet, 

R. Lopez-Vilella, M. Portoles-sanz, e. Rosello-Lleti, M. Rivera-Otero, A. salvador-sanz 

(Valencia, es) 

Psychosocial stress at time of wait listing is associated with worse survival after heart 

transplantation in high urgency status P1549 

H. spaderna, K. Gali, L. Rausch, J.M.A. smits, G. Weidner (Mainz, de; Leiden, NL; 

san Francisco, Us) 

168


Effects of donor pretreatment with norepinephrine on heart transplant recipients 

survival. P1550 

F.d.C. Fatima das dores Cruz, V.s.I. Victor sarli Issa, s.A.F. silvia Ayub Ferreira, 

G.e.C. Germano emilio Conceicao, F.B. Fernando Bacal, R. Honorato, A.I. Fiorelli, 



Efficiency of 9-component heart failure rehabilitation program on exercise capacity 

and 3-year survival of heart failure patients P1551 

T. Lelyavina, M.Y.U. sitnikova, e.V. shlyakhto (st. Petersburg, RU) 

Impact of a community-based heart failure unit on hospitalizations P1552 

J.M. Weinstein, V. Amitai, Y. stanovsky, O. slutzky, d. Cohen (Beer sheva, IL) 

The rate of use of b-blockers in a tertiary care heart failure clinic in Saudi Arabia P1553 

A. elasfar, K.F. Alhabib, W. Alshaghaa, R. Bahmaid, Z. Alharfi, M.A. Youssef (Riyadh, sA) 

Heart failure - after discharge reassessment and care: 2 years results P1554 

M. Miranda, C. Guedes, R. simoes, e. sousa, L. Tavares (santa Maria da Feira, PT) 

Heart failure - clinical outcomes of an outpatient clinic P1555 

M. Miranda, C. Guedes, R. simoes, e. sousa, L. Tavares (santa Maria da Feira, PT) 

Coronary revascularization in patients with chronic heart failure but without angina, 

real world experience P1556 

L. Vandor, K. Heltai, I. simon, B. Merkely (Budapest, HU) 

Clinical process maturity assessment for structured improvement of heart failure care 

in a tertiary-care hospital in Germany P1557 

N. stephan, P. Fischer, M. Pauschinger (erlangen and Nuremberg, de) 

Device-related complications in patients with cardiac resynchronization therapy and 

cardioverter defibrillators: experience of a center P1558 

B. Brochado, P. Rodrigues, d. Anjo, M. santos, M.J. sousa, P. Vieira, V. Lagarto, H. Reis, 

H. Carvalho, s. Torres (Porto, PT) 

National heart failure registry: effect of the patient observation, monitoring and 

education on clinical and economical outcomes. P1559 

J. Begrambekova, V.U. Mareev, M. danielan (Moscow, RU) 

Physical fitness matters more than physical activity in controlling cardiovascular 

disease risk factors P1560 

B. sassen (Utrecht, NL) 


Guideline adherence in CHF: does dosage matter? Data from the Austrian Heart 

Failure registry (HIR-Austria) P1561 

G. Poelzl (Innsbruck, AT) 

Cardioprotector impact on quality of life of women with chronic heart failure and 

coronary heart disease P1562 

A. Koryagina (Perm, RU) 

Application of losartan for prevention of tubuloepithelial renal desorders in patients 


U. Kamilova, Z. Rasulova, I. Alikulov (Tashkent, UZ) 

Effects of serial Levosimendan infusions on global ventricular arrhythmic burden in 

patients with advanced heart failure P1564 

P. Jorge Perez, M.J. Garcia Gonzalez, J.J. Ferrer-Hita, A. Rodriguez Gonzalez, M. Cordero, 

R. Juarez Prera, M. Padilla Perez, e. Gonzalez Cabeza (s. Cristóbal de La Laguna - Tenerife, es) 

169 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Heart rate reduction with ivabradine and the Nt-ProBNP short-term variation in 

systolic heart failure outpatients P1565 


Influence of metabolic therapy with Mildronat on left and right ventricular function 

(tissue doppler study) P1566 

M. Tsverava (Tbilisi, Ge) 

Clinical characteristics and outcomes of young and very young adults with heart 

failure: the CHARM programme P1567 

C. Wong, N.M. Hawkins, P. Jhund, s.d. solomon, C.B. Granger, s. Yusuf, M.A. Pfeffer, 

K. swedberg, M.C. Petrie, J.J.V. Mcmurray (Glasgow and Liverpool, GB; Boston and 

durham, Us; Hamilton, CA; Gothenburg, se) 

Effectiveness of growth hormone in patients with dilated cardiomyopathy P1568 

s.I. Ismailov, B.U. Mardanov, B.e. Nazarova, T.A. Abdullaev, I.A. Choi (Tashkent, UZ) 

How many patients with systolic heart failure patients have an indication for 

ivabradine? P1569 

G. Balestrieri, K. Russell, N. Mcinnes, J.J.V. Mcmurray (Glasgow, GB) 

A double-blind randomized placebo pilot study comparing aggrenox versus placebo 

in heart failure patients (ASAP-HF trial) P1570 

P.-Y. Liu, Y.-H. Li, J.-H. Chen, L.-M. Tsai, J.-K. Liao (Tainan, TW; Chicago, Us) 

Target dose of neurohormonal antagonists are related to lower readmission rate and 

reduced hospital stay in elderly patients with heart failure P1571 

M.M. Baluta, A.d. Mateescu, M.M. Vintila (Bucharest, RO) 

Perhexiline improves functional outcome in patients with refractory angina and heart 

failure P1572 

e.s.P. Lee, L. edmunds, A.G. Fraser, Z. Yousef (Cardiff, GB) 

Effect of antiplatelet therapy on the immunity in heart failure in patients with 

rheumatic heart disease P1573 

R. Gazizov, e.A. Azel, N.I. Beilina, N.s. Volchkova, N.A. Klimova (Kazan, RU) 

Early effects of ivabradine in combination with bisoprolol versus bisoprolol uptitration 

on central hemodynamics assessed by applanation tonometry and left ventricular 

function in chronic CAD patient P1574 

K.M. Amosova, I.U. Rudenko, I. Katsytadze, A. Bezrodniy (Kyiv, UA) 

Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/ 

left ventricular dysfunction in the SHIFT trial P1575 

J.s. Borer, M. Bohm, I. Ford, M. Komajda, L. Tavazzi, K. swedberg, On Behalf Of shift 

Investigators (Brooklyn and New York, Us; Hamburg, de; Glasgow, GB; Paris, FR; 

Cotignola, IT; Gothenburg, se) 


Beta-blocker prevents in-hospital mortality in elderly patients with acute 

decompensated heart failure P1576 

s. sugihara, K. shirota, Y. Inoue, H. Ishii, F. Tunoda, A. Mimura, N. Mukai (Matue city, JP) 

Prognosis in advanced heart failure is related to betablocker doses P1577 

A.C. Pereira Barretto, d.s.B. Melo, C.H. del Carlo, J.N. Cardoso, M.e. Ochia, 

P.C. Morgado, R.T. Munhoz (sao Paulo, BR) 

Influence of different beta-blockers on NO metabolism in the ischemic heart failure 

patients with implanted cardiac pacemakers P1578 

T. Turovska, V.B. Kostogryz, L.I. Kardashevska, V.V. Adarichev (donetsk, UA) 

170



Cost effectiveness of zofenopril in patients with left ventricular systolic dysfunction 

after acute myocardial infarction: a post- hoc analysis of the SMILE-4 study P1579 

C. Borghi, e. Ambrosioni, s. Omboni, A.F.G. Cicero, s. Bacchelli, d. degli esposti, s. Novo, 

d. Vinereanu, G. Ambrosio, d. Zava (Bologna, solbiate Arno, Varese, Palermo, Perugia 

and Peschiera Borromeo, IT; Bucharest, RO) 

Exercise-induced ventricular arrhythmias in congestive heart failure and role of ARB P1580 

M. Barman, G. Koshy (doha, QA) 


Independent determinants for presence and degree of left ventricular systolic 

dyssynchrony in treatment-naive patients with hypertension P1581 

B.-J. Kwon, d.B. Kim, s.W. Jang, s.H. Ihm, H.Y. Kim, H.J. Youn, K.B. seung, J.H. Kim 

(seoul, KR) 

Behaviour of hemodynamic parameters in non-ischemic dilated cardiomyopathy 

patients in 2.5 long follow-up P1582 

W. Jachec, C. Wojciechowska, A. Tomasik, A. Gala, K. Krzemien-Wolska, d. Kawecki, 

G. Kubiak, e. Nowalany-Kozielska (Zabrze, PL) 

Genetic polymorphisms in coronary heart disease: clinical, angiographic and 

long-term follow-up evaluation in patients submitted to coronary percutaneous 

intervention. P1583 

I.P. Borges, R. Andrade, e.C.s. Peixoto, R.T.s. Peixoto, V.F.M. Marcolla (Rio de Janeiro, BR) 

Non-Invasive evaluation of vascular function in patients with heart failure. A report 

from SICA study. P1584 

F. Yassin, A. Joseph, P. Pellicori, T. Mabote, B. dicken, H. Al-Chamali, s. Rimmer, M. Ali, 

s. smith, J. Gf Cleland (Hull, GB) 

Cognitive dysfunction in relation to endothelial function, structural changes of large 

vessels and left ventricular function in patients with chronic heart failure P1585 

A.A. shchendrygina, Y.N. Belenkov, e.Y. Privalova, N.A. Pavlov, e.A. Zheleznykh, 

Y.A. danilogorskaya (Moscow, RU) 

Expression of pro-inflammatory, angiogenic factors, and endostatin in patients with 

heart failure in different stages of collateral circulation development P1586 

M. Kobusiak-Prokopowicz, B. Jolda-Mydlowska, T. Grzebieniak, K. Poczatek, A. Mysiak 

(Wroclaw, PL) 

Clinical -Metabolism/Diabetes mellitus 

History of diabetes mellitus type 2 and prognosis in acute heart failure with preserved 

ejection fraction. P1587 

A.P. Bohlen delgado, d. Moreira, B. Rodrigues, B. Marmelo, e. Correia, s. Nunes, 

P. Gama, O. santos (Viseu and Castelo Branco, PT) 

Influence of metabolic syndrome on myocardial infarction area, myocardial perfusions 

grade after PCI an in hospital-mortality in patients with acute coronary syndrome (ACS) P1588 

J. Gilis-Januszewski, K.-P. Mellwig, F. Van Buuren, T. Gilis-Januszewski, M. Moellenberg, 

M.-s. Hossain, B. Brockmeier, d. Horstkotte (Bad Oeynhausen, de) 

Can hyperglycemia predict adverse outcomes after hospitalization for an acute 

coronary syndrome? P1589 

A. Castro, A. Pereira, N. Moreno, R. santos, M.C. Queiros, P. Pinto (Penafiel, PT) 

Metabolic syndrome; the number of risk factors counts P1590 

A.M. saleh, W. sayed, M. shalaby, H. Negm, M. Haykal (Coburg, de; Cairo, eG) 

171 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Diastolic dysfunction an early manifestation of diabetic heart disease P1591 

e.R. Mustafa, O. Istratoaie, R. Musetescu, I. donoiu (Craiova, RO) 

Cardiac rehabilitation impact on metabolic profile after acute coronary syndrome P1592 

M.J. sousa, M. santos, P. Rodrigues, d. Anjo, B. Brochado, s. Viamonte, 

J. Preza Fernandes, J. silveira, J. Lopes Gomes, T. severo (Porto, PT) 


Assessing the normal heart/mediastinal I-123 meta-Iodobenzylguanadine (MIBG) 

ratios in neuroendocrine tumor patients without cardiac disease P1593 

R. Campeau, M.M. Chester, R.A. Beyl (New Orleans and New Orleans, LA, Us) 

Prevalence of atherosclerotic plaque in the carotid artery in a cohort of outpatients 


F. Ribeiro dias, R.C. Mendonca, L. Oliveira, L. Barros, M.A. Manhaes, M. Oliveira, 

M.L. Ribeiro, P.J. Camandaroba, R.F. Abreu, W.A. Martins (Niterói and Teresópolis, BR) 

Impaired left atrial function in heart failure with preserved ejection fraction: a speckle 

tracking echocardiography study P1595 

e. Kraigher-Krainer, d.K. Gupta, M.R. Zile, B. Pieske, A.A. Voors, M.P. Lefkowitz, 

M. Packer, J.J. Mcmurray, A.M. shah, s.d. solomon (Boston, Charleston, east Hanover 

and dallas, Us; Graz, AT; Groningen, NL; Glasgow, GB) 

Prognostic value of Iodine-123-Metaiodobenzylguanidine imaging in patients heart 

failure and severe left ventricular systolic dysfunction P1596 

P. Garcia-Gonzalez, O. Fabregat-Andres, P. Cozar-santiago, J. estornell-erill, 

B. Bochard-Villanueva, M. Ferrando-Beltran, N. Chacon, A. Quesada-dorador, 

R. Paya-serrano, F. Ridocci soriano (Valencia, es) 

Relationship between cardiac sympathetic activity (123I-MIBG) and appropriate ICD 

therapy P1597 

C. Gonzalez Canovas, M.T. Perez Martinez, L. Mohamed, F.J. Pastor Perez, 

I.P. Garrido Bravo, J. sanchez Mas, A. Lax Perez, M.C. Asensio Lopez, 

M.A. Claver Valderas, d.A. Pascual Figal (Murcia, es) 

Lung ultrasound for the evaluation of pulmonary congestion in heart failure 

outpatients: a comparison with clinical assessment, natriuretic peptides and 

echocardiography P1598 

M.H. Miglioranza, L. Gargani, R.T. sant'anna, M. Rover, V.M. Martins, A. Mantovani, 

e. Picano, R. sicari, R.A. Kalil, T.L. Leiria (Porto Alegre, BR; Pisa, IT) 

Prevalence of non-cardiac ultrasound pathologies in hospitalized male patients with 


L.A. Balaceanu, C.C. diaconu, G. Aron (Bucharest, RO) 

Prognostic value of left ventricular dyssynchrony assessed by ECG-gated Tc-99m 

tetrofosmin SPECT with phase analysis in patients with chronic kidney disease and 

narrow QRS. P1600 

H. Aoki (Ishikawa, JP) 

Intracoronary adenosine during primary PCI for ST-elevation myocardial infarction: 

does it offer better outcomes? P1601 

G. doolub, e. dall'armellina (Oxford, GB) 

Cardiac magnetic resonance imaging (CMRI) characteristics of different QRS 

morphologies in patients with suspected heart failure P1602 

P. Pellicori, A. Joseph, e. Lukaschuk, J. Zhang, N. sherwi, C. Bourantas, H. Loh, A.L. Clark, 


172


Obesity, physical activity, and baseline and longitudinal changes in cardiac geometry 

and function in adolescents and young adults - the Strong Heart Study P1603 

s. Jhamnani, A. Barac, H. Wang, N. shara, M. Roman, R. devereux, B. Howard 

(Washington and New York, Us) 

Determination of early cardiac deterioration in beta-thalassaemia major by 

echocardiography P1604 

O. Ozdogan, A. Alp, B. Atabay (Izmir and Aydin, TR) 

Correlation between left atrial deformation analysis by two-dimensional speckle 

tracking echocardiography and BNP levels in chronic heart failure P1605 

A. Malagoli, L. Rossi, M.F. Piepoli, G.Q. Villani (Piacenza, IT) 

Evaluation of pharmacological platelet inhibition using by multiplate electrode 

aggregometry and left ventricular systolic function parameters in patients with acute 


M. Isailovic-Kekovic, P. Kekovic (Prokuplje, Rs) 

Prognostic value of E/Ea ratio across the whole spectrum of acute heart failure patients P1607 

e. santas, J. Nunez, G. Minana, P. Merlos, L. Bondanza, C. Castillo, J. Mendez, 

B. Mascarell, s. Ventura, F.J. Chorro (Valencia, es) 

Echocardiographic assessment of left ventricular function in patients on chronic 

hemodialysis P1608 

P. Kekovic, M. Isailovic - Kekovic (Prokuplje, Rs) 

Hemodynamic evaluation in patients with acute myocardial infarction and its 

correlation with left ventricular remodeling P1609 

C.H. Xiu, L.F. Wang, Y.F. Gu, Z.Y. Cui (Harbin, CN) 

Assesment of reciprocal dependance of echocardiographic measurement markers in 

RV global and regional function P1610 

V.A. Andova, L.J.G.I. Georgievska-Ismail, e.s.K. srbinovska-Kostovska, P.Z. Zafirovska, 

M.M. Miletic (skopje, MK) 

Left ventricular remodeling, diastolic dysfunction and common carotid artery 

remodeling in patients with hypertension and obesity (w) P1611 

O. Gonchar (Kharkiv, UA) 

Relationship between Tissue Doppler (TD) parameters and renal function in elderly 


K.A. Bagrii, O.V. samoilova, O.A. Prikolota, L.s. Kholopov, e.V. schukina (donetsk, UA) 

Evaluation of right atrial longitudinal strain in patients with acute coronary syndrome 

with ST elevation P1613 

P. Zafirovska, A.V. Andova Valentina, G.I.L.J. Georgievska- Ismail Ljubica, 

M.M. Miletic Milena, s.K.e. srbinovska- Kostovska elizabeta (skopje, MK) 

Pulmonary artery systolic acceleration time in diagnosis of heart failure P1614 



Prognostic impact of NT-proBNP in patients with ST elevation myocardial infarction 

(STEMI): Relationship with infarct size and systemic inflammatory response P1615 

s. Madeira, H. dores, M. Castro, A. Tralhao, M. Carvalho, H. Vitorino, G. Cardoso, 

C. Aguiar, J. Ferreira, M. Mendes (Lisbon, PT) 

The averaged Nt-proBNP determined during clinical stability as a survival predictor in 

patients with systolic left ventricular dysfunction. 5 years of clinical follow-up. P1616 

L. sargento, s. Longo, M. satendra, N. Lousada, R. Palma dos Reis (Lisbon, PT) 

173 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Benefits of targeted therapy in patients with heart failure on biomarkers level P1617 

I. Petraskiene, A. Kavoliuniene, R. Grybauskiene (Kaunas, LT) 

NTproBNP is associated with myocardial injury and is an independent predictor of 

remodelling following ST-elevation myocardial infarction P1618 

N.A. Razvi, B. Grundy, L.L. Ng, G.P. Mccann, I.B. squire (Leicester, GB) 

Depletion of proBNP1-108 in HF patients prevents cross-reactivity with natriuretic 

peptides. Is it clinically relevant? P1619 

d. delseny, J.P. Cristol, A.M. dupuy, N. salvetat, C. Larue, d. Merle, J. Fareh, L. Guerrier, 

J.M. davy, F. Roubille (Montpellier and Marnes la vallée, FR) 

Cytokines level dynamic in the patients with acute coronary syndrome P1620 

s.A. Berns, e.A. shmidt, d.s. Zikova, O.L. Barbarash (Kemerovo, RU) 

Impact of physical training on exercise tolerance and inflammatory status in patients 

with heart failure: are there gender differences? P1621 

d. Marinkovic, M. deljanin-Ilic, V. Nikolic, s. Ilic, d. Petrovic, B. Ilic (Nis, Rs) 

Different kind of myocardial injury identified by cardiac troponin I and high-sensitivity 

troponin T implies additive prognostic value in chronic heart failure P1622 

e.R. Perna, M.L. Coronel, J.P. Cimbaro Canella, s.M. Macin, P. Acevedo, C. Gimenez, 

P. Barrios, J. escalante, M. Brizuela, B. Gonzalez Arjol (Corrientes, AR) 

Place of renal function markers (particularly Cystatin C) in predicting midterm 

functional symptoms in heart failure P1623 

W. selmi, s. Hamdi, M. Mosrati, s. Fendri, J. Walid, M. Chakroun, K. Ben Hamda, 

F. Maatouk (Monastir and sfax, TN) 

Reduction of plaque instability biomarkers decreased left ventricular dysfunction and 

readmission for heart failure in acute coronary syndromes P1624 

e. Bobescu, d. dobreanu, N. Aldulea, A. Covaciu (Brasov and Targu Mures, RO) 

Cystatin C versus NT-proBNP in heart failure prognostic evaluation P1625 

W. selmi, s. Hamdi, M. Mosrati, s. Fendri, W. Jomaa, M. Chakroun, K. Ben Hamda, 


Compared prognostic value of Cystatin C in heart failure with reduced versus 

preserved ejection fraction P1626 

W. selmi, s. Hamdi, M. Mosrati, s. Fendri, W. Jomaa, M. Chakroun, K. Ben Hamda, 


uric acid is a predictor of development of heart failure in acute coronary syndrome 

patients. P1627 

A. Fernandes, F.C. Caetano, I.A. Almeida, J.T. Trigo, P.M. Mota, A.L.M. Leitao Maques 

(Coimbra, PT) 

Prognostic value of proinflammatory markers in patients with ischemic chronic heart 

failure during one-year period P1628 

A. Berezin, A. Kremzer, T. samura, T. Berezina (Zaporozhye, UA) 

Minor increases of carbohydrate antigen 125 are associated with poor outcome in 

outpatients with heart failure P1629 

e.R. Perna, M.L. Coronel, J.P. Cimbaro Canella, s.M. Macin, G. Aristimuno, C. Burgos, 

e. Fernandez, L. Borgo, F. Medina, B. Gonzalez Arjol (Corrientes, AR) 

Classification and regression trees for long-term mortality risk stratification in heart 

failure using a combination of biomarkers P1630 

J. Lupon, M. de Antonio, A. Galan, M. domingo, R. Cabanes, L. Cano, e. Zamora, 

C. diez, R. Coll, A. Bayes-Genis (Badalona, es) 

174


Development of a novel heart failure risk score: the BCN Bio-HF calculator P1631 

J. Lupon, M. de Antonio, J. Vila, J. Penafiel, A. Galan, e. Zamora, A. Urrutia, B. Gonzalez, 

R. Cabanes, A. Bayes-Genis (Badalona and Barcelona, es) 

Is the endothelin-1/Nitric Oxide metabolites (NOx) ratio a useful predictor of positive 

clinical response to cardiac rehabilitation in patients with chronic heart failure? P1632 

B. Bacior, P. Rostoff, M. Wnuk, B. szlosarczyk, J. Nessler (Cracow, PL) 

Circulating biomarkers and heart rate variability in chronic heart failure patients with 

different response to active orthostatic test P1633 

P. shebeko (Tyumen, RU) 

Hyperglycemia, a biomarker of left ventricular systolic dysfunction in acute coronary 

patients? P1634 

A. Castro, N. Moreno, A. Pereira, R. santos, M.C. Queiros, P. Pinto (Penafiel, PT) 

High sensitivity cardiac troponin T in cirrhotic patients during transjugular intrahepatic 

portosystemic shunts insertion P1635 

M. Vasatova, R. Pudil, I. Karesova, T. Fejfar, V. safka, P. Hulek (Hradec Kralove, CZ) 

Predict value of circulating endothelial progenitor cells in patients with ischemic 


A. Berezin, A. Kremzer (Zaporozhye, UA) 

Monitoring of chronic heart failure with serum soluble ST2 P1637 

s. Piper, d. Hipperson, J. decourcey, R. sherwood, G. Amin-Youssef, T.A. Mcdonagh 

(London, GB) 

Cystatin C, serum markers of collagen turnovers in ischemic heart failure patients with 

atrial fibrillation P1638 

d. Lashkul (Zaporizhzhya, UA) 

Red cell distribution width is an effective tool for detecting diastolic dysfunction in 

chronic hemodialysis patients P1639 

H. Kumashiro, s. Hirohata, A. Yamanishi, C. Tomioka, s. Kusachi (Kurashiki and 

Okayama, JP) 

Is galectin-3 associated with atherosclerosis in the aorta and its abdominal branches 

in patients with heart failure? P1640 

N.s. sherwi, K. Wong, C. Bourantas, e. Lukachuk, J. Zhang, R. Nicholls, A.L. Clark, 


Correlation of collagen turnover biomarkers with echocardiographic parameters of 

heart failure and natriuretic peptide type-B P1641 

R. Andrea Riba, L. sanchis, C. Falces, M. sitges, F. Perez-Villa, M. sabate, M. Heras, 


Plasma TIMP4 predicts left ventricular remodelling independent of infarct size 

following ST-elevation myocardial infarction P1642 

N.A. Razvi, B. Grundy, L.L. Ng, G.P. Mccann, I.B. squire (Leicester, GB) 

Influence of optimal beta blocker therapy on biomarkers of inflammation and 

proliferation in elderly patients with chronic stable heart failure P1643 

s. Apostolovic, d. stanojevic, R. Jankovic-Tomasevic, s. salinger-Martinovic, 

d. djordjevic-Radojkovic, M. Pavlovic, e. Tahirovic, M. Lainscak, L. Musial-Bright, 

H.d. duengen (Nis, Rs; Berlin, de) 

B-type natriuretic peptide-guided vs. symptom-guided therapy in outpatients with 

chronic heart failure:a systematic review with meta-analysis P1644 

R. de Vecchis, C. esposito, G. di Biase, C. Ariano, C. Cioppa, A. Giasi, A. Fusco, 

s. Cantatrione (Naples and somma Vesuviana, IT) 

175 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Clinical, biochemical and echocardiographic correlates of plasma neutrophil 

gelatinase-associated lipocalin (NGAL) in adult patients with congenital heart disease P1645 

A. Frogoudaki, K. Andreou, J. Parissis, M. Nikolaou, e. Koutsotheodorou, I. Rizos, 

I. Paraskevaidis, G. Filippatos, M. Anastasiou-Nana (Athens, GR) 

urinary proteome analysis in hypertensive patients with left ventricular diastolic 


T. Kuznetsova, H. Mischak, W. Mullen, J.A. staessen (Leuven, Be; Glasgow, GB) 


Heart failure and nursing diagnoses in primary care: a cross-sectional observational 

study P1647 

d.M.s. Correia, e.T. Mesquita, M.L.G. Rosa, A.C.d. Cavalcanti, A.J.L. Jorge, s.F. Brock, 

N.A.C. Monteiro, V.C. Rodrigues, C.P. Monnerat, A.F.N. Cruz (Niterói, BR) 

Theoretical-practical training of students of vocational high school to care for cardiac 

arrrest: a prospective study P1648 

V. de Freitas Marcolla, V.F.M. Marcolla (Rio de Janeiro, BR) 

Experts views on transitional care for patients with heart failure in Beijing: in depth 

interview study P1649 

Y. Chen, T. Liang (Beijing, CN) 

Impact of a heart failure clinic: a centre experience P1650 

P. silva, A. Ferreira, M. soares, s. Ferreira, s. Neto, N. Moreno, C. Lourenco, A. Andrade, 

s. sousa, P. Pinto (Penafiel, PT) 

Guidance to the heart failure patient in a telemonitoring program P1651 

B.R. Wegener, A. Laustsen (Aarhus, dK) 

Nurse-led heart failure clinic as an effective strategy for patient review and up-titration 

of heart failure medication within primary care P1652 

s. Akrimi, M. Lasrado (London, GB) 


Heart failure is a determinant of painless acute coronary syndromes P1653 

d. Caldeira, I. Cruz, B. stuart, C. Martins, H. Pereira, On Behalf Of Investigators Of 

Portuguese National Register Of Acute Coronary syndromes (Almada and Lisbon, PT) 

Very elderly patients admitted to a cardiology department: clinical characterization 

and prognosis P1654 

P. Carrilho-Ferreira, A.C. Rocha, C. Jorge, A. Magalhaes, R. Placido, A.R. Ramalho, 

M. Nobre Menezes, d. silva, A. Nunes diogo, d. Brito (Lisbon, PT) 

Day of "heart failure": what our patients know? P1655 

N. Bylova, A.U. Kulinkovich, A.s. Tyukhtina, s.e. Gratsianskaya, e.A. Nikitina, 

G.P. Arutyunov (Moscow, RU) 

Waist-to-height ratio references for 10 to 18 year-olds in autonomous region of 

madeira, Portugal P1656 

B. sousa, B. Mendes de Oliveira, M.d.V. de Almeida (Porto, PT) 

Electrocardiographic patterns in a young and healthy Algerian population P1657 

W. Amara, N.H. Hammoudi, s.B. Bouallouch, A.e.H. el Hraiech, A.I. Iusuf, 

R.B. Bougherbel (Montfermeil, FR) 

Efficacy of acute heart failure treatment: a strategy problem or looking for the 

"wrong" end-point? P1658 

I. Campos Moreira de Almeida, F. Caetano, A. Fernandes, P. Mota, A. Leitao-Marques 

(Coimbra, PT) 

176


Prevalence of various diseases in population of patients with CHF in Russian Federation. P1659 

I. Fomin, Y.N. Belenkov, F.T. Ageev, e.G. Artemyeva, e.I. Tarlovskaya, s.s. Yakushin, 

Y.V. Badin, e.V. shcherbinina, V.Y. Malenkova, d.s. Polyakov (Moscow, Cheboksary, 

Kirov and Ryazan, RU) 

The association between alcohol intake and echocardiographic abnormalities in the 

community (w) P1660 

H. Yousaf, K.A. Ammar (Milwaukee, Us) 

Healthcare utilisation, co-morbidities and polypharmacy in community heart failure 


J. Gallagher, J. Mulqueen, L. O Connell, e. O Connell, M. Ledwidge, K. Mcdonald, 

A. Murphy, L. Glynn (dublin and Galway, Ie) 

Relationship between quality of life and frailty in general population with heart failure P1662 

P. Gastelurrutia, J. Lupon, M. de Antonio, B. Gonzalez, R. Cabanes, L. Cano, A. Urrutia, 

M. domingo, s. Altimir, A. Bayes-Genis (Badalona, es) 

Patient characteristics and treatment patterns in patients with systolic heart failure 

across different physician groups in Germany - the REFLECT-HF study P1663 

C. Tschoepe, U. Tebbe, J.H. Wirtz, J. Lokies, e. Turgonyi, A. strunz, K. Lins, P. Bramlage, 

M. Boehm (Berlin, detmold, dinslaken, Mahlow and Hamburg, de; 

Walton Oaks, GB) 

Regional differences in patient characteristics, therapy and and one-year outcomes in 

the heart failure pilot survey (ESC-HF pilot) P1664 

A.P. Maggioni, U. dahlstrom, G. Filippatos, O. Chioncel, M. Crespo-Leiro, 

J. drozdz, F. Fruhwald, O. Wendelboe Nielsen, F. Zannad, L. Tavazzi (Florence and 

Cotignola, IT; Linkoping, se; Athens, GR; Bucharest, RO; La Coruna, es; Lodz, PL; 

Graz, AT; Copenhagen, dK; Vandœuvre-Les-Nancy, FR) 

Factors related to short-term outcome in heart failure patients hospitalized in a Clinical 

Hospital as a part of data EuRObservational Research Program 2011/2012 P1665 

F.e. Fazlibegovic, M.H. Hadziomerovic, d.P. Pravdic, B.P. Palic (Mostar, BA) 


Difference in the appearance of cardiovascular symptoms in postmenopausal women 

according to the cardiovascular risk factors (w) P1666 

M.s. shin, J.G. seo, B.R. Kim, s.J. Park, s.W. Han, I.M. Chung, d.J. Choi (Incheon, seoul 

and seongnam, KR) 

Construct validity of the FEW-16 questionnaire as a measure of physical wellbeing in 

patients with diastolic heart failure P1667 

d. Jahamdar Lashki, e. Tahirovic, L. Musial-Bright, G. Cherain, s. Inkrot, T. Trippel, 

V. Tscholl, F. Krackhardt, W. Haverkamp, H.-d. duengen (Berlin, de) 

Training in advanced heart failure: is end-of-life care being addressed? P1668 

Y. Ismail, K. shorthose, A.K. Nightingale (Bristol and Taunton, GB) 

Exercise-based cardiac rehabilitation does not improve mental health in patients with 


J. Gonzalez-Costello, M. Gomez-Cuba, M. Nebot, d. Camara, M.J. Barbosa, I. Tatjer, 

L. Mateu, N. Manito, R. Planas-Balague, A.R. Cequier (L'Hospitalet de Llobregat, 

Barcelona and Barcelona, es) 

Psychologic distress in heart failure patients: validation of the distress thermometer P1670 

J. sharp, d. Holly (Glasgow and Kilmarnock, GB) 

177 

MODERATED 

pOsTER sEssiOn 3

MODERATED 




N-terminal pro-B-type natriuretic peptide level is correlated with post-exercise heart 

rate recovery in heart failure P1671 

A. Gwizdala, e. straburzynska-Migaj, T. Krauze, R. Ochotny, s. Grajek, P. Guzik 

(Poznan, PL) 

Correlation between physical activity in daily life and cardiopulmonary exercise testing 

in patients with heart failure P1672 

M. Morita, F. Bacal, J. Roque, J.F.C. Belli, I.s. Teixeira-Neto, P. Chizzola, e.A. Bocchi, 

G.V. Guimaraes (sao Paulo, BR) 

Characteristics of chronic heart failure patients presenting with exercise oscillatory 

ventilation P1673 

I. Giverts, M. Poltavskaya, O. dikur, A. doletskiy, V. sedov, V. sviridenko, P. Chomakhidze, 

e. Yakubovskaya, A. syrkin (Moscow, RU) 

Beta blockers therapy is associated with improved left ventricular systolic function and 

sustained exercise capacity in elderly patients with heart failure - CIBIS-ELD sub-study P1674 

H.-d. duengen, M. dekleva, e. Tahirovic, L. Musial-Bright, s. Inkrot, G. Gelbrich, 

J. suzic Lazic, M. Pavlovic Kleut, W. Haverkamp, F. Waagstein (Berlin and Wurzburg, de; 

Belgrade, Rs; Gothenburg, se) 

Chronotropic incompetence in coronary artery disease patients: the impact of cardiac 

rehabilitation P1675 

M. santos, d. Anjo, P. Rodrigues, M.J. sousa, B. Brochado, s. Viamonte, P. Fernandes, 

A. Barreira, s. Cabral, s. Torres (Porto, PT) 

Gender related predictors of limited exercise capacity in heart failure P1676 

G. Bajraktari, N. Rexhepaj, R. Tafarshiku, s. elezi, P. Ibrahimi, F. Jashari, M.Y. Henein 

(Pristina, Ks; Umea, se) 

Pre-Intervention Considerations When Aiming to Increase Physical activity and 

Exercise in Chronic heart failure? P1677 

H. Patel, N.M. Albert, M. Borjesson (Gothenburg and stockholm, se; Cleveland, Us) 

utility of cardiopulmonary exercise testing to distinguish between patients with stable 

compensated heart failure and sedentary elderly adults with cardiovascular risk factors P1678 

T.J. Yeo, s.F. Yap, R.C.C. Wong L H Ling R santhanakrishnan, T.P. Ng, d.K.L. sim, 

G.K.T. Leong, F. Jaufeerally, P. Chai A M Richards C s P Lam, d.P.s. Yeo, H.Y. Ong 

(singapore, sG) 

Hemoglobin and NT-proBNP influence on exercise functional capacity in systolic heart 

failure patients P1679 

M. satendra, L. sargento, A. Arsenio, C. sousa, s. Longo, N. Lousada, R. Palma dos Reis 

(Lisbon, PT) 

Is the anaerobic threshold a correct definition? Four stages of incremental exercise P1680 

T. Lelyavina, M.Y.U. sitnikova, A.V. Beresina, e.V. shlyakhto (st. Petersburg, RU) 


Regional differences between female populations from The Cardiac Insufficiency 

BIsoprolol Study in ELDerly (CIBIS ELD) P1681 

H.-d. duengen, L. Musial-Bright, e. Tahirovic, s. Inkrot, d. stanojevic, 

s. salinger-Martinovic, R. Jankovic-Tomasevic, W. Haverkamp, G. Gelbrich, s. Apostolovic 

(Berlin and Wurzburg, de; Nis, Rs) 

Predictors of survival in a population with advanced heart failure P1682 

N. Moreira, F. soares, H. Martins, J. Ferreira, A.R. Ferreira, s. Mendes, F. Franco, 

s. Costa, M.J. Ferreira, M. Pego (Coimbra, PT) 

178


Sudden death in patients with heart failure and myocardial infarction after prior 

revascularization; 13-year experience P1683 

P. Mitrovic, B. stefanovic, Z. Vasiljevic, M. Radovanovic, N. Radovanovic, G. Matic, 

d. Rajic, A. Novakovic (Belgrade, Rs) 

Prognostic value of hyperglycaemic index in acute heart failure P1684 

R.A. Pontes dos santos, N. Moreno, A. da silva Castro, A. Pereira, C. Lourenco, P. Pinto 

(Penafiel, PT) 

Predictors and prognosis of acute heart failure in patients with acute myocardial 

infarction treated with primary percutaneous coronary intervention in a tunisian 

tertiary care center P1685 

W. Jomaa, M. Chakroun, s. Hamdi, T.R. Trimech, K. Ben Hamda, F. Maatouk 

(Monastir, TN) 

OPeRA-HF study design (Risk Arm): an observational study to assess and predict the 

in-patient course, risk of readmission and mortality for patients hospitalised for or with 


A. Crundall-Goode, K.M. Goode, A. shoaib, G. Geleijnse, J.J.G. de Vries, e. Robson, 

K. dobbs, K. Wong, A.L. Clark, J.G.F. Cleland (Hull, GB; eindhoven, NL) 

Predictor of readmission and mortality of heart failure at 5 years follow up P1687 

B.B. siswanto, M. Arman, R. Mahkota, N. Kodim (Jakarta and depok, Id) 

Chronic kidney disease in heart failure patients with reduced left ventricular ejection 

fraction: the beginning of the end? P1688 

L. Rassi, R. Rodrigues, s. Goncalves, P. Amador, L. Mendes, J. santos, A. Lourenco, 

s. Correia, R. Caria, L. soares (setubal, PT) 

The new Q waves at admission ECG and early ST segment resolution as predictors for 

outcome in STEMI patients treated with primary PCI P1689 

s. Obradovic, B. dzudovic, N. djenic, s. Vukotic, Z. Jovic, R. Romanovic (Belgrade, Rs) 

Optimization of neurohumonal blockade in patients with heart failure with reduced 

left ventricular ejection fraction P1690 

L. Rassi, R. Rodrigues, P. Amador, s. Goncalves, L. Mendes, J. santos, s. Mateus, 

A. Lourenco, R. Caria, L. soares (setubal, PT) 

Mehran risk score in acute myocardial infarction with ST segment elevation: adverse 

cardiovascular events and contrast nephropathy predictor after primary percutaneous 

coronary intervention? P1691 

V. Ramos, C. Braga, C. Vieira, J. Martins, C. Arantes, J. Marques, A. Gaspar, P. Azevedo, 

M. Alvares Pereira, A. Correia (Braga, PT) 

Predictors of in-hospital mortality in elderly women (>= 80 years) with acute 

myocardial infarction with st elevation P1692 

A.R. santos, B. Picarra, A.F. damasio, M. Celeiro, A. Bento, J. Aguiar, s.P.C. Rnsca 

(Évora, PT) 

A straightforward model for prognostication in advanced heart failure P1693 

F. soares, H. Martins, N. Moreira, J.M. Ferreira, R. Ferreira, R. Baptista, s. Costa, F. Franco, 

L. Goncalves, M. Pego (Coimbra, PT) 

Body mass index and prognosis in acute heart failure with preserved ejection 

fraction-the paradox remains at follow-up in the medium to long term? P1694 

A.P. Bohlen delgado, B. Marmelo, B. Rodrigues, d. Moreira, s. Nunes, P. Gama, O. santos 

(Viseu and Castelo Branco, PT) 

179 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Impact of Permanent pacemaker implantation on clinical outcome in patients 

undergoing transcatheter aortic valve implantation with CoreValve prosthesis P1695 


A.J. dominguez Franco, J.H. Alonso Briales, J.M. Hernandez Garcia, e. de Teresa Galvan 

(Malaga and Jaén, es) 

Clinical outcome following Transcatheter Aortic Valve Implantation in patients with 

impaired left ventricular systolic function P1696 


I. Rodriguez Bailon, J.J. Gomez doblas, A.J. dominguez Franco, J.H. Alonso Briales, 

J.M. Hernandez Garcia, e. de Teresa Galvan (Malaga and Jaén, es) 

Risk prediction with amino-terminal B type natriuretic peptide in comparison with 

multi-marker risk scores in patients admitted to the intensive cardiac care unit P1697 

M. Castro, H. dores, J. Ferreira, s. Madeira, H. Vitorino, J. Abecasis, A. Ferreira, 

C. Aguiar, e. Junior, M. Mendes (Lisbon, PT) 

Relationship between heart rate and long-term mortality according to the presence of 

sinus rhythm or atrial fibrillation in heart failure patients P1698 

M. de Antonio, J. Lupon, M. domingo, e. Zamora, B. Gonzalez, L. Cano, A. Urrutia, 

C. diez, s. Altimir, A. Bayes-Genis (Badalona, es) 

Hyperbilirubinemia - useful non-cardiac parameter of biventricular failure and 

negative prognosis in acute heart failure patients P1699 

I. Varga, P. Lesny, B. Liska, P. solik, M. Luknar, s. Babej, e. Goncalvesova (Bratislava, sK; 

Weiden, de) 

Prognosis and response to therapy of first inpatient and outpatient heart failure event 

in MADIT-CRT P1700 

H. skali, e. dwyer, R.e. Goldstein, M. Haigney, R. Krone, M. Kukin, e. Lichstein, 

s.A. Mcnitt, A. Moss, s. solomon (Boston, Newark, Bethesda, Md, saint Louis, New York, 

Brooklyn and Rochester, Us) 

Clinical outcome and predictors of late mortality after transcatheter aortic valve 

implantation of severe symptomatic aortic stenosis with the CoreValve prosthesis P1701 

A.J. Munoz Garcia, e. Munoz Garcia, M. Munoz Garcia, P. Hernandez Rodriguez, 

M.F. Jimenez Navarro, A.J. dominguez Franco, J.H. Alonso Briales, J.J. Gomez doblas, 

J.M. Hernandez Garcia, e. de Teresa Galvan (Malaga and Jaén, es) 

Glomerular filtration rate estimated by a new equation, Berlin Initiative Study (BIS) 

is not a better predictor for cardiovascular events in elderly patients with acute heart 

failure: data from Korea (w) P1702 

J. Oh, s.M. Kang, N. Hong, J.C. Youn, s. Park, s.H. Lee, Y. Jang, N. Chung (seoul, KR) 

Clinical - Pathophysiology 

State of nervous-muscular apparatus at patients with chronic heart failure (CHF) of 

ischemic genesis P1703 

O.A. Koval, J.V. Tkachenko (dnipropetrovsk, UA) 

Parathyroid hormone is associated with hemodynamics and disease severity in 


J. Kliebhan, C. Trenkler, M. ess, P. Wuertinger, A. Griesmacher, s. Kaser, M. Frick, 

G. Poelzl (Innsbruck, AT) 

180


Prediction of ongoing myocardial damage by noradrenergic response and 

haemodynamic impairment during exercise in systolic heart failure. Non invasive 

estimation of Frank-Starling curve. P1705 

L.e. Pastormerlo, C. Prontera, A. Agazio, e. Benelli, A. Gabutti, C. Mammini, R. Poletti, 

A. Clerico, C. Passino, M. emdin (Pisa, IT) 


Parameters of in hospital mortality in pulmonary thromboendarterectomy performed 

in chronic thromboembolic pulmonary hypertension: preliminary results of a 

single-center experience P1706 

T. Kivrak, B. Hunuk, M. sunbul, B. Mutlu, B. Yildizeli (Istanbul, TR) 

Noninvasive prognostic indicators in treated patients with pulmonary arterial 


M. Jasiewicz, R. skiepko, M. Knapp, P. Jasiewicz, A. szpakowicz, B. sobkowicz, 

A. Bodzenta-Lukaszyk, W.J. Musial, K.A. Kaminski (Bialystok, PL) 

Iron deficiency in patients with idiopathic pulmonary arterial hypertension P1708 

V. Van empel, J. Lee, T.J. Williams, d.M. Kaye (Melbourne, AU) 

Clinical implication of repeated measurements of right ventricular pressure wave 

reflection in patients with pulmonary arterial hypertension P1709 

B. Kjellstrom, A. Manouras, P. Moradinia, G. Wikstrom (stockholm and Uppsala, se) 

Right and left ventricular function as predictors of mortality in pulmonary arterial 


R. Placido, P. Loureiro, s. Martins, J. silva Marques, A. Almeida, s. Goncalves, 

A.N.A.G. Almeida, A. Nunes diogo (Lisbon, PT) 


Right ventricular dysfunction and heart failure in patients operated for tetralogy 

of Fallot P1711 

J.R. Beramendi Calero, I. Rilo Miranda, K. echegaray Ibanez, M. Telleria Arrieta, 

M. Castillo Judez, I. solla Ruiz, I. Villanueva Benito, J. echeverria Oses, N. Garrido Asenjo, 

F. de La Cuesta Arzamendi (san sebastian, es) 

Evaluation of right ventricular outflow tract systolic excursion in the assessment of 

right ventricular function P1712 

N. Moreno, A. silva Castro, A. Pereira, R. Pontes dos santos, R. sousa, M. Pires, 

R. Carvalho, A. Andrade, P. Pinto (Penafiel, PT) 

Right ventricular and atrium volume index in chronic heart failure in patients with 

chronic obstructive pulmonary disease P1713 

L. Agoston-Coldea, s. Lupu, d. Petrovai, T. Mocan (Cluj-Napoca and Targu Mures, RO) 

Early right ventricular remodeling in hypertensive patients with altered left ventricular 

function P1714 

A. sljivic, V. Celic, M. Pavlovic Kleut, B. Pencic, A. Majstorovic, s. Backovic, I. Ilic, A. Andric, 

B. stojcevski, M. Tadic (Belgrade, Rs) 


Left ventricular systolic function, heart rate variability and presence of atrial fibrillation 

in patients after myocardial infarction P1715 

s. djordjevic, s. Raspopovic, V. Bisenic, N. Ninkovic, s. Banicevic, V. Radivojevic, 

G. Krljanac, G. Nikcevic, B. Milovanovic (Belgrade, Rs) 

181 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Impact of optimizing of heart failure therapy in cardiac remodeling reversal: 

morphological, electrical and functional analysis. P1716 

M. Avila samuel, s.M. Ayub-Ferreira, V.s. Issa, M.L.C. Vieira, G.V. Guimaraes, J.F.C. Belli, 

M.B. Pereira, T.N. Valette, e.A. Bocchi (sao Paulo, BR) 

Development of left ventricular function in premature infants. P1717 

Y. Kikuchi (Tochigi, JP) 

Critical infarct size and adverse left ventricular remodeling following myocardial 

infarction P1718 

e. singsaas, A. Carlsen, K. dickstein, s. Orn (stavanger and Bergen, NO) 

Can tissue doppler imaging reveal early left ventricular function abnormalities in 

obstructive sleep apnea? P1719 

e. Manov, N. Runev, R. shabani, T. donova, O. Georgiev (sofia, BG) 

Assesment of diastolic function in two types of left ventricle P1720 

I. Nikolic Pavlovic, M. deljanin Ilic, M. Krstic (Niska Banja, Rs) 

Impact of residual left ventricular function in a residual primary angioplasty program P1721 

e. Cambronero Cortinas, M.J. Corbi Pascual, A. Gomez Perez, J.C. Garcia Lopez, 

M.I. Barrionuevo sanchez, G. Gallego sanchez, V.M. Hidalgo Olivares, 

M.A. simon Garcia, J.G. Cordoba soriano, M.J. Fernandez Anguita (Albacete, es) 

Clinical - Hypertension/LV hypertrophy 

Left ventricle hypertrophy in hypertensive patients and diabetes as risk factor P1722 


Relevance of homocysteine on brachial flow-mediated vasodilation and carotid and 

femoral intima-media thickness in siblings of hypertensive patients P1723 

M.F. elnoamany, H. Badran, H. ebraheem, A. Reda, N. elsheekh (shebeen el-Koom, eG) 

Structure and function of arterial wall depending on frank of left ventricle 

hypertrophy in patients with chronic heart failure and arterial hypertension. P1724 

N. Koziolova, M. surovtseva, A. Chernyavina, I. shatunova (Perm, RU) 

Impact of obesity and hypertension on cardiac function and exercise capacity 

in women (w) P1725 

M.s. shin, B.R. Kim, J.G. seo, J.G. Moon, W.J. Chung, T.H. Ahn (Incheon and seoul, KR) 

MicroRNA-143 and microRNA-145 levels in peripheral blood mononuclear cells 

associate with left ventricular hypertrophy in patients with essential hypertension P1726 

J. Kontaraki, M. Marketou, s. Maragkoudakis, e. Zacharis, F. Parthenakis, J. Logakis, 

P. Vardas (Heraklion, GR) 

Clinical - HFpEF - Heart failure with preserved ejection fraction 

The role of global strain and strain rate analysis in patients with asymptomatic 

hypertensive heart disease-Diagnose-DHF-Pilot study P1727 

e. Belyavskiy, e. Kraigher-Krainer, M. Url-Michitsch, G. steiner, A. schmidt, B. Pieske 

(Graz, AT) 

Correlation between pulse pressure and sub-maximal functional capacity in patients 

with heart failure with preserved ejection fraction P1728 

C.A. smiderle, R. Vilanova, J. Junqueira, L.C. danzmann (Canoas, BR) 

Left ventricular reverse remodeling as an outcome of secondary prevention and 

rehabilitation program after coronary revascularization in patients with preserved 

systolic function P1729 

e.B. Vataman, A.A. Grivenco, d.M. Lisii, s.A. Filimon, s.A. Aprodu (Chisinau, Md) 

182


Comparison of myocardial scintigraphy with I123-MIBG in patients with heart failure 

with preserved versus decreased left ventricular ejection fraction. P1730 

s.M. Miranda, s.d. Moscavitch, A. de Oliveira, J.C. de Azevedo, L.R. Messias, 

R.C. Rodrigues, R.A. Freitas, e.T. Mesquita, C.T. Mesquita (Niteroi and Rio de Janeiro, BR) 

Systematic review of diastolic stress tests and rationale for a new diastolic stress echo 

protocol from the Cardiff MEDIA (The Metabolic Road to Diastolic Heart Failure) centre P1731 

T. erdei, Z. Yousef, A.G. Fraser (Cardiff, GB) 

The evaluation of cardiac asynchrony in symptomatic and asymptomatic patients with 

diastolic dysfunction P1732 

O. Imadoglu, K. soylu, s. Yuksel, s. demircan, O. Gulel, O. Yilmaz, M. sahin 

(Kurupelit-samsun, TR) 

Heart failure with preserved and reduced ejection fraction: two entities with similar 

long term prognosis but different predictors of outcome P1733 

R. Cardiga, F. Marques, M. Proenca, I. Araujo, R. Ferreira, M. Alface, A. Botella, A. Leitao, 

C. Fonseca, F. Ceia (Lisbon, PT) 

Levels of Galectin-3, BNP and NT-pro BNP in 1 year after STEMI in patients with 

preserved LVEF P1734 

V. Ryabov, T. suslova, V. shurupov, e. Nikonova, V. Markov (Tomsk, RU) 

Prognostic importance of clinical and hemodynamic parameters in patients with heart 

failure and preserved ejection fraction P1735 

C. Tufaro, J. Mascherbauer, B. Marzluf, T. Binder, I.M. Lang, d. Bonderman (Vienna, AT) 

The effects of worsening diastolic dysfunction in patients with heart failure with 

preserved ejection fraction on muscle strength, haemoglobin and transferrin 

saturation* P1736 

T. Bekfani, N. ebner, M. Valentova, A. sandek, s.d. Anker, W. doehner, s. Von Haehling 

(Berlin, de) 

Galectin-3 in heart failure with preserved versus reduced ejection fraction P1737 

R. santhanakrishnan, J.P.C. Chong, T.P. Ng, L.H. Ling, R. Wong, P. Chai, A.F. Low, J.e. Ho, 

A.M. Richards, C.s.P. Lam (singapore, sG; Boston, Us) 

Differences of ventricular-arterial coupling and its relation to exercise intolerance in 

patients with heart failure with reduced and preserved ejection fraction P1738 

O. dikur, M. Poltavskaya, I. Giverts, A. doletskiy, V. sedov, P. Chomachidze, 

e. Yakubovskaya, A. syrkin (Moscow, RU) 

Clinical factors associated with health-related quality of life in heart failure-preserved 

ejection fraction: a PARAMOuNT study P1739 

e.F. Lewis, H. Guan, M. Zile, M. Packer, B. Pieske, A.A. Voors, M. Lefkowitz, 

C. deschaseaux, K. Kulich, s.d. solomon (Boston, Charleston, dallas and east Hanover, Us; 

Graz, AT; Groningen, NL) 

Clinical - Molecular biology/Genetics 

Impact of genetic polymorphisms in end-stage heart failure prognosis after rapid up 

titration of beta- blockers. P1740 

d.M. Melo, A.C.P.B. Barretto, A.I.O. Oliveira, J.N.C. Cardoso, F.s.A.M. Melo, M.e.O. Ochiai, 

P.C.M. Morgado, J.A.F.R. Ramirez (sao Paulo and Jaboatao dos Guararapes, BR) 

The correlation between I/D ACE gene polymorphism and symptoms of heart failure 

after acute myocardial infarction P1741 

L. Polak, A. Ledakowicz-Polak, M. Zielinska, K. Chizynski (Lodz, PL) 

183 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Clinical - other 

Adherence to guidelines in the in-hospital management of congestive heart failure in 

the Philippines: a prospective study P1742 

M.J. Reyes, e.W. Timbol, M.d. san Juan (Manila, PH) 

Basic - EC coupling 

Inner and outer environment of plasma membrane in cardiac myocytes P1743 

Z. Nichtova, I. Zahradnik, M. Novotova (Bratislava, sK) 

Changes in dyad morphogenesis in cardiac myocytes due to isoproterenol-induced 

myocardial injury P1744 

M. Novotova, Z. Nichtova, I. Zahradnik (Bratislava, sK) 

Metformin prevents doxorubicin cardiotoxicity through mitochondrial stabilization P1745 

M.C. Asensio-Lopez, J. sanchez-Mas, d.A. Pascual-Figal, s. Abenza, M.T. Perez-Martinez, 

L. Caballero, M. Valdes-Chavarri, A.M. Lax (Murcia, es) 

Impaired cardiomyocyte relaxation in a rat model of compensated renal failure and 

diastolic heart failure P1746 

U. Primessnig, s. Pfeiffer, P. Wakula, M. stipacek, T. Rau, T. stojakovic, B. Pieske, F. Heinzel 

(Graz, AT) 

Levosimendan sensitises receptor-stimulated inotropic responses through PDE3 

inhibition and not calcium sensitisation in normal rat heart P1747 

O. Orstavik, T. skomedal, J.B. Osnes, F.O. Levy, K.A. Krobert (Oslo, NO) 

Na+/K+ ATPase function is enhanced during early stages of heart failure in 

beta1-adrenergic receptor transgenic mice P1748 

P. schoenleitner, F.R. Heinzel, P. Wakula, s. engelhardt, B. Pieske, G. Antoons (Graz, AT; 

Munich, de) 

Changes of calcium release and of dyadic structure in cardiac myocytes due to 

isoproterenol-induced myocardial injury P1749 

I. Zahradnik, A. Zahradnikova Jr, M. Novotova, A. Zahradnikova (Bratislava, sK) 


Diacerein promotes better left ventricle remodeling after myocardial ischemia injury P1750 

A.G. Torina, K. Reichert, F. Lima, K.A.s. Vilarinho, C.F.R. Lavagnoli, L.M. silveira-Filho, 

P.P.M. Oliveira, P. eghtesady, O. Petrucci (Campinas, BR; st. Louis, Us) 

Memory B cells are present in transplanted cardiac tissue and may contribute to 

immune-mediated graft failure P1751 

A. Gareau, G. Hirsch, A. Rice, T. Lee (Halifax, CA; London, GB) 

Heart rate reduction with Ivabradine has no effect on peripheral cytokine profile 

following heart transplantation P1752 

B. sekar, W. Critchley, L. Archer, T. entwistle, L. Beresford, s. Williams, s. shaw, J. Fildes 

(Manchester, GB) 

Plasma levels of adipokines in an animal model of heart failure with preserved ejection 

fraction P1753 

d. Miranda-silva, I. Falcao-Pires, d. Fontoura, A.P. Lourenco, A.F. Leite-Moreira (Porto, PT) 

Leptin induces the generation of microparticles by human mononuclear cells (w) P1754 

s. Petrini, C. Balia, T. Neri, V. scalise, s. Cianchetti, R. Pedrinelli, A. Celi (Pisa, IT) 

184


Correlation between circulating neutrophils and long term mortality in patients with 

recent onset dilated cardiomyopathy is contributed by suppressed Toll-like receptor 

4/IRF-3-pathway P1755 

A. Riad, M. Hundt, s. Gamradt, L.R. Herda, M. Nauck, M. doerr, s.B. Felix 

(Greifswald, de) 

Evidence for the predictive role of alternatively activated macrophages for the 

outcome of mechanical circulatory support P1756 

K. Wassilew, e. Potapov, T. Krabatsch, M. dandel, B. song, A. Mickley, C. schmuttermaier, 

A. Gratchev, R. Hetzer, J. Kzhyshkowska (Berlin and Mannheim, de) 

Basic - Metabolism 

Increased generation of reactive oxygen species is associated with a specific complex I 

defect of the respiratory chain in pressure overload induced heart failure P1757 

M. schwarzer, A. Lunkenbein, A. schrepper, P.A. Amorim, T. doenst (Jena, de) 

Cause of oxidative stress and the bioenergetic performance of ATP- production in 

mitochondria: the Kadenbach- hypothesis and its clinical relevance P1758 

s. Vogt, P. Weber, R. Ramzan (Marburg, de) 

Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance 

spectroscopy analysis P1759 

M. Biagioli, P. Pantaleo, C. Lippi, B. Alterini, L. Tenori, X. Hu, F. Biagini, G. Castelli, 

G.F. Gensini, I. Bertini (Florence, IT) 

Age-dependent mitochondrial energy dynamics in the mice heart: role of superoxide 

dismutase-2 P1760 

K. das (Lubbock, Us) 

Analysis and characterization of mitochondrial proteins in hypertrophied heart of 

animals with heart failure P1761 

L.A.d.e.O. Rocha, O.R.T. Torres, O.C.F. Franco (Brasilia, BR) 

L-cysteine improves Frank-Starling mechanism and protects heart from reperfusion 

injury P1762 

Y. Goshovska, T.V. shimanskaya, V.F. sagach (Kiev, UA) 

Relation between left ventricular function and heart rate variability in patients after 

myocardial infarction with diabetes P1763 

V. stoickov, s. Ilic, M. deljanin Ilic, L.J. Nikolic, M. stoickov (Nis and Niska Banja, Rs) 

The role of the level of serum erythropoietin on the patients with anemic heart failure P1764 

K. Zahidova (Baku, AZ) 

Basic - Vascular 

The role of TGF beta and the transcription factor KLF-10 in the function of eEPCs P1765 

O. dadush Raz, d. Leshem-Lev, A. Battler, e. Lev (Petah Tikva, IL) 

Hyperpolarization mediated coronary dilation in heart failure P1766 

V. Cobet, A.V. derbentsev (Chisinau, Md) 

Contrast echocardiography reveals apparently normal coronary perfusion in a rat 

model of stress-induced (Takotsubo) cardiomyopathy P1767 

B. Redfors, Y. Yangzhen, A. Ali, e. Omerovic (Gothenburg, se) 

Endo-/epicardial perfusion and microvascular adaptation in a rabbit model of 

developing heart failure assessed with a 3D imaging cryomicrotome P1768 

M.G.J.T.B. Van Lier, N. Hakimzadeh, R. Coronel, J.A.e. spaan, M. siebes, 

J.P.H.M. Van den Wijngaard (Amsterdam, NL) 

185 

MODERATED 

pOsTER sEssiOn 3

MODERATED 



Blood outgrowth endothelial cells in patients with severe ischemic cardiomyopathy 

maintain pro-angiogenic phenotype without senescence P1769 

d. dauwe, K. Verdonck, H. Gillijns, A. Luttun, s. Janssens (Leuven, Be) 

Combined gene delivery of VEGF and HGF induces angiogenesis and proliferation in 

ischemic rat myocardium P1770 

P.I. Makarevich, K.V. dergilev, Z.I. Tsokolaeva, e.V. Gluhanyuk, Y.e.V. Parfyonova 

(Moscow, RU) 

Effects of acute hyperglycaemia on cardiac function and blood flow pattern 

abnormalities in hypertensive patients P1771 

L. Malinova, T. Povarova, G. simonenko, T. denisova, T. Tuchin (saratov, RU) 

Basic - Cardiac remodeling and hypertrophy 

A mutation in the transcriptional cofactor Eya4 causes age-dependent onset of 

adverse cardiac physiology and heart failure P1772 

T. Williams, M. Hundertmark, s. schraut, J. schoenberger, P. Nordbeck, s. Voll, 

M. Muehlfelder, I. elsner, L. seidlmayer, O. Ritter (Wurzburg, de) 

The transcription cofactor Eya4 aggravates pressure overload-induced adverse cardiac 

remodeling P1773 

T. Williams, M. Hundertmark, s. schraut, J. schoenberger, P. Nordbeck, s. Voll, 

M. Muehlfelder, I. elsner, L. seidlmayer, O. Ritter (Wurzburg, de) 

Relationship between p53 and adiponectin expression in epicardial adipose tissue 

from heart failure patients P1774 

R.M. Agra Bermejo, e. Teijeira Fernandez, d. Pascual-Figal, J.s.M. Jesus sanchez Mas, 

A. Fernandez Trasancos, J.R.G.J. Jose Ramon Gonzalez Juanatey, s. eiras 

(Murcia and santiago de Compostela, es) 

Reverse remodelling in Wistar rats after surgical removal of chronic pressure-overload P1775 

I. Falcao-Pires, d. Miranda-silva, C. Moura, P. Rodrigues, A.F. Leite-Moreira (Porto, PT) 

Stress-induced cardiomyopathy versus acute myocardial infarction: different 

cardiocirculatory profiles P1776 

B. Redfors, Y. shao, A. Ali, e. Omerovic (Gothenburg, se) 

Preventive effect of apocynin on molecular and structural heart remodeling in 

borderline and spontaneous hypertension P1777 

O. Pechanova, s. Vrankova, A. Barta, F. Jagla (Bratislava, sK) 

Myocardial injury markers in patients with ambulatory class NyHA III-IV ischemic heart 

failure P1778 

N. Maroz-Vadalazhskaya, I. Russkikh, M. Kaljadka, Y. seljun, s. Kurganovich, Y. Ostrovski 

(Minsk, BY) 

Serum ACE2 changes correlates effective cardiac resynchronization therapy in patients 

with systolic heart failure P1779 

K. Uri, M. Fagyas, A. Kertesz, Z. Csanadi, G. sandorfi, M. Clemens, Z. Papp, I. edes, 

A. Toth, e. Lizanecz (debrecen, HU) 

Basic - Diastolic function 

SPECAM-1 in diastolic heart failure and diabetes mellitus: correlation with carotids 

structural changes and platelets aggregation P1780 

e. shorikov, d. shorikova, O. Khukhlina (Chernivtsi, UA) 

The relationship between insulin like growth factor-1 and left ventricle diastolic 

function values in hypertensive patients with and without type 2 diabetes mellitus P1781 

s. Koval, L. Reznik, T. starchenko, K. Pershina (Kharkov, UA) 

186


Limited prediction of incomplete left ventricular relaxation from diastolic time intervals 

and the isovolumic relaxation constant tau P1782 

M. schwarzl, A. Alogna, B. Zirngast, P. steendijk, H. Maechler, B.M. Pieske, H. Post 

(Graz, AT; Leiden, NL) 

End-systolic volume as primary determinant of ejection fraction in HFpEF vs. HFrEF P1783 

P.L.M. Kerkhof, J.K.-J. Li, J.Y. Kresh (Amsterdam, NL; Piscataway and Philadelphia, Us) 

NT-proBNP, cystatin C, troponin I and indicators of autonomic regulation heart rate in 

patients with systemic forms of amyloidosis P1784 

A. Polyakova, e. Melioranskaia, e. semernin, A. Goodkova, e. shlyakhto 


Basic - Receptor signaling, cyclic nucleotides, second messengers 

NSC 23766, a known inhibitor of Rac1 activation additionally acts as a competitive 

antagonist at cardiac M2 muscarinic acetylcholine receptors P1785 

M. Levay, K.A. Krobert, K. Wittig, N. Voigt, d. dobrev, F.O. Levy, T. Wieland 

(Mannheim, de; Oslo, NO) 

FRET measurements of local cAMP signaling in the sarcolemmal / T- tubular 

compartment of cardiomyocytes P1786 

R.K. Perera, V.O. Nikolaev (Göttingen, de) 

Local cAMP dynamics in the SERCA2 signalling compartment studied by a targeted 

FRET biosensor in adult mouse cardiomyocytes P1787 

J.U. sprenger, V.O. Nikolaev (Göttingen, de) 

The role of inhibitory G protein (Gi) upon beta-adrenoceptor-mediated signalling and 

inotropic responses in normal and failing rat heart left ventricle: functional evidence 

of "tonic" Gi activation P1788 

C.B. Melsom, R.I. Hussain, J.M. Aronsen, I. sjaastad, J.B. Osnes, T. skomedal, F.O. Levy, 

K.A. Krobert (Oslo, NO) 

Phoshodiesterase-2 is upregulated in Human Failing Hearts and Blunts Beta- 

Adrenergic Responses in Cardiomyocytes P1789 

H. Mehel, J. emons, C. Vettel, P. Lechene, L. Maier, V.O. Nikolaev, G. Vandecasteele, 

R. Fischmeister, A. elarmouche (Chatenay-Malabry, FR; Göttingen, de) 

Expression of non-canonical Wnt-11 signalling components in human heart failure 

and functional effects in murine cardiomyocytes P1790 

P. Wakula, G. Antoons, s. Radulovic, s. Ljubojevic, M. sereinigg, F.R. Heinzel, B. Pieske 

(Graz, AT) 

AT2 receptor agonism improves cardiac function, prevents remodeling and reduces 

proteolytic activity of MMP9 in the heart after experimental myocardial infarction P1791 

d. Lauer, s. slavic, M. sommerfeld, T. Unger, U.M. steckelings, e. Kaschina (Berlin, de; 

Vienna, AT; Maastricht, NL; Odense, dK) 

Effects of the soluble guanylate cyclase (sGC) stimulator BAy 41-8543 on myocardial 

function in healthy pigs P1792 

M. schwarzl, A. Alogna, B. Zirngast, P. steendijk, H. Maechler, B.M. Pieske, H. Post 

(Graz, AT; Leiden, NL) 

Beta-adrenergic regulation of cAMP and L-type Ca2+ channels at the T-tubules and 

surface membrane in rat ventricular myocytes P1793 

C. e Molina, Y. Kyoung son, F. Lefebvre, R. Fischmeister (Châtenay-Malabry, FR) 

187 

MODERATED 

pOsTER sEssiOn 3

MODERATED 




Rapid recovery from acute myocarditis under levosimendan treatment: report of two 

cases P1794 

s. ercan, V. davutoglu, M. Cakici, e. Kus, H. Alici, I. sari (Gaziantep, TR) 

Short and long-term outcome of impedance-guided preemptive therapy provided to 

prevent pulmonary congestion-edema in the course of acute myocardial infarction P1795 

M. shochat, A. shotan, M. Kazatsker, A. Asif, L. Vasilenko, Y. Levy, I. dahan, I. Levy, 


Heart failure in a patient with transposition of the great arteries P1796 

e. Cambronero Cortinas, M.J. Corbi Pascual, M.d. Rubio, L. deiros Bronte, 

N. Rivero Jimenez, A. Gomez Perez, C. Labrandero, M. Ortega Molina, A. Fernandez Ruiz, 

M. Burgueros (Albacete and Madrid, es) 

Ischemic cardiomyopathy in young woman missdiagnosed as peripartum 


C. saldarriaga, N. Gonzalez-Jaramillo (Medellin, CO) 

Pericardial mesothelioma: a diagnostic challenge P1798 

P. Rodrigues, N. Antunes, V. dias, R. Ribeiro, s. Cabral, F. Oliveira, L. sousa-Pereira, 

P. Palma, s. Torres (Porto, PT) 

An unusual presentation of a congenital cardiomyopathy P1799 

P. Rodrigues, L. sousa-Pereira, F. Oliveira, s. Cabral, P. Palma, I. sa, d. Anjo, M. santos, 

M.J. sousa, s. Torres (Porto, PT) 

Fabry disease as a cause of idiopathic left ventricular hypertrophy: a case report P1800 

J. Tasic, I. Zupan, M. Cvijic, R. Zbacnik, P. Berden, Z. dolenc-strazar (Ljubljana, sI) 

Iatrogenic ventricular tachycardia P1801 

V. Ribeiro, R. Mota Garcia, A. Goncalves, T. Pinho, R. Almeida, s. Ferreira, M.J. Maciel 

(Porto, PT) 

Wide complex tachycardia in patient with ischemic heart disease P1802 

F. Melao, P. dias, V. Araujo, M. Vasconcelos, T. Pinho, R. Almeida, J. Campos, s. Oliveira, 


Reversal of dilated cardiomypathy after radiofrequency catheter ablation of incessant 

fascicular tachycardia in 15-year old patient P1803 

M. Marinkovic, N. Mujovic, A. Kocijancic, s. Mrdja, V. Kovacevic, T. Potpara, N. Jankovic, 

d. simic, A. Ristic, P. seferovic (Belgrade, Rs) 

Lifesaving catheter ablation of incessant supraventricular tachycardia complicating 

with congestive heart failure during pregnancy P1804 

N. Mujovic, M. Marinkovic, A. Kocijancic, s. Mrdja, V. Kovacevic, T. Potpara, I. Petrovic, 

d. simic, A. Ristic, P. seferovic (Belgrade, Rs) 

Cardioversion of incessant ventricular tachycardia with the support of novel 

percutaneous ventricular assist device- impella cp P1805 

d. Gajanana, O. Afolabi-Brown, I. Opoku-Asare, B. Bozorgnia, s. Mainigi, C. Witzke 

(Philadelphia, Us) 

A rare case of apical hypertrophic cardiomyopathy P1806 

M. Miletic, P. Zafirovska, V. Andova, s. Kaeva, I. danilovska, L.J. Georgievska-Ismail, 

e. srbinovska-Kostovska (skopje, MK) 

The 6-min walking test in children with idiopathic dilated myocardiopathy. Preliminary 

results P1807 

A.C. Tavares, I.s. Teixeira-Neto, R.e. Castro, A.C. Tanaka, e.A. Bocchi, G.V. Guimaraes 


188


Ambulatory monitoring of blood pressure 24h (ambp-24) in children with idiopathic 

dilated myocardiopathy. Preliminary results. P1808 

A.C. Tavares, I.s. Teixeira-Neto, R.e. Castro, A.C. Tanaka, e.A. Bocchi, G.V. Guimaraes 


Novel mutation of lamin a/c gene manifesting as ventricular tachycardia P1809 

G. Kourgiannidis, A. Anastasakis, K.M. Lampropoulos, e. Zahariadi, T. Iliopoulos 

(Athens, GR) 

Recurrent ventricular tachycardia as the main manifestation of myocarditis: case report P1810 

F. Melao, A.s. Correia, M. Vasconcelos, P. dias, J. Campos, M.J. Maciel (Porto, PT) 

Oxalate deposit as a rare cause of cardiomyopathy P1811 

P. Jorge Perez, M.J. Garcia Gonzalez, M.s. Garcia Rebollo, J.J. Ferrer Hita, F. Bosa Ojeda, 

A. Lara Padron, A. sanchez-Grande Flecha, I. Laynez Cerdena (santa Cruz de Tenerife, es) 

Familial tako-tsubo cardiomyopathy; clinical and diagnostic features including 

echocardiographic and magnetic resonance imaging findings P1812 

T. Tak, H. Ramsey, U. sharma, H. Whitney, C. Cagin (La Crosse, Us) 

Acute pulmonary edema and peripartum cardiomyopathy in a primigravida patient 

with severe preeclampsia. P1813 

A. Tounsi, dorra. Abid, Leila Abid, Ahmed siala, Feten Triki, Malek Akrout, 

Mabrou Bahloul, Mourad. Hentati, Mounir Bouaziz, samir Kammoun (sfax, Tn) 

AL amyloidosis - a cause of heart failure not to miss P1814 

d.A. Moreira, A. delgado, B. Marmelo, L. Abreu, L. Nunes, O. santos (Viseu, PT) 

Cardiac complications of endovascular catheters : what about the Pinch-off syndrome? P1815 

H. Benhalla, C. sorea, d. Plein (Brussels, Be) 

Severe regurgitation into the left atrium through an aneurism of the left atrial wall, 

assessed in tridimensional transoesopahgeal echocardiography P1816 

M. strachinaru, P. Wauthy, A. sanoussi, s. Queron, M. Morissens, I. Jousten, I. Costescu, 

e. Catez (Brussels, Be) 

Brucella endocarditis: a lurking cause of heart failure P1817 

d. Hadzovic, e. Brkic, d. Loncar, d. Mrsic, e. sijercic, e. smajic (Tuzla, BA) 

An unusual presentation of acute mitral regurgitation P1818 

M.M. Alqaseer, M. saleem, A. Aithan, H. elsamiri, M. Mowla, A. Jelani (Al Ahsa, sA) 

A rare presentation of an aortic valve endocarditis complicated with aortic dissection P1819 

A. Pereira, A. Castro, N. Moreno, R. santos, d. Araujo, P. Pinto (Penafiel, PT) 

189 

MODERATED 

pOsTER sEssiOn 3

HFA WINTER MEETING POSTERS 

New this year! 

The following abstracts presented at the Heart Failure Winter Meeting 2013 will be 

on display for the entire duration of the congress. 

Come and meet the presenters. 

Heart Failure Winter Meeting 2013 Posters 

saturday 25 May 14:00 - Tuesday 28 May 12:30 

Research 

New Therapies 

191 

Interventions 

Knowledge 

hfa winter 

meeting posters

HFA winter meeting poster sessions 

Heart Failure Winter Meeting 2013 Posters 

Saturday 25 May 14:00 - Tuesday 28 May 12:30 

New this year! 

193 

Poster Area 

The following abstracts presented at the Heart Failure Winter Meeting 2013 will be on display for 

the entire duration of the congress. Come and meet the presenters. 

Early cardiorenal effects of Off Pump Coronary Artery Bypass (OPCAB) in 

patients with and without metabolic syndrome: associations with cardiac 

remodeling P1820 

A. Iakovleva, O. Mirolyubova (Arkhangelsk, RU) 

Circulating osteoprotegerin as a marker of coronary vasculature damage in 

diabetic populations P1821 

A. Berezin, A. Kremzer (Zaporozhye, UA) 

Prognostic significance of serum uric acid in heart failure with preserved 

systolic function and atrial fibrillation P1822 

M.s. deshko, V.A. snezhitskiy, G.A. Madekina, I.A. dolnik (Grodno, BY) 

Myeloperoxidase activity and sodium restricted diet in heart failure patients 

with preserved ejection fraction P1823 

O. Vittos, F. Halici, B. Toana, d. Marta, A. Vittos, e. Moldoveanu (Bucharest, RO) 

Renal sympathetic denervation suppresses atrial fibrillation in a pig model for 

sleep apnea P1824 

M. Hohl, d. Linz, A. Nickel, U. schotten, F. Mahfoud, C. Maack, K. Wirth, 

M. Boehm (Homburg and Frankfurt/Main, de; Maastricht, NL) 

Levosimendan exhibits anti-inflammatory effects on human cardiac myocytes 

and human endothelial cells in vitro P1825 

K.A. Krychtiuk, L. Watzke, C. Kaun, s. demyanets, s.P. Kastl, A. Zuckermann, 

G. Maurer, K. Huber, J. Wojta, W.s. speidl (Vienna, AT) 

Exercise activated cytoplasmic CamKII corrects post-myocardial infarction 

cardiac exication-contraction-coupling dysfunction. P1826 

A.s. Johnston, M. dunne, W.R. Giles, G.L. smith, O.J. Kemi (Glasgow, GB; 

Calgary, CA) 

Heme catalyzed protein oxidation disturbs contractile function of human 

cardiomyocytes P1827 

G. Alvarado Contreras, A. Toth, V. Jeney, T. Huynh, H. Csaba, Z. Papp, J. Balla 

(debrecen, HU) 

Altered Na regulation during the development of myocardial hypertrophy: 

role of phospholemman P1828 

A. Boguslavskyi, d. Pavlovic, K.L. Aughton, W. Fuller, M.J. shattock (London and 

dundee, GB) 

Increased inflammatory and alternative monocyte/macrophage markers in 

patients with hypertension and heart failure with preserved ejection fraction P1829 

N. Glezeva, V. Voon, C. Watson, M. Ledwidge, K. Mcdonald, J. Baugh (dublin, Ie) 

hfa winter 

meeting posters

hfa winter 

meeting posters 

hfa winter meeting poster sessions 

Mitochondrial respiration is not controlled by endogenous nitric oxide during 

beta-adrenergic stimulation in cardiac myocytes P1830 

M. Kohlhaas, s. Bergem, A.G. Nickel, M. Meiser, M. Hohl, U. Laufs, M. Boehm, 

C. Maack (Hamburg, de) 

The RacGAP ArhGAP15 protects against hypertension and pressure 

overload-induced contractile dysfuntion P1831 

A. Ghigo, J. Cimino, e. Hirsch (Turin, IT) 

Cardiac myocyte beta3 adrenergic receptor protects from cardiac fibrosis 

through inhibition of paracrine signaling to fibroblasts: proteomic analysis of 

the myocyte secretome P1832 

N. Hermida, e. dubois, J. Hammond, J. Hamelet, A. Markl, M. Mayr, J.L. Balligand 

(Brussels, Be; London, GB) 

De novo troponin I expression in subcutaneous adipose tissue-derived 

progenitor cells (ATDPCs) seeded into a bioimplant and transplanted in a 

mouse model of myocardial infarction P1833 

C. soler-Botija, J.R. Bago, A. Llucia-Valldeperas, M. Monleon Pradas, C. semino, 

J.C. Chachques, A. deten, C. Martinez, A. Valles, A. Bayes-Genis (Badalona, 

Barcelona and Valencia, es; Paris, FR; Leipzig, de) 

High throughput functional screening identifies microRNAs inducing cardiac 

regeneration P1834 

M. Cunha Mano, A. eulalio, M. dal Ferro, L. Zentilin, s. Zacchigna, M. Giacca 

(Trieste, IT) 

Failing myocardium as additional erythropoietin source. Local endogenous 

erythropoietin and erythropoietin receptor xxpression P1835 

P. Leszek, B. sochanowicz, K. Brzoska, P. Kolsut, T. Rywik, W. Piotrowski, 

J. Rozanski, M. Kruszewski (Warsaw, PL) 

Myoscape (Muscle enriched Calcium-Channel associated protein), a novel 

regulator of L-type Calcium Channel dependent calcium cycling and 

contractile function in vivo P1849 

M. eden, B. Meder, R. Will, M. Voelkers, C. Heymes, P. Most, W. Rottbauer, 

H.A. Katus, N. Frey (Kiel, Heidelberg and Ulm, de; Paris, FR) 

Tissue printed cardiac progenitor cell patch improve myocardial function in 

a mouse model of MI. P1850 

R. Gaetani, d. Feyen, R. slaats, V. Verhage, e. Messina, A. Giacomello, 

P. doevendans, J. sluijter (Utrecht, NL; Rome, IT) 

Cardiorenal Anaemia Syndrome in Chronic Heart Failure contributes to 

increased sympathetic nerve activity P1851 

A. Pathak, F. despas, N. Franchitto, M. Labrunee, M. Galinier, J.M. senard 

(Toulouse, FR) 

Inhibition of dipeptidyl peptidase IV improves left ventricular compliance in 

obese diabetic mice. P1852 

A.-s. Hervent, N. Hamdani, I. de Meester, W. Linke, W. Paulus, 

G.W.A. de Keulenaer (Antwerp, Be; Amsterdam, NL; Bochum, de) 

PDE3 regulates basal cGMP levels and cGMP/cAMP cross-talk in adult mouse 

ventricular cardiomyocytes P1853 

K.R. Goetz (Göttingen, de) 

194

HFA winter meeting poster sessions 

Ablation of mafbx/atrogin-1 blocks autophagy leading to restrictive 

cardiomyopathy and premature death 

T. Zaglia, G. Milan, A. Ruhs, M. Kruger, M. Franzoso, e. Bertaggia, P. Pesce, 

d. Glass, M. Mongillo, M. sandri (Padova, IT; Bad Nauheim, de; Cambridge, Us) 

Cardiac fibroblast-secreted microRNAs mediating cardiomyocyte hypertrophy. 

C. Bang, s. dangwal, s. Batkai, A. Zeug, M. Mayr, A. schmiedl, T. Thum 

(Hannover, de; London, GB) 

Cardiac sympathetic neurons establish and maintain cardiomyocyte size 

heterogeneity throughout the myocardium. 

N. Pianca, T. Zaglia, L. Nalotto, M. Franzoso, P. Brum, M. sandri, M. Mongillo 

(Padova, IT; sao Paulo, BR) 

Cyclic GMP enhancing therapy promotes titin phosphorylation and corrects 

high cardiomyocyte passive stiffness in diastolic heart failure 

N. Hamdani, M.M. Redfield, W.A. Linke (Bochum, de; Rochester, Us) 

Determinants of abnormal resting heart rate and chronotropic exercise 

response in advanced systolic heart failure - evidence for distinct. 

J. Benes, M. Kotrc, B.A. Borlaug, K. Lefflerova, P. Jarolim, B. Bendlova, A. Jabor, 

J. Kautzner, V. Melenovsky (Prague, CZ; Rochester, Us) 

FRET measurements of local cAMP signalling in the sarcolemmal T-tubular 

compartment of cardiomyocytes. 

R.K. Perera, V.O. Nikolaev (Göttingen, de) 

Genetic deletion of phosphatase inhibitor-1 versus betablocker treatment in 

severe CaMKIIdeltaC-induced heart failure. 

M. dewenter, s. Neef, C. Brammen, J.H. Brown, L.s. Maier, A. el-Armouche 

(Göttingen, de; Los Angeles, Us) 

HDAC4 reduces pathological but stimulates physiological cardiac remodeling. 

L.H. Lehmann, Z. Jebessa, M.M. Kreusser, A. Horsch, L. Frischbier, U. Oehl, 

H.J. Groene, H.A. Katus, J. Backs (Heidelberg, de) 

Histone deacetylase 4 controls reactivation of ANP in heart failure by 

regulating rapid demethylation of H3K9 through association with SuV39H1. 

M. Hohl, M. Wagner, J.C. Reil, L. Lehmann, A.M. Zimmer, M. Tauchnitz, J. Backs, 

M. Boehm, C. Maack (Homburg and Heidelberg, de) 

Local cAMP dynamics in the SERCA2 signalling compartment studied by a 

targeted FRET biosensor in adult mouse cardiomyocytes. 

J.U. sprenger, V.O. Nikolaev (Göttingen, de) 

Nitric oxide regulates cardiac intracellular Na levels by modulating Na/K 

ATPase via PKC and phospholemman-dependent mechanism. 

d. Pavlovic, A. Hall, e. Kennington, K. Aughton, W. Fuller, s. despa, d. Bers, 

M. shattock (London and dundee, GB; davis, Us) 

Regulation of pathological cardiac remodeling following myocardial 

infarction: the role of miR-199b. 

B. duygu, L. Philippen, G.J.J. silva, N. Bitsch, L.J. de Windt, 


Titin phosphorylation deficit and high cardiomyocyte stiffness in an animal 

model of metabolic risk induced heart failure with preserved ejection fraction. 

N. Hamdani, I. Falcao-Pires, A.P. Lourenco, C.P.M. Franssen, A.F. Leite-Moreira, 

W.J. Paulus, W.A. Linke (Bochum, de; Porto, PT; Amsterdam, NL) 

195 

hfa winter 

meeting posters

millions of people in the world have 

heart failure 

NeW CONTeNT 

One website can help them understand their condition 

and take the necessary steps to live full and active lives. 

www.heartfailurematters.org 

Captivating animations Personal experience 

videos 

Heartfailurematters.org is an educational website for people with heart failure, 

their families and carers. It was developed by cardiologists, nurses and primary care 

physicians from the Heart Failure Association of the European Society of Cardiology. 

197 

Practical patient 

information 

Arabic version - summer 2013 

What are 

the warning signs? 

Helping you understand 

heart failure 

Advice on what 

you can do 

Tips for living 

with heart failure 

Downloadable tools 

INDEX

199 

SESSIoNS by toPIC 

Name/Page Number 

Acute heart failure ........................................................................................................................................................................................22, 56, 62, 77 

Acute heart failure (management) ...............................................................................................................................................................................44 

Acute heart failure (therapy)................................................................................................................................................................................... 37, 56 

Arrhythmias and treatment .............................................................................................................................................................................19, 31, 32 

Assist devices ...........................................................................................................................................................................................................21, 29, 36 

biomarkers ...............................................................................................................................................................................................28, 33, 45, 58, 82 

Cancer/Cardiotoxicity ..........................................................................................................................................................................................................51 

Cardiac resynchronisation therapy ..............................................................................................................................................................................34 

Cardiomyopathy ...........................................................................................................................................................................................................60 , 63 

Cell Signalling ...........................................................................................................................................................................................................................61 

Co-morbidities ........................................................................................................................................................................................29, 38, 52, 61, 72 

Devices / Artificial heart / CRt / ICD ...........................................................................................................................................................................28 

Devices and technology ........................................................................................................................................................................................... 23, 51 

Diagnosis ....................................................................................................................................................................................................................................35 

Disease management programmes ............................................................................................................................................................................22 

Drug therapy, other ...................................................................................................................................................................40, 41, 44, 59, 68, 69 

Exercise testing ............................................................................................................................................................................................................... 38, 63 

Gene and cell therapy ............................................................................................................................................................................................... 33, 39 

HFpEF - Heart failure with preserved ejection fraction ...................................................................................................................20, 41, 59 

Hypertension / LV hypertrophy ............................................................................................................................................................................ 52, 68 

Imaging, other ............................................................................................................................................................................................................... 20, 55 

Left ventricular function .....................................................................................................................................................................................................33 

Metabolism / Ischemia / Reperfusion / Preconditioning .................................................................................................................................57 

Miscellaneous ...................................................................................18, 24, 26, 27, 30, 31, 40, 43, 48, 49, 53, 54, 55, 57, 62, 64, 65, 

69, 70, 71, 72, 73, 74, 78, 83, 119, 155, 191 

Molecular biology / genetics ...........................................................................................................................................................................................29 

Nursing ...............................................................................................................................................................................................................39, 42, 73, 80 

Population studies / Epidemiology ..................................................................................................................................................................... 18, 19 

Prognosis ....................................................................................................................................................................................................................................81 

Pulmonary hypertension .......................................................................................................................................................................................... 32, 58 

telemedecine ...........................................................................................................................................................................................................................79 

Valvular heart disease (diagnosis, management and interventional therapies) .....................26, 27, 35, 37, 48, 49, 50, 60 

INDEX

INDEX 

SESSIoNS by CAtEGoRy 


Advanced heart failure management - VAD and transplant 

• From circulatory support to transplantation ..........................................................................................................................................................29 

• From pharmacological management to destination therapy .......................................................................................................................21 

basic Science 

• Rapid Fire Session 2 ...........................................................................................................................................................................................................64 

• Young Investigator Award: Basic Science ................................................................................................................................................................43 

basic Science - translational 

• Amplifier and economizer in cardiac beta-adrenergic signaling ..................................................................................................................61 

• Epigenetics of heart failure .............................................................................................................................................................................................31 

• Gene therapy for heart failure: ready for the clinic? ..........................................................................................................................................55 

• Basic & translational Science Highlights of the Heart Failure Congress 2013 .......................................................................................74 

• Novel concepts for myocardial regeneration ........................................................................................................................................................39 

• Oxidative stress in heart failure: mechanisms and treatment ........................................................................................................................57 

• The matrix modulates cardiac cell fate in heart failure......................................................................................................................................33 

Clinical Practice 



• Young Investigator Award: Clinical .............................................................................................................................................................................30 

Current evidence-based management 

• Gender, pregnancy and heart failure ........................................................................................................................................................................18 

• Non-pharmacological management of HFREF ....................................................................................................................................................73 

• U-shape relationship in heart failure? ........................................................................................................................................................................68 

• Update on optimised pharmacological management in heart failure with reduced ejection fraction ....................................69 

• What is controversial in the 2012 ESC Heart Failure Guidelines? ...............................................................................................................40 

• What you should know about exercise training .................................................................................................................................................63 

Education 

• Controversies in the management of heart failure .............................................................................................................................................62 

• HFA/ESC Cardiologists of Tomorrow session: the heart failure specialist of tomorrow .....................................................................69 

• How to manage arrhythmias in heart failure ........................................................................................................................................................32 

• How to manage valvular disease in heart failure ................................................................................................................................................60 

• The heart failure patient with Coronary Artery Disease ...................................................................................................................................38 


• Failing hearts and failing brains ..................................................................................................................................................................................61 

• Heart failure in cardiomyopathies ...............................................................................................................................................................................63 

• Management of co-morbidities in heart failure ....................................................................................................................................................52 

• New chronic heart failure medications at the horizon .....................................................................................................................................59 

• Pulmonary hypertension in heart failure .................................................................................................................................................................32 

• The heart and cancer ........................................................................................................................................................................................................51 

• Update on myocarditis and pericarditis ...................................................................................................................................................................60 

• What a busy clinician needs to know about hypertension ............................................................................................................................68 

Guidelines into Practice 

• What is controversial in the 2012 ESC Heart Failure Guidelines? ...............................................................................................................40 

HFA Focus 


• Diagnosis of heart failure and co-morbidities ........................................................................................................................................................29 


• How to manage valvular disease in heart failure ................................................................................................................................................60 

• Pharmacological treatment and referral to cardiology .....................................................................................................................................41 

• The heart failure patient with Coronary Artery Disease ...................................................................................................................................38 

200

201 

SESSIoNS by CAtEGoRy 


Imaging and biomarkers 

• Biomarkers: state-of-art and the future .....................................................................................................................................................................28 

• Imaging in heart failure 1: update 2013 .................................................................................................................................................................20 


• Novel biomarkers in heart failure: targets for therapy? ....................................................................................................................................33 

Interventions Devices and telemonitoring 

• Device therapy in heart failure: news and innovations ...................................................................................................................................51 

• More on new devices for heart failure .....................................................................................................................................................................28 

• Renal denervation: from heart failure prevention to heart failure therapy? ...........................................................................................52 

• Telemonitoring in heart failure: what is needed to make this ready for routine use? .......................................................................39 

• Valvular interventions in the heart failure patient ...............................................................................................................................................37 

Joint Session 

• Cardiac rehabilitation and exercise training in heart failure ...........................................................................................................................38 

• From circulatory support to transplantation ..........................................................................................................................................................29 


• How to treat HFPEF in 2013: practical considerations .....................................................................................................................................41 


• Management of acute heart failure: 2013 update and perspectives .......................................................................................................56 

• Management of co-morbidities in heart failure ....................................................................................................................................................52 

• Novel concepts for myocardial regeneration ........................................................................................................................................................39 

• The heart and cancer ........................................................................................................................................................................................................51 

• Ventricular arrhythmias and sudden death in heart failure: modern therapy ......................................................................................19 

• What a busy clinician needs to know about hypertension ............................................................................................................................68 

Latest Updates 

• Late breaking trials 1 ..........................................................................................................................................................................................................31 

• Late breaking trials 2 ..........................................................................................................................................................................................................55 

• What’s new in Industry? ...................................................................................................................................................................................................57 

Local session 

• Cardiac rehabilitation and exercise training in heart failure ...........................................................................................................................38 

• Diagnosis of heart failure and co-morbidities ........................................................................................................................................................29 

• How to improve heart failure care and investigation in Portugal ...............................................................................................................19 


• Management of acute heart failure: 2013 update and perspectives .......................................................................................................56 

• Pharmacological treatment and referral to cardiology .....................................................................................................................................41 

Patient Care 

• Nursing Investigator Award ...........................................................................................................................................................................................42 

• Should I take my medicine? ...........................................................................................................................................................................................73 

• Telemonitoring in heart failure: what is needed to make this ready for routine use? .......................................................................39 

INDEX

INdEX 

CHAIRPERSONS & JudgES* 


A 

Abraham W.T.: 21 

Adamopoulos S.: 72 

Angermann c.: 42* 

Annest L.: 27, 50 

Anker S.D.: 19, 23, 24, 31, 35, 44, 51, 57, 58, 59, 62, 68 

Auricchio A.: 23, 34 

B 

Bacal F.: 20 

Bauersachs J.: 39 

Bitter T.: 49 

Boehm M.: 40, 52 

Brito D.: 32, 41, 56 

Brito J.A.: 29 

Brutsaert D.L.: 39, 59 

C 

Cavusoglu Y.: 32 

Clark A.L.: 63 

Cleland J.G.F.: 22, 39, 73 

Coats A.: 30 

Cohen-Solal A.: 38, 73, 81 

Cowie M.: 22, 58, 68 

Crespo-Leiro M.G.: 42*, 61, 70 

D 

De Teresa Galvan E.: 35 

De Windt L.: 31, 43* 

Dickstein K.: 34, 40, 51, 62 

Doughty R.: 82 

e 

Ekman I.: 39, 42* 

Emdin M.: 63 

Ertl G.: 61 

Eschenhagen T.: 55 

F 

Felker G.M.: 53 

Filippatos G.: 37, 44, 55, 58, 72 

Fischmeister R.: 43* 

Fitzsimons D.: 42 

Fontes Carvalho R.: 69 

Force T.L.: 51 

G 

Goncalves L.M.: 19 

Gonzalez Juanatey J.R.: 20, 38 

202 

H 

Hasenfuss G.: 38, 56 

Herrscher Bjorkeng T.E.: 26 

Heymans S.: 43, 78 

Hilfiker-Kleiner D.: 33 

Hindricks G.: 79 

Hoes A.: 41 

Homma S.: 40 

Hu Dayi: 19 

I 

Isobe M.: 68 

J 

Jaarsma T.: 73 

Jorde U.: 36 

K 

Kautzner J.: 29 

Kleber F.X.: 22 

Koehler F.: 58 

Komajda M.: 22 

Krum H.: 41 

L 

Lainscak M.: 42* 

Lam C.S.: 41, 59 

Lambrinou E.: 42, 73 

Latini R.: 82 

Laufs U.: 68 

Leite-Moreira A.: 33 

Lip G.Y.J.: 31 

Lopez-Sendon J.L.: 32 

Lyon A.: 78 

M 

Maack C.: 43, 64, 74 

Madeira H.: 19 

Maier L.S.: 43* 

Maisel A.: 28, 45 

Manito Lorite N.: 29 

Mareev V.: 31 

Marzullo P.: 35 

Massie B.M.: 62 

McDonagh T.: 80 

McMurray J.J.V.: 31, 34, 40 

Mebazaa A.: 33 

Molkentin J.: 31, 55 

Moura B.E.: 41 

Mueller C.: 28

N 

Nanas J.: 21 

Neyses L.: 61, 69 

Nieminen M.: 56 

Nihoyannopoulos P. : 55 

O 

O’Connor C.: 59 

P 

Packer M.: 30*, 69 

Papp Z.: 43*, 74 

Parissis J.T.: 77 

Paulus W.J.: 20 

Peneda M.T.: 41 

Pepper J.R.: 29 

Piepoli M.F.: 53, 79, 80 

Pieske B.M.: 24, 41, 51, 55, 72 

Pinto F.J.: 20, 45, 55 

Pitt B.: 30* 

Ponikowski P.: 35, 37, 52, 60, 62, 72 

Post H.: 57 

R 

Ramachandran V.S.: 69 

Regitz-Zagrosek V.: 18, 28* 

Romitelli P.: 26, 49 

Ruilope L.M.: 52 

Ruschitzka F.: 18, 28, 32, 38, 57 

S 

Sadoshima J.: 61, 64 

Schillinger W.: 37 

Schultheiss H.-P.: 63 

Seferovic P.: 18, 30 

Senni M.: 30* 

Shah A.M.: 57 

Shlyakhto E.V.: 60, 77 

Silva-Cardoso J.D.: 29 

Smiseth O.: 60 

Souza Neto J.: 52 

Suter T.M.: 51 

Swedberg K.: 44 

T 

Tavazzi L.: 63, 81 

Triposkiadis F.K.: 56 

Tschoepe C.: 60 

203 

CHAIRPERSoNS & JUDGES* 


V 

Van Der Meer P.: 18 

Vanhaecke J.: 70 

Van Hees D.: 26, 49 

Vardas P.E.: 24, 28 

Von Haehling S.: 33 

Voors A.: 37, 44 

Z 

Zannad F.: 34 

Zimpfer D.: 36 

INDEX

INDeX 

speakers 

Name/Index Number 

A 

Abraham W.T.: 180, 325, 327, 64 

Adamopoulos S.: 188 

Ahmed A.: 355, 6 

Aid-si-Ali S.: 88 

Alfieri O.: 158, 347 

Almeida A.M.G.: 30 

Amorim S.M.R.: 74 

Anand I.S.: 22, 70 

Angermann C.E.: 358 

Anker S.D.: 141, 163, 196, 224, 453, 55 

Ascencao R.: 199 

Auricchio A.: 131 

B 

Bacal F.: 256 

Backs J.: 364 

Bai R.: 20 

Bakris G.: 250, 403, 412 

Baldus S.: 157, 346 

Baptista R.: 16 

Basso C.: 377 

Bauersachs J.: 151, 185, 306 

Bettencourt N.: 29 

Blankenberg S.: 155, 346 

Bocchi E.A.: 258 

Boehm M.: 253 

Borggrefe M.: 237 

Borlaug B.: 24, 298 

Bover Freire R.: 171 

Boyne J.: 176 

Brito D.: 13, 57 

C 

Camici P.G.: 299, 31 

Camm A.J.: 105 

Campelo M.B.: 201 

Cardim N.: 16 

Carrier L.: 277 

Channer K.S.: 451 

Christensen G.: 127 

Clark A.L.: 404, 457 

Clausell N.: 312 

Cleland J.G.F.: 132, 197, 203, 37, 374, 38, 62, 422 

Coats A.J.S.: 174, 247, 380, 453, 455, 51, 63 

Colombo A.: 167, 348 

Cotter G.: 226, 46 

Cowie M.R.: 201, 222, 324, 45, 49 

Crespo-Leiro M.G.: 77 

204 

D 

Da Costa Martins P.A.: 89 

Davies K.: 277 

De Boer R.A.: 232, 67 

Dickstein K.: 118, 135 

Doehner W.: 356, 456 

Doughty R.: 202 

e 

Eaton P.: 362 

Edelmann F.: 384 

Ekman I.: 40, 464 

El-Armouche A.: 361 

Elliott P.M.: 378 

Ertl G.: 461 

Ewer M.: 244 

F 

Fedele F.: 146 

Felker G.M.: 372 

Fenelon G.: 113 

Ferreira Santos J.: 16 

Filippatos G.S.: 190, 225, 329, 342 

Fischmeister R.: 360 

Fonseca C.: 11, 72 

Foo R.: 86 

Force T.L.: 243 

Fruhwald F.M.: 179 

G 

Gaspar M.A.: 200 

Gheorghiade M.: 160, 304, 374 

Giacca M.: 181, 276 

Gilard M.: 156 

Gomez Sanchez M.A.: 36 

Guazzi M.: 117, 341 

Gustafsson F.: 151, 240 

H 

Halle M.: 382 

Harjola V.-P.: 303 

Hasenfuss G.: 348, 239, 34, 50 

Haverkamp W.: 110 

Heinzel F.R.: 17 

Heymans S.: 126, 2 


Hindricks G.: 111 

Hirsch E.: 363 

Hoes A.W.: 175, 462 

Hohl M.: 87 

Holzmeister J.: 295

Homma S.: 109 

Hu D.: 194 

Hulot J.-S.: 279 

I 

Imazio M.: 353 

J 

Jaarsma T.: 424 

Jankowska E.A.: 357, 418, 450 

Jessup M.: 415, 76 

Jorde U.: 150, 154 

K 

Kautzner J.: 18 

Keren A.: 375 

Kirsch M.: 153 

Kleber F.X.: 42 

Kober L.: 169 

Koehler F.: 178, 458 

Komajda M.: 221, 43, 44 

Komuro I.: 322, 409 

Kraigher-Krainer E.: 23 

Krum H.: 251 

Kuck K.-H.: 168, 108, 144, 19, 52, 61 

L 

Lainscak M.: 248, 359 

Lam C.S.P.: 115, 373 

Landmesser U.: 29 

Lang I.M.: 114 

Laufs U.: 465 

Laurent S.: 249 

Lehmann L.H.: 90 

Leite-Moreira A.: 169, 348 

Linde C.: 133, 189 

Lip G.Y.H.: 106, 193 

Liu P.: 227 

Lopez-Sendon J.L.: 309, 374 

Lousada N.J.: 16, 74 

Lyon A.: 280 

M 

Maack C.: 319 

Maggioni A.P.: 113, 142, 187, 407, 459 

Mahfoud F.: 252 

Maisel A.: 123, 233, 332, 39 

Mamas M.: 257, 454 

Manolis A.S.: 107 

Mareev V.: 423 

Martins E.: 14 

R 

Ramachandran V.S.: 335 

Riley J. : 177 

Ristic A.D.: 351 

Robalo Martins M.S.: 16, 310 

Rohde E.: 27 

Roig E.: 75 

Rosano G.M.C.: 354, 452 

Rosenhek R.: 143, 146, 345 

205 

SPEAkERS 


Marzullo P.: 148 

Massie B.M.: 453 

Mayr M.: 130 

McDonagh T.A.: 416, 463 

McMurray J.J.V.: 136, 137, 162, 191, 330, 365, 422, 71 

Mebazaa A.: 119, 302, 374 

Mendes M.: 172 

Metra M.: 161, 301, 32, 366 

Milicic D.: 152, 166 

Molkentin J.: 129 

Mont L.: 112 

Moura B.E.: 12 

Mueller C.: 124, 331, 47 

Mullens W.: 134 

N 

Nihoyannopoulos P.: 28 

Nieminen M.S.: 414 

O 

O’Connor C.: 369 

P 

Packer M.: 229, 367 

Pankuweit S.: 349, 376 

Papp Z.: 321, 334 

Parissis J.T.: 311 

Paulus W.J.: 206, 26, 338 

Peacock W.F.: 122, 164, 234 

Pedrazzini T.: 182 

Pepper J.R.: 348, 35, 374 

Peres M.: 16 

Pieper P.G.: 8 

Piepoli M.F.: 173, 381 

Pieske B.M.: 223, 337, 339, 54, 59 

Pina I.: 383, 406 

Pinto F.J.: 113, 231, 3 

Pitt B.: 138, 420 

Pleger S.: 278 

Ponikowski P.: 145, 195, 220, 308, 453 

Potena L.: 78 

Proenca V.: 74 

INDEX

INDeX 

speakers 


Rosenkranz S.: 116, 169, 373, 408 

Ruschitzka F.: 236, 326, 417 

Rutten F.H.: 254 

S 

Sadoshima J.: 320 

Saito Y.: 411 

Schillinger W.: 157, 348 

Scholte A.J.H.A.: 147 

Schultheiss H.P.: 350 

Schwitter J.: 297 

Seferovic P.: 201, 379 

Senni M.: 343 

Shah A.M.: 7 

Silva-Cardoso J.: 15, 57 

Sliwa-Hahnle K.: 9 

Smiseth O.A.: 296 

Solomon S.: 336, 340 

Sonntag S.: 41 

Springer J.: 449 

Sterba M.: 245 

Suter T.: 246 

Swedberg K.: 219, 421 

Szeto H.: 323 

T 

Taborsky M.: 53 

Tato R.: 73 

Tavares Aguiar C.M.: 201 

Teerlink J.R.: 241, 305, 368 

Thum T.: 128 

Tousoulis D.: 120 

Triposkiadis F.K.: 205 

Trochu J.-N.: 4, 65 

Tschoepe C.: 352, 413 

206 

V 

Van Laake L.W.: 183 

van Veldhuisen D.J.: 121, 69 

Vanhaecke J.: 79 

Vardas P.E.: 56, 60 

Vilas-Boas F.: 170 

Voigt J.U.: 300 

Von Haehling S.: 385, 405 

Voors A.A.: 186, 228, 230, 255, 48 

W 

Wachter R.: 453 

Werdan K.: 33 

Wollert K.C.: 1, 68 

Y 

Yu C.M.: 204, 21 

Z 

Zannad F.: 139, 238, 410 

Zeisberg E.: 89 

Zimmermann W.-H.: 184 

Zimpfer D.: 149, 152

A 

A Low P.C.H.A.I.: P1482 

Aakhus S.: P1455 

Abassi Z.: P1441, P623 

Abate E.: P1469 

Abdallah S.: P1277 

Abdel Ghani M.: P1277 

Abdelfattah I.: P1159, P1282 

Abdelfattah R.: P1016 

Abdelhamid M.: P1423 

Abdelhamid M.A.: P994 

Abdelmoneim M.A.: P1121 

Abdelrehim S.S.: P1203 

Abdennadher M.E.D.: P1071, P1376 

Abdullaev T.A.: P1022, P1129, 

P1568, P592, P636, P643, P700, 

P879 

Abdullaeva C.H.: P1138 

Abdullaeva S.Y.: P848 

Abdullayeva S.Y.: P733 

Abe H.: P1047, P549 

Abecasis J.: P1172, P1697 

Abenza S.: P1745, P926, P928 

Abid D.O.R.R.A.: P1034, P1034, 

P1071, P1376, P1506, P1813, P544, 

P547 

Abid L.E.I.L.A.: P1034, P1034, P1071, 

P1376, P1506, P1813, P544, P547 

Ablasser K.: P1119 

Abozeid A.: P1423, P994 

Abraham W.T.: 274 

Abraham W.T.: P1102, P1104 

Abramov A.A.: P1331 

Abreu A.: P1155, P1163, P1186, 

P1251, P548, P977 

Abreu L.: 431, P1814 

Abreu R.F.: P1594 

Abukhudair W.A.: P1121 

Acevedo P.: P1622 

Achilli F.: P1387, P935, P953 

Adamayn K.G.: P1417 

Adamo M.: P1135 

Adamopoulos S.: P1528 

Adams K.: P786 

Adamson P.B.: P1102 

Adao R.: P909 

Adarichev V.V.: P1578 

Adeyemi O.M.: P785 

Admon D.: P1265 

Adonina E.: P1430 

Adragao P.: P1374 

Aelst L.V.: P897 

Afolabi-Brown O.: P1805 

Afonso J.: P899 

Agazio A.: P1705 

Ageev F.: P784 

Ageev F.T.: P1136, P1136, P1659 

Aggelopoulos P.: P988 

Agha Y.A.: P724 

Agoston-Coldea L.: P1713 

Agostoni P.: P510, P514 

Agostoni P.G.: P512, P821 

Agra Bermejo R.M.: P1774 

Agren S.: 207, P504 

Aguiar C.: P1374, P1615, P1697 

Aguiar J.: P1306, P1402, P1404, 

P1407, P1408, P1692 

Aguilar-De La Torre D.: P1344 

Agustin J.A.: P750 

Ahmed A.U.M.: P646 

Ahn J.: P576 

Ahn T.H.: P1725 

Aichinger J.: P1509 

Aithan A.: P1818 

Aithan A.S.: P955 

Ajam A.A.: P1105 

Ajmi H.A.S.S.E.N.: P1071 

Ajoku N.: P540 

Akao H.: P603 

Akasheva D.: P858 

Akasheva D.U.: P1157 

Akay Y.: P626 

Akchurin R.: P1351 

Akchurin R.S.: P1073, P1352 

Akhmadullina L.: P1208 

Akhmatov Y.R.: P700 

Akhmetov R.: P1037, P1150 

Akimova N.S.A.: P1487, P633 

Akpinar I.: P763 

Akrimi S.: P1652 

Akrout M.A.L.E.K.: P1071, P1376, 

P1506, P1813 

Akyildiz M.: P741 

Akyildiz Z.I.L.K.E.: P1292, P873 

Al Barjas M.: P1180, P745 

Al Najjar M.M.H.: P1105 

Al Najjar M.M.H.: P1121 

Al Zein A.: P944 

Alaeva E.: P1454 

Alameen E.W.: P1462 

Al-Amin A.: P574 

Alawi Y.: P1434 

Albert N.M.: P1677 

Albino-Teixeira A.: P899 

Albuquerque A.: P1096, P648, P649, 

P940 

207 

AUtHoRS 


Al-Chamali H.: P1584 

Aldamiz Echevarria Castillo G.: P1382 

Alderighi C.: P1518 

Aldulea N.: P1624 

Aleem Q.: P968 

Alehagen U.: 440 

Alexander D.: P1039 

Alexanian I.: P971 

Alface M.: P1733 

Al-Habbaa A.: P574 

Alhabib K.F.: P1553, P799 

Alharfi Z.: P1553, P799 

Ali A.: P1767, P1776 

Ali F.: P944 

Ali M.: P1584 

Alici H.: P1794 

Alieva T.: P1201 

Alikulov I.: P1044, P1138, P1563, 

P620 

Allon E.: P623 

Almansa Valencia I.: P562 

Almeida A.: P1238, P1710 

Almeida A.N.A.G.: P1710 

Almeida I.: P532, P568, P572, P618, 

P699 

Almeida I.A.: P1627 

Almeida R.: P1801, P1802 

Almeida R.C.M.: P1375 

Almenar-Bonet L.: P1548, P970 

Almeria C.: P750 

Al-Mohammad A.: P719 

Alogna A.: 402, P1347, P1782, 

P1792, P488, P888, P889 

Alonso Briales J.H.: P1064, P1695, 

P1696, P1701 

Alp A.: P1604 

Alqarni A.K.: P1434 

Alqaseer M.M.: P1434, P1818, P955 

Alradhi D.R.: P883 

Alshaghaa W.: P1553 

Al-Shawabkeh N.: P597 

Altara R.: P1316 

Alter P.: P823 

Alterini B.: P1425, P1759 

Altimir S.: P1662, P1698 

Alvarado Contreras G.: P1827 

Alvares Pereira M.: P1691 

Alvelos M.: P1144, P1254, P716, 

P841 

Alves M.: P1179, P1366, P956, P992 

Alves T.: P1155 

Amabile A.: P682 

Amador P.: P1166, P1369, P1688, 

INDEX

INDEX 

AUTHORS 


P1690 

Amaducci A.: P948 

Amara W.: P1221, P1535, P1657 

Ambrosio G.: P1579 

Ambrosioni E.: P1579 

Ambrosy A.: P541, P842 

Ambrosy A.P.: P774 

Amelina T.M.: P770 

Amin V.A.: P1109 

Amin-Youssef G.: P1493, P1637 

Amir O.: P1102 

Amitai V.: P1552 

Ammar K.A.: P1660, P751 

Ammar W.: P1277 

Ammirati E.: P705 

Amodeo A.: P1349 

Amorim M.: P1184, P1254 

Amorim P.A.: P1328, P1329, P1757 

Amorim S.: P1115, P1304, P1451, 

P1471, P588, P593, P717, P772 

Amorim S.M.R.: P1456, P596 

Amosova E.: P963 

Amosova K.M.: P1574 

Amosova K.M.: P1185, P1286 

Amraoui S.: P1086, P1510, P659 

Anastasakis A.: P1809 

Anastasiou-Nana M.: 262, P1645, 

P505, P812, P965, P971 

Ancsin B.: P1090, P1259, P1380, 

P714 

Andersson C.: 209 

Andersson K.B.: P489 

Ando K.: P1533 

Andossova S.: P1526 

Andova V.: P1806 

Andova V.A.: P1610, P754, P934 

Andova Valentina A.V.: P1613 

Andrade A.: P1650, P1712, P756 

Andrade Junior J.R.: P1114 

Andrade M.J.: P1172 

Andrade R.: P1305, P1583 

Andrea Riba R.: P1248, P1641, P777 

Andreae C.: P501 

Andreassen J.: P1455 

Andreev S.L.: P515 

Andreoli C.: 262 

Andreou C.: P1088 

Andreou J.: P852 

Andreou K.: P1645 

Andric A.: P1057, P1193, P1285, 

P1714 

Andrikopoulou E.: P1109 

Angel Fernandez Trasancos A.F.T.: 

P1774 

Angeli P.: P1472 

Angelidi A.: P1158 

Angelini A.: 427, P689 

Angelov A.A.: P826 

Angermann C.: P476, P518 

Angermann C.E.: P813 

Angermann C.E.: 436, P523, P807 

Anjo D.: P1025, P1050, P1239, 

P1307, P1516, P1519, P1558, 

P1592, P1675, P1799, P654, P676 

Anker S.: P1102, P1141 

Anker S.D.: P734 

Anker S.D.: P1049, P1065, P1226, 

P1298, P1503, P1736, P625, P640, 

P787, P989 

Anna Junior M.S.: 435 

Annabi M.S.: P1253 

Antenore A.: P1318 

Antohi E.-L.: P637 

Antohi L.: P541 

Antolic B.: P1379 

Anton Bravo T.: P1385 

Antoncecchi V.: P1046, P1475, P613 

Antonijevic N.: P972 

Antonio N.: P652, P657 

Antoniou C.: P852 

Antony R.: P1093, P1095, P1199, 

P1252, P1293, P1523, P519, P723, 

P724 

Antoons G.: P1748, P1790, P888, 

P889 

Antunes A.M.: P1007, P1008, P1058, 

P1478 

Antunes M.: P1540, P484 

Antunes N.: P1307, P1798 

Aoki H.: P1600, P603 

Apostolo A.: P821 

Apostolovic S.: P1082, P1421, 

P1537, P1643, P1681, P776 

Apple F.: P1198 

Aprodu S.A.: P1729 

Aquaro G.D.: P1461, P612, P742 

Aquino A.V.: P1453 

Arai H.: P946 

Arai K.: P1520 

Arama D.: P570 

Aramburu Bodas O.: P1210 

Aramburu O.: P983 

Arandjelovic A.: P1156, P757 

Arantes C.: P1691 

Arao M.: P581, P582 

Arat Koc N.: P1364, P1527, P741 

208 

Arat M.: P1364 

Araujo A.C.: P1115 

Araujo C.: P1308, P1403 

Araujo D.: P1819, P853 

Araujo I.: P1409, P1733 

Araujo J.P.: P716 

Araujo V.: P1118, P1243, P1802 

Archer L.: P1752 

Ardashev A.: P1004 

Ardashev A.V.: P575 

Ardashev V.: P1004, P575 

Arenas M.: P503 

Arentz T.: P861 

Arestedt K.: 207, P501 

Arevalo-Lorido J.C.: P1210 

Ariano C.: P1040, P1192, P1644 

Arisi A.: P1291 

Aristimuno G.: P1629 

Ariti C.A.: P707 

Ariyaratnam P.: P907 

Arkhipova E.: P760 

Arman M.: P1687 

Armengou Arxe A.: P1210 

Arnaudova Dezhulovikj F.: P1053 

Arnaudova F.: P1048, P736 

Arnaudova-Dezulovik F.: P936 

Arnold J.M.O.: P866 

Arnous A.A.: P1105 

Arokiaraj M.A.R.K.: P1081 

Aron G.: P1599 

Aronsen J.M.: P1788 

Aronson D.: P1441, P479, P623 

Arpesella G.: P1541 

Arruda C.S.: P1215 

Arsenio A.: P1679, P816, P819 

Artemenko S.: P661 

Artemyeva E.G.: P1224, P1659 

Arutinova Y.A.: P1130 

Arutunyan I.V.: P706 

Arutynov G.P.: P801 

Arutyunov G.P.: P1655, P638 

Asai K.: P594, P962 

Asanin M.: P1258, P833, P972 

Asensio Lopez M.C.: P1597 

Asensio S.: P794, P795 

Asensio-Lopez M.C.: P1745, P926, 

P928 

Asfalou I.: P752 

Ashfaq M.: P998 

Ashihara K.: P1520 

Asif A.: 266, P1795, P478, P530, 

P674, P937, P938, P939 

Askevold E.T.: P1321, P1455

Assayag P.: P553 

Atabay B.: P1604 

Atamna A.: P479 

Athanaselis S.: P971 

Atkin P.: P1095 

Atkin S.: 82 

Atroschenko E.S.: P1275 

Attisani M.: P1108 

Aughton K.: 216 

Aughton K.L.: P1828 

Augusto S.: P1409 

Aukrust P.: P1455 

Austin J.: 208 

Avalli L.: P935 

Avila M.: P684 

Avila M.S.: P1116, P685 

Avila P.: P1257, P825 

Avila Samuel M.: P1716, P686 

Ayad M.: 267 

Aydin B.: P1197 

Aydin M.: P1280, P763 

Ayub S.F.: P1465, P1545, P543, P684 

Ayub-Ferreira S.M.: P1116, P1368, 

P1716, P685, P686 

Azel E.A.: P1573 

Azevedo A.: P1144, P1184, P1254, 

P1308, P1400, P1403, P1436, P716 

Azevedo P.: P1691 

Azmy R.: P730 

Azzam Z.: P479 

Azzolin K.O.: P506 

B 

Babal P.: P1355 

Babayev J.: P876 

Babej S.: P1699 

Bacal F.: P1116, P1117, P1124, 

P1368, P1465, P1545, P1547, 

P1672, P543, P684, P685, P686, 

P814 

Bacchelli S.: P1579 

Bacic D.: P677 

Bacior B.: P1632 

Backovic S.: P1057, P1193, P1285, 

P1714 

Backs J.: 390, 393 

Bacova B.: P1326 

Baczko I.: P1312 

Badila E.: P1497, P634 

Badin Y.V.: P1659 

Badoni G.: P809 

Badran H.: 267, P1016, P1169, 

P1282, P1723, P762 

Baessler A.: P513 

Baglini R.: P948 

Bago J.R.: P1833, P923 

Bagrii K.A.: P1612, P990 

Bagriy A.E.: P713 

Bagyura Z.: P1183 

Bahchoyan M.R.: P1543 

Bahloul M.A.B.R.O.U.: P1813, P544, 

P547 

Bahmaid R.: P1553 

Baig M.: P709, P710 

Bajraktari G.: P1676 

Bakhshaliyev A.: P1120 

Balaceanu L.A.: P1222, P1497, 

P1599, P634 

Balachandran K.: P968 

Baldasseroni S.: P1054, P1318 

Baldock-Apps G.: P475 

Baleon Esponoza R.U.B.E.: P950 

Balestrieri G.: P1569 

Bali H.-K.: P656 

Balia C.: P1754, P486 

Balla J.: P1827 

Ballesteros S.: P929 

Balligand J.L.: P1832 

Ballot J.: P1011 

Baluta M.: P577 

Baluta M.M.: P1256, P1438, P1571 

Ban E.G.Y.: P702 

Banasiak W.: P1405, P1419, P625, 

P640, P952, P995 

Bang C.: P480 

Bani R.: P496 

Banicevic S.: P1715, P832 

Banner N.R.: 426 

Banovic M.: P1156, P1182, P677, 

P757 

Baptista A.: P1027, P1281, P765, 

P782 

Baptista M.: P1540 

Baptista R.: P1540, P1693 

Bar Yosef S.: P1099 

Barac A.: P1603 

Barambio Ruiz M.: P1062, P1382, 

P1496 

Baranova E.: P1319 

Barbarash O.: P1127, P778 

Barbarash O.L.: P1620 

Barbati G.: 271, P1019, P1024, 

P1030, P1457, P1469 

Barberis V.: P1122 

Barbieri A.: P1266 

Barbone A.: 425 

209 

AUtHoRS 


Barbosa M.J.: P1669, P794, P795 

Barge Caballero E.: P931 

Bari Z.: P1380 

Barison A.: P1461, P612 

Barman M.: P1580 

Barnett D.: P719 

Barnett O.: P904, P905, P906 

Barra S.: P568 

Barreira A.: P1239, P1675 

Barreiro M.: P1361, P555 

Barreiro Perez M.L.: P542, P545 

Barretto A.C.P.: P1399 

Barretto A.C.P.B.: P1740 

Barriales V.: P527, P534, P555, P667, 

P681 

Barrio I.: P1401 

Barrionuevo Sanchez M.I.: P1721 

Barrios P.: P1622 

Barron A.J.: P1244 

Barros C.: P1313 

Barros L.: P1594 

Barroso W.M.: P1112, P1212 

Bart B.B.: P1262, P1495 

Barta A.: P1355, P1777 

Barta J.: P1334 

Barten M.J.: P673 

Barthez O.: P1294 

Bartoli N.: P1054, P1318 

Bartolome M.V.: P929 

Bartos D.: P1222, P1497, P634 

Bartunek J.: 270, P675 

Basaran Y.: P1023 

Basargina E.: P760 

Bashforth J.: P719 

Basiak M.: P744 

Bateman P.: 84 

Batkai S.: P480 

Battaia E.: P512 

Battler A.: P1765 

Bauditz J.: P1049 

Bauer M.: P734 

Bauer W.R.: P1345 

Bauersachs J.: 80 

Baugh J.: P1229, P1336, P1339, 

P1358, P1360, P1829 

Bautin A.E.: P1111 

Bayes-Genis A.: P1227, P1350, 

P1630, P1631, P1662, P1698, 

P1833, P487, P503, P624, P922, 

P923 

Bazdaric K.: P981 

Bazhenova E.: P1319 

Bdeir D.R.: P1470 

INDEX

INDEX 

AUTHORS 


Bdeir M.B.: P1028, P1462, P1464, 

P796 

Becerra Luna B.: P1344 

Beck K.: P550, P561 

Beckers P.: P1317 

Begrambekova J.: P1559 

Behin A.: P605 

Beijer M.: P793 

Beilina N.I.: P1573 

Bekbossynov S.: P1526 

Bekfani T.: P1065, P1298, P1503, 

P1736, P989 

Belada N.: P578 

Belardinelli R.: P512 

Beldekos D.: P731 

Belehrad M.: P1492 

Belenkov Y.N.: P1017, P1224, P1585, 

P1659, P725 

Belham M.R.D.: P494 

Belin A.: P1092, P666 

Belinchon Paraiso J.C.: P1125 

Bell A.J.: P692 

Bellanca M.: P1209 

Belli J.F.C.: P1672, P1716, P814 

Belli R.: P1266 

Bello N.: P872 

Belskaya M.I.: P611 

Beltrame Tomatis S.: P1382 

Beltrami M.: 264, P1323, P1484 

Belyaeva I.: P1300 

Belyaeva O.: P1319 

Belyavskiy E.: P1727 

Ben Amor F.: 85, P974 

Ben Gal T.: P1099, P1102, P850 

Ben Hamda K.: P1623, P1625, 

P1626, P1685, P964, P985, P987 

Ben Omrane S.: P679 

Ben Romdhane M.: P1060 

Bendlova B.: 433 

Benedetti S.: P1452 

Benelli E.: P1705 

Benes J.: 433 

Benhalla H.: P1481, P1815, P997 

Benitah J.P.: P1311 

Benito E.: P1501 

Benito Martin E.M.: P537, P545 

Ben-Mordechai T.: 217 

Bennett A.: P810, P996 

Bennett R.: P907 

Benova T.: P1326 

Bento A.: P1306, P1402, P1404, 

P1407, P1408, P1692 

Benyass A.: P752 

Beramendi Calero J.R.: P1036, 

P1401, P1711 

Berden P.: P1800 

Berejnaya O.O.: P801 

Beresford L.: P1752 

Beresina A.V.: P1271 

Beresina A.V.: P1680 

Berezikova E.N.: P517 

Berezin A.: P1628, P1636, P1821 

Berezin I.I.: P1204 

Berezina A.: P1319 

Berezina T.: P1628 

Bergem S.: P1830 

Berilgen R.I.D.A.: P1292, P873 

Berkovich O.: P1319 

Berliner D.: 436, P476, P518, P523 

Bernardez S.: P1241, P1246 

Bernardino L.L.: P1051 

Bernardino S.: P940 

Bernardo M.J.: P1214, P1501, P681 

Bernheim A.M.: P1274 

Berns S.A.: P1620 

Berra G.: P1420 

Bers D.: 216 

Bertaggia E.: 394 

Berteaux G.: P1294 

Bertens L.C.M.: P1207, P560 

Berthelot E.: P553 

Bertini I.: P1759 

Bertolin F.: P1263 

Bertolotti A.M.: P629 

Bertolotti M.: P728 

Berton E.: P1469, P514 

Bertuccio G.: P1418 

Bescos C.: 275 

Bestetti R.: P1432 

Betbout F.: 85, P974 

Bettari L.: P718 

Bettencourt N.: P818 

Bettencourt P.: P1143, P1144, P1184, 

P1254, P1400, P1436, P716, P841, 

P843, P899, P983 

Bettou K.: P822 

Beygui F.: P798 

Beyl R.A.: P1593 

Bezlyak V.: P1415 

Bezrodniy A.: P1574 

Bezrodny A.: P1185 

Bezrodnyi A.: P1286 

Bhagra S.K.: P993 

Biagini F.: P1425, P1759 

Biagioli M.: P1425, P1759 

Bianco N.: P1010 

210 

Biannic C.: P1092, P666 

Biegus J.: P1405, P1419, P995 

Bihry N.: P553 

Bilovol A.N.: P1055 

Bina P.: P851 

Binaghi G.: P969 

Binder T.: P1735 

Biondi-Zoccai G.: P764 

Birchall A.: P719 

Birner C.: P483 

Birtalan E.: P927 

Biseli B.: P684 

Biselli B.: P1116, P1368, P685, P686 

Bisenic V.: P1715, P832 

Bisping E.: P884 

Bitsch N.: 397, P890 

Bitter T.: P1365, P1378, P1398, 

P1488, P630, P631, P632 

Bittner H.B.: P673 

Bjurman C.: P520 

Blanco J.: P923 

Blankesteijn W.M.: P1316 

Blankova Z.: P1136 

Blann A.D.: P1001 

Blasco C.: P503 

Blazquez Arroyo L.B.A.: P1384 

Bleakley C.: P844 

Bloch K.D.: P892 

Blondheim D.: 266, P1795, P530, 

P674, P937 

Blue L.: 208 

Blum T.: P861 

Boardman J.: P709, P710 

Boban M.: P1220 

Bobbo M.: P1030, P1469 

Bobescu E.: P1624 

Boccanelli P.A.B.: P951 

Bocchi E.A.: P1124 

Bocchi E.A.: P1116, P1117, P1368, 

P1391, P1465, P1545, P1547, 

P1550, P1672, P1716, P1807, 

P1808, P543, P566, P684, P685, 

P686, P726, P814, P898, P917, 

P918, P919 

Bochard-Villanueva B.: P1091, P1596 

Bochenina Y.: P1068 

Bodnar L.: P580 

Bodzenta Lukaszyk A.: P1067 

Bodzenta-Lukaszyk A.: P1707 

Boehm M.: 390, 392, P1142, P1663, 

P1824, P1830, P711, P887 

Boehm M.B.: P1332 

Boehmer J.: P561

Boel E.: P675 

Boesgaard S.: P1529, P1531, P668 

Boffini M.: P1108 

Bogeski I.: 392 

Bogunovic N.: P1429, P1447 

Bogush Z.: P1021 

Boguslavskyi A.: P1828 

Bohlen Delgado A.P.: P1587, P1694, 

P522 

Bohm M.: P1575 

Boilson B.: P1542 

Boivin V.: P900 

Bojic S.: P1182 

Boletis J.: P1477 

Bollini M.: P680 

Bollmann A.: P590 

Bonanad C.: P1261, P1397, P474, 

P788 

Bonato R.: P1108 

Bonda T.: P1325 

Bondanza L.: P1261, P1397, P1607, 

P474, P788 

Bondareva Z.G.: P706 

Bonderman D.: P1735, P876 

Bondi M.: P728 

Bonnekoh J.: 392 

Bonomi A.: 275 

Borbely A.: 401 

Bordachar P.: P1086, P1510, P659 

Bordier P.: P712 

Borer J.: P711 

Borer J.S.: P1142, P1575 

Borger M.A.: P673, P678 

Borges I.P.: P1305, P1583, P800 

Borges S.: P1416 

Borggrefe M.: P1103 

Borghi C.: P1579 

Borgo L.: P1629 

Boricic M.: P1080 

Borjesson M.: P1677 

Borlaug B.A.: 433 

Borovickova M.: P1428 

Borsanyi T.: P1090, P1380, P714 

Bortsova M.A.: P1111 

Bosa Ojeda F.: P1811 

Bosch J.: P604 

Bosev M.: P1048 

Boshev M.: P936, P949 

Boskovic A.: P578 

Boskovic S.: 272, P645 

Botelho A.: P532, P572, P699 

Botelho A.M.: P568 

Botella A.: P1733 

Bothe W.: P1107 

Bott-Fluegel L.: 273 

Bouallouch S.A.: P1221 

Bouallouch S.B.: P1657 

Bouaziz M.O.U.N.I.R.: P1813, P544, 

P547 

Bouee S.: 434 

Bougherbel R.: P1221 

Bougherbel R.B.: P1657 

Boukef R.: P556 

Boukili A.: P752 

Bourantas C.: P1267, P1428, P1602, 

P1640 

Bouraoui H.: P1060 

Bouslenko Z.: P1263 

Bouzerda A.: P752 

Bover R.: 275 

Bovolini A.: P908 

Boyagina O.: P647 

Boyne J.: P793 

Boytsov S.A.: P1157, P858 

Bozic D.: P687 

Bozinovic N.: P1082 

Bozorgnia B.: P1805 

Bracali I.: P1054 

Bracho M.J.: P1296 

Braga A.A.: P1112, P1212, P690 

Braga C.: P1691 

Bragos R.: P1350, P487, P922 

Brahmbhatt D.H.: P494 

Bramanti F.: P780 

Bramlage P.: P1663 

Brammen C.: 399 

Brancalhao E.C.O.: P1399 

Branco L.: P1250 

Brandao L.: P1241, P1246 

Brandao S.: P1124 

Brandao S.M.G.: P1391 

Brandao S.M.: P686 

Bransford T.: P1295 

Branzi A.: P1541, P682, P805 

Brasolin B.: P1395, P536 

Bras-Silva C.: P909 

Brault Meslin O.: P553 

Braunschweig F.: P1103 

Bravo C.: P1214 

Bree A.: P793 

Brenner S.: 436, P476, P523, P691, 

P807 

Brili S.: P852, P988 

Briones A.: P929 

Bristow M.R.: P524 

Brito D.: P1195, P1654, P768, P775, 

211 

AUtHoRS 


P781, P804, P831 

Brizuela M.: P1622 

Brkic E.: P1817, P856 

Broch K.: P1455 

Brochado B.: P1025, P1050, P1239, 

P1307, P1516, P1519, P1558, 

P1592, P1675, P654, P676 

Brock S.F.: P1647 

Brockmeier B.: P1588 

Broda G.: 428, P698 

Broncel M.: P806 

Brouwers C.J.: P670, P671, P895 

Brown J.H.: 399 

Brscic E.: P1418 

Brucato A.: P1266 

Bruder O.: P1085, P651 

Brugada J.: P1248, P1641, P777 

Bruguera Cortada Jordi J.B.C.: P472, 

P490 

Brum P.: 214 

Brunhofer G.: P912 

Brunner - La Rocca H.P.: P1316 

Brunner-La Rocca H.P.: P1274 

Bruno N.: P1395, P536 

Brzoska K.: P1835 

Brzozowska-Czarnek A.: P864 

Bubalo T.: P687 

Bubenek S.: P541, P774, P842 

Buckley N.: P719 

Bugani G.: P805 

Bulgak A.: P921 

Bulut M.: P1023 

Buraya N.: P1106 

Burey L.: P1216 

Burger A.J.: P623 

Burgos C.: P1629 

Burgueros M.: P1796 

Burillo Gomez F.: P562 

Burra P.: P1472 

Bury K.: P639, P732, P806 

Buryachkovskaya L.I.: P602 

Buser P.: P1274 

Bustanul P.: P976 

Buswell K.: P692 

Butler J.: P978 

Butter C.: 441 

Byczkowska K.J.: P1029 

Byk K.: P1340 

Bylova N.: P1655, P801 

INDEX

INDEX 

AUTHORS 


C 

Caballero Borrego J.: P562 

Caballero L.: P1745, P926, P928 

Cabanelas N.: P1250, P1511, P1515, 

P992 

Cabanes R.: P1227, P1630, P1631, 

P1662, P503 

Cabral C.: P1449, P586 

Cabral S.: P1239, P1516, P1675, 

P1798, P1799 

Cabre M.: P1167 

Cacciatore G.: P1388, P622, P735 

Cachofeiro V.: P929 

Caeiro D.: P1096, P648, P649, P940 

Caetano F.: P1139, P1658, P532, 

P568, P572, P618, P699 

Caetano F.C.: P1627 

Cafe H.: P894 

Caffarel J.: 275 

Cagin C.: P1812 

Cagnan P.: P1387, P953 

Cakici M.: P1794 

Calcagno S.: P536 

Caldas C.: P782 

Caldas J.: P818 

Caldeira D.: P1653 

Caliskan K.: P670, P671, P895 

Calisto C.: P775, P779, P831, P847 

Callan P.: P519 

Calmon G.E.: P1296 

Caluwe E.: P892 

Calvier L.: P933 

Camandaroba P.J.: P1594 

Camara D.: P1669 

Camargo C.P.: 211 

Camargo M.E.J.: P1524 

Camboni D.: P669 

Cambronero Cortinas E.: P1062, 

P1382, P1496, P1721, P1796 

Cambronero Cortinas E.S.T.H.E.R.: 

P1371 

Camici P.G.: P1452 

Caminiti G.: P1291 

Camoes A.: P769 

Campagna M.S.: 264, P1323 

Campbell N.G.: P1003 

Campbell P.: P1100 

Campeanu A.L.: P1128, P1202 

Campeau R.: P1593 

Campelo M.: P1304, P1451, P1456, 

P1471, P588, P596, P717, P772, 

P836, P943 

Campelo M.B.: P593 

Campia U.: P978 

Campos J.: P1802, P1810 

Campos Moreira De Almeida I.: 

P1139, P1658 

Canario-Almeida F.: P1154, P1514, 

P701 

Canas Da Silva P.: P1189 

Canavese G.: P1418 

Cankovic M.: P1538 

Cannon C.: P670, P671 

Cano L.: P1214, P1227, P1630, 

P1662, P1698, P503 

Cantatrione S.: P1192, P1644 

Cantor E.: P1003 

Cao Y.S.: 213 

Capin E.: P527, P534, P667 

Capin Sampedro C.: P537, P542, 

P545, P559 

Capin Sampedro E.: P537, P559 

Carballo M.: P629 

Carballo S.: P1420 

Carboni G.C.: P951 

Cardelli P.: P790 

Cardiga R.: P1409, P1733 

Cardinalli Neto A.: P1432 

Cardoso G.: P1615 

Cardoso J.N.: P1399, P1577 

Cardoso J.N.C.: P1740 

Cardoso J.S.: P1449, P586 

Cardoso M.N.: P1399 

Caredda C.: P969 

Caretta G.: P718 

Caria R.: P1369, P1688, P1690 

Carla Sousa C.S.: P1089 

Carles-Trullas J.: P843 

Carlos I.: P1155 

Carlsen A.: P1718 

Carlsen C.M.: P868 

Carlson C.R.: 215 

Carmo M.: P1251 

Carnero G.: 268, P1084 

Carrasco F.J.: P983 

Carrasco Sanchez F.J.: P843, P871 

Carreira I.M.: P484 

Carretero-Gomez J.: P1210 

Carriere C.: P1469 

Carrilho-Ferreira P.: P1070, P1187, 

P1189, P1507, P1508, P1654, P804, 

P847 

Carroll D.L.: P1211 

Carrolo M.: P548, P977 

Carr-White G.: P1510 

Carr-White G.S.: P591 

212 

Carteciano M.: P1394 

Cartwright E.J.: 395 

Carty R.: P709, P710 

Carubelli V.: P1135 

Carvalho B.M.: P1098 

Carvalho F.: P1254, P899 

Carvalho H.: P1050, P1307, P1558, 

P676 

Carvalho J.: P899 

Carvalho M.: P1144, P1615, P716 

Carvalho M.S.: P1172 

Carvalho R.: P1712, P756, P853 

Carvalho S.: P782, P840 

Carvas Junior N.: P566 

Casado Cerrada J.: P1210 

Casado J.: P983 

Casal Moura M.: P1144, P1254, P716 

Casali E.: P660 

Casiraghi B.: P696 

Cassi A.: P697 

Cassinerio E.: P851 

Cassino J.P.: P1302 

Castella A.: P1452 

Castellani C.: P689 

Castelli G.: P1759, P583 

Castelo Branco M.: P828 

Castermans M.: P793 

Castillo C.: P1607, P788 

Castillo Judez M.: P1036, P1711 

Castillo-Martinez L.: P1061, P1063, 

P1151, P1344, P1406, P1489, P979 

Castrini A.I.: P1135 

Castro A.: P1191, P1589, P1634, 

P1819, P853 

Castro Beiras A.: P931 

Castro Lopes A.: P775 

Castro M.: P1172, P1615, P1697 

Castro R.: 435 

Castro R.E.: P1807, P1808, P566, 

P726, P814 

Castro-Beiras A.: P893 

Catez E.: P1072, P1816 

Catrinoiu D.: P1160, P627 

Cattadori G.: P510, P514 

Cavalcante A.C.D.: P1375 

Cavalcante Guedes M.V.: P1212 

Cavalcanti A.C.: P1215, P507 

Cavalcanti A.C.D.: P1647 

Cavusoglu Y.: P1140, P715 

Cebola R.: P820 

Ceia F.: P1409, P1733 

Celeiro M.: P1404, P1407, P1408, 

P1692

Celeiro M.R.: P1306, P1402 

Celi A.: P1754, P486 

Celic D.: P587 

Celic V.: P1057, P1193, P1285, 

P1714 

Cellamaro T.: P1518 

Cemerlic-Adjic N.: P1538 

Cepeda Rodrigo J.M.: P871 

Cequier A.R.: P1031, P1669, P794, 

P795 

Ceresuela Eito L.M.: P1210 

Cerqueiro Gonzalez J.M.: P871 

Cerrato E.: P764 

Cerrito A.: P1291 

Cervirgen C.: P1356 

Cetin M.: P626 

Cettolo F.: P680 

Chaabene K.A.I.S.: P1034, P1034 

Chaar M.: P944 

Chaari A.N.I.S.: P544, P547 

Chaari Z.I.E.D.: P1376 

Chachques J.C.: P1833 

Chacon N.: P1596 

Chaggour S.: P1535 

Chai A M Richards C S P Lam P.: 

P1678 

Chai H.-T.: P1032 

Chai P.: P1500, P1737 

Chaib A.: P752 

Chakova N.N.: P1013 

Chakroun M.: P1623, P1625, P1626, 

P1685, P964, P985, P987 

Chanakira N.: P1493 

Chantziara K.: P1088 

Charisopoulou D.: 426 

Charitos C.: P1532 

Charlot M.G.: 209 

Chattree K.K.: P656 

Chauhan H.K.C.: P656 

Chavez Leal S.: P931 

Chebotaryova N.V.: P1013 

Chen C.H.: P1000 

Chen C.-L.: P1032 

Chen H.: P1038 

Chen J.-H.: P1570 

Chen S.-M.: P1032 

Chen Y.: P1649 

Chen Z.: P1510 

Chenevard R.: P1437 

Cheng Y.-F.: P1032 

Cherain G.: P1667 

Cherian G.: P1426 

Cherkashin D.: P729 

Chermont S.: P1241, P1246 

Chernyavina A.: P1149, P1724, P704 

Chesnikova A.I.: P1521 

Chester M.M.: P1593 

Chibungu A.C.: P1498 

Chin J.: P1238 

Chinaglia A.: P1266, P1388, P622, 

P735 

Chioncel O.: P1664, P541, P637, 

P774, P842 

Chipepo A.: P1007 

Chizh K.: P1066 

Chizynski K.: P1741 

Chizzola P.: P1124, P1545, P1672, 

P814 

Chizzola P.R.: P1116, P1391, P566 

Chlopicki S.: P1340 

Chmielewska-Michalak L.: P771 

Choe K.H.: P973 

Choi C.O.: P865 

Choi D.J.: 263, P1033, P1145, 

P1666, P973 

Choi H.M.: P1440 

Choi I.A.: P1022, P1129, P1568, 

P636, P643, P879 

Choi J.-H.: P546, P982 

Choi J.J.: P865 

Choi S.W.: P815 

Choi Y.S.: P1442 

Chomachidze P.: P1738 

Chomakhidze P.: P1673 

Chong J.P.C.: P1737 

Chorro F.J.: P1397, P1607, P788 

Chorro Gasco F.J.: 83 

Choudhary R.: 265 

Chowdhury P.: 265 

Choy A.M.: P511 

Christensen G.: 215, P1321, P489, 

P930 

Christensen S.B.: 209 

Christodorescu R.M.: P824 

Chrysohoou C.: P852, P957, P988 

Chudzik M.: P1522 

Chumachenko P.V.: P602 

Chumburidze S.H.: P1459 

Chung I.M.: P1033, P1666 

Chung N.: P1702 

Chung W.B.: P1442 

Chung W.J.: P1725 

Ciaccheri M.: P583 

Cianchetti S.: P1754, P486 

Ciccone M.M.: P1046, P1475, P613 

Cicero A.F.G.: P1579 

213 

AUtHoRS 


Cicoira M.A.: P512 

Ciesiolka E.: P771 

Ciftci C.: P1527, P741 

Cikes M.: P687 

Cimadevilla O.C.: P681 

Cimbaro Canella J.P.: P1622, P1629 

Cimino J.: P1831 

Cimpoesu D.: P854 

Cincin A.: P1023 

Cinque A.: P1395 

Cinteza M.: P1289, P958 

Cinti L.: P805 

Ciobanu A.O.: P1289, P958 

Cioffi G.: P622 

Cioppa C.: P1192, P1644 

Ciosek J.: P1303 

Ciric-Zdravkovic S.: P1537 

Ciro’ A.: P1387, P935, P953 

Citarelli G.: P1046, P1475, P613 

Clague J.R.: P1525 

Clark A.L.: P1093, P1164, P1199, 

P1267, P1293, P1414, P1422, 

P1428, P1523, P1602, P1640, 

P1686, P509, P519, P531, P724, 

P749, P773, P810 

Clark R.A.: P665 

Clavell E.S.: P1296 

Claver Valderas M.A.: P1597 

Cleland J.: 275, P1422 

Cleland J.G.F.: 274, P509, P519 

Cleland J.G.: P1093, P1102, P1164, 

P1686, P477, P531 

Cleland J.G.F.: 82, P1095, P1199, 

P1226, P1252, P1267, P1293, 

P1389, P1414, P1428, P1523, 

P1602, P1640, P665, P723, P724, 

P749, P773, P810, P996 

Clemens M.: P1779 

Clemenza F.: P604, P947, P948 

Clerico A.: P1705 

Clopton P.: 265 

Cobb V.: P1075 

Cobbe S.M.: P1415 

Cobet V.: P1766 

Coccolo F.: P1541 

Cochet H.: P1086 

Cohen D.: P1552 

Cohen-Solal A.: P553, P556 

Coldea-Agoston L.: P1131 

Coll R.: P1227, P1630 

Collier P.: P1336, P1339, P1358 

Comazzi F.: P1263 

Comin Colet Josep C.C.J.: P472 

INDEX

INDEX 

AUTHORS 


Comin Colet Josep J.C.C.: P490 

Conboy T.: P1028, P1464, P1470, 

P796 

Conceicao G.E.: P1117, P1545, P543 

Conceicao-Souza G.E.: P685 

Conde Martel A.: P871 

Conde Y.: P584 

Conde-Martel A.: P843, P983 

Conraads V.: P1317 

Conraads V.M.: P1103 

Conradi A.O.: P911 

Contini M.: P514, P821 

Conway A.: P665 

Cook S.: 395 

Corbi Pascual M.J.: P1062, P1371, 

P1496 

Corbi Pascual M.J.: P1382, P1721, 

P1796 

Cordero M.: P1564 

Cordoba Soriano J.G.: P1371, P1496, 

P1721 

Cordtz J.: P1529 

Coronel M.L.: P1622, P1629 

Coronel R.: P1768 

Corra U.: P510 

Correa Vilches C.: P562 

Corredoura A.S.: P769 

Correia A.: P1691 

Correia A.S.: P1035, P1118, P1243, 

P1810, P589 

Correia C.E.: P1449, P586 

Correia D.M.S.: P1223 

Correia D.M.S.: P1647 

Correia E.: 431, P1587, P522 

Correia S.: P1132, P1166, P1369, 

P1688, P830 

Corrieri N.: P1046, P1475, P613 

Corros C.: P534 

Corsini A.: P805 

Cortes Garcia M.: P1257, P825 

Cortes M.: P655 

Cortez-Dias N.: P1070, P1189, 

P1195, P1446, P1508, P775, P779, 

P781, P831, P847 

Costa A.L.: P1446 

Costa C.: P1366, P956 

Costa Filho J.E.: P690 

Costa J.A.: P1223 

Costa L.: P1446 

Costa M.: P1104, P572 

Costa S.: P1540, P1682, P1693 

Costanzo P.: 82, P1164 

Costescu I.: P1072, P1816 

Cotrim C.: P1238 

Cotter G.: 260, P1389, P1405, 

P1419, P497 

Coufal Z.: P1264 

Couper G.: P1100 

Coutance G.: P1092, P666 

Couto M.: P1143, P1436 

Covaciu A.: P1624 

Cowburn P.: 275 

Cowburn P.J.: P960 

Cowie M.R.: 426, 84 

Cowie M.R.: P1039, P1103, P1134, 

P1525, P529 

Cozar-Santiago P.: 430, P1596 

Cramer M.J.M.: P1207 

Crea F.: P1348, P1349 

Crespo-Leiro M.: P1664 

Crespo-Leiro M.G.: P893, P931 

Cristea A.: P1128, P1202, P570 

Cristol J.P.: P1619 

Cristovao J.: P652 

Critchley W.: P1752 

Critoph C.H.: P585 

Crown J.: P1011 

Crundall-Goode A.: P1686, P531 

Cruz A.F.N.: P1647 

Cruz Berlanga E.: P655 

Cruz F.: P1124 

Cruz F.D.: P1116 

Cruz F.D.C.: P1117, P1465, P1545, 

P1547, P543, P684 

Cruz Ferreira R.: P1155 

Cruz I.: P1238, P1653 

Cruz J.E.: P950 

Cruz L.: P814 

Csaba H.: P1827 

Csanadi Z.: P1779 

Csato V.: P910 

Cuartero Navarro J.: P1382, P1496 

Cubillos-Arango A.: 430 

Cuello F.: P932 

Cui Z.Y.: P1609 

Cumetti D.: P1266 

Cunha F.: P1184 

Cunha F.A.: P1436 

Cunha G.A.: 435 

Cunha Mano M.: P1834 

Cunha P.: P1186, P1251, P1515, 

P548, P977 

Cunha P.S.: P1250, P1511 

Cuocolo A.: P1161 

Cuttitta F.: P1209 

Cvetkovic P.: P1082 

214 

Cvijic M.: P1379, P1800, P942 

Cwetsch A.: P722 

Czolbe M.: 400, P1333 

D Da Costa M.: P1179 

Da Costa Martins P.A.: 387 

Da Costa Martins P.A.: 397, P890 

Da Silva Castro A.: P1684 

Dadashova G.: P1120 

Dadush Raz O.: P1765 

Dae-Kyeong K.I.M.: P954 

Dahan I.: 266, P1795, P478, P530, 

P674, P937, P938, P939 

Dahl C.P.: P1321 

Dahlstrom U.: P1664, P516 

Dahmeni R.: P1253 

Dai Z.I.X.U.A.N.: P481 

Dakic S.: P1537 

Dal Ferro M.: P1834 

Dalageorgou C.: 81 

Dalila J.D.: P1223 

Dall’armellina E.: P1601 

Dalzell J.R.: P1415 

D’amario D.: P1348, P1349 

Damasio A.: P1306, P1402 

Damasio A.F.: P1404, P1407, P1408, 

P1692 

D’amato R.: P1452 

Damjanovic M.: P776 

Damjanovic S.: P1156, P757 

Damy T.: P628 

Dandel M.: P1539, P1756 

Dang C.: P1012 

Dangwal S.: P480 

Danielan M.: P1559 

Danilogorskaya Y.A.: P1585, P725 

Danilovska I.: P1806 

Dankevich I.V.: P1185 

Danzmann L.C.: P1728 

Darabantiu D.: P824 

Darawsha W.: P479 

Dargie H.J.: P477 

Darragh K.: P1134 

Das K.: P1760 

D’ascenzo F.: P764 

Dassie F.: P608 

Datsenko S.V.: P1111 

Daubert J.C.: 274 

D’auria F.: P925 

Dauwe D.: P1769 

Davar J.: P1180, P745 

Davidson P.M.: P791

Davies L.C.: P1003 

Davila Ramos M.F.: P871 

Davirova S.S.: P1022, P592, P643, 

P879 

Davis M.: P692 

Davison B.A.: P497 

Davison B.A.: 260, P1389 

Davtyan A.R.: P1194 

Davutoglu V.: P1410, P1794 

Davy J.M.: P1619, P811 

Davy J.-M.: P628 

Dawood A.: P1159, P1273, P730, 

P759, P882 

Dawson D.: P849 

Day S.: P916 

De Almeida M.D.V.: P1656 

De Antonio M.: P1227, P1630, 

P1631, P1662, P1698, P503, P624 

De Azevedo J.C.: P1730, P737 

De Berardinis B.: P790 

De Freitas Marcolla V.: P1213, P1648 

De Jonge N.: P670, P671 

De Keulenaer G.W.A.: P1852 

De Keulenaer G.W.: 388, 389, P909, 

P913 

De La Cruz E.: P1257, P825 

De La Cuesta Arzamendi F.: P1036, 

P1401, P1711 

De La Hera J.M.: P534 

De Marco M.: P925 

De Maria D.M.R.: P951 

De Maria R.: P697 

De Meester I.: 388, P1852 

De Oliveira A.: P1730 

De Pauw F.: P675 

De Proft M.: P675 

De Rosa R.: P925 

De Teresa Galvan E.: P1064, P1695, 

P1696, P1701 

De Teresa-Galvan E.: P743 

De Vecchis R.: P1040, P1192, P1644 

De Vries J.J.G.: P1686, P531 

De Windt L.J.: 387 

De Windt L.J.: 397, P890 

Deales A.: P697 

Deaton M.C.: P1216 

Dechend R.: P1427 

Decourcey J.: P1493, P1637 

Dedovic V.: P677 

Degli Esposti D.: P1579 

Deiros Bronte L.: P1796 

Dekany M.: P1090, P1259, P714 

Dekleva M.: P1674 

Del Carlo C.H.: P1577 

Del Franco A.: P1461, P612, P742, 

P780 

Deleanu D.: P637, P774, P842 

Delgado A.: 431, P1279, P1814 

Delgado A.P.: P1260 

Delgado-Perez A.: P1061, P1063, 

P1406, P1489 

D’elia E.: P697 

Deljanin - Ilic M.: P1245 

Deljanin Ilic M.: P1206, P1337, 

P1720, P1763 

Deljanin-Ilic M.: P1621 

Della Casa G.: P1266 

Dell’angela L.: P680 

Delseny D.: P1619, P811 

Demartini C.: P1003 

Demikhova N.: P1042, P1288 

Demir M.: P1504 

Demir O.M.: P1134 

Demir S.: P766 

Demircan S.: P1732 

Demirozu O.: P741 

Demirozu T.: P1527 

Demkow M.: P1370 

Demolder M.: 388 

Demyanets S.: P1825 

Denguir R.: P679 

Denis A.: P1086 

Denisevich T.L.: P1077, P611 

Denisova T.: P1771 

Denollet J.: P670, P671 

Derbentsev A.V.: P1766 

Derchi G.E.: P851 

Dergilev K.: P1351 

Dergilev K.V.: P1770 

Dernarova L.: P817 

Deroy L.U.C.: P997 

D’errigo P.: P809 

Desai A.S.: P872 

Deschaseaux C.: P1739 

Deshko M.S.: P1822, P727 

Despa S.: 216 

Despas F.: P1851 

Dessi C.: P851 

Deten A.: P1833 

Detournay B.: 434 

Deutzmann R.: P483 

Devaux Y.D.: P1332 

Devereux R.: P1603 

Devlin G.: P692, P867 

Dewenter M.: 399 

Dhalla N.S.: P1334 

215 

AUtHoRS 


Dhingra R.: P924 

Dhinoja M.: P1003 

Dhople V.: P1458 

Dhutia N.: P1244 

Di Biase G.: P1192, P1644 

Di Biase L.: P496 

Di Carli M.: P1100 

Di Gesaro G.: P604, P947, P948 

Di Lenarda A.: P1019, P1024, P1030, 

P1388, P1457, P1469, P510, P514, 

P735 

Di Resta C.: P1452 

Di Somma S.: P790 

Di Tano G.: P718 

Diab I.: P1003 

Diab M.: P1107 

Diaconu C.C.: P1222, P1497, P1599, 

P634 

Diaconu N.: P1002, P1006, P999 

Dias A.: P1096 

Dias C.: P841 

Dias K.: P1241 

Dias P.: P1308, P1403, P1802, P1810 

Dias V.: P1798 

Diaz Anton B.: P1385 

Diaz Anton B.D.A.: P1384 

Diaz B.: P534, P681 

Diaz E.: P1361, P527, P534, P555, 

P667 

Diaz Molina B.: P1501 

Diaz-Guemes I.: P1350, P922 

Diaz-Molina B.: P1361 

Dicken B.: P1252, P1293, P1523, 

P1584, P509, P723, P773, P996 

Dickstein K.: P1718 

Dieffenbach B.: 265 

Dierckx R.: 270, P1093, P1095, 

P1252, P1293, P1523, P509, P675, 

P724, P773, P810, P996 

Dietl A.: P483 

Diez C.: P1630, P1698, P669 

Diez J.: P933 

Dik I.: P1300 

Dikur O.: P1673, P1738 

Dilekci B.: P1364, P741 

Dimitriadis Z.: P1398, P631 

Dimitriadou A.: P731 

Dimitriou P.: P1088 

Dimova M.S.D.: P829 

Dinis P.: P568 

Dirkx E.: P890 

Djahit A.: P1414 

Djenic N.: P1689 

INDEX

INDEX 

AUTHORS 


Djordjevic S.: P1715, P832 

Djordjevic-Radojkovic D.: P1643, 

P776 

Djukic P.: P1536 

Dobbs K.: P1686, P531 

Dobreanu D.: P1624, P637 

Dobrev D.: P1785 

Dodic S.: P1538 

Doehner W.: P1049, P1065, P1298, 

P1503, P1736, P565, P571, P625, 

P640, P734, P787, P989 

Doenst T.: P1107, P1328, P1329, 

P1757 

Doerr M.: P1755 

Doevendans P.: P1850 

Dolenc-Strazar Z.: P1800 

Doletskiy A.: P1673, P1738 

Dolgushina E.: P1004, P575 

Dolliner P.: 440 

Dolnik I.A.: P1822 

Dolzhenko M.N.: P720, P857 

Domenech Garcia N.: P931 

Domenech N.: P893 

Domingo M.: P1227, P1630, P1662, 

P1698, P503, P624 

Domingo Pascual -Figal D.P.G.: 

P1774 

Domingo Valero D.: P1548 

Dominguez Franco A.J.: P1064, 

P1695, P1696, P1701 

Dominguez Mafe E.: 83 

Dompinier A.: P1535 

Donahue M.: P786 

Doney A.S.F.: P1284 

Dong-Kie K.I.M.: P1272, P954 

Dong-Soo K.I.M.: P1272, P954 

Donnelly L.A.: P1284 

Donoiu I.: P1591 

Donova T.: P1719 

Doo-Il K.I.M.: P1272, P954 

Doolub G.: P1502, P1601 

Dorantes-Garcia J.: P1151 

Dorazilova Z.: P1546, P683 

Dores H.: P1172, P1615, P1697 

Dorofeyeva N.A.: P1327 

Doronzo A.: P1046, P1475, P613 

D’ortho M.-P.: P628 

Doschitsyn V.: P1300 

Dostanko N.: P1066 

Doughty R.N.: P707, P867 

Doyle F.: P1237 

Dragan S.: P824 

Dragnic S.: P578 

Dragoi R.: P1289 

Dragoumanos V.: P1158, P731 

Drapkina J.: P1490 

Dreas L.: P680 

Dridi Z.: 85, P974 

Drinkovic N.J.: P1220 

Drohomirecka A.: P1106, P1383 

Drori Y.: P600 

Drozdov I.: P932 

Drozdz J.: P1664, P639, P806 

Duan Q.: P563 

Duarte C.S.: 435 

Duarte Faria R.M.: P818 

Duarte Rodrigues J.C.: P1089 

Duarte Rodrigues J.D.R.: P802 

Duboc D.: P605 

Dubois E.: P1832 

Dubovik T.: P1468 

Duckett S.D.: P960 

Dudas K.: P500 

Dudinskaya E.N.: P1157, P858 

Dudley S.C.: P916 

Duengen H.D.: P1643 

Duengen H.-D.: P1421, P1426, 

P1427, P1667, P1674, P1681, P565, 

P734, P966 

Duengen H.-D.: P1228 

Dufoix-Cusin S.: P1198 

Dulgheru E.R.: P1289 

Dundar C.: P1023 

Dunne M.: P1826, P885 

Duplyakov D.: P1430 

Dupuy A.M.: P1619 

Duraes C.: P701 

Durao D.: P992 

Duray G.: P1090 

Duray G.Z.: P1380, P714 

Durighel G.: P849 

Dursun H.: P1280 

Duru F.: P1437 

Dusceac D.: P1128, P1202 

Dutka D.P.: P494 

Dutka D.P.: P495 

Duygu B.: 387, 397 

Duygu H.A.M.Z.A.: P1292, P873 

Dwight J.: P1502 

Dwyer E.: P1700 

Dyakonyuk V.: P558 

Dzhetybayeva S.: P1526 

Dzhoyashvili N.A.: P1352 

Dzielinska Z.: P1370 

Dziemidowicz M.: P1325 

Dzilic E.: P912 

216 

Dzudovic B.: P1689 

Dzyak G.V.: P1433 

e 

E Molina C.: P1312, P1793 

E Molina P.: P1312 

Earle N.: P707 

Earley M.J.: P1003 

Ebert M.: P861 

Ebina Y.: P1153 

Ebner B.: P1174 

Ebner C.: P1505, P1509 

Ebner N.: P1065, P1298, P1503, 

P1736, P571, P989 

Ebraheem H.: P1723 

Ece T.: P1364 

Echegaray Ibanez K.: P1036, P1401, 

P1711 

Echeverria Oses J.: P1036, P1711 

Edellmann F.: P1228 

Eden M.: P1849 

Edes I.: P1314, P1779, P910 

Edmonds M.: P866 

Edmunds L.: P1572, P662 

Edwards N.: P663 

Efimenko A.Y.: P1352 

Efimova I.: P1083 

Efken C.: P630, P632 

Efremov A.V.: P517 

Efremovtseva M.: P619 

Eghtesady P.: P1750 

Egstrup K.: P1362 

Eicher J.-C.: P1294 

Ejima K.: P1520 

Ekman I.: P500 

Ekmekci C.: P1280 

Ekren H.: P626 

El Hosssary H.: P1277 

El Hraiech A.: P1221, P1535 

El Hraiech A.E.H.: P1657 

El Moghrabi S.: P1354 

Elarmouche A.: P1789 

El-Armouche A.: 399, P1356 

Elasfar A.: P1218, P1553, P797, P799 

Elder D.H.: P1284, P511 

Eleuteri E.: P1263 

Elezi S.: P1676 

Elhabashy M.: P759 

Elhabeeby M.: P1273 

Elisabete Martins E.M.: P1089 

Ellery S.: P1075 

Elliott P.: 81 

Elliott P.M.: P585

Elloumi A.: 85, P974 

Elnajjar M.: P730 

Elnoamany M.F.: 267, P1016, P1159, 

P1169, P1273, P1282, P1723, P730, 

P759, P762, P882 

Elrakshy Y.: P1196 

Elsamiri H.: P1434, P1818 

Elsedi M.: P1016 

Elsheekh N.: P1723 

Elshereef A.: 267 

Elsner I.: P1772, P1773 

Elvas L.: P657 

Elvas L.D.: P652 

Elvis Teijeira Fernandez E.T.F.: P1774 

Emdin M.: P1461, P1705, P496, 

P510, P612, P658, P742, P780 

Emons J.: P1356, P1789 

Emre E.: P626 

Engelhardt S.: P1748 

Enger U.H.: 215 

Engin C.: P688 

Engleman Z.J.: P952 

Enina T.N.: P1322 

Enjuanes Grau C.: P472, P490 

Enseleit F.: P1133, P1148, P1437 

Entwistle T.: P1752 

Epperson L.E.: P524 

Ercan S.: P1410, P1794 

Erdei T.: P1731 

Erdogan T.: P1197 

Ergene O.K.T.A.Y.: P1292, P873 

Erglis E.: P1104 

Eris Gudul N.: P763 

Erker T.: P912 

Ernez S.: P1060 

Erntell H.: P516 

Ertas G.: P626 

Ertl G.: 436, P1345, P476, P518, 

P523, P691, P807, P813 

Escalante J.: P1622 

Escalante J.P.: P1116, P1368, P1465, 

P685, P686 

Escobar A.: P1401 

Esis C.E.: P1296 

Esposito C.: P1040, P1644 

Ess M.: 432, P1269, P1704, P789, 

P845 

Esteban Fernandez A.: P526 

Esteve P.: P533 

Estornell-Erill J.: 430, P1091, P1596 

Estrella-Holder E.: P866 

Eulalio A.: P1834 

Ewens S.: P1356 

Eymard B.: P605 

Ezz Eldin M.: P762 

Ezzat M.: P1016, P574 

F 

F Jaufeerally D.S.I.M.: P1482 

Faber L.: P1429, P1447 

Fabregat Andres O.: P1091 

Fabregat-Andres O.: 430, P1596 

Fabri M.: P1538 

Fabris E.: 271 

Fadel E.: P796 

Faerber G.: P1107 

Faganello G.: P1030 

Fagyas M.: P1779 

Faillace B.L.R.: P1368 

Falcao J.L.A.A.: P690 

Falcao Pires I.: P482 

Falcao S.N.: P1114 

Falcao S.N.R.S.: P1098, P690 

Falcao-Pires I.: 391, 401, P1313, 

P1338, P1451, P1753, P1775, P909 

Falces C.: P1248, P1641, P777 

Falco A.: P925 

Falk C.: P897 

Falkenham A.: P901, P902 

Faller H.: P813 

Falletta C.: P604, P948 

Fallon L.: P1134 

Famoso G.: 427, P1472, P608, P689 

Fang X.H.: P1000 

Farah I.: P1462 

Fareh J.: P1619 

Farhan A.: 267 

Faria R.: P1096, P940 

Farias M.S.Q.: P1098 

Farina S.: P821 

Farman N.: P1354 

Farre J.: P1257, P825 

Farrugia S.: 84 

Fatima Das Dores Cruz F.D.C.: P1550 

Faustino A.: P572 

Faustino A.C.: P568 

Favale S.: P1046, P1475, P613 

Favaloro L.: P629 

Favaloro L.E.: P629 

Favaloro R.R.: P629 

Fayed A.F.: P1196 

Fayez M.: P1473 

Fazal I.A.: P993 

Fazendas P.: P1238 

Fazlalizadeh H.: P1422 

Fazlibegovic F.E.: P1665 

217 

AUtHoRS 


Fedele F.: P1395, P536 

Fedorco M.: P653 

Fedotov P.A.: P1111, P1188 

Fedrigo M.: 427, P689 

Fedyk-Lukasik M.: 428, P698 

Fehri W.: P1253 

Feig M.: P1458 

Feij N.: P793 

Feinberg M.S.: 217 

Fejfar T.: P1635 

Feliciano J.: P1511 

Felix S.: 261, P1458 

Felix S.B.: P1755 

Felker G.M.: P497, P961 

Felker G.M.: 260, P786 

Felsoci M.: P1264 

Fendri S.: P1623, P1625, P1626 

Fenk S.: P513 

Fernandes A.: P1139, P1627, P1658, 

P532, P572, P618, P699 

Fernandes A.R.: P484 

Fernandes B.: P548, P977 

Fernandes F.: P915 

Fernandes J.R.: P1098 

Fernandes J.P.: P1050, P676 

Fernandes J.R.: P1112, P1114, 

P1212, P1544 

Fernandes M.: P1514, P701 

Fernandes M.J.: P1154 

Fernandes P.: P1096, P1239, P1675 

Fernandes R.G.M.: P1223 

Fernandes-Silva M.M.: P566 

Fernandez Anguita M.J.: P1721 

Fernandez Asensi D.: P1214 

Fernandez E.: P1629, P527, P534, 

P667 

Fernandez Ruiz A.: P1796 

Fernandez-Del Palacio M.J.: P926, 

P928 

Fernando B.A.C.A.L.: P1391 

Fernando Bacal F.B.: P1550 

Ferraironi A.: P951 

Ferrando-Beltran M.: 430, P1596 

Ferrari M.: P1452 

Ferraro M.R.: P1518 

Ferrazzi E.: P1472 

Ferreira A.: P1650, P1697, P782, 

P840 

Ferreira A.R.: P652 

Ferreira A.M.: P1007 

Ferreira A.R.: P1682 

Ferreira C.: P1027, P1281, P765, 

P782, P840 

INDEX

INDEX 

AUTHORS 


Ferreira Da Silva G.: P1179, P992 

Ferreira E.: P599 

Ferreira F.: P1154 

Ferreira J.: P1374, P1615, P1682, 

P1697, P652 

Ferreira J.M.: P1693 

Ferreira M.J.: P1515, P1682, P657 

Ferreira P.L.C.: P1260 

Ferreira P.P.S.: P800 

Ferreira R.: P1163, P1186, P1250, 

P1251, P1511, P1515, P1693, P1733 

Ferreira S.: P1650, P1801 

Ferreira S.A.: P1117, P566 

Ferreira S.M.A.: P1124, P1391 

Ferrer Hita J.J.: P1811 

Ferrer-Hita J.J.: P1564 

Ferrer-Rebolleda J.: 430 

Ferroni F.: P1266 

Feyen D.: P1850 

Fiedler J.: P891, P897 

Field L.J.: P1353 

Figueira-Coelho J.: P535 

Figueroa-Lopez C.: P1406, P1489, 

P979 

Figuerola-Chaparro L.: P1151, P1344 

Fildes J.: P1752 

Fili’ D.: P604 

Filimon S.A.: P1729 

Filipa Melao F.M.: P1089 

Filipecki A.: P1303 

Filipescu D.: P541, P842 

Filipiak K.J.: 440 

Filippatos G.: 260, 262, 429, P1645, 

P1664, P505, P812, P965, P971 

Filippatos G.M.: P497 

Finlay M.: P585 

Fioreli A.I.: P898 

Fiorelli A.I.: P1547, P1550 

Fischer M.: P513 

Fischer P.: P1557 

Fischmeister R.: P1789, P1793 

Fisher R.: P692 

Fishman A.Y.: P1521 

Fiuza M.: P1189, P1446, P779 

Fiuzat M.: P786 

Flammer A.: P1148, P1437 

Flammer A.J.: P1133 

Fletcher T.: P695, P875 

Fliegner D.: P1324 

Florencio R.S.: P1112, P1114, P1212 

Florescu M.: P1289 

Florez J.P.: P527, P667 

Folino F.: P1472 

Follath F.: 262, P965, P980 

Foltan M.: P669 

Fomin I.: P1224, P1659 

Fonarow G.C.: P846 

Fondinho C.: P1163 

Fonseca C.: P1409, P1733 

Fonseca K.C.B.: P915 

Fonseca N.: P1132, P830, P941 

Fontana A.: P1387, P935, P953 

Fontes De Carvalho R.: P818 

Fontes P.: P782 

Fontes-Carvalho R.: P649 

Fontoura D.: P1753 

Ford I.: P1142, P1415, P1575, P711 

Formica F.: P935 

Formiga F.: P983 

Formiga Perez F.: P1210, P871 

Formiga-Perez F.: P843 

Formisano R.: P1161 

Fornaro A.: P583 

Forni G.L.: P851 

Forssmann W.: 261 

Fortune C.: P998 

Foschini A.: P1054, P1318 

Fouad D.A.: P1203 

Fountoulaki K.: P965 

Foussas S.: P1158, P731 

Fousteris E.: P1158, P731 

Fox H.: P1378, P1398, P630, P631 

Fraguas H.: P1084 

Franchi F.: P660 

Franchini A.: P1291 

Franchitto N.: P1851 

Franchuk Svetlana F.S.: P1287 

Franci B.: 264, P1323, P1484 

Francis D.P.: P1244 

Francisco A.: P1366 

Franco D.: P893 

Franco F.: P1540, P1682, P1693 

Franco J.A.: P1257, P825 

Franco O.C.F.: P1761 

Franekova J.: P525 

Frankenstein L.: P820 

Franssen C.: P482 

Franssen C.P.M.: 391 

Franzen O.: 441 

Franzoso M.: 214, 394 

Fraser A.G.: P1572 

Fraser A.G.: P1731 

Frattini S.: P718 

Frattola A.: P1387, P935, P953 

Frea S.: P764 

Freire M.D.C.: P1223 

218 

Freitas A.I.: P894 

Freitas A.P.: P1008 

Freitas A.T.: P484 

Freitas C.: P1416 

Freitas R.A.: P1730, P737 

Freitas S.: P894 

Frey N.: P1849 

Freytes D.O.: P487 

Frick M.: P1269, P1704, P789, P845 

Friedrichsen M.: P499 

Frigerio M.: P697, P705 

Frikha I.M.E.D.: P1071, P1376 

Frimerman A.: 266, P674 

Frioes F.: P1184, P1400, P1436, P841 

Frischbier L.: 393 

Froehlich H.: P820 

Frogoudaki A.: P1645 

Fronczak-Baniewicz M.: P606 

Fruhwald F.: P1119, P1664 

Frutuoso C.: P943 

Fu M.: P1032 

Fu M.L.X.: P520 

Fuentes Manso R.: P1371, P1382 

Fujibayashi K.: P603 

Fujii S.: P1101, P1533 

Fujioka N.: P603 

Fujita W.: P603 

Fujiwara H.: P552, P783 

Fujiwara T.: P946 

Fukunami M.: P1392, P1396 

Fukuzawa S.: P1043 

Fuller W.: 216, P1828 

Furman A.: P639, P732 

Fusco A.: P1192, P1644 

G 

Gabutti A.: P1705, P742 

Gacem K.: P1535 

Gaetani R.: P1850 

Gaggin H.K.: P790 

Gahramanova S.: P1120 

Gaisin I.R.: P493 

Gaita F.: P764 

Gaitani S.: P505 

Gajanana D.: P1805 

Gala A.: P1582, P595 

Galan A.: P1630, P1631, P624 

Galar B.: P1067 

Gali K.: P1549 

Galinier M.: P1851, P798 

Galizio N.: 268, P1084 

Galkova L.: P1492 

Gallagher J.: P1229, P1237, P1661

Gallego Sanchez G.: P1721 

Gallego Villalobos M.L.: P542 

Galrinho A.: P1250 

Galvez-Monton C.: P1350, P922, 

P923 

Gama P.: P1587, P1694, P522 

Gama V.: P1096, P648, P649, P818, 

P940 

Gamble G.D.: P867 

Gamra H.: 85, P974 

Gamradt S.: P1755 

Ganiyev T.Z.: P573 

Ganslmeier P.: P669 

Gao G.: P916 

Garbade J.: P673, P678 

Garcia- Aranda Dominguez B.G.A.D.: 

P1384 

Garcia Fernandez M.: P750 

Garcia Garcia Cosme C.G.G.: P472 

Garcia Garrido L.L.: P1214 

Garcia Gonzalez M.J.: P1564 

Garcia Gonzalez M.J.: P1811 

Garcia Lopez J.C.: P1062, P1721 

Garcia Lopez M.: P526 

Garcia Martin E.P.: P1385 

Garcia Martin E.P.G.M.: P1384 

Garcia Perez L.A.U.R.A.: P537 

Garcia Perez M.L.: P542, P545 

Garcia Rebollo M.S.: P1811 

Garcia Rodriguez Marina M.G.R.: 

P472 

Garcia S.: P1401 

Garcia-Gonzalez P.: 430, P1091, 

P1596 

Garcia-Pinilla J.M.: P743 

Gardner R.: P492 

Gardner R.S.: P1415 

Gareau A.: P1751, P901 

Gargani L.: P1598 

Gargano A.: 268, P1084 

Gargiulo P.: P821 

Garin N.: P1420 

Garkina S.: P1430 

Garrido Asenjo N.: P1036, P1711 

Garrido Bravo I.P.: P1597 

Gasimov Z.: P1120 

Gaspar A.: P1691 

Gaspar I.M.: P484 

Gasparini S.: P697 

Gastelurrutia P.: P1662 

Gatti G.: P680 

Gavazzi A.: P697 

Gavira Gomez J.J.: P526 

Gavrielatos G.: P971 

Gawor R.: P1009, P580 

Gawor Z.: P1009, P580 

Gayat E.: P556, P980 

Gazar A.: P574 

Gazimzyanova A.S.: P493 

Gazizov R.: P1573 

Ge J.: 263 

Gebhard B.: P691 

Gelbrich G.: 436, P1421, P1674, 

P1681, P523, P691, P813 

Geleijnse G.: P1686, P531 

Gelis L.: P1468 

Gencer E.: P1140, P715 

Gendlin G.E.: P1476 

Gensini G.F.: P1425, P1759, P583 

Georgiev O.: P1719 

Georgieva J.G.T.: P829 

Georgievska- Ismail Ljubica G.I.L.J.: 

P1613 

Georgievska-Ismail L.J.: P1806 

Georgievska-Ismail L.J.G.I.: P1610, 

P754 

Geraghty L.: P1011 

Germano Emilio Conceicao G.E.C.: 

P1550 

Gerosa G.: 427, P689 

Gerritse B.: P1103 

Gerula O.: P963 

Geske J.: P1542 

Gf Cleland J.: P1584 

Ghani F.G.: P1041 

Gheorghe G.: P570 

Gheorghiade M.: P541, P774, P842, 

P978 

Gherghinescu C.L.: P1289 

Ghigo A.: P1831 

Ghrairi A.: P1060 

Giacca M.: P1834 

Giacomello A.: P1850 

Giallauria F.: P1263 

Giambartolomei C.: 81 

Giannakoulas G.: P1177, P1178 

Gianni L.: P1012 

Giannico M.B.: P1348 

Giannoni A.: P1461, P612, P780 

Giannuzzi P.: P1263 

Giasi A.: P1192, P1644 

Gibbons E.: P692 

Gibbons V.: P692 

Gielerak G.G.: P1152 

Gietl M.: P669 

Gietzen F.: P691 

219 

AUtHoRS 


Gigantino A.: P925 

Gigunova L.: P784 

Gil K.: P1029, P606 

Gil R.J.: P1029, P606 

Gilbert E.M.: P524 

Giles W.R.: P1826 

Gilis-Januszewski J.: P1588 

Gilis-Januszewski T.: P1588 

Gilliam F.R.: P550 

Gillijns H.: P1769, P892 

Gilon D.: P839 

Gimenez C.: P1622 

Gimsing P.: P610 

Gin-Sing W.: P849 

Ginzburg M.: P1343 

Giordano P.: P1518 

Giordano U.: P947 

Giovannardi M.: P512 

Gironi C.: P1425 

Gislason G.H.: 209 

Giudici V.: P696 

Giverts I.: P1673, P1738 

Givertz M.: P1100 

Gjata A.: P1494, P870 

Gjerakaroska M.: P1053 

Gjertsen E.: P1455 

Gkouziouta A.: P1528 

Glass D.: 394 

Glavas D.: P635 

Glavas S.: P981 

Glerici G.: P1535 

Glezeva N.: P1360, P1829 

Gluhanyuk E.V.: P1770 

Glynn L.: P1661 

Goethals M.: 270, P675 

Goetschalckx K.: P1274 

Goetz K.R.: P1853 

Gold M.R.: 274 

Goldstein R.E.: P1700 

Golitsyn S.P.: P602 

Golubovic Petrovic D.G.P.: P860 

Golz S.: P1312, P489 

Gomes F.: P1144, P1184, P1254, 

P716 

Gomes L.: P1050, P676 

Gomes Loques Filho O.: P664 

Gomes M.J.: P781 

Gomes M.S.B.: P1112 

Gomes S.: P1416, P894 

Gomez A.M.: P1311 

Gomez Diego J.J.: P750 

Gomez Doblas J.J.: P1064, P1696, 

P1701 

INDEX

INDEX 

AUTHORS 


Gomez Leon J.: P950 

Gomez M.F.: P930 

Gomez Perez A.: P1062, P1371, 

P1382, P1496, P1721, P1796 

Gomez-Cuba M.: P1669 

Gomez-Doblas J.J.: P743 

Gomez-Huelgas R.: P843 

Goncalves A.: P1035, P1118, P1801, 

P589, P601, P607, P717, P753, 

P772, P836, P859 

Goncalves C.: P1478 

Goncalves L.: P1540, P1693 

Goncalves M.: P1163, P1251, P548, 

P977 

Goncalves Rodrigues P.: P1313 

Goncalves S.: P1166, P1270, P1369, 

P1688, P1690, P1710 

Goncalvesova E.: P1326, P1699, 

P835 

Goncalves-Rodrigues P.: P1338 

Gonchar O.: P1611 

Goncharov I.: P1037 

Goncharova N.S.: P1271 

Gondoni E.: P821 

Gonet M.: P1340 

Gong J.: 269, 439, P1486 

Gonzalez Arjol B.: P1622, P1629 

Gonzalez B.: P1227, P1631, P1662, 

P1698, P503, P624 

Gonzalez Cabeza E.: P1564 

Gonzalez Canovas C.: P1597 

Gonzalez Costello J.: P1031 

Gonzalez J.: 268, P1084 

Gonzalez Tobledo Gina G.G.R.: P490 

Gonzalez-Costello J.: P1669, P794, 

P795 

Gonzalez-Jaramillo N.: P1236, 

P1483, P1797, P694 

Gonzalo Pascua S.: P1125 

Goode K.: 82, P1095, P1252, P810 

Goode K.M.: P1686, P509, P531 

Goodkova A.: P1784 

Gorda I.: P1286 

Gorda I.I.: P1185 

Gordeeva E.: P1543 

Gorgels A.P.M.: P1316 

Gorovenko N.G.: P827 

Goshovska Y.: P1762 

Gotsman I.: P1265, P839 

Gouveia M.R.: P484 

Gracida M.: P1031, P795 

Grajek S.: P1240, P1671, P771 

Grajkowska W.: P1029, P1367 

Gramovich V.V.: P1331 

Granda Nistal C.G.N.: P1384 

Granger C.: P872 

Granger C.B.: P1567 

Grant E.: P1235 

Grapsa J.: P849 

Gratchev A.: P1756 

Gratii C.: P1002, P1006, P999 

Gratsianskaya S.E.: P1655 

Graziani F.: P1348 

Grechko S.: P558 

Greco C.: P809 

Greenberg B.H.: P497 

Greenberg B.H.: 260 

Greene S.: P774, P842 

Gregori D.: P1024 

Greszata L.: P644 

Griesmacher A.: P1269, P1704, P789 

Griffin S.: P907 

Griffiths M.: P1039 

Griffiths M.R.: P529 

Grigioni F.: P1541, P682 

Grille Cancela Z.: P931 

Grivenco A.A.: P1729 

Groene H.J.: 393 

Grollier G.: P1092, P666 

Groschner K.: P884 

Grosso Marra W.: P764 

Grosu A.: P1002, P1006, P999 

Grujicic M.: P1373 

Grundy B.: P1618, P1642 

Gruner H.: P1007, P1008, P1058, 

P1478 

Grybauskiene R.: P1617 

Grzebieniak T.: P1586 

Gu L.: P916 

Gu Y.F.: P1609 

Guan H.: P1739 

Guardado J.: P1154, P701 

Guasch A.: P1350, P922 

Guberna S.: P1289 

Gueder G.: 436, P476, P523, P691, 

P807 

Guedes C.: P1554, P1555 

Gueldner F.H.: P1085, P651 

Guennem F.: P1535 

Guentner S.M.: P807 

Guermazi M.E.D.: P1034, P1034 

Guerreiro Castro S.: P1007, P1008, 

P1058, P1478 

Guerrero L.U.I.S.: P1081 

Guerrier L.: P1619 

Guha K.: P1078 

220 

Guidetti F.: P1135 

Guidi G.: P1094 

Guillen Lopez Luisa L.G.L.: P472 

Guimaraes G.: P1124 

Guimaraes G.V.: P1672, P1716, 

P1807, P1808, P566, P726, P814 

Guimaraes M.J.: P701 

Gul L.: P1021, P1466 

Gulaga O.I.: P1390, P770 

Gulel O.: P1732 

Guler A.: P1023 

Gullestad L.: P1455 

Gullo G.: P1011 

Gunes H.: P1197 

Guo J.Y.: 212 

Guo Y.: P1198 

Gupalo E.M.: P602 

Gupta D.: P1100 

Gupta D.K.: P1595 

Gupta J.: P695, P875 

Gupta R.C.: 396, P473 

Gupta S.K.: P897 

Gupta T.: P695, P875 

Gursoy Y.C.: P763 

Gustafsson F.: 209, P1529, P1531, 

P610, P668 

Gutleben K.J.: P1378 

Gutor S.S.: P1026, P515 

Guvenc S.: P1364 

Guzik P.: P1240, P1671 

Gwang-Won S.E.O.: P1272, P954 

Gwizdala A.: P1240, P1671 

Gwyther L.: P1219, P1225 

Gyamdjyan K.: P1147 

Gyamdzhyan K.: P1268 

H Habbal R.: P1481 

Hadamitzky M.: 273 

Hadziomerovic M.H.: P1665 

Hadzovic D.: P1817, P856 

Hagerman I.: P502 

Hagglund E.: P502 

Haggui A.: P1253 

Haghikia A.: 80 

Hagiwara N.: P1234, P1520 

Haigney M.: P1700 

Haissaguerre M.: P1086, P659 

Hajiyev M.: P1120 

Hajlaoui N.: P1253 

Haj-Yahia S.: P492 

Hakim M.: P679 

Hakimzadeh N.: P1768

Halianishcha V.: P1372 

Halici F.: P1823 

Hall A.: 216 

Hall C.: P511 

Haller P.: P912 

Hamano G.: P1047, P549 

Hamazaki N.: P1153 

Hamdan R.: P944 

Hamdani N.: 388, 391, 401, 402, 

P1313, P1852, P482, P485 

Hamdi S.: P1623, P1625, P1626, 

P1685, P964, P985, P987 

Hamelet J.: P1832 

Hamid T.: P968 

Hamilton M.A.: P846 

Hamm C.W.: P761 

Hammarsten O.: P520 

Hammer E.: P1458 

Hammer F.: 436, P523 

Hammerman H.: P1441, P1534 

Hammond J.: P1832 

Hammoudi N.: P1221 

Hammoudi N.H.: P1657 

Hamzaoui A.: P985, P987 

Han S.W.: P1033, P1145, P1666 

Hancocks M.: P1422 

Handanis S.: P731 

Handy B.C.: P1198 

Hang C.-L.: P1032 

Hanke M.: P691, P807 

Hansen P.B.: P1529, P1531, P668 

Han-Young J.I.N.: P1272 

Haouala H.: P1253 

Haq N.: P1498, P564 

Harb M.: P944 

Harbinson M.T.: P844 

Harbinson M.T.: P641 

Harding R.: P1219, P1225 

Hardman S.M.: P477 

Harjola V.P.: P557 

Harjola V.-P.: P767 

Harper R.M.: P846 

Hartmann D.: P891 

Hasanov M.S.: P848 

Hasenfuss G.: 438, P1353 

Hashimoto Y.: P1299, P1309 

Hasic A.: P930 

Hasin T.: P1099, P850 

Hassan A.: P975 

Hassine M.: 85, P974 

Hata N.: P551, P803, P962 

Hatala R.: P1310 

Hatjimiltiadis S.: P1177 

Hauck S.: 273 

Hausleiter J.: 441 

Hausmann M.: P1198 

Haverkamp W.: P1228, P1421, 

P1426, P1427, P1667, P1674, 

P1681, P565, P966 

Hawkins N.: P492 

Hawkins N.M.: P1567, P707 

Haykal M.: P1473, P1590 

Hayward C.: P1525 

Heather D.: P511 

Hegarova M.: P1546, P683 

Heinrich J.: P1365, P1488, P630, 

P632 

Heinzel F.: P1746 

Heinzel F.R.: P1748, P1790, P884, 

P889 

Heller S.: P1119 

Heltai K.: P1556 

Hempel D.: P748 

Henein M.Y.: P1676 

Henig I.: P1441 

Henriques-Coelho T.: P908 

Hentati M.O.U.R.A.D.: P1034, 

P1034, P1071, P1376, P1506, 

P1813, P544, P547 

Hepburn D.: 82 

Heras M.: P1248, P1641, P777 

Herda L.R.: P1755 

Hermans H.: P892 

Hermans J.J.R.: P1316 

Hermida N.: P1832 

Hernandez Baravoglia C.M.: P604, 

P948 

Hernandez Garcia J.M.: P1064, 

P1695, P1696, P1701 

Hernandez I.: P1257, P825 

Hernandez Rodriguez P.: P1701 

Hernandez-Torres F.: P893 

Herrera J.E.: P1162 

Herrera-Gomez N.: P1123 

Herrmann-Lingen C.: P1426 

Herro G.: P550 

Hersunarti N.: P976 

Herum K.M.: P1321, P930 

Hervent A.S.: 388 

Hervent A.-S.: 389, P1852, P913 

Heshmat H.: P1423 

Hessel M.H.M.: P1316 

Hetzer R.: P1097, P1312, P1539, 

P1756 

Heuschmann P.: P518 

Heuschmann P.U.: 436, P523 

221 

AUtHoRS 


Heverin M.: P1237 

Heymans S.: P897 

Heymes C.: P1849 

Heyndrickx G.R.: P1297 

Hiari N.: P494 

Hidalgo Olivares V.: P1382 

Hidalgo Olivares V.M.: P1721 

Hidi L.: P927 

Higginbotham E.: 265 

Higuchi M.L.: P898, P917, P918, 

P919 

Higueras-Ortega L.: 430 

Hildick-Smith D.: P1075 


Hilker M.: P669 

Hill M.: P1103 

Hillege H.L.: P1389, P1393 

Hiller K.H.: P1345 

Hillestad V.: P489 

Hilton J.: P591 

Hindricks G.: P590 

Hinic S.: P832 

Hintersteininger M.: P912 

Hipolito R.: P654 

Hipperson D.: P1493, P1637 

Hirohata S.: P1639 

Hirono A.: P521 

Hirooka K.: P1047, P549 

Hirose S.: P598 

Hirsch E.: P1831 

Hirsch G.: P1751 

Hirt S.: P669 

Hjelmfors L.: P499 

Ho J.E.: P1737 

Hobkirk J.: P1293 

Hockey D.: 208 

Hodorogea A.: P570 

Hoekstra T.: P1393 

Hoes A.W.: P808 

Hoes A.W.: P1207, P560 

Hohl M.: 390, P1824, P1830, P887 

Holek M.: P491, P672 

Holly D.: P1670 

Holme Jung M.: P1531 

Holzendorf V.: P691 

Holzhuetter H.G.: P1324 

Honarbakhsh S.: P529 

Hong N.: P1702 

Honorato R.: P1550 

Hoppe U.C.: P550 

Horgan S.: P1229, P1336, P1339 

Hori M.: P1392, P1396 

Horiguchi M.: P1386, P822 

INDEX

INDEX 

AUTHORS 


Horrillo Sanchez L.: P1125 

Horsch A.: 393 

Horstkotte D.: P1365, P1378, P1398, 

P1429, P1447, P1488, P1588, P630, 

P631, P632 

Horszczaruk G.J.: P722 

Horton-Breshears M.: P665 

Hoskova L.: P525, P683 

Hossain M.-S.: P1588 

Houben R.: P675 

Housseiny F.: P944 

Hoving C.: P793 

Howard B.: P1603 

Howlett J.G.: P866 

Hsu H.-W.: P1032 

Hu X.: P1425, P1759 

Huang C.O.N.G.X.I.: P481 

Huang F.Q.: P1170, P538 

Huang J.: P1000 

Huang Y.-T.: P1032 

Hubank M.: 81 

Huber K.: P1825 

Huber S.: P1347, P488, P888, P889 

Hudakova A.: P817 

Huenlich M.: P1353 

Hughes A.D.: P1244 

Hulek P.: P1635 

Humar F.: P697 

Hundertmark M.: P1772, P1773 

Hundt M.: P1755 

Hunter L.E.: P524 

Hunuk B.: P1706 

Hurlimann D.: P1437 

Hussain R.I.: P1788 

Huynh T.: P1827 

Hwang J.J.: 263 

Hwang K.K.: P1145 

I 

Iaconelli A.: P1348 

Iacoviello M.: P1046, P1475, P613 

Iadanza E.: P1094 

Iakovleva A.: P1820 

Ianni B.: P917 

Ibrahim I.: P1394 

Ibrahimi P.: P1676 

Ichikawa S.: P1043 

Idris N.K.: P1203 

Igarashi A.: P1153 

Ignaszewski A.: P866 

Ihm S.H.: P1581 

Iizuka H.: P1217 

Ikeda A.: P1043 

Ikegami R.N.: P917, P918 

Ikonomidis I.: 262, P965 

Ilan-Bushari L.: P600 

Ilic B.: P1621 

Ilic I.: P1714 

Ilic S.: P1206, P1337, P1621, P1763 

Ilic V.: P1206 

Ilic-Djordjevic I.: P1285 

Iliceto S.: 427, P1472, P608, P689 

Iliesiu A.: P1202 

Iliesiu A.M.: P1128 

Iliopoulos T.: P1809 

Imadoglu O.: P1732 

Imaev T.E.: P1073 

Imazio M.: P1266, P1418 

Imekraz L.: P798 

Inagaki M.: P1043 

Inazumi H.: P552, P783 

Incaurgarat B.: P1198 

Ince H.: P1104 

Ines P.C.: P1453 

Infante-Vazquez O.: P1151, P1344 

Inglis S.C.: P665 

Inkrot S.: P1228, P1421, P1426, 

P1667, P1674, P1681, P565 

Inoko M.: P1074, P598 

Inoue K.: P1533 

Inoue T.: P1217 

Inoue Y.: P1576 

Inzani F.: P1349 

Iorio A.: P1030, P1469, P514 

Iqbal N.: 265 

Irisov D.B.: P573 

Irwin B.: P709, P710 

Isabekova A.: P863 

Isaikina Y.: P921 

Isailovic - Kekovic M.: P1608 

Isailovic-Kekovic M.: P1606, P755 

Isayev E.L.N.U.R.: P1448 

Iscar M.: P1501 

Ishigooka J.: P1234 

Ishii H.: P1576 

Islas F.: P750 

Ismail Y.: P1668 

Ismailov S.I.: P1568 

Ismailova J.: P1044 

Ismayilova N.R.: P1231 

Isobe M.: P1299, P837, P946 

Issa M.: P944 

Issa V.: P918 

Issa V.I.: P1117 

Issa V.S.: P1124, P1368, P1391, 

P1465, P1545, P1716, P543, P566, 

222 

P685 

Isshiki T.: P1533 

Istratoaie O.: P1591 

Ito H.: P1101 

Iudice G.: P780 

Iusuf A.: P1221 

Iusuf A.I.: P1657 

Ivanis V.: P1220 

Ivanova E.: P703 

Ivanovic B.: P1363 

Ivern Diaz Consol C.I.D.: P490 

Izumi T.: P1392, P1396 

J 

Jaarsma T.: 207, 210, P1099, P1102, 

P1393, P498, P499, P504 

Jabaren M.: P600 

Jablonska M.: P1340 

Jabor A.: 433, P1546, P525 

Jachec W.: P1582, P595 

Jackson C.E.: P1415 

Jacobs S.: P1103 

Jacobshagen C.: 438 

Jae-Sik J.A.N.G.: P1272, P954 

Jafri L.: P1041 

Jagla F.: P1777 

Jahamdar Lashki D.: P1667 

Jahandar Lashki D.: P565 

Jahangirov T.: P1120 

Jaisser F.: P1354 

Jakob P.M.: P1345 

Jakubikova M.: P817 

James R.: P1075 

Jan M.: P942 

Janas J.: P644 

Janczak D.: P952 

Janega P.: P1355 

Jang S.W.: P1581 

Jang Y.: P1702 

Janjic A.: P1373 

Janjic Z.: P1373 

Jankovic N.: P1803, P896 

Jankovic-Tomasevic R.: P1643, 

P1681, P776 

Jankowska E.: P1226, P639 

Jankowska E.A.: P1405, P1419, 

P625, P640, P952, P995 

Janot-Berthier A.S.: P1420 

Jans J.: P793 

Janssen B.J.A.: P1316 

Janssens S.: P1769, P892 

Januzzi J.J.: P790 

Japp A.: P492

Jarkovsky J.: P1264 

Jarnert C.: P1460 

Jarolim P.: 433 

Jasarevic A.: P856 

Jashari F.: P1676 

Jasiewicz M.: P1067, P1707, P855 

Jasiewicz P.: P1707 

Jasinski K.: P1340 

Jaufeerally F.: P1678 

Jaufeerally F.R.: P1500 

Jazwiec P.: P952 

Jdaida B.: P1253 

Jebessa Z.: 393 

Jehmlich N.: P1458 

Jelani A.: P1434, P1818, P955 

Jendekova L.: P1355 

Jeney V.: P1827 

Jensen J.: P520 

Jeon E.S.: P973 

Jeon H.K.: P1444 

Jeong J.O.: P815 

Jeong J.W.: P865 

Jeong-Sook S.E.O.: P1272, P954 

Jeridi G.: P1060 

Jesus I.: P1463, P1474 

Jesus S.: P1409 

Jesus Sanchez Mas J.S.M.: P1774 

Jewell S.: P1075 

Jh L.I.M.: P1440 

Jhamnani S.: P1603 

Jhund P.: P1567 

Jibran R.: P519 

Jimenez Cruz M.: P950 

Jimenez Mazuecos J.M.: P1062, 

P1496 

Jimenez Navarro M.F.: P1064, P1695, 

P1696, P1701 

Jimenez-Fernandez M.: P1123 

Jin G.: P889 

Jin S.A.: P815 

Joao Carlos Silva J.C.S.: P802 

Joao I.: P1238 

Johnsen S.P.: P1362 

Johnston A.: P885 

Johnston A.S.: P1826 

Jojko J.: P744 

Jolda-Mydlowska B.: P1586 

Jomaa W.: P1625, P1626, P1685, 

P964, P985, P987 

Joo S.-J.: P546, P982 

Jorge A.J.L.: P1302, P1647 

Jorge C.: P1070, P1189, P1195, 

P1270, P1507, P1508, P1654, P768, 

P775, P779, P781, P804, P831, P847 

Jorge Perez P.: P1564, P1811 

Jorgensen L.: P516 

Jose Pedro Nunes J.P.N.: P802 

Jose Ramon Gonzalez Juanatey 

J.R.G.J.: P1774 

Jose Silva Cardoso J.S.C.: P1089 

Joseph A.: P1164, P1267, P1584, 

P1602, P810, P996 

Joshi A.: P1428 

Jousten I.: P1072, P1816 

Jovanova S.: P1048, P1053 

Jovic Z.: P1689 

Jr Gibbs S.: P849 

Juarez Escobar K.Y.: P950 

Juarez Prera R.: P1564 

Julia I.: P1312 

Julia Maciel M.: P717 

Jung L.: P834, P986 

Jungbauer C.: P483 

Junior E.: P1697 

Junqueira J.: P1728 

Jurado-Lopez R.: P929 

Juraszynski Z.: P644 

Jurcevic Zidar B.: P635 

Jurczak B.: P1447 

Jurjevic N.: P981 

K 

Kaan A.: P670, P671, P866 

Kaczmarska E.: P1370 

Kada A.: P579 

Kadoglou N.: 262 

Kadota K.: P1101, P1533 

Kaeva S.: P1806, P949 

Kaeva S.K.: P934 

Kahya Eren N.I.H.A.N.: P1292, P873 

Kain D.: 217, P1320 

Kajinami K.: P603 

Kalashnykova O.S.: P1433 

Kalasz J.: 401, P1334 

Kaldara E.: P1477, P1532, P508 

Kalejs O.K.: P1513 

Kalfat T.: P679 

Kalicinska E.: P625 

Kalil Filho R.: P898, P917, P918, P919 

Kalil R.A.: P1598 

Kalinina N.I.: P1352 

Kaliyev R.: P1526 

Kaljadka M.: P1530, P1778 

Kallvikbacka-Bennett A.: P1164 

Kalogirou F.: P1052, P1122 

Kalusche D.: P861 

223 

AUtHoRS 


Kalvelis A.: P740 

Kalyva N.: P1290, P1450 

Kamakura S.: P579 

Kamal A.: P1159, P1169 

Kamilova U.: P1044, P1138, P1201, 

P1563, P620 

Kaminski K.: P1067, P1325 

Kaminski K.A.: P1707, P855 

Kamiya K.: P1153 

Kammoun S.A.M.I.R.: P1034, P1034, 

P1071, P1376, P1506, P1813, P544, 

P547 

Kamperidis V.: P1177, P1178 

Kanaan M.Z.: P719 

Kanazirev B.N.K.: P829 

Kang H.C.: P1223 

Kang M.S.: 263 

Kang S.M.: P1702, P973 

Kang X.F.: 212 

Kao D.P.: P1230, P524 

Kapelios C.: P1477, P1532, P508 

Kapelko V.I.: P1331 

Kapetanakis S.S.: P591 

Kaplunova V.Y.: P1017 

Kara T.: P1492 

Karaahmet T.: P1023 

Karabag T.: P763 

Karakaya Z.: P766 

Karakus G.: P876 

Karan R.: P1005, P1536 

Kararigas G.: P1312, P1324 

Karaskov A.: P661 

Karauzum K.: P626 

Karavidas A.: 429 

Karavolias G.: P1528 

Kardash V.: P921 

Kardashevska L.: P1431 

Kardashevska L.I.: P1578 

Karen S.: P785 

Karesova I.: P1635 

Karimpour-Fard A.: P524 

Karlstaedt A.: P1324 

Karpov R.: P1226 

Karpova I.S.: P1275 

Karvounis H.: P1177, P1178 

Kasai A.: P1386, P822 

Kaschina E.: P1791 

Kasem H.: P994 

Kaser S.: P1269, P1704, P789 

Kashif W.K.: P1041 

Kashtalap V.: P1127, P778 

Kaspar M.: 436, P523 

Kassianides X.: P1414 

INDEX

INDEX 

AUTHORS 


Kastl S.P.: P1825 

Kasturirangan S.: P916 

Kataoka H.: P1485, P621 

Kato T.: P1074, P598 

Katsaros L.: P1532 

Katsoulas T.: P812 

Katsytadze I.: P1574, P963 

Katus H.A.: 393, P1849, P820 

Kaufmann B.A.: P1274 

Kaun C.: P1825 

Kaun K.: P1357 

Kautzner J.: 433, P525 

Kavoliuniene A.: P1617 

Kawai Y.: P603 

Kawakami J.T.: P917, P918, P919 

Kawanishi K.: P579 

Kawano M.: P1153 

Kawashima M.: P783 

Kawecka E.: P787 

Kawecki D.: P1582, P595, P744 

Kaya H.: P1197 

Kaye D.M.: P1708 

Kazakov A.: 392 

Kazakov V.A.: P1026, P515 

Kazatsker M.: 266, P1795, P478, 

P530, P674, P937, P938, P939 

Kazimli A.V.: P1271 

Kazmierski M.: P1303 

Kealy J.: P670, P671 

Kedev S.: P1048, P936 

Kehl D.W.: 265 

Kekovic P.: P1606, P1608, P755 

Kelly D.: P663, P960 

Kelly R.: P998 

Kemal H.: P688 

Kemi O.J.: P885 

Kemi O.J.: P1826 

Kennington E.: 216 

Kepka C.: P1370 

Kerber S.: P691 

Kerec Kos M.: P1056, P1141 

Keren A.: P1265, P839 

Kerins D.: P1229 

Kerkhof P.L.M.: P1783 

Kerkhof P.L.M.: P1297 

Kertesz A.: P1779 

Keshavarzi F.: P509 

Ketata N.I.Z.A.R.: P1034, P1034, 

P1506 

Kettner J.: P491, P672 

Khabarova N.V.: P1017 

Khaleva O.: P1428, P749 

Khalil T.: P1169, P1273, P1282, P762 

Khalil Y.: P759 

Khan A.H.K.: P1041 

Khan F.Z.: P495 

Khanna A.: P1525 

Khateeb M.: P1464 

Khayati A.: P679 

Khmelnitskaya K.A.: P881 

Kholopov L.S.: P1612, P990 

Khoo C.W.: P1001 

Khosroshvili L.: P1459 

Khukhlina O.: P1780 

Khushaba R.: 84 

Khusro F.: 265 

Kiencke S.: P1274 

Ki-Hun K.I.M.: P1272, P954 

Kikuchi Y.: P1717, P569 

Kilicaslan B.: P1280 

Kilpatrick E.: 82 

Kilter H.K.: P1332 

Kim B.R.: P1033, P1666, P1725 

Kim D.B.: P1581 

Kim D.H.: P576 

Kim E.: P834, P986 

Kim H.S.: P1145 

Kim H.Y.: P1581 

Kim J.B.: P961 

Kim J.H.: P1581 

Kim J.Y.: P1442 

Kim K.-S.: P546, P982 

Kim S.H.: P1145 

Kim S.J.: P865 

Kim S.-Y.: P546, P982 

Kim T.H.: P1412, P576 

Kim W.: P834, P986 

Kim Y.J.: P1145 

Kimura T.: P1533 

Kind B.: 434 

Kiran S.: P763 

Kirshenbaum L.A.: P924 

Kiseleva E.: P1343 

Kisheva A.R.: P826 

Kisko A.: P817 

Kiss L.Z.: P1183 

Kiss R.G.: P1090, P1259, P1380, 

P714 

Kitada H.: P549 

Kitahara Y.: P581, P582 

Kitayama M.: P603 

Kivrak T.: P1706 

Kizhvatova N.V.: P1543 

Kjellstrom B.: P1460, P1709 

Klabnik A.: P877 

Klester Elena K.E.: P1233 

224 

Klester Karolina K.K.: P1233 

Kliebhan J.: P1269, P1704, P789 

Klimenko A.: P619 

Klimova N.A.: P1573 

Kmec J.: P817 

Knapp M.: P1707, P855 

Knezl V.: P1310, P1326 

Knops M.: P571, P734 

Knorr A.: P489 

Knosalla C.H.: P1539 

Knusel B.: P961 

Knyazkova I.: P1055 

Ko J.: P834, P986 

Kobalava Z.: P619 

Kobayashi N.: P803, P962 

Kober L.: P868 

Kobusiak-Prokopowicz M.: P1586 

Koca R.: P763 

Kocabas U.G.U.R.: P1292, P873 

Kocharli M.: P1120 

Kochegura T.: P784 

Kochetov A.G.: P1454 

Kocic G.: P1206 

Kocijancic A.: P1156, P1803, P1804, 

P757, P896 

Kockskaemper J.: P1315 

Kodim N.: P1687 

Kodziszewska K.: P1367 

Koerber B.: P1398, P630, P631, P632 

Kogerakis N.: P1528 

Kohlhaas M.: 392, P1830 

Koide M.: P1047, P549 

Kojsova S.: P1355 

Kokeny G.: P927 

Kokocinska D.: P787 

Kokshagina N.V.: P1157, P858 

Koksheneva I.: P1130 

Kokubo Y.: P579 

Kolb C.: 273 

Kolesnikova E.A.: P638 

Koller A.: P910 

Kolodina D.: P1319 

Kolodziej P.: 428 

Kolsut P.: P1106, P1835 

Komajda M.: P1142, P1575, P711 

Komissarova S.: P1013 

Komlev A.E.: P1073 

Konev A.: P1004, P575 

Konoplyanik L.: P720, P857 

Konradi A.: P1491 

Kontaraki J.: P1726 

Kop W.J.: P895 

Kopec G.: P959

Koracevic G.: P1537 

Korelskaya N.: P1319 

Koretsune Y.: P1047, P549 

Korewicki J.: 428, P1110, P698 

Korkmaz S.: P927 

Korostovtseva L.: P1491 

Koryagina A.L.E.X.A.N.D.R.: P1562, 

P642 

Kosheleva N.A.: P1255 

Kosheleva N.A.: P1247 

Koshkina D.: P758 

Koshlataya O.V.: P1275 

Koshy G.: P1580 

Kosiuk J.: P590 

Kosmacheva E.D.: P1543 

Kostalova J.: P1492 

Kostic T.: P1082 

Kostkiewicz M.: P1113, P1165 

Kostogryz V.B.: P1578 

Kostova N.: P736 

Kotowski M.: P1303 

Kotrc M.: 433 

Kotroyiannis J.: P852 

Kourgiannidis G.: P1809 

Koutalas E.: P590 

Koutsotheodorou E.: P1645 

Kovacevic V.: P1803, P1804, P896 

Kovacevic-Kostic N.: P1005, P1536 

Kovacevic-Preradovic T.: P1373 

Kovacs A.: P1334 

Koval O.: P1359 

Koval O.A.: P1703 

Koval S.: P1781 

Kowal J.J.: P1152 

Koyama S.: P552, P783 

Kozar-Kaminska K.: P1383 

Kozdag G.: P626 

Kozelj M.: P942 

Kozic M.: P1373 

Koziolova N.: P1149, P1724, P704 

Kozlenok A.: P1491 

Kozlenok A.V.: P911 

Kozlova S.: P1491 

Kraai I.H.: P1393 

Krabatsch T.: P1097, P1756 

Krachak D.: P1530 

Krackhardt F.: P1228, P1421, P1426, 

P1667, P966 

Kraigher-Krainer E.: P1295, P1595, 

P1727 

Kramer F.: P489 

Krasnaliev Y.: P1137 

Krasnova O.: P880, P880 

Kraus W.: P786 

Krause C.: P1065, P1503, P989 

Krauze T.: P1240, P1671 

Kravchun P.: P1411, P903 

Kravchyn P.: P616 

Kreibich M.: P912 

Kremastinos D.: P971 

Kremers W.: P1542 

Kremzer A.: P1628, P1636, P1821 

Kresh J.Y.: P1297, P1783 

Krestjyaninov M.V.: P869 

Kreusser M.M.: 393 

Krishnamoorthy S.: P1001 

Kristo D.: P1177, P1178 

Krivolapov S.: P1512 

Krljanac G.: P1258, P1715 

Krobert K.A.: P1785, P1788 

Krobert K.A.: P1747 

Krone R.: P1700 

Krop I.: P1012 

Krotin M.: P832 

Krpuljevic M.: P761 

Krssak M.: P1357 

Krstic M.: P1245, P1720 

Krstic N.: P1082 

Kruger M.: 394 

Kruglikova A.S.: P1157, P858 

Krukov N.: P1343 

Krumina G.: P740 

Krupnova E.V.: P1013 

Kruszewski M.: P1835 

Krychtiuk K.A.: P1825 

Krynicka J.: P1357, P912 

Krzemien-Wolska K.: P1582, P595 

Krzesinski P.: P1152 

Kuatbayev Y.: P1526 

Kubiak G.: P1582, P595 

Kubo M.: P1101 

Kuchmin A.: P729 

Kucukaksu S.: P1527 

Kucur C.: P1197 

Kuhn J.: P886 

Kukes V.: P1147, P1268 

Kukin M.: P1700 

Kulich K.: P1739 

Kulinkovich A.U.: P1655 

Kumagai S.: P598 

Kumar A.: 440 

Kumar R.: P846 

Kumashiro H.: P1639 

Kunchev O.G.: P826 

Kurbanov N.A.: P1022, P592, P643, 

P879 

225 

AUtHoRS 


Kurganovich S.: P1778 

Kurjata P.: 428, P698 

Kurlianskaya A.K.: P1077, P611 

Kuroiwa N.: P1043 

Kurshubadze E.: P1288 

Kurt Y.: P1319 

Kurushko T.: P1372 

Kuryata O.: P650 

Kuryata O.V.: P615 

Kus E.: P1794 

Kusachi S.: P1639 

Kushnir Y.: P650 

Kusmierczyk M.: P1106 

Kusuoka H.: P1047, P549 

Kuznetsov G.E.: P1068 

Kuznetsov V.A.: P1322 

Kuznetsova T.: P1646 

Kvaloy H.: 215 

Kwasiborski P.J.: P722 

Kwon B.-J.: P1581 

Kycina P.: P609 

Kydd A.C.: P495 

Kyoung Son Y.: P1793 

Kyriakides Z.S.: P1088 

Kyyak H.: P906 

Kyyak Y.: P904, P905, P906 

Kzhyshkowska J.: P1756 

L 

La Gioia R.: P512 

Labandeiro J.: P1155 

Labrandero C.: P1796 

Labrousse L.: P659 

Labrunee M.: P1851 

Lacerda I.C.: P1212 

Lacerda L.: P785 

Lacerda N.S.V.: P1112 

Ladeiras-Lopes R.: P1338 

Laemmle S.: P1356 

Laforet P.: P605 

Lagarto V.: P1516, P1519, P1558, 

P654 

Lagoeiro Jorge A.J.: P1223 

Lahidheb D.: P1253 

Lahitton B.: P1535 

Lahmann C.: P513 

Lai M.-E.: P851 

Lainscak M.: P1056, P1141, P1142, 

P1427, P1643, P966 

Lakatamitou I.: P1052 

Lakhova Y.E.: P784 

Lakomkin S.V.: P1331 

Lakomkin V.L.: P1331 

INDEX

INDEX 

AUTHORS 


Lam C.: P1500 

Lam C.S.P.: P1482 

Lam C.S.P.: P1737, P867 

Lambert J.L.: P1361, P1501, P527, 

P534, P667, P681 

Lambiase P.: P585 

Lambrinou E.: P1052, P1122 

Lampropoulos K.M.: P1809 

Lancioni M.: P1518 

Landa-Rouben N.: 217, P1320 

Landesberg A.: P1534 

Landman M.J.: P808 

Landman M.J.: P1207 

Lang C.: P1499 

Lang C.C.: P1284, P511 

Lang I.M.: P1735 

Langenstroth E.M.: P673 

Lapshina L.: P616 

Lara Olivares A.: P950 

Lara Padron A.: P1811 

Larcombe T.: P695 

Laribi S.: P556 

Larina V.N.: P1262, P1495 

Larue C.: P1619 

Lashkul D.: P1638 

Lasica R.: P833 

Lasrado M.: P1652 

Lassus J.: P556, P557 

Lassus J.P.E.: P767 

Laszczynska O.: P1143, P1144, 

P1184, P1254, P716 

Latouche C.: P1354 

Lau Y.C.: P968 

Lauer D.: P1791 

Laufs U.: P1830 

Laule M.: 437 

Launay J.M.: P556 

Laurendeau C.: 434 

Laurent G.: P1294 

Laustsen A.: P1651 

Lavagnoli C.F.R.: P1242, P1750 

Laviano A.: P1220 

Lawlor L.: P663 

Lawrenson R.: P692 

Lax A.: P926, P928 

Lax A.M.: P1745 

Lax Perez A.: P1597 

Laynez Cerdena I.: P1811 

Lazaro S.: P652 

Lazic B.: P587 

Lazic S.: P587 

Lazzarini V.: P1135 

Le T.T.: P538 

Leal S.: P1058 

Leao S.: P782 

Lebedev D.: P1083, P1087, P1517 

Lebedeva V.: P1087, P1517 

Leblanc M.-H.: P866 

Lebreiro A.: P1015, P1168, P1451, 

P588, P589, P836 

Lechene P.: P1789 

Leclercq F.: P811 

Lecour S.: P785 

Ledakowicz-Polak A.: P1741 

Ledwidge M.: P1011, P1229, P1336, 

P1339, P1358, P1360, P1661, P1829 

Ledwidge M.T.: P663 

Lee D.H.: P1444 

Lee D.Y.: P1440 

Lee E.S.P.: P1572, P662 

Lee J.: P1394, P1708 

Lee L.: P1075 

Lee S.: P834, P986 

Lee S.E.: P1440 

Lee S.H.: P1702, P973 

Lee T.: P1751 

Lee T.D.G.: P901 

Lee T.G.D.: P902 

Lefebvre F.: P1793 

Lefflerova K.: 433 

Lefkowitz M.: P1295, P1739 

Lefkowitz M.P.: P1595 

Lefowitz M.: 269, 439, P1486 

Legare J.F.: P901, P902 

Lehmann L.: 390 

Lehmann L.H.: 393 

Lehmann R.: P1429, P1447, P630, 

P632 

Lehmann S.: P673 

Lei L.: P961 

Leiria T.L.: P1598 

Leitao A.: P1409, P1733 

Leitao Maques A.L.M.: P1627 

Leitao Marques A.: P618 

Leitao-Marques A.: P1139, P1658, 

P532, P568, P572, P699 

Leite A.R.: P1223 

Leite L.: P652 

Leite Moreira A.: P482 

Leite S.: P772 

Leite S.M.: P593, P717 

Leite-Moreira A.: P908 

Leite-Moreira A.F.: 391, 401, P1313, 

P1753, P1775, P909 

Leite-Moreira A.L.: P1338 

Lejnieks A.L.: P1513 

226 

Lekakis J.: P505 

Lelyavina T.: P1551, P1680 

Lelyavina T.A.: P1188 

Lemonidou C.: P1122 

Lemos-Neto P.A.: P1368 

Leone A.M.: P1348, P1349 

Leong G.: P1482, P1500 

Leong G.K.T.: P1678 

Leor J.: 217, P1320 

Leosco D.: P1161 

Lesevic H.: 273 

Leshem-Lev D.: P1765 

Lesniak-Sobelga A.: P1113, P1165 

Lesny P.: P1699, P835 

Leszek P.: 428, P1367, P1835, P698 

Lev E.: P1765 

Levay M.: P1785 

Levine R.O.B.E.R.T.: P1081 

Levisianou D.: P731 

Levy F.O.: P1785 

Levy F.O.: P1747, P1788 

Levy I.: P1795 

Levy P.: P628 

Levy Y.: P1795, P530, P674, P937, 

P938, P939 

Lewis C.C.: P1237 

Lewis E.F.: P1739 

Lezha M.: P1494, P870 

Lezhnev A.A.: P515 

Li J.: P1038 

Li J.K.-J.: P1297, P1783 

Li X.L.: 213 

Li Y.-H.: P1570 

Li Z.: 212 

Liang J.: P1542 

Liang T.: P1649 

Liao J.-K.: P1570 

Libhaber E.: 80 

Licata G.: P1209 

Lichstein E.: P1700 

Licina M.: P1439 

Liepieieva O.: P1411 

Ligabue G.: P1266 

Lihachev Rodion L.R.: P1233 

Lika P.: P845 

Liljeroos M.: 207, P504 

Lilliu M.: P969 

Lim S.L.: P1482 

Lima F.: P1750 

Lima J.S.: 435 

Lima Medina E.: P664 

Lima R.P.: P1432 

Limburg A.: P808

Limongelli G.: P512 

Lin M.H.: P1480 

Lin S.J.: 263 

Linas Alonso Ana A.L.A.: P490 

Linas Rodriguez A.: P1214 

Linde C.: 274 

Lindemberg S.: P1246 

Lindenfeld J.: P1230 

Ling L.H.: P1482 

Ling L.H.: P1737, P867 

Linhart A.: P1264 

Linke W.: 402, P1313, P1852 

Linke W.A.: 388, 391, 401, P482, 

P485, P930 

Linn A.C.: P506 

Lino S.: P535 

Lins B.: P1215 

Lins K.: P1663 

Linz D.: P1824 

Lip G.Y.H.: P1001 

Lipp P.: P887 

Lippi C.: P1425, P1759 

Lishmanov Y.: P1083, P1278 

Lisii D.M.: P1729 

Liska B.: P1699 

Liskova Y.: P1335 

Lisowska A.: P1067 

Liteanu A.: P570 

Littarru G.P.: 440 

Litwinski P.: P1106 

Liu M.Y.: P1205 

Liu P.: P866 

Liu P.-Y.: P1570 

Liu T.: P1000, P1038 

Lizanecz E.: P1779 

Ljubas J.: P687 

Ljubojevic S.: P1315, P1790, P884 

Llach-Martinez A.: P1311 

Llanos Guerrero C.: P1062, P1371 

Llucia-Valldeperas A.: P1833, P487 

Lobzeva V.I.: P638 

Locatelli A.: P696 

Lochs H.: P1049 

Loeffler J.R.: 392 

Loew T.: P513 

Logakis J.: P1726 

Logeart D.: P553, P556 

Loghin F.: P1458 

Loh H.: P1267, P1428, P1602 

Loiselet P.: P1092, P666 

Lokies J.: P1663 

Lokker M.E.: P1219, P1225 

Lollini V.: P874 

Lombardi C.: P1135 

Lombardi M.: P1461, P612, P742 

Lombardo A.: P1348 

Loncar D.: P1817, P856 

Loncar G.: P1427, P966 

Londono O.: P528 

Londono Sanchez O.: P1167, P533 

Lonetti C.: P1541 

Lonetto G.: P1318 

Longo S.: P1171, P1173, P1175, 

P1176, P1276, P1565, P1616, 

P1679, P617, P746, P747, P816, 

P819 

Lopatin Y.M.: P721 

Lopes A.N.M.: 211 

Lopes Gomes J.: P1592 

Lopes M.G.: P1070, P1187, P1507, 

P1508 

Lopes M.R.: P1215 

Lopes R.: P836 

Lopez Andres N.: P1301, P878 

Lopez Fernandez S.: P1123 

Lopez Neyra I.: P1062, P1371 

Lopez S.: P1167 

Lopez-Andres N.: P1354, P890, 

P929, P933 

Lopez-Ramirez Y.: P1061, P1406 

Lopez-Rodriguez Y.: P1063, P1489 

Lopez-Vilella R.: P1548 

Lopuszanska M.: P640 

Lorga Filho A.M.: P1432 

Loria P.: P728 

Lotan C.: P1265, P839 

Louati D.O.L.I.R.A.: P1034, P1034 

Loubani M.: P907 

Louca L.: P1528 

Louch W.E.: P930 

Loureiro P.: P1710 

Lourenco A.: 401, P1132, P1154, 

P1166, P1514, P1688, P1690, P701, 

P830 

Lourenco A.P.: 391, P1753, P482, 

P909 

Lourenco C.: P1650, P1684 

Lourenco P.: P1436, P841 

Lourenco S.: P535 

Lousada N.: P1171, P1173, P1175, 

P1176, P1276, P1565, P1616, 

P1679, P617, P746, P747, P816, 

P819 

Lousinha A.: P1250, P1511 

Low A.F.: P1737 

Lowes B.D.: P524 

227 

AUtHoRS 


Lu C.: P1038 

Luaces M.: P929 

Lubimceva T.: P1087, P1517 

Luca A.: P604 

Lucci D.: P622, P735 

Luchev Valerii L.V.: P1233 

Luchinat C.: P1425 

Luchinskaya Y.: P720, P857 

Luchinsky S.: P1300 

Luchner A.: P483 

Lucisano L.: P536 

Ludka O.: P1492 

Ludman A.: P1039 

Lueger A.: P888 

Luehr P.: P866 

Luess H.: 261 

Lukachuk E.: P1640 

Lukaschuk E.: P1267, P1428, P1602 

Luknar M.: P1699, P835 

Lukoshkova E.V.: P1331 

Lund M.: P867 

Lunde I.G.: 215, P1321, P930 

Lunkenbein A.: P1757 

Lupi L.: P978 

Lupon J.: P1227, P1630, P1631, 

P1662, P1698, P503, P624 

Lupu S.: P1713 

Luscher T.F.: P1133, P1148, P1437 

Lutman C.: P1024 

Luttik M.L.A.: P1393 

Luttun A.: P1769 

Lutz S.: P1356 

Luz A.: P1307 

Lv R.L.: 212 

Lyasnikova E.: P693 

Lymar Y.: P857 

Lyon A.R.: P1134, P1525 

Lyons K.: P844 

Lyons T.: P1011 

M 

Maack C.: 390, 392, P1824, P1830 

Maack C.M.: P1332 

Maatouk F.: P1623, P1625, P1626, 

P1685, P964, P985, P987 

Mabote T.: P1093, P1095, P1199, 

P1252, P1293, P1414, P1523, 

P1584, P519, P723, P724, P996 

Macarie C.: P1341, P1342, P541, 

P637, P774, P842 

Macedo F.: P1035, P589, P601, 

P607, P753, P859 

Macera F.: P705 

INDEX

INDEX 

AUTHORS 


Macey P.M.: P846 

Macgowan G.A.: P993 

Machado C.: P1172 

Machado I.: P1154, P701 

Machalinski B.: P1303 

Maciel J.: P772 

Maciel M.J.: P593 

Maciel M.J.: P1015, P1035, P1115, 

P1118, P1168, P1243, P1304, 

P1451, P1456, P1471, P1801, 

P1802, P1810, P588, P589, P596, 

P599, P601, P607, P738, P753, 

P836, P859, P943 

Macin S.M.: P1622, P1629 

Madeira S.: P1374, P1615, P1697 

Madekina G.A.: P1822 

Madsen M.: 209 

Madureira A.: P1451, P588, P593, 

P607, P859, P943 

Madureira A.J.: P1015, P1168, P601 

Mady C.: P915 

Maechler H.: P1347, P1782, P1792, 

P488 

Maeder M.T.: P1274 

Maekawa J.: P1043 

Maestroni S.: P1266 

Maffei P.: P608 

Magalhaes A.: P1187, P1189, P1195, 

P1270, P1446, P1507, P1508, 

P1654, P768, P775, P779, P781, 

P804, P831 

Magalhaes F.G.: P1007, P1008, 

P1058, P1478 

Magalhaes Moreira T.M.: P1212 

Magalhaes P.: P1027, P1281, P765, 

P782 

Magatelli M.: P1135 

Magda L.S.: P1289 

Maggioni A.: P1388, P735, P978 

Maggioni A.P.: P1664 

Magnani G.: P682 

Magno J.D.A.: P1453 

Magona P.: P1219, P1225 

Magrini L.: P790 

Magurova D.: P817 

Mahdhaoui A.: P1060 

Mahfoud F.: P1824 

Mahkota R.: P1687 

Maia-Rocha C.: P909 

Maier L.: P1789 

Maier L.S.: 399, P1353 

Mainigi S.: P1805 

Maisano F.: 441 

Maisel A.: 265 

Majda J.: P625 

Majstorovic A.: P1057, P1193, 

P1285, P1714 

Majumder A.A.S.: P984 

Majzner M.: P1009, P580 

Makarevich P.: P784 

Makarevich P.I.: P1770 

Makeyeva A.: P1466 

Makhul N.: P975 

Malagoli A.: P1605, P660 

Malangatana G.: P599 

Malavasi V.: P660 

Malek F.: P1264 

Malek I.: P1546, P525, P683 

Malenkova V.Y.: P1224, P1659 

Malik F.I.: P961 

Malikov K.: P1491 

Malinova L.: P1208, P1771 

Mallek S.O.U.A.D.: P1506 

Malone C.P.: P998 

Malovichko S.I.: P713 

Mamalyga M.: P1346 

Mammini C.: P1705 

Mamontov O.V.: P911 

Manaka T.: P1520 

Manas P.: P794 

Manca M.: P1316 

Mancio J.: P648, P649, P940 

Mancone M.: P1395, P536 

Manfredini V.: P1541, P682 

Mangini S.: P898, P917, P918, P919 

Manhaes M.A.: P1594 

Maniotis C.: P1088 

Manitiu I.: P1479 

Manito N.: P1031, P1669, P794, 

P795 

Manka M.: P513 

Manokar P.: P1018 

Manolis A.G.: P1088 

Manouras A.: P1709 

Manov E.: P1719 

Mansour M.: P574 

Mantovani A.: P1598 

Mantziari L.: P1178 

Manuel Campelo M.C.: P1089, P802 

Manuel R.C.: P1453 

Manzano L.: P983 

Maragkoudakis S.: P1290, P1450, 

P1726 

Maramao F.: P584 

Maraschini A.: P809 

Marazzi G.: P1291 

228 

Marchese L.: P1246 

Marchese L.D.: P1241 

Marchionni N.: P1054, P1318 

Marcolla V.F.M.: P1305, P1583, 

P1648, P800 

Marcos Alberca P.: P750 

Mardanov B.U.: P1129, P1568, 

P636, P700 

Mareev V.U.: P1559 

Mareev V.Y.: P1224 

Marella A.G.: P1054, P1318 

Margari Z.: P508 

Maria Julia Maciel M.J.M.: P1089, 

P802 

Mariana Vasconcelos M.V.: P802 

Marina Ribeiro De Miranda S.: P664 

Maring C.: P861 

Marinkovic D.: P1206, P1621 

Marinkovic M.: P1803, P1804, P896 

Marino P.: P1039 

Mario Amorim M.A.: P802 

Mariotti R.: P1518 

Marjanovic M.: P972 

Marketou M.: P1290, P1450, P1726 

Markides V.: P1525 

Markl A.: P1832 

Markov V.: P1734 

Marmelo B.: 431, P1279, P1587, 

P1694, P1814, P522 

Marmelo B.F.L.: P1260 

Marona M.: P644 

Marougas M.: P1477 

Maroz-Vadalazhskaya N.: P1530, 

P1778 

Marques C.: P828 

Marques F.: P1409, P1733 

Marques J.: P1691 

Marques M.: P940 

Marques N.: P1463, P1474 

Marques V.: P484 

Marquez-Zepeda B.: P1061, P1063, 

P1406, P979 

Marrero Frances J.: P1125 

Marrugat J.: P1308, P1403 

Marshall M.: P932 

Marston S.B.: P920 

Marta D.: P1202, P1823 

Marta L.: P1179, P1366, P956, P992 

Martensson J.: P499 

Martin Asenjo R.: P1385 

Martin De La Fuente P.: P562 

Martin Fernandez M.L.: P559 

Martin M.: P527, P534, P667, P681

Martin P.Y.: P1420 

Martinenghi N.: 268, P1084 

Martinez C.: P1833 

Martinez E.: P929 

Martinez Huertas S.: P562 

Martinez Memije R.: P1344 

Martinez-Dolz L.: P1548, P970 

Martinez-Memije R.: P1151 

Martini C.: P608 

Martini G.: 264 

Martins C.: P1375, P1653 

Martins E.: P1015, P1035, P1168, 

P1304, P1451, P1456, P1471, P588, 

P589, P593, P596, P607, P717, 

P738, P772, P836, P859 

Martins H.: P1682, P1693 

Martins J.: P1691 

Martins R.: P1058, P1478, P657 

Martins R.T.: P1008 

Martins S.: P1179, P1270, P1710 

Martins V.: P1366 

Martins V.M.: P1598 

Martins W.A.: P1594 

Martins W.A.: P1241, P1246, P1375, 

P507 

Martin-Suarez S.: P1541 

Marton G.Y.: P1090 

Martynovich T.V.M.: P1487, P633 

Marzluf B.: P1735, P876 

Marzoa Rivas R.: P931 

Marzocchi A.: P682 

Mascarell B.: P1261, P1397, P1607, 

P474, P788 

Mascarell Gregori B.: 83 

Mascherbauer J.: P1735, P876 

Mascia G.: P658 

Mascioli G.: P496, P658 

Masenko V.P.: P758 

Masetti M.: P1541 

Maslov L.N.: P739 

Maslova E.: P1079 

Massa L.: P1030 

Massetti M.: P1348, P1349 

Masters J.: P960 

Masuda T.: P1153 

Masumura M.: P946 

Mateescu A.: P577 

Mateescu A.D.: P1256, P1438, 

P1571 

Mateo P.: P1311 

Mateu L.: P1669 

Mateus P.: P1027, P1281, P765, 

P782, P840 

Mateus S.: P1132, P1166, P1369, 

P1690 

Mathe A.: P1294 

Mathe L.: P702 

Matheeussen V.: 388 

Mather P.J.M.: P1109 

Matias A.: P1027, P1281, P765 

Matic D.: P972 

Matic G.: P1249, P1683, P838 

Matic M.: P1258, P833 

Matic S.: P1363 

Mats I.: P850 

Matsagos S.: P1158 

Matskeplishvili S.: P1130 

Matsue Y.: P1309 

Matsumori A.: P1473 

Matsumoto S.: P598 

Matsumura A.: P1309 

Matsushita M.: P551, P803 

Matsuzaki M.: P1392, P1396 

Matura L.A.: P1211 

Matyas C.: P927 

Maurer G.: P1825, P876 

Mavric Z.: P981 

Maximov M.: P1147, P1268 

Mayanskaya S.D.: P517 

Mayanskiy N.: P760 

Mayordomo Gomez S.: P1385 

Mayordomo Gomez S.M.G.: P1384 

Mayr M.: P1832, P480, P932 

Mayr U.: P932 

Mazevet M.: P1311 

Mazilu L.: P1160, P627 

Mazur I.D.: P827 

Mbakwem A.: P540 

Mc Caffrey D.J.: P998 

Mc Donagh T.: P1493 

Mc Donald K.M.: P663 

Mc Kenna W.: 81 

Mc Murray J.J.V.: P961 

Mcadam B.: P1237 

Mccann A.: P844 

Mccann G.P.: P1618, P1642 

Mccormick L.M.: P495 

Mcdonagh T.: P1078 

Mcdonagh T.A.: P1637, P477 

Mcdonald J.: P968 

Mcdonald K.: P1229, P1336, P1339, 

P1358, P1360, P1661, P1829 

Mcdonald K.M.: P1011 

Mcdonough A.: P1211 

Mcevoy L.: P475 

Mcgarrigle L.: P1237 

229 

AUtHoRS 


Mchugh C.: P1237 

Mcilvennan C.K.: P1230 

Mcinnes N.: P1569 

Mcintyre H.F.: 208, P475 

Mckeag N.: P641 

Mckeown P.P.: P641 

Mckinley M.C.: P641 

Mcmurray J.: P1295, P492 

Mcmurray J.J.V.: 269, 439, P1486, 

P1569, P872 

Mcmurray J.J.: P1595 

Mcmurray J.J.V.: P1415, P1567, P707 

Mcnitt S.A.: P1700 

Mcveigh G.E.: P844 

Mebazaa A.: 262, P556, P965, P980 

Medalion B.: P1099 

Meder B.: P1849 

Medina F.: P1629 

Medressova A.: P1526 

Medvedeva E.A.: P1204 

Medvedeva I.S.: P1073 

Mehel H.: P1789 

Mehra M.: P1100 

Meini M.: P742 

Meireles A.: P909 

Meisel S.: 266, P1795, P478, P530, 

P674, P937, P938, P939 

Meiser M.: P1830 

Mejia J.A.: P1544 

Mejia J.A.C.: P1114, P690 

Mejia J.C.: P1098 

Melandri G.: P682, P805 

Melao F.: P1115, P1118, P1243, 

P1304, P1308, P1403, P1802, 

P1810, P599, P607, P859 

Melenovsky V.: 433 

Melero-Ferrer J.: P970 

Melgares-Moreno R.: P1123 

Melidonis A.: P1158, P731 

Melioranskaia E.: P1784 

Melis M.: P851 

Mello F.: P1215 

Mello L.: P1246 

Mellwig K.-P.: P1588 

Melnikov N.N.: P1322 

Melo D.M.: P1740 

Melo D.S.B.: P1577 

Melo F.: P507 

Melo F.S.A.M.: P1740 

Melsom C.B.: P1788 

Menachemi D.: P550 

Mendes De Oliveira B.: P1656 

Mendes De Paula Pessoa V.L.: P1212 

INDEX

INDEX 

AUTHORS 


Mendes L.: P1045, P1051, P1132, 

P1166, P1369, P1688, P1690, P830, 

P941 

Mendes M.: P1172, P1374, P1615, 

P1697 

Mendes S.: P1682 

Mendes-Ferreira P.: P909 

Mendez J.: P1607 

Mendonca M.: P1416, P894 

Mendonca R.C.: P1594 

Menezes M.: P1446, P768 

Mentz R.: P978 

Mercondes-Braga F.G.: P686 

Merk D.: P678 

Merkely B.: P1183, P1556, P927 

Merle D.: P1619 

Merlo M.: 271, P1019, P1024, 

P1030, P1457, P514 

Merlos P.: P1261, P1397, P1607, 

P788 

Merono Duenas Oona O.M.D.: P472 

Mert K.U.: P1140, P715 

Mesquita C.T.: P1730, P737 

Mesquita E.T.: P1223 

Mesquita E.T.: P1241, P1246, P1302, 

P1647, P1730, P507, P737 

Messias L.R.: P1730, P737 

Messina E.: P1850 

Metallinos G.: P852 

Metaxa V.: P988 

Metra M.: 260, P1135, P1388, P497, 

P510, P622, P735 

Metrass M.J.: P1070, P1187, P1507, 

P1508 

Meyer M.: 261 

Meyer S.: P1389 

Meyns B.: 425 

Mezhonov E.: P1190 

Mezni F.: P1253 

Mezzani A.: P512 

Miana M.: P929 

Michalek A.: P606 

Michas C.: P971 

Michel L.: P1092, P666 

Mickley A.: P1756 

Micovic S.: 272, P645 

Middleton N.: P1122 

Miglioranza M.H.: P1598 

Miguel Gutierrez A.: P1385 

Mihaila S.: P958 

Mihajlovic B.: P1538 

Mihajlovic B.B.: P1538 

Mikhailichenko I.S.: P1431 

Mikhailov A.: P893 

Mikhalenko _.P.: P1013 

Mikolaskova M.: P1492 

Mikulicic S.: P1220 

Mikusova T.: P1492 

Milan G.: 394 

Milasinovic D.: P972 

Milasinovic G.: P1080 

Miletic B.: P1220 

Miletic M.: P1806 

Miletic M.M.: P1610, P754, P934 

Miletic Milena M.M.: P1613 

Milicic D.: P635, P687 

Miljkovic M.: P860 

Millar A.: P844 

Miller O.: P1300 

Milli M.: P1094 

Milliez P.U.: P1092 

Milovanovic B.: P1715 

Mimura A.: P1576 

Min S.Y.: P1274 

Mina C.: P947 

Mina’ C.: P604 

Minamino E.: P1074, P598 

Minana G.: P1261, P1397, P1607, 

P788 

Minarik T.: P653 

Minin S.: P1083 

Miranda C.: P1051 

Miranda M.: P1554, P1555 

Miranda S.M.: P1730, P737 

Miranda-Silva D.: P1313, P1753, 

P1775 

Mircheva L.G.: P1059, P826 

Mirek-Bryniarska E.: P806 

Mirizzi G.: P780 

Mirolyubova O.: P1200, P1820 

Mirolyubova O.L.G.A.: P1200 

Mironova N.A.: P602 

Miroshnichenko A.O.: P615 

Mirra M.: P925 

Mischak H.: P1646 

Misfeld M.: P678 

Misgeld C.: P734 

Mist B.: P585 

Mitrovic P.: P1005, P1249, P1683, 

P838 

Mitrovic V.: 261, P761 

Mitsudo K.: P1101, P1533 

Mitsuke Y.: P1069 

Mittal S.: P661 

Miura H.: P1047, P549 

Miyamoto Y.: P579 

230 

Miyazaki K.: P1047, P549 

Mizukami A.: P1309 

Mizuno K.: P551, P581, P582, P594, 

P803, P962 

Mleyhi S.: P679 

Mo R.: P1455 

Mocan T.: P1713 

Modena M.G.: P660 

Moellenberg M.: P1588 

Moerth E.M.: P884 

Moguchaya E.: P1491 

Mohamed L.: P1597 

Mohamed T.M.: 395 

Mohan M.: P1499 

Mohr F.W.: P673, P678 

Moiseev V.: P1037, P1150 

Moiseeva O.M.: P1271 

Moldoveanu E.: P1202, P1823 

Molin D.: 387 

Molina Martin De Nicolas J.: P1385 

Molina Martin De Nicolas J.M.M.N.: 

P1384 

Mollar A.: P1261 

Monami M.: P1318 

Mongillo M.: 214, 394 

Monitillo F.: P1046, P1475, P613 

Moniuszko M.: P1067 

Monleon Pradas M.: P1833 

Monnerat C.P.: P1647 

Montanez-Orozco A.: P1061, P1151, 

P1344, P1406, P1489, P979 

Montanez-Suarez A.: P1063 

Monteiro C.: P484 

Monteiro I.: P1179, P1366, P956, 

P992 

Monteiro M.: P769 

Monteiro N.A.C.: P1647 

Monteiro V.: P1514 

Montero Cabezas J.M.: P1385 

Montero Cabezas J.M.M.C.: P1384 

Montero M.: P843, P983 

Montero Perez Barquero M.: P871 

Montero Perez-Barquero M.: P1210 

Moon J.: P1412 

Moon J.G.: P1725 

Moons K.G.M.: P1207 

Moors L.: P793 

Moradinia P.: P1709 

Morato M.: P899 

Morawiec B.: P744 

Morcillo-Hidalgo L.: P743 

Moreira D.: P1260, P1449, P1587, 

P1694, P522, P586

Moreira D.A.: 431, P1279, P1814, 

P539 

Moreira Da Silva S.: P1143 

Moreira I.: P1027, P1281, P765, 

P782, P840 

Moreira N.: P1682, P1693, P657 

Moreira-Goncalves D.: P1338, P908 

Morel E.: P1311 

Morell S.: P1091 

Moreno A.: 435 

Moreno Escobar E.: P562 

Moreno N.: P1191, P1589, P1634, 

P1650, P1684, P1712, P1819, P756, 

P853, P908 

Moreno Terribas G.: P562 

Moretti C.: P764 

Moretti M.: 271 

Morgado P.C.: P1577 

Morgado P.C.M.: P1740 

Mori K.: P1386 

Morice A.: P907 

Morin L.: P628 

Morissens M.: P1072, P1816 

Morita M.: P1672, P726, P814 

Moriwaki K.: P1386, P822 

Morley-Smith A.: P1078 

Morosin M.: 271 

Morozova T.: P703 

Morris A.D.: P1284 

Morris R.: P1180, P745 

Mortara A.: P1388, P622, P735 

Mortensen S.A.: 440 

Moscavitch S.D.: P1730, P737 

Moschini L.: P718 

Mosrati M.: P1623, P1625, P1626 

Moss A.: P1700 

Mossello E.: P1054 

Most P.: P1849 

Mota Carmo M.: P1163, P1186 

Mota Garcia R.: P1801 

Mota P.: P1139, P1658, P532, P618, 

P699 

Mota P.M.: P1627 

Mota-Garcia R.: P943 

Mouine N.: P752 

Moura B.: P1456, P1471, P593, 

P596, P772 

Moura C.: P1338, P1775 

Mouratoglou S.A.: P1177, P1178 

Mowla M.: P1818 

Mowla M.M.: P1434 

Mozenska O.: P1029, P606 

Mrdja S.: P1803, P1804, P896 

Mrdovic I.: P1258, P833, P972 

Mroskova M.: P817 

Mrsic D.: P1817 

Mubarak S.K.: P998 

Muehlfeld C.: P1330 

Muehlfelder M.: 400, P1333, P1772, 

P1773 

Muela Molinero A.: P1210 

Mueller A.M.: P1332 

Muessigbrodt A.: P590 

Muhtarenko S.Y.: P1126 

Mujovic N.: P1803, P1804, P896 

Muk B.: P1090, P1259, P714 

Mukai N.: P1576 

Mukharjee S.M.: P1498 

Mullen W.: P1646 

Mulqueen J.: P1661 

Munhoz R.T.: P1577 

Munoz Calvo B.: P1301, P1377, 

P878 

Munoz Garcia A.J.: P1064, P1695, 

P1696, P1701 

Munoz Garcia E.: P1064, P1695, 

P1696, P1701 

Munoz Garcia M.: P1064, P1695, 

P1696, P1701 

Murataliev T.: P1126 

Murin J.: P1065, P1503, P609, P877 

Murninkas D.: P1099, P850 

Murphy A.: P1661 

Murray S.: P1235 

Murtagh G.: P1011 

Murzagaliyev M.: P1526 

Musetescu R.: P1591 

Mushawar S.: P709, P710 

Musial W.: P1067 

Musial W.J.: P1325, P1707, P855 

Musial-Bright L.: P1228, P1421, 

P1426, P1643, P1667, P1674, 

P1681, P565, P966 

Mussi C.: 211, P728 

Mustafa E.R.: P1591 

Mutlu B.: P1706 

Mutlu F.: P1140, P715 

Muzzarelli S.: P1274 

Myers T.: P902 

Mykhailova I.: P616 

Myles R.C.: P1415 

Mysiak A.: P1586 

Mysuta M.: 268, P1084 

Mytrokhina O.: P650 

Mzoughi S.: P1253 

231 

AUtHoRS 


N 

Naber C.K.: P1085, P651 

Nadador Patino V.: P1301, P1377, 

P878 

Nadarajah C.: P945 

Nadir A.: P1140, P715 

Nagahori W.: P1309 

Nagao K.: P1074 

Nagel E.: P591 

Nagel F.: P1357 

Naghi D.N.: P1121 

Nagy L.: P1314 

Nair D.: P1180, P745 

Najih H.: P1481 

Najjar C.: P944 

Nakano A.: P1362 

Nakaya R.: P1069 

Nakovska M.: P1053 

Nalbantgil S.: P688 

Nalbantgil S.A.N.E.M.: P1448 

Nalotto L.: 214 

Nam H.J.: P1440 

Nanas J.: P1477, P1532, P508 

Nanea I.T.: P570 

Nanea T.: P1128 

Naneishvili T.: P1319 

Nanni S.: P805 

Narducci M.L.: P1349 

Nart D.: P688 

Narusov O.U.: P1020 

Narusov O.Y.: P1454 

Narvaez-David R.: P1151 

Nasierowska-Guttmejer A.M.: P606 

Nassar P.: P944 

Nassar Y.: 267 

Natale A.: P496 

Natario A.: P1045 

Nauck M.: P1755 

Naumova M.A.: P602 

Navarro Cuartero J.: P1062, P1371 

Navas M.A.: P1257 

Navas M.A.: P825 

Nawrocka N.: P1419 

Nawrocka S.: P1405, P995 

Nayar V.: P494 

Naymushin A.V.: P1271 

Nazarova B.E.: P1568 

Nazli C.E.M.: P1292, P873 

Neary R.: P1358 

Nebot M.: P1669, P794, P795 

Nebot Margalef M.: P1214 

Nechita A.: P854 

Nedeljkovic I.: P1182 

INDEX

INDEX 

AUTHORS 


Neef S.: 399 

Neely M.: P786 

Nega K.: P640 

Negm H.: P1473, P1590 

Negri F.: P680 

Negrieva N.: P967 

Negro Cusa E.: P953 

Nekludova Y.N.: P1126 

Nelson L.M.: P610 

Nemeth B.: P927 

Neri P.: P696 

Neri T.: P1754 

Nesser H.J.: P1505, P1509 

Nessler J.: P1632, P639, P732, P806 

Nesvetov V.: P1445 

Neto S.: P1650 

Netz P.: P1398, P631, P632 

Neuberger H.R.: P887 

Neves D.C.H.S.: P1238 

Neves Z.: P535 

Neyses L.: 395 

Ng L.L.: P1618, P1642 

Ng T.P.: P1678 

Ng T.P.: P1737 

Nguyen T.D.: P1329 

Nicholls R.: P1640 

Nichols S.: P1422 

Nichtova Z.: P1743, P1744 

Nicin S.: P1538 

Nickel A.: 392, P1824 

Nickel A.G.: P1830 

Nicolao P.: P629 

Niedziela J.: P787 

Nielsen O.W.: P868 

Nieminen M.S.: P557, P767 

Nienaber C.: P1104 

Niewinski P.: P952 

Nightingale A.K.: P1668 

Nihoyannopoulos P.: P849 

Nikcevic G.: P1715 

Nikishin A.G.: P733, P848 

Nikitina E.A.: P1655 

Nikolaev K.Y.: P706 

Nikolaev V.O.: P1786 

Nikolaev V.O.: 218, 398, P1787, 

P1789 

Nikolakopoulou S.: P505 

Nikolaou M.: 429, P1645, P505, 

P812, P980 

Nikolic - Pavlovic I.: P1245 

Nikolic L.J.: P1337, P1763 

Nikolic Pavlovic I.: P1720 

Nikolic V.: P1621 

Nikonova E.: P1734 

Nilsson J.C.: P1529 

Ninkovic N.: P1715, P832 

Nino C.: P629 

Nishii N.: P1101 

Nishikawa S.: P1069 

Nishimura K.: P1234 

Niwano S.: P1153 

Niyazova S.S.: P1013 

Nobre Menezes M.: P1070, P1187, 

P1507, P1654, P804, P847 

Nobrega A.C.: 435 

Nobuyoshi M.: P1533 

Noda C.: P1153 

Nodari S.: P978 

Noelker G.: P1378 

Nogueira Da Silva M.: P1186, P1250, 

P1511 

Nogueira M.: P1155, P1251 

Nogueira-Silva L.: P1143, P1184 

Nohara R.: P1074, P598 

Noll G.: P1133, P1148, P1437 

Nonogi H.: P837 

Nordbeck P.: 400, P1333, P1345, 

P1772, P1773 

Norscini G.: P682, P805 

Novak I.: P991 

Novak K.: P635 

Novakovic A.: P1249, P1683, P838 

Novikova T.: P1079 

Novo S.: P1579 

Novotova M.: P1743, P1744, P1749 

Nowak J.: P787 

Nowalany-Kozielska E.: P1582, P595, 

P744 

Noyman E.: P478, P939 

Nranyan N.V.: P1283 

Ntai K.: 262, P965 

Ntalianis A.: P1477, P1532, P508 

Nunes A.C.: P484 

Nunes A.S.: P1215 

Nunes Diogo A.: P1070, P1187, 

P1189, P1195, P1270, P1446, 

P1507, P1508, P1654, P1710, P768, 

P775, P779, P781, P804, P847 

Nunes L.: 431, P1279, P1814, P539 

Nunes S.: P1587, P1694 

Nunes-Diogo A.: P831 

Nunez Botero E.: 83 

Nunez E.: P1397 

Nunez J.: P1261, P1397, P1607, 

P474, P788 

Nunez Villota J.: 83 

232 

Nurbaev T.A.: P733, P848 

Nurkovic J.S.: P1232 

Nusir Y.N.: P1105 

Nussbaum A.C.A.: P1545, P1547, 

P543 

Nuti R.: 264, P1323, P1484 

Nyolczas N.: P1090, P1259, P1380, 

P714 

O O Connell E.: P1661 

O Connell L.: P1661 

O’ Hanlon R.: P663 

O’ Mahony C.: 81 

Oberhofer M.: P887 

Obradovic D.: P1427, P565 

Obradovic S.: P1689 

Obrenovic-Kircanski B.: 272, P1005, 

P1536, P645 

Ochia M.E.: P1577 

Ochiai M.E.: P1399 

Ochiai M.E.O.: P1740 

Ochotny R.: P1240, P1671 

O’connell E.: P1011, P1229 

O’connor C.M.: P1389, P786 

Odeh R.: P1470, P796 

Oehl U.: 393 

Ogren J.A.: P846 

Ogston S.A.: P511 

Oh J.: P1702 

Oh J.W.: P973 

Ohno M.: P1309 

Ojji D.B.: P785 

Okada A.: P521 

Okamoto S.: P1043 

Okamoto Y.: P1101, P1533 

Okazaki H.: P551, P803, P962 

Okino S.: P1043 

Okobi A.: P540 

Okunova A.A.: P1126 

Olah A.: P927 

Oldenburg O.: P1365, P1378, 

P1398, P1488, P630, P631, P632 

Oliva F.: P1388, P622, P735 

Oliva F.G.: P705 

Olivares Flores S.: P1333 

Olivares M.: P1261 

Oliveira A.I.O.: P1740 

Oliveira A.M.: P915 

Oliveira E.: P1163 

Oliveira F.: P1798, P1799 

Oliveira L.: P1163, P1251, P1594 

Oliveira L.R.: P1524

Oliveira M.: P1155, P1163, P1186, 

P1250, P1511, P1515, P1594, P548, 

P648, P649, P940, P977 

Oliveira P.P.M.: P1242, P1750 

Oliveira S.: P1308, P1403, P1802 

Oliveira Santos J.: P1260 

Oliver S.: P662 

Olivotto I.: P1452, P583 

Olla S.: P821 

Olsen P.S.: P1529, P1531, P668 

Olsson L.-E.: P500 

Olszowska M.: P1113 

Omboni S.: P1579 

Omede’ P.: P764 

Omerovic E.: P1767, P1776 

Ong H.Y.: P1482, P1678 

Ong H.Y.: P1500 

O’nunain S.: P1075 

Ootsuji M.: P822 

Opie L.H.: P785 

Opoku-Asare I.: P1805 

Opolski G.: P639, P806 

Orazio S.: P712 

Orbovic B.: P1005, P1363 

Orea-Tejeda J.I.A.: P1061, P1063, 

P1151, P1344, P1406, P1489, P979 

O’regan D.: P849 

Orejas M.A.: P825 

Orn S.: P1718 

Ornaghi D.: 425 

Orso F.: P1054, P1318 

Orstavik O.: P1747 

Ortega Molina M.: P1796 

Orti-Suarez G.: P1489 

Ortiz-Suarez G.: P1061, P1063, 

P1151, P1344, P1406, P979 

Orynchak M.A.: P708 

Osiak A.: P1340 

Osip A.: P1340 

Osnes J.B.: P1788 

Osnes J.B.: P1747 

Osto E.: 427, P608 

Ostojic M.: P1156, P677, P757 

Ostojic M.C.: P1439 

Ostrovski Y.: P1530, P1778 

Ostrovskiy U.P.: P1077 

Otasevic P.: 272, P645 

Otljanska M.: P1048, P736, P936, 

P949 

O’toole L.: P719 

Ottenheijm C.A.C.: P482 

Ovchinnikov A.: P784 

Ovchinnikov A.G.: P1136, P1136 

Owada T.: P614 

Oyanguren Artola M.J.: P1214 

Oylumlu M.: P1410, P1410 

Ozaki A.: P598 

Ozbaran M.: P688 

Ozben B.: P1023 

Ozdogan O.: P1280, P1604 

Ozerkan F.I.L.I.Z.: P1448 

P 

Pacher V.: P705 

Packer M.: 269, 439, P1295, P1486, 

P1595, P1739 

Padeletti L.: P496, P658 

Padilla Perez M.: P1564 

Pagano G.: P1161 

Page R.L.: P1230, P1230 

Pagliaro M.: P1395 

Paiva L.: P572 

Paiva L.V.: P568 

Paiva M.: P1035, P1243, P601, P607, 

P750, P859 

Pajovic S.: P587 

Pakrashi T.: P1134 

Palacios I.G.O.R.: P1081 

Paladin A.: P838 

Palanca V.: P1091 

Palau Sampio P.: 83 

Palazzo A.: 268, P1084 

Palazzuoli A.: 264, 264, P1323, 

P1484 

Palermo P.: P821 

Palfy J.A.: P1257 

Palfy J.A.: P825 

Palic B.P.: P1665 

Paljoskovska Jordanova S.: P949 

Paljoskovska-Jordanova S.: P936 

Paljoskovska-Jordanova S.P.: P934 

Palma Dos Reis R.: P1171, P1173, 

P1175, P1176, P1276, P1416, 

P1565, P1616, P1679, P617, P746, 

P747, P816, P819, P894 

Palma P.: P1025, P1519, P1798, 

P1799 

Palmer C.N.A.: P1284 

Palomino S.A.P.: P898, P919 

Panaitescu E.: P1256 

Panayotov P.L.: P1137 

Panayotova D.: P1137 

Pani A.: P969 

Paniagua Martin M.J.: P931 

Panjwani P.: P900 

Pankuweit S.: P1228 

233 

AUtHoRS 


Pantaleo P.: P1425, P1759 

Pantano A.: P1469 

Pantsios C.: P508 

Paolillo S.: P1161 

Papaconstantinou M.: 429 

Papadaki E.: P1450 

Papadaki H.: P1290 

Papadopoulos C.: P1088 

Papathanassoglou E.: P1122 

Papp Z.: 401, P1314, P1334, P1779, 

P1827, P910 

Pappa Z.: P1177, P1178 

Pappalardo A.: 271, P680 

Pappas L.: P971 

Parada-Pereira F.: P1118, P1243 

Paradies V.: P1046, P1475, P613 

Parapid B.: P1536, P896 

Paraschiv B.: P1497, P634 

Paraskevaidis I.: P1645 

Parati G.: P510 

Paravolidakis K.: P505 

Parcharidou D.: P1177 

Parenica J.: P1264 

Parepa I.R.: P1160, P627 

Parfyonova E.V.: P1352 

Parfyonova Y.E.: P1351, P784 

Parfyonova Y.E.V.: P1770 

Parienti J.J.: P1092, P666 

Parissis J.: P1645, P980 

Parissis J.T.: 262, 429, P505, P812, 

P965, P971 

Park C.S.: P1442 

Park J.H.: P815, P815 

Park J.J.: 263 

Park J.P.: P1440 

Park S.: P1702 

Park S.J.: P1033, P1666, P815 

Parra Fuertes J.J.: P1385 

Parrinello G.: P1209 

Parry H.M.: P1284 

Parsons S.: P1095, P1252, P1523, 

P519, P723, P724, P773, P810, P996 

Parthenakis F.: P1290, P1450, P1726 

Partyka R.: P787 

Pascoa C.: P1195, P775 

Pascual Figal D.A.: P1597 

Pascual-Figal D.A.: P1745, P926, 

P928 

Pasero D.: P1108 

Pasha H.C.: P1105 

Pasic M.: P1539 

Pasquie J.L.: P811 

Passino C.: P1705, P512, P658, 

INDEX

INDEX 

AUTHORS 


P742, P780 

Pastor Perez F.J.: P1597 

Pastormerlo L.E.: P1705 

Pastromas S.: P590 

Pasztor E.T.: P1334 

Pasztor E.T.: 401 

Patarata E.: P1008 

Patel H.: P1677 

Patel V.: P585 

Paterna S.: P1209 

Pathak A.: P1851 

Patrianakos A.: P1290, P1450 

Patricio I.: P532 

Paulo Pinho P.P.: P802 

Paulus W.: P1852 

Paulus W.J.: 388, 391, 401, P482 

Pauschinger M.: P1557 

Pavel O.: P1072 

Pavlic G.: P1006, P999 

Pavlov N.A.: P1585 

Pavlova V.S.: P739 

Pavlovic D.: 216, P1828 

Pavlovic K.: P1538 

Pavlovic Kleut M.: P1674, P1714 

Pavlovic M.: P1082, P1537, P1643, 

P776 

Pavlovic R.: P1206 

Pavlovic-Kleut M.: P1193, P1285 

Pavone F.: P1094 

Pawlak A.: P1029, P606 

Pawlowska H.: P1106 

Paya R.: P1091 

Paya-Serrano R.: P1596 

Pechanova O.: P1355, P1777 

Pecherina T.: P1127, P778 

Pedersen S.S.: P671, P895 

Pedrazzini G.: 441 

Pedrinelli R.: P1754, P486 

Pedro A.J.: P1195 

Pedrosa V.: P788 

Pego M.: P1540, P1682, P1693, 

P652, P657 

Pehar-Pejcinovic V.: P1220 

Peixoto E.C.S.: P1305, P1583 

Peixoto R.T.S.: P1305, P1583 

Pejkov H.P.: P934 

Pektok E.: P1527 

Pelaez-Hernandez V.: P1406, P1489, 

P979 

Pelargonio G.: P1349 

Pelesa E.S.: P727 

Pelewicz K.: P1106 

Pella D.: 440 

Pellegrini M.: 264, P1323, P1484 

Pellegrino T.: P1161 

Pellicori P.: 82, P1093, P1095, P1164, 

P1199, P1226, P1252, P1267, 

P1293, P1422, P1523, P1584, 

P1602, P509, P519, P724, P810, 

P996 

Penafiel J.: P1631, P624 

Pena-Popoca G.: P1406, P1489, 

P979 

Pencic B.: P1714 

Pencic-Popovic B.: P1057, P1193, 

P1285 

Pender N.: P1237 

Penkalla A.: P1539 

Pennacchi M.: P536 

Peovska I.: P736 

Pepin J.-L.: P628 

Peradejordi M.: P629 

Peraira R.: P1214 

Perchatkin D.: P1079 

Pereira A.: P1154, P1191, P1416, 

P1589, P1634, P1684, P1712, 

P1819, P756, P853, P894 

Pereira Barretto A.C.: P1577 

Pereira D.: P1416, P894 

Pereira H.: P1238, P1653 

Pereira J.G.: P738 

Pereira J.J.: P917 

Pereira J.M.V.: P1215, P507 

Pereira M.: P1308, P1403 

Pereira M.B.: P1716 

Pereira N.: P1542 

Pereira S.B.: P737 

Pereira V.H.: P1154, P701 

Pereira V.H.: P1514 

Perera R.K.: P1786 

Perera R.K.: 218 

Peres M.: P1179, P992 

Perez Calvo J.I.: P1210 

Perez De Isla L.: P750 

Perez M.L.: P533 

Perez Martin A.: P1125 

Perez Martinez M.T.: P1597 

Perez-Calvo J.I.: P843, P983 

Perez-Martinez M.T.: P1745, P926, 

P928 

Perez-Villa F.: P1248, P1641, P777 

Perisic Z.: P1082 

Perna E.R.: P1622, P1629 

Perna F.: P1349 

Perna S.: P1131 

Perrier A.: P1420 

234 

Perrone-Filardi P.: 82, P1161 

Perrotta L.: P496, P658 

Persashvily D.G.P.: P633 

Pershina K.: P1781 

Persic V.: P1220 

Persson H.: P516 

Perunicic J.: P1258 

Pesce P.: 394 

Pessoa F.G.: P915 

Pessoa V.: P1544 

Pessoa V.L.: P1112 

Pessoa V.L.M.P.: P1098, P1114 

Petelina T.I.: P1322 

Petraglia L.: P1161 

Petraskiene I.: P1617 

Petrela E.: P1494, P870 

Petrescu L.: P854 

Petrie M.: P1104, P492 

Petrie M.C.: P1415, P1567, P707 

Petrini S.: P1754, P486 

Petris A.: P541, P774 

Petris A.O.: P854 

Petrischeva A.V.: P642 

Petrovai D.: P1131, P1713 

Petrovic D.: P1245, P1621 

Petrovic I.: P1080, P1804 

Petrovic M.: P1080, P1156, P1182, 

P757 

Petrovic M.T.: P1080 

Petrovic-Nagorni S.: P1537 

Petrucci O.: P1242, P1750 

Pettenati M.C.: P1094 

Pettit S.: P492 

Peuhkurinen K.: P767 

Pezzotti E.: P1135 

Pfaffenberger S.: P876 

Pfannmueller B.: P678 

Pfeffer M.: P1100 

Pfeffer M.A.: P872 

Pfeffer M.A.: P1567 

Pfeiffer S.: P1746 

Pfister 0.: P1076 

Pharithi R.B.: P998 

Philip J.-L.: P1294 

Philippen L.: 397 

Philippen L.E.: P890 

Pianca N.: 214 

Picano E.: P1598 

Picarra B.: P1306, P1402, P1404, 

P1407, P1408, P1515, P1692 

Pichel I.A.: P1361, P555 

Piepenburg S.M.: P813 

Piepoli M.: P510

Piepoli M.F.: P1605, P660 

Pieragnoli P.: P496, P658 

Pieske B.: P1119, P1295, P1315, 

P1330, P1347, P1595, P1727, 

P1739, P1746, P1748, P1790 

Pieske B.M.: 402, P1782, P1792, 

P488, P884, P888, P889 

Piga A.: P851 

Pilant D.: P874 

Pilleri A.: P969 

Pil-Sang S.O.N.G.: P1272, P954 

Pimenta J.: P1143, P1144, P1184, 

P1254, P1400, P1436, P716 

Pimenta R.: P1250 

Pimentel R.: P1144, P1184, P1436 

Pina I.: P786 

Pinamonti B.: 271, P1019, P1030, 

P1457, P680 

Pinheiro I.: P768 

Pinheiro M.L.: P1098 

Pinheiro T.: P1186 

Pinheiro Torres J.: P1115 

Pinheiro-Vieira A.: P1519 

Pinho P.: P1115, P1514 

Pinho T.: P1035, P1451, P1456, 

P1801, P1802, P588, P593, P601, 

P607, P859 

Pinna C.: P969 

Pinto F.J.: P779, P847 

Pinto P.: P1191, P1589, P1634, 

P1650, P1684, P1712, P1819, P756, 

P853 

Pinto R.: P548, P977 

Pinton F.A.: P1368 

Piotrowicz E.: P1152 

Piotrowicz R.: P1152 

Piotrowska M.: P1383 

Piotrowski G.: P1009, P580 

Piotrowski W.: 428, P1835, P698 

Pipa J.: P539 

Piper C.: P631 

Piper S.: P1493, P1637 

Piper S.E.: P591 

Pirelli S.: P718 

Pires A.L.: P1338 

Pires M.: P1712, P756, P853 

Pirk J.: P1546, P525, P683 

Pirnazarov M.M.: P733 

Piscione F.: P925 

Pisoni M.: P696 

Pitsavos C.: P852, P957, P988 

Pitta M.L.: P1366 

Pivetta A.: P1019, P1024 

Pivetta E.: P748 

Placido R.: P1187, P1189, P1195, 

P1270, P1507, P1508, P1654, 

P1710, P768, P779, P781, P804, 

P831, P847 

Plagnol V.: 81 

Planas-Balague R.: P1669 

Platz E.: P748 

Platzer V.: P1119 

Plein D.: P1815 

Plokhova E.V.: P1157, P858 

Ploux S.: P1086, P659 

Plymen C.: P1493 

Plymen C.M.: P591 

Pobivantseva N.F.: P727 

Pocas J.F.: P1051 

Poczatek K.: P1586 

Podesser B.K.: P1357, P912 

Podewski E.: 80 

Podolec P.: P1113, P1165, P959 

Podzimkova M.: P683 

Poels E.: 387 

Poelzl G.: 432, P1269, P1561, 

P1704, P789, P845 

Pokreisz P.: P892 

Pokushalov E.: P661 

Polak L.: P1741 

Poletti A.: P680 

Poletti R.: P1705 

Polic S.: P635 

Pollesello P.: P1314 

Polonski L.: P639, P787, P806 

Polovina M.: P1439 

Poltavskaya M.: P1673, P1738 

Polyakov D.S.: P1224, P1659 

Polyakova A.: P1784 

Polyanska O.S.: P1390, P770 

Pomerantzeff P.M.: P898 

Ponikowska B.: P625 

Ponikowski P.: 260, P1405, P1419, 

P497, P625, P639, P640, P806, 

P952, P995 

Pons C.: P528 

Pons-Kuehnemann J.: P761 

Ponte M.: P1096, P818 

Pontes Dos Santos R.: P1712, P756 

Pontes Dos Santos R.A.: P1684 

Pontikoglou C.H.: P1290, P1450 

Pop C.: P1458, P854 

Popiak H.: P771 

Poposka L.: P1381 

Popov S.: P1512 

Popova A.A.: P517 

235 

AUtHoRS 


Popovic B.: P1156, P757 

Popovic D.: P1156, P1182, P757 

Poppe K.: P707 

Porcu M.: P969 

Porhanov V.A.: P1543 

Portela I.: P768, P781, P831 

Portoles-Sanz M.: P1548, P970 

Portugues J.: P1154, P1514, P701 

Possemiers N.: P1317 

Post H.: 402, P1330, P1347, P1782, 

P1792, P488, P888, P889 

Potapov E.: P1097, P1756 

Potashev S.: P720, P857 

Potemski P.: P1009, P580 

Potena L.: P1541, P682 

Potluri R.: P709, P710 

Potocki M.: P1076 

Potpara T.: P1439, P1803, P1804 

Povarova T.: P1771 

Pozdnyakov U.: P1300 

Pozzi R.: P697 

Pradere G.: P1092, P666 

Prapa M.: P1293, P996 

Prapa S.: P1164 

Prasad R.: P494 

Prasad S.K.: P1134 

Prata S.: P1179 

Pratesi A.: P1054, P1318 

Prat-Vidal C.: P1350, P487, P922 

Pravdic D.P.: P1665 

Prehar S.: 395 

Previato M.: 427 

Preza Fernandes J.: P1592 

Price S.: P1039, P529 

Prieto D.: P1540 

Prieto Mateos D.: P1371, P1382, 

P1496 

Prikolota A.V.: P713 

Prikolota O.A.: P1612, P990 

Primessnig U.: P1746 

Prinz C.: P1429, P1447 

Privalova E.V.: P1017, P725 

Privalova E.Y.: P1585 

Proenca M.: P1409, P1733 

Prokopova L.V.: P1188 

Pronicki M.: P1367 

Prontera C.: P1705 

Protopapas A.: P1122 

Protopsaltis I.: P1158 

Providencia R.: P568, P572 

Prudky I.: P1286 

Prudkyi I.: P963 

Pryce-Hawkins H.: P1134 

INDEX

INDEX 

AUTHORS 


Przybylski M.: P1029, P606 

Przywara-Chowaniec B.: P744 

Ptaszynska Kopczynska K.: P1067 

Ptaszynska K.: P855 

Puccini M.: P528 

Pudil R.: P1635 

Puetz V.: P1085, P651 

Puga-Martinez M.: P1123 

Pugh P.J.: P494 

Pugliese N.R.: P1461, P612, P742, 

P780 

Puhl S.L.: P1332 

Puig-Sanvicens V.: P1350, P922 

Pulkki K.: P767 

Puls M.: 438 

Pun F.: P527, P667 

Puspoki Z.: P1259 

Pustovetova M.G.: P517 

Puzzovivo A.: P1046, P1475, P613 

Pya Y.: P1526 

Q 

Qadjiyev G.: P1435 

Qin F.: P1038 

Qin S.: P563 

Quadri G.: P764 

Quarta A.: P851 

Queiros M.C.: P1191, P1589, P1634 

Quelhas I.: P1514 

Queron S.: P1816 

Quesada A.: P1091 

Quesada-Dorador A.: P1596 

Quezada C.A.: P1501 

Quintao M.: P1241 

Quintao M.M.P.: P1246 

Quinzani F.: P1135 

Qurbanov R.D.: P573 

R 

R Leeder S.: P791 

R Santhanakrishnan T P Ng 

R.W.O.N.G.: P1482 

Raafat D.M.: P1203 

Rabajoli F.: P1418 

Rabelo E.R.: 211 

Rachok L.: P1468 

Racila V.: P1002, P1006, P999 

Radivojevic V.: P1715 

Radosinska J.: P1310, P1326 

Radovanovic M.: P1249, P1683, 

P838 

Radovanovic N.: P1249, P1683, 

P838 

Radovanovic S.: P896 

Radovits T.: P927 

Radulova Y.: P1137 

Radulovic S.: P1315, P1790 

Rafouli-Stergiou P.: P812 

Raghunath R.: P1422 

Rahman Haley S.: 426 

Rahman M.T.: P984 

Raissouni M.: P752 

Rajab M.F.: P1105 

Rajani R.: P591 

Rajic D.: P1249, P1683, P838 

Rakisheva A.: P863 

Ramalho A.: P1195, P1270, P768, 

P779, P781 

Ramalho A.R.: P1070, P1187, P1508, 

P1654, P775, P804, P831, P847 

Rameev V.: P1037 

Ramires F.: P915 

Ramirez J.: P1483 

Ramirez J.A.F.R.: P1740 

Ramon Ferrandis J.M.: 83 

Ramos I.: P1015, P1168 

Ramos V.: P1691 

Ramsay A.: P1235 

Ramsey H.: P1812 

Ramzan R.: P1758 

Rana Z.A.: P1321 

Rangel I.: P1035, P1118, P1243, 

P1304, P1471, P589, P601, P607, 

P753, P772, P836, P943 

Rapezzi C.: P1541 

Rappaport D.: P1102 

Raquel Mota Garcia R.M.G.: P1089 

Rashad R.: P1423, P994 

Raspopova T.N.: P1495 

Raspopovic S.: P1715, P832 

Rassi L.: P1132, P1166, P1369, 

P1688, P1690, P830, P941 

Rastogi S.: 396, P473 

Rasulova Z.: P1044, P1563, P620 

Rau T.: P1746 

Rausch L.: P1549 

Raza A.: P1414 

Razvi N.A.: P1618, P1642 

Rebrov A.P.: P1247, P1255 

Recio Platero A.: P1214 

Reda A.: P1723 

Redfield M.M.: P485 

Redfors B.: P1767, P1776 

Rega F.: 425 

Regitz-Zagrosek V.: P1312, P1324 

Reichert C.: P476 

236 

Reichert K.: P1750 

Reid S.: P475 

Reil G.-H.: P887 

Reil J.C.: 390, 392 

Reil J.-C.: P711, P887 

Reina-Couto M.: P1400, P899 

Reis H.: P1519, P1558 

Reis M.A.R.T.I.N.S.: P917 

Reis M.M.: P898, P918, P919 

Reitsma J.B.: P1207 

Rekant K.: P1102 

Rema J.: P1400, P841 

Rengo G.: P1161 

Renilla A.: P1501 

Renilla Gonzalez A.: P1361, P545, 

P555 

Rentoukas E.: P812 

Repasos E.: P1477, P508 

Repnikov I.: P1079 

Requena A.: P794, P795 

Resch M.: P483 

Restle C.: P861 

Restum J.: P1259 

Reuter S.P.: P1353 

Rexhepaj N.: P1676 

Rey M.: P1257 

Reyes M.J.: P1742 

Reynbakh O.: P1300 

Reznik E.: P1476 

Reznik L.: P1781 

Rhee S.J.: P865 

Rhew J.Y.: P1440 

Riad A.: P1755 

Ribas Barquet Nuria N.R.B.: P472 

Ribeiras R.: P1172 

Ribeiro Dias F.: P1594 

Ribeiro Filho J.D.: P690 

Ribeiro G.S.: P737 

Ribeiro H.: P840 

Ribeiro M.L.: P1594 

Ribeiro M.L.: P1375 

Ribeiro N.: P657 

Ribeiro R.: P1798 

Ribeiro S.B.: P1112 

Ribeiro V.: P1115, P1243, P1304, 

P1308, P1403, P1801, P599, P738 

Ribezzo M.: P1108 

Ricalde-Alcocer A.: P1151, P1344 

Ricci D.: P1108 

Ricci R.R.: P951 

Ricciardi G.: P496, P658 

Rice A.: P1751 

Richards A.M.: P1482

Richards A.M.: P1500, P1737, P867 

Richardson J.A.: P1525 

Richter S.: P590 

Richter U.: P1174 

Ridocci Soriano F.: 430, P1596 

Ridocci-Soriano F.: P1091 

Riegger G.: P483, P513 

Rieth A.: P761 

Rigby A.: P1093, P996 

Rikova S.: P703 

Riley J.: P1219, P1225 

Rilo Miranda I.: P1036, P1401, P1711 

Rimmer S.: P1164, P1584 

Rinaldi A.: P1510 

Rinaldi M.: P1108 

Ring L.M.: P495 

Rinkevich-Shop S.: 217 

Rio P.: P1155, P1163, P1186 

Ripoli A.: P780 

Riscado V.: P1007, P1008, P1058, 

P1478 

Rispler S.: P1441, P1534 

Ristic A.: 261, P1803, P1804 

Ritter O.: 400, P1333, P1345, P1772, 

P1773, P886 

Ritter P.: P1086, P659 

Rivera-Otero M.: P1548, P970 

Rivero J.: P1100, P748 

Rivero Jimenez N.: P1796 

Rizkala A.R.: 269, 439, P1486 

Rizos I.: P1645 

Rjabceva I.: P740 

Rnsca S.P.C.: P1692 

Robalo Martins S.: P1189, P779, 

P847 

Robba D.: P718 

Robertson M.: P711 

Robledo-Carmona J.: P743 

Robles F.: 268, P1084 

Robson E.: P1686, P531 

Roca Elias J.: P1031 

Roca J.: P794, P795 

Roca Villanueva B.: P871 

Rocca P.: P696 

Rocha A.: P1118, P1243 

Rocha A.C.: P1654, P804 

Rocha L.A.D.E.O.: P1761 

Rocha Lopes L.: 81 

Rodrigo Lopez J.: P750 

Rodrigues A.: P818 

Rodrigues B.: 431, P1279, P1514, 

P1587, P1694, P522, P539 

Rodrigues B.F.: P1260 

Rodrigues Dos Santos J.: P1070, 

P1187, P1507, P1508 

Rodrigues J.: P1118, P717, P753, 

P836 

Rodrigues M.: P1416, P894 

Rodrigues P.: P1025, P1050, P1239, 

P1307, P1516, P1519, P1558, 

P1592, P1675, P1775, P1798, 

P1799, P654, P676 

Rodrigues R.: P1132, P1166, P1369, 

P1688, P1690, P830, P941 

Rodrigues R.C.: P1730, P737 

Rodrigues V.C.: P1647 

Rodriguez Bailon I.: P1696 

Rodriguez Capitan J.: P743 

Rodriguez Garrido J.: P931 

Rodriguez Gonzalez A.: P1564 

Rodriguez-De Munoz Y.: P970 

Rodriguez-Serrano M.: P970 

Roentgen P.: 80 

Roeters Van Lennep J.: P895 

Roli L.: P728 

Rolim J.: P690 

Roman Garcia F.: P1301, P1377, 

P878 

Roman M.: P1603 

Romanenko O.: P647 

Romano G.: P947, P948 

Romanov A.: P661 

Romanovic R.: P1689 

Romanovskiy D.V.: P1077 

Romero A.M.: P1257 

Romero A.M.: P825 

Romuk E.: P595 

Ronco C.: P1323, P1484 

Rondinini L.: P1518 

Roque C.: P1516, P1519, P654 

Roque J.: P1672, P726, P814 

Rosa M.L.G.: P1223 

Rosa M.L.G.: P1647 

Rosano G.: P1226, P1291 

Rosario I.: P1172 

Rosato S.: P809 

Rosell-Ferrer J.: P487 

Rosello-Lleti E.: P1548, P970 

Rosenfeldt F.: 440 

Rosenschein U.: P975 

Rosin N.: P902 

Rosin N.L.: P901 

Rosner E.: P600 

Rossi L.: P1605, P660 

Rossignol P.: P1354, P933 

Rossing K.: P1531, P668 

237 

AUtHoRS 


Rostoff P.: P1632, P732 

Rotim A.: P1220 

Rottbauer W.: P1849 

Roubille C.: P811 

Roubille F.: P1619, P811 

Rouleau J.L.: 269, 439, P1486 

Roura S.: P487, P923 

Rousseau E.: P933 

Rousseva E.: P513 

Rover M.: P1598 

Rovero G.: P1108 

Rozado J.: P1361, P555 

Rozanski J.: P1106, P1835, P644 

Rozenmann Y.: P550 

Rozentryt P.: P1226, P639, P787, 

P806 

Rubina K.: P1351 

Rubio Alonso B.R.A.: P1384 

Rubio M.D.: P1796 

Rubis P.: P1113, P959 

Rucinski A.: P952 

Rudenko I.U.: P1286, P1574 

Rudenko T.: P1288 

Rudyk I.: P1146 

Rueda-Calle E.: P743 

Ruhs A.: 394 

Rui Rodrigues R.R.: P802 

Ruiz Bustillo Sonia S.R.B.: P472 

Ruiz Rodriguez Pilar P.R.R.: P490 

Ruiz-Zamora I.: P743 

Rulli F.: P584 

Runev N.: P1719 

Ruocco G.: 264, P1323, P1484 

Ruperto C.: P947 

Rupp H.: P823 

Rusak M.: P1067 

Ruschel K.B.: 211 

Ruschitzka F.: P1133, P1148, P1437 

Russell K.: P1569 

Russkikh I.: P1530, P1778 

Rutledge C.: P916 

Rutten F.H.: P808 

Rutten F.H.: P1207, P560 

Ruzic A.: P981 

Ruzov V.I.: P869 

Ryabceva O.Y.: P1136, P1136 

Ryabov V.: P1734 

Rychkov A.Y.U.: P1322 

Ryczek R.: P722 

Ryden L.: P1460 

Rylova A.K.: P638 

Rylova N.V.: P638 

Ryndina N.: P903 

INDEX

INDEX 

AUTHORS 


Ryu K.H.: P1145 

Ryu K.H.: P973 

Ryu K.-H.: P546, P982 

Rywik H.: 428, P698 

Rywik T.: 428, P1835, P698 

Ryzhkova D.: P1278 

Ryzhkova D.V.: P739 

Ryzkov A.V.: P1271 

S 

Sa C.: P941 

Sa I.: P1799 

Saab M.: P944 

Sabate M.: P1248, P1641, P777 

Sabatier R.: P1092, P666 

Sabbah H.N.: 396, P473 

Sabry M.: P752 

Saburov M.Y.: P1129 

Sacherer M.: P1315, P884 

Sacilotto M.C.B.: P1242 

Safarova A.: P1150 

Safiullina A.A.: P1020 

Safka V.: P1635 

Safronov I.D.: P517 

Sagach V.F.: P1327, P1762 

Sahakyan L.G.: P1194 

Sahin M.: P1732 

Sahin T.: P626 

Saidova M.A.: P1073 

Sairafian K.: P846 

Saito T.: P594 

Saji Y.: P1074 

Sajjid J.: P709, P710 

Sakabe S.: P1386, P822 

Sakkas G.: P812 

Sakovych Olena S.O.: P1287 

Salama M.: P1282 

Salas Nieto J.: P1062 

Salazar J.: P794, P795 

Salazar Mendiguchia Y Garcia J.: 

P1031 

Saldarriaga C.: P1236, P1483, 

P1797, P694 

Saldiva P.: P915 

Saleem M.: P1818, P955 

Saleh A.M.: P1473, P1590 

Salemi V.M.: P915 

Salerno G.: P790 

Salgado Aranda R.: P1385 

Salih H.: P1535 

Salikova S.P.: P1335 

Salinger S.: P1082 

Salinger-Martinovic S.: P1643, P1681, 

P776 

Salmeron Martinez F.M.: P1496 

Salov R.: P1526 

Salterain Gonzalez N.: P526 

Salvador-Sanz A.: P1548, P970 

Salvetat N.: P1619 

Salvi N.: P536 

Salvioni E.: P510, P514, P821 

Sammut E.: P1510 

Samoilova O.V.: P1612, P990 

Sampaio F.: P818 

Samura T.: P1628 

San Juan M.D.: P1742 

Sanchez B.: P487 

Sanchez Lazaro I.J.: P970 

Sanchez Mas J.: P1597 

Sanchez Ramos J.G.: P562 

Sanchez Ruderisch H.: P1324 

Sanchez V.: P1167, P528, P533 

Sanchez-Grande Flecha A.: P1811 

Sanchez-Lazaro I.: P1548 

Sanchez-Margallo F.M.: P1350, P922 

Sanchez-Mas J.: P1745, P926, P928 

Sanchez-Terrones B.: P1350, P922 

Sanchis Fores J.: 83 

Sanchis J.: P1261, P1397, P474, 

P788 

Sanchis L.: P1248, P1641, P777 

Sandek A.: P1049, P1065, P1298, 

P1503, P1736, P989 

Sander K.: P1529, P1531, P668 

Sandorfi G.: P1779 

Sandra Amorim S.A.: P1089 

Sandri M.: 214, 394 

Sandukhadze B.: P1130 

Sanfins V.: P1514 

Sanganalmath S.K.: P1334 

Sanmartin Prado A.: P1125 

Sanosyan A.A.: P1194 

Sanoussi A.: P1072, P1816 

Santa Clara H.: P1163, P1186 

Santa Clara M.H.: P548, P977 

Santa-Clara H.: P1251 

Santana R.: P507 

Sant’anna R.T.: P1598 

Santarelli G.: P926, P928 

Santas E.: P1607, P474 

Santer D.: P1357 

Santhanakrishnan R.: P1737, P867 

Santi A.: P1387, P953 

Santos A.: P1306, P1402 

Santos A.R.: P1404, P1407, P1408, 

P1515, P1692 

238 

Santos J.: P1166, P1369, P1688, 

P1690 

Santos J.F.: P1045, P1132, P830, 

P941 

Santos L.: P1446 

Santos M.: P1025, P1050, P1172, 

P1239, P1307, P1516, P1519, 

P1558, P1592, P1675, P1799, P676 

Santos M.H.: P917 

Santos M.H.H.: P918, P919 

Santos N.: P1155 

Santos Nussbaum A.: P686 

Santos Nussbaum A.C.A.: P1116, 

P685 

Santos O.: 431, P1279, P1449, 

P1587, P1694, P1814, P522, P539, 

P586 

Santos R.: P1191, P1589, P1634, 

P1819, P853 

Santos R.C.: P1098, P1114 

Santos S.: P1511, P1515, P484 

Santos V.G.: P1391 

Santova T.: P817 

Sapozhnychenko L.V.: P1433 

Saranovic M.: P1014, P1722, P862 

Saranovic S.: P1014, P1722, P862 

Sardella G.: P536 

Sargento L.: P1171, P1173, P1175, 

P1176, P1276, P1565, P1616, 

P1679, P617, P746, P747, P816, 

P819 

Sari I.: P1794 

Sasaoka T.: P837, P946 

Sassen B.: P1560 

Satendra M.: P1171, P1173, P1175, 

P1176, P1276, P1565, P1616, 

P1679, P617, P746, P747, P816, 

P819 

Sato K.: P1386, P822 

Sato S.: P594 

Sato Y.: P552, P783 

Satue J.A.: P1125 

Saushkina Y.: P1083 

Sautova E.: P1079 

Savage H.O.: 84 

Savage H.O.: P1078 

Savarese G.: P1161 

Saveliych B.: P1422 

Savenkova G.: P1512 

Savic L.: P1258, P833 

Sawa T.: P552 

Sawhney V.: P1003 

Sayed W.: P1590

Sayin M.R.: P763 

Sazonova Y.U.: P1491 

Scabo T.: P734 

Scalise V.: P1754, P486 

Scardovi A.B.: P512 

Scardovi A.B.S.: P951 

Scardulla C.: P604, P947, P948 

Scarlini S.: P728 

Scarparo P.: P1395 

Scelza N.: P1518 

Schaefer U.: 441 

Schaer B.: P1076 

Schauerte P.: 275 

Scherbakov N.: P571, P734 

Scheurweghs L.: P1317 

Schiavon B.: P689 

Schilling R.J.: P1003 

Schillinger W.: 438, 441 

Schindhelm K.: 84 

Schipke J.: P1330 

Schmid C.: P669 

Schmid P.: P483 

Schmidt A.: P1119, P1330, P1727 

Schmiedl A.: P480 

Schmitz D.: P1085, P651 

Schmitz G.: P513 

Schmuttermaier C.: P1756 

Schneider H.-J.: P669 

Schoenberger J.: P1772, P1773 

Schoendube F.: 438 

Schoenleitner P.: P1748, P889 

Schoepe M.: P1328 

Schotten U.: P1824 

Schraut S.: P1772, P1773 

Schrepper A.: P1328, P1757 

Schroeder J.: P483 

Schroedl W.: P1049 

Schukina E.V.: P1612, P990 

Schwarzer M.: P1328, P1329, P1757 

Schwarzl M.: 402, P1347, P1782, 

P1792, P488, P888, P889 

Scofano B.S.: P1215 

Scorcu G.: P969 

Scrima G.: P1418 

Secades Gonzalez S.: P537 

Secades S.: P1501, P527, P534, 

P667, P681 

Seccareccia F.: P809 

Secnik P.: P525 

Sedej S.: P1315, P1330, P884 

Sedov V.: P1673, P1738 

Seeburger J.: P678 

Seferovic P.: 261, P1080, P1156, 

P1182, P1803, P1804, P677, P757, 

P972 

Seferovic P.M.: P896 

Segato G.: P1472 

Seica R.: P1338 

Seidlmayer L.: 400, P1772, P1773 

Seidlmayer L.K.: P886 

Seifert I.: P1085, P651 

Seiler S.: 402, P488 

Seipelt R.: 438 

Sekar B.: P1752 

Sekine M.: P581, P582 

Seko T.: P1386, P822 

Sekularac N.: P1427 

Selaru A.: P1341, P1342 

Selas M.: P1186, P1251 

Selcuk M.: P766 

Seleznev E.I.: P1204 

Seljun Y.: P1530, P1778 

Selmi W.: P1623, P1625, P1626, 

P985, P987 

Semernin E.: P1784 

Semino C.: P1833 

Semino C.E.: P1350, P922 

Semjonova O.S.: P1513 

Semochkin S.V.: P1181 

Semprini F.: P805 

Sena C.: P1338 

Senard J.M.: P1851 

Senchili V.: P991 

Senior C.: 208 

Senni M.: P1388, P622, P735 

Senzolo M.: P1472 

Seo J.G.: P1666, P1725 

Seol S.H.: P1272, P954 

Serag A.: P1169 

Seredenina E.M.: P1136, P1136 

Sereinigg M.: P1790, P884 

Sergio Machado Leite S.M.L.: P1089, 

P802 

Seronde M.-F.: P556 

Serra E.: P969 

Setoguchi M.: P1299 

Seung K.B.: P1581 

Severin T.: 260 

Severino D.: P1366, P956 

Severino E.S.B.O.: P1242 

Severo T.: P1592 

Sfakianaki T.: P1477, P508 

Sfirakis P.: P1528 

Sgarito G.: P947 

Sge Howard L.: P849 

Sh J.O.H.N.: P1440 

239 

AUtHoRS 


Shabani R.: P1719 

Shah A.: P1295 

Shah A.M.: P1595, P932 

Shaheen M.: 395 

Shakaryants G.A.: P1017 

Shalaby M.: P1473, P1590 

Shalaev S.: P1190 

Shankarhari M.: P932 

Shantsila A.: P1001 

Shantsila E.: P1001 

Shao Y.: P1776 

Shara N.: P1603 

Sharif D.: P975 

Sharif-Rasslan A.: P975 

Shariya M.A.: P1020 

Sharma R.: P1018, P1039, P1078 

Sharma R.K.: P1134, P1525, P529 

Sharma U.: P1812 

Sharp J.: P1670 

Shattock M.: 216 

Shattock M.J.: P1828 

Shatunova I.: P1724 

Shauer A.: P839 

Shaw S.: P1752 

Shchendrygina A.A.: P1585, P725 

Shcherbinina E.V.: P1224, P1659 

Shchukin Y.V.: P1204 

Shchukina E.V.: P713 

Shebeko P.: P1633 

Shebeko P.V.: P1322 

Shefer A.: P975 

Shehu E.S.: P934 

Shelia G.: P1459 

Shen H.: P1205 

Sheremeta O.M.: P708 

Sherfesee L.: 274 

Sherwi N.: P1428, P1602 

Sherwi N.S.: P1640 

Sherwood R.: P1637 

Shi V.C.: 269, 439, P1486 

Shiga T.: P1234, P1520 

Shigekiyo M.: P521 

Shilov S.N.: P517 

Shim W.J.: P1145 

Shimanskaya T.V.: P1762 

Shimizu W.: P579 

Shin H.C.: P1444 

Shin M.S.: P1033, P1145, P1666, 

P1725 

Shin S.N.: P865 

Shinada T.: P551, P803, P962 

Shingu Y.: P1329 

Shipulin V.M.: P1026, P515 

INDEX

INDEX 

AUTHORS 


Shiraishi T.: P521 

Shirakabe A.: P551, P803, P962 

Shirinsky V.P.: P1331 

Shirokova N.: P661 

Shirota K.: P1576 

Shishkina N.: P963 

Shkolnik E.: P1445 

Shkolnik L.: P1445 

Shkurat I.A.: P827 

Shlyakhto E.: P1226, P1319, P1491, 

P1784, P693 

Shlyakhto E.V.: P1111, P1188, 

P1551, P1680, P881, P911 

Shmidt C.: P908 

Shmidt E.A.: P1620 

Shoaib A.: P1199, P1252, P1414, 

P1523, P1686, P509, P531, P723, 

P724 

Shochat A.: P530 

Shochat I.: 266, P478, P530, P674, 

P937, P938, P939 

Shochat M.: 266, P1795, P478, 

P530, P674, P937, P938, P939 

Shoda M.: P1520 

Sholy H.: P1441 

Shorikov E.: P1780, P914 

Shorikova D.: P1780, P914 

Shorthose K.: P1668 

Shotan A.: 266, P1795, P478, P674, 

P937, P938, P939 

Shpak N.V.: P727 

Shukla C.P.: P656 

Shulte P.: P786 

Shurupov V.: P1734 

Shvarts Y.G.S.: P1487, P633 

Siabani S.: P791, P791 

Siala A.H.M.E.D.: P1813 

Siasos G.: P852 

Sibellas F.: P556 

Sicari R.: P1598 

Siddiqui I.S.: P1041 

Sideris A.: P971 

Sidorenko I.: P1021, P1372, P1466 

Siebes M.: P1768 

Siedlecki J.A.S.: P644 

Sievert H.: 441, P550 

Sigalov T.: P478, P938 

Siirila-Waris K.: P557, P767 

Sijbrands E.: P895 

Sijercic E.: P1817 

Silva A.L.: P1436 

Silva B.: 435, P1416, P894 

Silva Cardoso J.: P1015, P1115, 

P1168, P1471, P593, P717 

Silva Carvalho S.: P1027, P1281, 

P765 

Silva Castro A.: P1712, P756 

Silva D.: P1051, P1070, P1187, 

P1189, P1195, P1270, P1446, 

P1507, P1654, P768, P775, P781, 

P804, P831 

Silva E.: P1296 

Silva E.F.: P1432 

Silva E.N.: P1375 

Silva F.: P1144, P1254, P716 

Silva G.J.J.: 397 

Silva L.F.: P1212 

Silva M.: P1007, P1008, P1058, 

P1478 

Silva M.L.F.: P800 

Silva M.N.: P1515 

Silva Marques J.: P1270, P1710 

Silva P.: P1650 

Silva S.: P1400, P1436, P548, P977 

Silva T.: P1155 

Silva V.A.: P1215, P507 

Silva W.A.: P690 

Silva-Cardoso J.: P1451, P1456, 

P588, P596, P753, P772 

Silva-Cardoso J.C.: P1035, P589 

Silveira J.: P1307, P1592, P654 

Silveira-Filho L.M.: P1242, P1750 

Silvia Ayub Ferreira S.A.F.: P1550 

Sim D.: P1500 

Sim D.K.L.: P1678 

Simeunovic D.: 261 

Simic D.: P1803, P1804 

Simic D.V.: P896 

Simoes L.: P648, P649, P818, P940 

Simoes R.: P1554, P1555 

Simoes S.: P800 

Simon A.: 425, 426 

Simon Garcia M.A.: P1721 

Simon I.: P1556 

Simonds A.K.: 84 

Simonenko G.: P1771 

Simpkin V.L.: P1039, P529 

Simsek E.: P688 

Sinagra G.: 271, P1019, P1024, 

P1030, P1457, P1469, P510, P514, 

P680 

Singh R.: P968 

Singsaas E.: P1718 

Sisakyan H.S.: P1194 

Siswanto B.B.: P1687, P976 

Sitges M.: P1248, P1641, P777 

240 

Sitnikova M.: P693 

Sitnikova M.Y.: P1111, P1188 

Sitnikova M.Y.U.: P1551, P1680 

Siwolowsk P.: P1405 

Siwolowski P.: P1419, P995 

Sjaastad I.: 215, P1321, P1788, P930 

Skali H.: P1100, P1700 

Skiepko R.: P1707 

Skinner J.S.: P993 

Skomedal T.: P1747, P1788 

Skorak I.: P687 

Skoric B.: P687 

Skorka T.: P1340 

Skoromna A.: P1359 

Skorup L.: P981 

Skrbic B.: 215, P1321, P930 

Skvortsov A.A.: P758 

Slaats R.: P1850 

Slatova L.N.: P1204 

Slavic S.: P1791 

Slavov M.: P1137 

Slepneva E.M.: P801 

Slezak J.: P1310, P1326 

Sliwa K.: 80 

Sljivic A.: P1057, P1193, P1285, 

P1714 

Sluijter J.: P1850 

Slutzky O.: P1552 

Smagulov N.: P1526 

Smajic E.: P1817, P856 

Smaldone C.: P1348, P1349 

Smiderle C.A.: P1728 

Smidi D.: P792 

Smirnova E.A.: P1224 

Smith G.L.: P885 

Smith G.L.: P1826 

Smith S.: P1164, P1584 

Smits J.M.A.: P1549 

Smitt M.: P1012 

Snezhitskiy V.A.: P1822, P727 

Snider J.: P1413 

Soares F.: P1682, P1693, P657 

Soares L.: P1132, P1166, P1369, 

P1688, P1690, P830, P941 

Soares M.: P1650 

Soares R.: P1251 

Sobien B.: P959 

Sobieszczanska-Malek M.: P1110 

Sobisiak B.: 438 

Sobkowicz B.: P1707 

Sobotka P.A.: P952 

Sochanowicz B.: P1835 

Sofoterova T.: P1130

Sohal M.: P1510 

Sokolowska M.: P1325 

Sokolski M.: P1405, P1419, P995 

Sola E.: P1540 

Soldatova A.M.: P1322 

Soler-Botija C.: P1833, P487 

Solik P.: P1699, P835 

Solla Ruiz I.: P1036, P1401, P1711 

Solomon S.: P1100, P1295, P1700, 

P872 

Solomon S.D.: 269, 439, P1486, 

P1567, P1595, P1739, P748 

Solovei S.P.: P1275 

Solowjowa N.: P1539 

Soltan G.: P1016 

Sommerfeld M.: P1791 

Somoza M.I.: P629 

Song B.: P1756 

Song J.E.: P1440 

Song W.: P920 

Sonia Eiras S.E.: P1774 

Sonne C.: 273 

Soos P.: P1183 

Soosova I.: P835 

Sopel M.J.: P902 

Sopel M.J.H.: P901 

Sorea C.: P1815, P997 

Sossalla S.: P1353 

Sothiriou S.: P812 

Soukup T.: P1326 

Sourtzi P.: P1122 

Sousa A.: P1451, P1471, P588, 

P836, P943 

Sousa A.C.: P1416 

Sousa A.R.: P1446 

Sousa B.: P1656 

Sousa C.: P1035, P1118, P1243, 

P1304, P1471, P1679, P589, P601, 

P607, P717, P753, P772, P816, 

P819, P836, P943 

Sousa E.: P1554, P1555 

Sousa M.J.: P1307, P1592, P654 

Sousa M.J.: P1025, P1050, P1239, 

P1516, P1519, P1558, P1675, 

P1799, P676 

Sousa R.: P1712, P756, P853 

Sousa S.: P1650 

Sousa T.: P899 

Sousa-Pereira L.: P1798, P1799 

Sousounis V.: P1477, P1532, P508 

Souza A.C.B.: P800 

Souza E.N.: 211, P506 

Souza G.: P1124 

Souza G.E.C.: P1391 

Souza J.D.: P1544 

Souza Junior C.V.: P1302 

Souza Neto J.: P1114 

Souza Neto J.D.: P1098, P1112, 

P1212, P690 

Souza R.: P507 

Soya O.: P650 

Soya O.V.: P615 

Soydinc S.: P1410 

Soylu K.: P1732 

Spaan J.A.E.: P1768 

Spaderna H.: P1549 

Spc R.N.S.C.A.: P1404, P1407, P1408 

Speidl W.S.: P1825 

Spence M.: P1216 

Sperduti I.: P584 

Spiesshoefer J.: P1365, P1398, 

P1488, P630, P632 

Spinar J.: P1264, P1492 

Spinnler M.T.: P1418 

Spoladore R.: P1452 

Sporton S.: P1003 

Sposato B.: P1291 

Sprenger J.U.: 398, P1787 

Springer J.: P1141 

Spritzer T.S.: P800 

Spruit M.A.: P1103 

Squire I.: 275 

Squire I.B.: P1618, P1642, P707 

Srbinovska E.: P1381, P736 

Srbinovska- Kostovska Elizabeta S.K.E.: 

P1613 

Srbinovska-Kostovska E.: P1806 

Srbinovska-Kostovska E.S.K.: P1610, 

P754 

Srdic S.: P1373 

Stachura M.: P722 

Stadnikov A.A.: P1335 

Staessen J.A.: P1646 

Stafford N.: 395 

Stahn A.: P966 

Stanetic B.: P1373 

Stangl K.: 437 

Stangl V.: 437 

Stankovic G.: P972 

Stankovic S.: P972 

Stanojevic D.: P1082, P1537, P1643, 

P1681, P776 

Stanojlovic T.: P1082 

Stanovsky Y.: P1552 

Starchenko T.: P1781 

Stauffenberg S.: P518 

241 

AUtHoRS 


Steckelings U.M.: P1791 

Steendijk P.: 402, P1347, P1782, 

P1792, P488, P887 

Stefanadis C.: P852, P957, P988 

Stefanidis C.: P1072 

Stefanovic B.: P1249, P1683, P838 

Steinberg J.S.: P661 

Steiner G.: P1727 

Stepanenko A.: P1097 

Stepanova R.: P1492 

Stephan N.: P1557 

Stepinska J.: P644 

Stepniewski J.: P1113, P959 

Steurer G.: 440 

Stiegler P.: P884 

Stio R.E.: P536 

Stipacek M.: P1746 

Stockinger J.: P861 

Stoerk S.: 436, P1228, P476, P518, 

P523, P691, P813 

Stoian I.: P1341, P1342 

Stoickov M.: P1337, P1763 

Stoickov V.: P1206, P1337, P1763 

Stojakovic T.: P1746 

Stojanovic G.: P1536 

Stojanovic I.: P645 

Stojcevski B.: P1057, P1193, P1285, 

P1714 

Stojkovic T.: P605 

Stolfo D.: P1019, P1457 

Stolic R.: P587 

Storer S.: P1391 

Stork S.: P807 

Storozhakov G.I.: P1476 

Stoschitzky G.: P1119 

Straburzynska-Migaj E.: P1240, 

P1671, P771 

Strachinaru M.: P1072, P1816 

Strack C.: P513 

Strand M.E.: P1321 

Strasen J.: P1333 

Strasser R.H.: P1174 

Strazhesko I.D.: P1157, P858 

Stromberg A.: 207, 210, P498, P499, 

P501, P502, P504 

Struber M.: 425 

Strueber M.: P673 

Strunz A.: P1663 

Struthers A.D.: P511 

Strzelecki P.: P1009, P580 

Stuart B.: P1238, P1653 

Stubbe H.C.: P474 

Studenik C.H.: P912 

INDEX

INDEX 

AUTHORS 


Stueflotten W.: P1455 

Sturmberger T.: P1505, P1509 

Styliadis I.: P1177, P1178 

Stylianaki E.: P812 

Suarez N.: P931 

Subacius H.: P978 

Subirana I.: P1308 

Suceveanu A.: P1160, P627 

Suceveanu A.I.: P1160, P627 

Sudano I.: P1133, P1148, P1437 

Sugihara S.: P1576 

Sugimoto T.: P1386, P822 

Sugioka J.: P1043 

Suhodolo I.V.: P1026, P515 

Sukhonos V.: P1288 

Sulicova A.: P817 

Summer H.: P1312 

Sunbul M.: P1706 

Sunderji I.: P773 

Suprobo D.: P976 

Surarso R.: P976 

Surial B.: P1076 

Surovtseva M.: P1149, P1724, P704 

Susam I.: P1280 

Suslova T.: P1734 

Suter T.: P1012 

Suzic Lazic J.: P1674 

Suzuki A.: P1520 

Suzuki M.: P1217, P1309 

Suzuki T.: P1234, P1520 

Svendsen M.L.: P1362 

Svendsmark R.: P1455 

Sveric K.M.: P1174 

Sviridenko V.: P1673 

Sviryaev Y.U.: P1491 

Swedberg K.: 269, 439, P1142, 

P1486, P1567, P1575, P500, P516, 

P711, P872 

Sweeney R.: P561 

Sweeney R.J.: P550 

Swidsinski A.: P1049 

Swinnen M.: P892 

Syrkin A.: P1673, P1738 

Syrris P.: 81 

Sysoeva V.: P1351 

Szabo B.: P1090, P1259, P1380, 

P714 

Szabo G.: P1380, P927 

Szachniewicz J.: P1405, P1419, P995 

Szarszoi O.: P525 

Szelemej R.: P639 

Szelid Z.: P1183 

Szilagyi S.: P1314 

Szklarska A.: P640 

Szlosarczyk B.: P1632 

Szot W.: P1165 

Szpakowicz A.: P1707, P855 

Szuksztul M.: P1113 

Szymkiewicz S.: P1010 

Szynaka B.: P1325 

T 

Tabakovic M.: P856 

Taborsky M.: P653 

Tada E.: P1074 

Tadic M.: P1193, P1285, P1714 

Taeger T.: P820 

Tafarshiku R.: P1676 

Tahirovic E.: P1228, P1421, P1426, 

P1427, P1643, P1667, P1674, 

P1681, P565, P966 

Tai J.T.: P1041 

Taieb J.: P1535 

Taiyem A.: P1028 

Tak T.: P1812 

Takamura T.: P1386, P822 

Takano H.: P594 

Takatsu Y.: P552, P783 

Takeichi K.: P521 

Takeishi Y.: P614 

Talavera Calle P.: P1125 

Talavera M.L.: P629 

Taleski J.: P1381 

Tamisier R.: P628 

Tamura K.: P521 

Tan R.S.: P1170, P538 

Tanabe K.: P603 

Tanada Y.: P552, P783 

Tanaka A.C.: P1807, P1808 

Tang A.S.L.: 274 

Tang J.: P1394 

Tarantini F.: P1054 

Tarantini G.: 427 

Tarantini L.: P622 

Tarasov A.: P1300 

Targonski R.: 428, P698 

Tarjus A.: P1354 

Tarlovskaya E.I.: P1224, P1659 

Tarnowska A.: P1383 

Tarro Genta F.: P1263 

Tartaglione I.: P851 

Tarvasmaki T.: P557, P767 

Tasaka H.: P1101, P1533 

Tashchuk V.: P558, P914 

Tashchuk V.K.: P1390, P770 

Tasic J.: P1800 

242 

Tatjer I.: P1669 

Tatu-Chitoiu G.: P637, P854 

Taub P.: 265 

Tauchnitz M.: 390, P887 

Tavares A.C.: P1807, P1808 

Tavares A.C.: P566, P726 

Tavares L.: P1554, P1555 

Tavares N.: P1474 

Tavares N.E.L.S.O.N.: P1463 

Tavazzi G.: P1039 

Tavazzi L.: P1103, P1142, P1388, 

P1575, P1664, P622, P711, P735 

Tavora F.: P1114, P1544 

Tawfeek M.S.K.: P1203 

Tayiem A.: P1462 

Tea I.: P1336, P1358 

Tebbe U.: P1663 

Tecuceanu R.: P1341, P1342 

Teerlink J.R.: P497, P961 

Teerlink J.R.: 260 

Teixeira M.: P818 

Teixeira Neto I.S.: P726 

Teixeira R.: P657 

Teixeira-Neto I.S.: P1672, P1807, 

P1808, P566, P814 

Tellatin S.: 427, P1472, P608, P689 

Telleria Arrieta M.: P1036, P1401, 

P1711 

Tellez-Olvera L.: P1061, P1063, 

P1489, P979 

Temirsultanova T.H.: P721 

Temporelli P.L.: P1263 

Tendera M.: P1303 

Tenori L.: P1425, P1759 

Tentolouris C.: P957 

Teodoru A.: P1479 

Teodoru M.: P1479 

Teplyakov A.T.: P517 

Ter Horst H.: 275 

Terblanche M.: P932 

Tercero Martinez A.: P1371 

Terekhov V.: P921 

Tereschenko S.N.: P1331, P758 

Tereshchenko S.N.: P1020, P1454 

Terrovitis J.: P1477, P1532, P508 

Tesic M.: P1080 

Tespili M.: P696 

Testani J.M.: P1209 

Thanikachalam S.: P1018 

Theodosis-Georgilas A.: P1158 

Thiene G.: P689 

Thomas J.: P1216 

Thomas M.: P1075, P1104

Thum T.: P480, P891, P897 

Tidu M.: P1263 

Tigen K.: P1023 

Timbol E.W.: P1742 

Timler D.: P1009, P580 

Timmermans W.: P675 

Tinoco Mesquita C.: P664 

Tint D.: P854 

Tiradentes C.A.: P1375 

Tkachenko J.V.: P1703 

Tkacheva O.N.: P1157, P858 

Tkachuk V.: P1226, P1351 

Tkaczyszyn M.: P640 

Tkalec W.: P1509 

Toana B.: P1823 

Toepper A.: P734 

Toischer K.: P1353 

Tokat Y.: P741 

Toledo Frias P.: P562 

Tolonen J.: P557, P767 

Tomas M.T.: P548, P977 

Tomasik A.: P1582 

Tomberli B.: P583 

Tomioka C.: P1639 

Tomita K.: P551, P803, P962 

Tona F.: 427, P1472, P608, P689 

Tonnessen T.: 215 

Torabi A.: P1093, P1199, P1414, 

P1523, P509, P723, P724 

Torim J.U.J.U.: P517 

Torina A.G.: P1750 

Torrado M.: P893 

Torres A.F.: P1544 

Torres D.: P1209 

Torres O.R.T.: P1761 

Torres Ramalho P.: P841 

Torres S.: P1025, P1050, P1239, 

P1307, P1516, P1558, P1675, 

P1798, P1799, P654, P676 

Tosu A.: P766 

Toth A.: P1779, P1827, P910 

Tounsi A.: P1034, P1071, P1376, 

P1506, P1813, P544 

Tounsi A.H.M.E.D.: P547 

Tousoulis D.: P988 

Tousouls D.: P852 

Trabulo M.: P1374 

Tralhao A.: P1374, P1615 

Travers B.: P663 

Treede H.: 441 

Trenkler C.: P1269, P1704, P789, 

P845 

Trenti T.: P728 

Trescher K.: P1357, P912 

Tribulova N.: P1310, P1326 

Trifunovic D.: P1080, P1182 

Triggiani M.: P978 

Trigo J.: P572, P618 

Trigo J.T.: P1627 

Triki F.E.T.E.N.: P1034, P1034, P1071, 

P1376, P1506, P1813 

Triki N.: P679 

Trimech T.: P985, P987 

Trimech T.R.: P1685, P964 

Trimeche B.: P1060 

Trippel T.: P1421, P1426, P1427, 

P1667, P565, P966 

Trninic D.: P1373 

Trobec K.: P1056, P1141 

Trocino G.: P953 

Trojahn M.: 211 

Troughton R.: P867 

Troyanova T.A.: P1077 

Trukshina M.: P1087, P1517, P693 

Trullas J.C.: P983 

Trullas Vila J.C.: P871 

Tsai L.-M.: P1570 

Tsamatsoulis M.: P1532 

Tschoepe C.: P1663 

Tscholl V.: P1421, P1667, P565, P966 

Tsiaousis G.: P1158, P731 

Tsibulsky Y.: P1534 

Tsikas D.: 80 

Tsokolaeva Z.I.: P1770 

Tsokolov A.: P991 

Tsorlalis I.K.: P1415 

Tsukamoto K.: P1520 

Tsurumi M.: P551, P803, P962 

Tsushima Y.: P1101 

Tsutani H.: P1069 

Tsverava D.: P1424, P1614, P567 

Tsverava M.: P1424, P1566, P1614, 

P567 

Tsygankov A.I.: P1055 

Tubek S.: P952 

Tuchin T.: P1771 

Tudose I.V.A.N.: P1467 

Tufaro C.: P1735, P876 

Tuluce K.A.M.I.L.: P1448 

Tumasyan L.R.: P1417 

Tunoda F.: P1576 

Turazza F.M.: P705 

Turco M.C.: P925 

Turgeman Y.: P600 

Turgonyi E.: P1663 

Turgut O.O.: P1197 

243 

AUtHoRS 


Turovska T.: P1578 

Turovskaya T.V.: P1431 

Turrini F.: P728 

Tuzzolino F.: P604 

Tyrankiewicz U.: P1340 

Tysarowski A.: P644 

Tytova G.: P1411, P616, P903 

Tyukhtina A.S.: P1655 

Tzerefos S.: P1158 

Tzourou E.: P505 

U 

Udovychenko M.: P1146 

Ueyama K.: P1074 

Ugolini M.: P697 

Ulbrich S.: P1174 

Ulhoa Junior M.B.: P686 

Ulhoa M.B.: P1116, P1368, P685 

Ulus T.: P1140, P715 

Umeda A.: P1217 

Uncanin D.: P1373 

Undrovinas N.A.: P1331 

Unemori E.: P497 

Unger A.: P930 

Unger T.: P1791 

Ural D.: P626 

Urban L.: P1310 

Urbanek B.: P1522 

Urbanik A.: P864 

Urbano J.: P1143 

Uri K.: P1779 

Urina S.V.: P1111 

Url-Michitsch M.: P1727 

Urrutia A.: P1227, P1631, P1662, 

P1698, P503, P624 

Urrutia De Diego A.: P871 

Urso R.: P1388 

Uscoiu G.: P1128, P1202 

Uslu A.U.: P1197 

Ussia G.P.: 441 

V 

Vachulova A.: P1310 

Vaclavik J.: P1264 

Vadas R.: P1183 

Vaduganathan M.: P774, P842 

Vagany D.: P714 

Vagnarelli F.: P682, P805 

Vaikhanskaya T.: P1021, P1372, 

P1466 

Vaina S.: P957, P988 

Vaizov V.H.: P515 

Vakrou S.: P1532 

INDEX

INDEX 

AUTHORS 


Valdes M.: P926, P928 

Valdes-Chavarri M.: P1745 

Vale L.: P899 

Valente B.: P1250, P1511, P1515 

Valente F.: P1366, P956, P992 

Valente M.J.: P899 

Valentino L.: P969 

Valentova M.: P1049, P1065, P1298, 

P1503, P1736, P989 

Valero-Munoz M.: P929 

Valette T.N.: P1716 

Valle A.: P1091 

Valleggi A.: P496, P658 

Vallejos X.: 268, P1084 

Valle-Munoz A.: 430 

Valles A.: P1833 

Vamos M.: P1090, P1380, P714 

Van Ackeren K.: P1317 

Van Buuren F.: P1429, P1447, P1588 

Van Craenenbroeck A.: P1317 

Van Craenenbroeck E.: P1317 

Van De Werf F.: P892 

Van Den Akker N.: 387 

Van Den Wijngaard J.P.H.M.: P1768 

Van Der Heide A.: P1219, P1225 

Van Der Meer P.: P1389 

Van Der Wal M.H.L.: 210 

Van Empel V.: P1274, P1708 

Van Lier M.G.J.T.B.: P1768 

Van Mourik Y.: P1207, P560 

Van Riet E.E.S.: P808 

Van Veldhuisen D.J.: P1103 

Van Zuydam N.R.: P1284 

Van Zuylen L.: P1219, P1225 

Vandecasteele G.: P1789 

Vandekerckhove L.: 389, P913 

Vandenwijngaert S.: P892 

Vanderheyden M.: 270, P550, P675 

Vandor L.: P1556 

Vanduganathan M.: P978 

Vardas P.: 429, P1290, P1450, P1726 

Varenne O.: P605 

Varga I.: P1699, P835 

Vargas Penafiel J.: P950 

Varlan G.: P1445 

Vasatova M.: P1635 

Vasconcellos I.: P507 

Vasconcelos G.G.: P1098, P1112, 

P1114, P1544 

Vasconcelos M.: P1015, P1168, 

P1802, P1810, P588, P599, P717, 

P943 

Vasic D.V.: P860 

Vasilenko L.: 266, P1795, P478, 

P530, P937, P938, P939 

Vasiljevic Z.: P1249, P1683, P838 

Vasilts L.M.: P642 

Vasilyeva L.I.: P1433 

Vasoncelos G.: P1524 

Vasyuk Y.: P1445 

Vataman E.B.: P1729 

Vaughan C.: P1229 

Vavlukis M.: P736 

Vazir A.: P1039, P1134, P529 

Veiga G.G.: P1391 

Velasco E.: P527, P667 

Velicki L.: P1538 

Velinovic M.: P1005, P1536 

Venge P.: P1198 

Venskutonyte L.: P1460 

Ventosa A.: P1374 

Ventura M.: P1007, P1008, P1058, 

P1478, P652 

Ventura S.: P1261, P1397, P1607, 

P474 

Verberne L.: P793 

Verde A.: P705 

Verde S.: P718 

Verderber J.: 402, P888 

Verdonck K.: P1769 

Verdu Rotellar Jose Maria J.V.R.: P490 

Vergara Lozano P.: 83 

Vergaro G.: P1461, P612, P658, 

P780 

Verhage V.: P1850 

Verheijden Klompstra L.: P498 

Vermeulen K.M.: P1393 

Vernet M.A.: P1198 

Verras C.: P731 

Verstreken S.: 270, P675 

Vettel C.: P1356, P1789 

Vettor R.: P608 

Viamonte S.: P1050, P1239, P1592, 

P1675, P676 

Vicaut E.: P798 

Victor Palomares V.: P1301, P1377, 

P878 

Victor Sarli Issa V.S.I.: P1550 

Vida-Simiti L.: P854 

Vieira C.: P1691, P750 

Vieira G.C.: P507 

Vieira G.C.A.: P1215 

Vieira K.R.: P1399 

Vieira M.L.C.: P1716 

Vieira P.: P1516, P1558, P654 

Vieira T.: P738 

244 

Vierecke J.U.L.I.A.N.E.: P1097 

Vigano’ E.: P1387, P953 

Vignati C.: P821 

Vigorito C.: P1263 

Vikhorev P.: P920 

Vikmane M.V.: P1513 

Vila J.: P1403, P1631, P624 

Vilanova R.: P1728 

Vilarinho K.A.S.: P1242, P1750 

Vilas Boas N.: P1027, P1281, P765 

Villa M.T.: P696 

Villa Martinez A.: P1301, P1377, 

P878 

Villaca Lima M.: P1399 

Villacorta Junior H.: 435 

Villagraz Tecedor L.V.T.: P1384 

Villani G.Q.: P1605, P660 

Villanueva Benito I.: P1036, P1401, 

P1711 

Villasmil J.J.: P1296 

Villevalde S.: P1150, P619 

Vincenzi A.: P1387, P935, P953 

Vinereanu D.: P1289, P1579, P541, 

P637, P774, P842, P958 

Vintila M.: P577 

Vintila M.M.: P1256, P1438, P1571, 

P577 

Virdee M.S.: P495 

Virtuoso N.: P925 

Vistnes M.: P1321 

Vitali E.: 425 

Vitorino H.: P1615, P1697 

Vitovec J.: P1264 

Vittos A.: P1823 

Vittos O.: P1823 

Vitulano G.: P925 

Vladimirskaya T.: P921 

Vladoianu M.: P854 

Vlaisavljevic S.: P1373 

Vlasenko M.A.: P1042 

Voelkers M.: P1849 

Voevoda M.I.: P706 

Vogt J.: P1429 

Vogt S.: P1758 

Voigt N.: P1785 

Voinea F.: P627 

Volchkova N.S.: P1573 

Volker U.: P1458 

Voll S.: P1772, P1773 

Vollroth M.: P678 

Volterrani M.: P1291 

Von Haehling S.: P1049, P1065, 

P1141, P1226, P1298, P1503,

P1736, P571, P625, P640, P734, 

P787, P989 

Von Hardenberg A.: 392 

Voon V.: P1229, P1829, P663 

Voors A.: P1295 

Voors A.A.: P497 

Voors A.A.: 260, P1389, P1595, 

P1739 

Voronkov L.G.: P827 

Voska L.: P683 

Vozenin M.C.: P1311 

Vranes M.: P1005, P1536 

Vrankova S.: P1777 

Vrbska J.: P1546 

Vrints C.: P1317 

Vujisic-Tesic B.: 272, P1080, P1156, 

P1182, P645, P757 

Vukcevic V.: P677, P972 

Vukomanovic V.: P1057 

Vukotic S.: P1689 

Vunjak-Novakovic G.: P487 

Vyborov O.N.: P1331 

Vyskocilova M.: P1492 

W 

Waagstein F.: P1674 

Wachter R.: P1228, P1426, P1427 

Wagenaar K.P.: P560 

Wagner D.R.W.: P1332 

Wagner M.: 390 

Wahbi K.: P605 

Wakasa M.: P603 

Wakula P.: P1746, P1748, P1790, 

P889 

Waleed M.: P1414 

Walid A Abukudair W.A.: P1105 

Walid J.: P1623 

Wallenborn J.: P518 

Walshe J.: P1011 

Wang H.: P1603 

Wang L.F.: P1609 

Wang M.: 396, P473 

Wang X.U.L.E.: P481 

Warden J.: P1164, P1422 

Wariar R.: P550 

Warriner M.: P719 

Warrings B.: P813 

Wasserman S.M.: P961 

Wassilew K.: P1756 

Waszkiewicz E.: P1067 

Watanabe A.: P1101 

Watanabe M.: P579 

Watson A.: P1049 

Watson C.: 208, P1229, P1339, 

P1360, P1829 

Watson C.J.: P1336, P1358 

Watt V.: P719 

Watzke L.: P1825 

Wauthy P.: P1072, P1816 

Weber D.: P1345 

Weber P.: P1758 

Weber S.: P605 

Wegener B.R.: P1651 

Wei M.: P1205 

Weichert I.: P945 

Weidner G.: P1549 

Weinshilboum R.: P1542 

Weinstein J.M.: P1552 

Weiss G.: P845 

Weitmann K.: P1458 

Wells G.A.: 274 

Wen M.S.: 263 

Wendelboe Nielsen O.: P1664 

Wensel R.: P1244 

Weston J.: P1093 

Weston J.M.: P723 

Whalley G.A.: P707 

Whellan D.: P786 

Whitehead C.: P1095 

Whitney H.: P1812 

Wians F.H.: P820 

Wichitkosoom W.: P554 

Widimsky P.: P1264 

Wieczorek P.: P1303 

Wieland T.: P1785 

Wielocha L.: P1106 

Wikstrom G.: P1709 

Wild K.: P1216 

Wilkinson R.: P920 

Wilkolek P.: P959 

Will R.: P1849 

Willeit P.: P932 

Williams O.: P1525 

Williams S.: P1752 

Williams T.: 400, P1333, P1772, 

P1773 

Williams T.J.: P1708 

Wimmerova S.: P835 

Winkel I.: P483 

Winkler M.: P866 

Winnicka M.M.: P1325 

Wirth K.: P1824 

Wirtz J.H.: P1663 

Wisniewska J.: P1383 

Wittig K.: P1785 

Wittkoepper K.: P1356 

245 

AUtHoRS 


Witzke C.: P1805 

Wnuk M.: P1632 

Wojakowski W.: P1303 

Wojciechowska C.: P1582, P744 

Wojciechowska C.A.: P595 

Wojta J.: P1825 

Wojtas K.: P625 

Wojtkowska I.: P644 

Wolf A.: P500 

Wolf J.-E.: P1294 

Wolf P.: 273 

Wong C.: P1567, P707 

Wong K.: P1199, P1428, P1640, 

P1686, P531, P723, P749 

Wong K.Y.: P519 

Wong L H Ling R Santhanakrishnan 

R.C.C.: P1678 

Wong R.: P1737 

Wong R.C.C.: P1394, P1500 

Wong T.: P1525 

Woo M.A.: P846 

Woodside J.V.: P641 

Wranicz J.K.: P1522 

Wu A.: P1413 

Wu S.L.: P1000 

Wuertinger P.: P1269, P1704, P789 

Wuertz C.M.: P1356 

X 

Xiao J.I.N.P.I.N.: P481 

Xiu C.H.: P1609 

Xu N.: P1012 

Xu Y.: P1286 

Xue Y.M.: P1000 

Y 

Yaari V.: P1099, P850 

Yacoub M.: 267, P1016 

Yagdi T.: P688 

Yagil C.: P1320 

Yagil Y.: P1320 

Yagur V.: P1066 

Yahalom M.: P600 

Yakar Tuluce S.E.L.C.E.N.: P1448 

Yakovleva N.F.: P517 

Yakubbekov N.T.: P733, P848 

Yakubovskaya E.: P1673, P1738 

Yakushin S.S.: P1224, P1659 

Yalcin F.Y.: P564 

Yamamoto E.: P594 

Yamamoto Y.: P551, P803, P962 

Yamanishi A.: P1639 

Yan Y.F.: P1038 

INDEX

INDEX 

AUTHORS 


Yang X.M.: P1205 

Yang Z.Z.: 213 

Yangzhen Y.: P1767 

Yap S.F.: P1678 

Yaseen R.: P1169 

Yassin F.: P1584 

Yasumura Y.: P1047, P549 

Yasutake M.: P594 

Yavuzgil O.G.U.Z.: P1448 

Yazicioglu N.: P1527 

Yeo D.: P1500 

Yeo D.P.S.: P1678 

Yeo P.S.D.: P1482 

Yeo T.J.: P1678 

Yeo T.J.: P1500 

Yeong J.L.: P511 

Yildizeli B.: P1706 

Yilmaz I.: P626 

Yilmaz M.B.: P1197, P980 

Yilmaz O.: P1732 

Yin X.: P932 

Yokoyama H.: P837 

Yokoyama S.: P551 

Yonemoto N.: P837 

Yong C.-C.: P1032 

Yoo B.S.: 263, P1145, P973 

Yoo N.J.: P865 

Yoshida M.: P1309 

Yoshihisa A.: P614 

Yotov Y.T.: P1059, P826 

Youn H.J.: P1442, P1444, P1581 

Youn J.C.: P1702 

Young J.B.: 274 

Young Q.: P670, P671 

Yousaf H.: P1660, P751 

Yousef Z.: P1572, P1731, P662 

Youssef M.A.: P1553, P799 

Yu C.H.: P1480 

Yu J.S.: P1442 

Yu S.H.E.N.G.B.: P481 

Yuksek U.M.I.T.: P1292, P873 

Yuksekdag V.: P766 

Yuksel S.: P1732 

Yun H.: P834, P986 

Yurchenko A.: P693 

Yurova E.: P1181 

Yusuf S.: P1567, P872 

Z 

Z Cabrita I.: P849 

Zacchigna S.: P1834 

Zacharis E.: P1290, P1450, P1726 

Zafar H.: P875 

Zafirovska B.: P1381 

Zafirovska P.: P1613, P1806 

Zafirovska P.Z.: P1610, P754 

Zaglia T.: 214, 394 

Zahariadi E.: P1809 

Zahidova K.: P1764 

Zahradnik I.: P1743, P1744, P1749 

Zahradnikova A.: P1749 

Zahradnikova Jr A.: P1749 

Zahran S.: P1159 

Zaja M.: P832 

Zakirov N.U.: P573 

Zamaklar D.: P677 

Zambon E.: P1469, P514 

Zamora E.: P1227, P1630, P1631, 

P1698, P624 

Zancla B.: P790 

Zaninovic Jurjevic T.: P981 

Zannad F.: P1354, P1664, P933 

Zapatero Gaviria A.: P1125 

Zaputovic L.: P981 

Zaromytidou M.: P988 

Zava D.: P1579 

Zavadovsky K.: P1278 

Zbacnik R.: P1800, P942 

Zbir E.: P752 

Zdrale Z.: P1443 

Zecchin M.: P1019, P1024 

Zekavati A.: 81 

Zembala M.: P806 

Zentilin L.: P1834 

Zeug A.: P480 

Zhadan A.: P647 

Zhan W.: P1353 

Zhan X.Z.: P1000 

Zhang D.Y.: P563 

Zhang H.: P1205 

Zhang J.: 263, P1093, P1095, 

P1199, P1252, P1267, P1414, 

P1422, P1602, P1640, P509, P519, 

P723, P749, P773, P810 

Zhang K.: 396, P473 

Zhang Q.H.: P1000 

Zhang Y.: P561 

Zhao Q.: P481 

Zharova O.: P760 

Zhebel Vadym Z.V.: P1287 

Zheleznykh E.A.: P1585, P725 

Zhelyakov E.: P1004, P575 

Zhernosechenko A.: P921 

Zhong L.: P1170, P538 

Zhu W.: P1205 

Zhuiko A.L.E.N.A.: P921 

246 

Zi M.: 395 

Ziadi J.: P679 

Zibalova T.: P1066 

Ziegelstein R.Z.: P1498 

Zielinska M.: P1741 

Zielinski T.: P1106, P1110, P1367, 

P1383 

Zikova D.S.: P1620 

Zile M.: P1295, P1739 

Zile M.R.: 269, 439, P1486, P1595 

Zimmer A.M.: 390 

Zimmermann W.H.: P1356 

Zirngast B.: P1782, P1792, P488 

Zisimos C.: P988 

Zivkovic M.: P1080, P1537 

Zizek D.: P1379, P942 

Zoghi M.: P688 

Zografos T.: P1088 

Zolotaikina V.: P616 

Zuckerman T.: P1441 

Zuckermann A.: P1825 

Zugck C.: 275 

Zupan I.: P1379, P1800 

Zurmanova J.: P1326 

Zusmam J.: P850 

Zvartau N.: P1491 

Zventsova V.K.: P1126 

Zwas D.R.: P1265, P839 

Zweiker D.: P888 

Zymlinski R.: P1405, P1419, P995

ESC Heart Failure Congress 2013 Final Programme - European ...

Create successful ePaper yourself

Delete template?

Save as template?